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Abstract 
Knowledge translation (KT) has become a ubiquitous and important component 
within the Canadian health research funding environment. Despite a large and burgeoning 
literature on the topic of KT, research on the science of KT spans a very narrow 
philosophical spectrum, with published studies almost exclusively positioned within 
positivism. Grounded in a constructionist philosophical position and influenced by actor-
network theory, this dissertation aims to contribute to the Canadian KT discussion by 
imagining new possibilities for conceptualizing KT.   
This is an empirical-theoretical study which is based on eight months of data 
collection, including interviews, participant observation, and document analysis. This data 
collection took place in a basic science laboratory, a clinic, and amongst families involved in 
genomic research pertaining to Autism Spectrum Disorder in a Canadian city. Interviews 
were transcribed verbatim and organization of the data was aided by QSR Nvivo software. 
Theoretical insights put forward in this dissertation are based on a detailed description of the 
everyday, local, micro-dynamics of knowledge translation within a particular case study of 
an autism genomics project. Through data collection I have followed the practices of a 
laboratory, clinic, and family homes through which genomic knowledge was assembled and 
re-assembled.  
Through the exploration of the practices of scientists, clinicians, and families 
involved in an autism genetics study, I examine the concepts of multiplicity, difference, and 
coordination. I argue that autism is practiced differently, through different technologies and 
assessments, in the laboratory, clinic, and home. This dissertation closes with a new 
framework for and model of the knowledge translation process called the Local Translations 
of Knowledge in Practice model. I argue that expanding the range of theoretical and 
philosophical positions attended to in KT research will contribute to a richer understanding 
of the KT process and move forward the Canadian KT agenda. Ethics approval for this 
research was obtained from The University of Western Ontario and from the hospital in 
which the data was gathered. 
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Preface 
"Ring, ring, ring!"  
I race to answer the phone at a speedy I-just-got-the-baby-sleeping pace. Hurdling a Sesame 
Street play toy I grab the phone from the charger and press talk.  
"Hello?" I say, trying not to sound out-of-breath. 
"Julia. It's Jeff. How are you doing?" 
"I'm great. How are you?" 
"Good. Is this a good time to talk?" 
"Um-hum, sure." 
"Ok great. I'm actually in the middle of a Genome Canada meeting and I had to call you. 
We're just having a 10-minute break and I stepped out of the room. There is this guy named 
Bob Lorenz [pseudonym] who just presented his current research and it's really amazing 
stuff. He's got some really interesting findings on copy number variations and autism. I just 
had to call and tell you about it…" 
 This was the beginning of a conversation that took place in the winter of 2008 which 
subsequently propelled my research in its current direction. Upon first applying to enter the 
PhD program I had tentatively proposed a research site in Montreal at a clinic providing pre-
implantation genetic diagnosis (PGD). At this point, my partner was still looking for a 
teaching position and was relatively free to move around; we also did not have any children. 
Fast-forward 18 months and we had a baby, a mortgage, and Ben had found a much-coveted 
teaching position - moving to Montreal for 8-12 months suddenly didn't seem so feasible. I 
was just returning from a maternity leave and I needed to find another research site. I was 
still interested in knowledge translation and genetic research and hoped to find some way of 
exploring the day-to-day practices or micro-dynamics of translation. I was especially 
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concerned with the narrow theoretical scope from which knowledge translation was being 
explored in the health sciences literature. I wanted to find a field site that could act as a case 
study in which to approach knowledge translation from a constructionist position, in contrast 
to the taken-for-granted positivist positions which seemed to dominate KT discussions.  I 
hoped to be able to demonstrate how knowledge translation could be approached from a 
different epistemological and methodological position in order to ignite discussion amongst 
those entrenched in positivist approaches to KT. When Jeff called, I jumped at the 
opportunity and began to explore autism genomics as a potential case study through which I 
could re-assemble KT.  
The year following this phone call from my supervisor was spent finishing my course 
work and writing my comprehensive exams. In December of 2009 my supervisor and I met 
with Dr Lorenz at his lab to talk with him about my ideas and to get a sense for how willing 
he might be to have me hanging around his laboratory for the better part of a year. Waiting 
outside his office, I remember feeling nervous. This Dr Lorenz [pseudonym] was obviously 
one of the top guys in this field. The space was beautiful, modern, state-of-the-art. An 
enormous lab filled with machines and bustling white lab coat clad bodies spanned the length 
of one side of the main hallway. Jeff told me that Dr Lorenz had previously been named one 
of Canada’s “Top 40 under 40” for scientific minds in this country. His office door opened 
and we sat down at a round table. Dr Lorenz was very friendly and low-key. He seemed 
amused or perhaps bemused that an anthropology/ health sciences student would be 
interested in his laboratory as a site that warranted ethnographic investigation. We talked for 
about fifteen minutes and by the time we left it was just a matter of doing the necessary REB 
paperwork before I could begin fieldwork as far as Dr. Lorenz was concerned. Before leaving 
his office, he also invited me to attend an annual meeting that was happening with all the 
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people involved in the autism genetics project across the country. It just so happened that this 
all-day meeting was to be held in his laboratory conference room in two days time.  
Two days later I found myself sitting in a chair pushed against a wall of a very 
crowded conference room. There were people from across Canada, both basic scientists and 
clinicians. A woman rushed in at the last minute as the doors were closing. She sat down on 
the only seat left in the room, which happened to be beside me. We went around the room 
quickly introducing ourselves and I came to realize that this woman beside me was actually 
Dr Felicia Morten [pseudonym], the director of the Autism Clinic. She was the very woman 
with whom I was hoping to talk about extending my field site into her territory. Needless to 
say, people quickly shuffled around and space was made for her at the table in the centre of 
the room. She was a major player in the Autism Genetics Project and her ability and need to 
speak at the table signified her importance. At a break for lunch I did manage to chat with her 
for about two minutes about my research and she said she would be happy to discuss it 
further with me. I ended up meeting with her again for about twenty minutes in the kitchen of 
the genetics laboratory before one of the subsequent Monday morning meetings about a 
month later. She was interested in this approach to examining knowledge translation and 
agreed to have me extend the fieldwork into the autism clinic.  
This dissertation describes some of what I have learned in the two years since these 
initial meetings.  
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  Chapter 1 
 
1.1. Finding an Entrance 
First Entrance 
I opened the London Free Press newspaper this morning and depicted on the front page was 
a photograph of a 5000 year old body found mummified in an Italian glacier. Scientists have 
just completed sequencing this man’s DNA and found him to be lactose intolerant and to 
have a predisposition for coronary problems. Strung out, letter by letter, his DNA sequence 
appears to be quite similar to that of the many human genome sequences created from 
amalgamations of people living today. The article mentions that the DNA sequence is being 
1.1. Finding an Entrance 
1.2. Research Questions 
1.3. Purpose 
1.4. Autism or ASD? 
1.5. Doing Fieldwork 
 a) Location 
 b) Timeline 
 c) Participants 
1.6. Methods 
 a) Types of Data Collected 
 b) Limitations to Data Collection 
1.7. Process of Interpretation and Representation 
1.8. Reflexivity 
1.9. Quality Criteria 
 a) Authenticity 
 b) Ethnographic Validity 
 c) Deploying Actors as Networks 
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openly shared on a website so that specialists from different disciplines can analyze it as 
there is more than a lifetime of work in analyzing this mummy’s sequence.  I only scanned the 
article briefly as I was also bouncing Eliza on my knee and eating a bagel but I need to 
follow up on it when I get a chance. I’m not sure how, but I think perhaps this article might 
provide an entrance into my dissertation. 
(JB journal entry, March 2nd, 2012) 
 
Genomic research is entering the public imagination and has been for several years. 
Popular movies (for example, Gattaca, Bladerunner), fiction (for example, Ian Douglas’s 
Inheritance Trilogy, 2009) and popular TV shows (for example, Bones, CSI, Who is my 
Baby’s Daddy?) are bringing the idea of genomics into the living rooms of many Canadians. 
Scholarly articles covering genomic findings filter through to daily newspapers, discussed 
over coffee and toast around the breakfast table. Of course, much of the genomic work 
carried out in laboratories across Canada is not on 5000 year old mummies. Within the 
purview of health research, genomics has been given the task of uncovering the secrets of 
single gene disorders such as cystic fibrosis (Kerem et al., 1989)(Riordan et al., 1989) and 
Huntington’s (Gusella et al., 1983) and is now moving on to complex polygenic conditions 
such as schizophrenia (Xu et al., 2012) and Autism Spectrum Disorder (Leblond et al., 2012).  
I like this newspaper article (Rose, 2012) on Otzi man’s genomic profile. Perhaps I am 
influenced by the summers working on archaeological digs during my undergraduate degree, 
the monotonous hours of sifting through dirt punctuated by instances of excitement in finding 
a clay pipe bowl or post-holes. The public sees the “Indiana Jones” exhilaration of finding 
amazing insights into our past. The vast majority of work that lays behind these findings 
remains eclipsed. These images conjured up out of archaeology appeal to me; they seem 
relevant to the hundreds of movements repeated over and over in the laboratory in order to 
map a genome sequence, occasionally yielding something the scientists find “interesting”.   
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Most of the work being conducted inside the genomics laboratory is beyond the view 
of the public. What really goes on in a genomics laboratory? How does this genomic research 
relate to clinical work and to individuals diagnosed with autism and their families? How is it 
translated? What if, instead of focusing on the findings, we focus on all the day-to-day work 
that lies behind them? If we keep in mind the bottles and beakers, buffers and pipettes, slides 
and chips, computers and people, the messiness of the practices in the laboratory, we might 
understand better how genomic research is constructed and how it relates and translates to the 
equally messy practices of the clinic and the family home.  
This is one way I could introduce the reader to my research, but there are other 
possibilities to consider as well. 
Second Entrance 
It is April, 2011. I have been invited by one of the senior clinicians in the clinic where 
I will be doing my research to sit in on a conference for parents of children with ASD. A 
large screen at the front of the room is showing a movie taken from a hidden camera in a 
school yard. In the movie, it is recess and the camera microphone detects a cacophony of 
children yelling and playing, seemingly enjoying themselves. There are children running 
around or just standing in groups talking. The presenter at the front of the room takes her 
laser pointer and tells us to “keep your eyes on this boy in the movie”. The boy in the movie 
is sitting alone on the side of the track and field track. He is bent over with his chin resting on 
his knees. It looks like he is holding a stick and is drawing in the dirt. Another boy comes 
toward him and kicks him, spraying dirt in his face, and then walks away. A minute later 
another boy yells at him and calls him a “loser”. The boy is wearing a hidden microphone but 
the sound is still kind of muffled amidst all the background noise. The bell rings shortly after 
and the boy slowly gets up and walks, head down, back toward the school. Another group of 
4 
 
kids approaches him and he is shoved hard. A teacher stands near-by but doesn’t seem to 
notice with the activity of rounding everybody back inside after recess. The movie ends and 
the presenter, a child psychologist, tells us that this boy is diagnosed on the autism spectrum. 
He and many other similarly diagnosed children often endure verbal and physical bullying. 
Her research has studied the school experiences of children with ASD and she wants to raise 
awareness of bullying in the education system. 
At the coffee break I talk to some of the people sitting near me. They all have 
children with autism. Their children are different ages, some toddlers, school aged, or young 
adults. Many of these parents have changed their lives, quit their jobs even, trying to cope 
with the challenges that face their children. I meet a woman who works at the autism clinic 
that I am studying for my research. She too has an adult son with autism and she has been an 
advocate for him and others like him for a long time. She explains that he is entering into a 
stage of life, adulthood, which will bring a whole new set of challenges for someone living 
with ASD.  
This is another entrance, through the lives of the people living with ASD. How is 
genomic research related to them and the activities they engage in? Many of the parents are 
keen to sign up for genetic research while others are more ambivalent, worried about what 
genetic findings might be used for in the future. How is genomic research changing the lives 
of people and families living with ASD? How does it translate into their everyday world?  
Third Entrance 
 Autism was first diagnosed by Leo Kanner in 1943 (Kanner, 1943). Since then, it has 
become entangled in and constructed through a wide variety of networks of associations, 
from psychodynamic to genetic. During the 1950’s and 1960’s a psychodynamic approach to 
autism was predominant. Through this approach autism was believed to be caused by 
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destructive interactions between a baby and his/her mother. One of the main proponents of 
this approach was Bruno Bettelheim (Bettelheim, 1967). Bettelheim believed that the causes 
of autism were environmental and could be traced back to infancy. He proposed that an 
anxious mother was unable to adapt her reactions to her baby’s cues. He suggested that 
children who were quiet and isolated in their first year of life may become autistic in their 
second year of life, upon learning to speak and walk, “when their reaching out to relations led 
to what they viewed as destructive responses. This, in my opinion, is why they gave up all 
initiative” (Bettelheim, 1967).  Thus, for Bettelheim, autism was a defence mechanism, a 
learned response to a hostile environment. He went so far as to compare the home 
environments of autistic children to concentration camps: “In the German concentration 
camps I witnessed with utter disbelief the nonreacting of certain prisoners to their most cruel 
experience…like others who have worked with autistic children, we were again and again 
confronted with a parallel blotting out of all pain”(Bettelheim, 1967).  
 In The Empty Fortress (1967), Bettelheim describes the relationship between a mother 
and her autistic child as “destructive and inescapable…because of the one single relation that 
propelled him out of a position of love and ambivalence with overwhelming force he 
became, so to say, glued to hate” (Bettelheim, 1967). Bettelheim directed an institution, The 
Sonia Shankman Orthogenic School at the University of Chicago, for the rehabilitation of 
children with emotional disturbances. Among the residents, autistic children were taken from 
their parents and placed in the School, often living there for years. Bettelheim (Bettelheim, 
1955) felt that “when a child is securely established at the School and accepts it is a reliable 
frame  of reference for his life, he becomes able to deal constructively with the experiences 
he had in a less secure world, with past failures and disappointments”. Thus, for several 
decades following Kanner’s initial description of infantile autism in 1943, Bettelheim and the 
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psychoanalytical approach prevailed, blaming so –called “refrigerator mothers” for autism.   
 Since this time, there has been a complete reversal in how autism is constructed in the 
clinic. Mothers are no longer blamed by psychologists for causing autism in their children. 
During the 1970’s, as twin studies were published, the genetic underpinnings of autism 
gained acceptance amongst the scientific community. Since this time many technological 
advancements in microbiology have changed the way that genomics is practiced. How are 
recent genomic findings in the laboratory seeping into the clinical practice of autism?  How 
is autism constructed in the clinical context? Who and what are the various actors that 
reassemble autism in the various spaces and activities of the clinic?  
Each of these entrances provides a different context from which to explore genetic 
research in autism. In setting out to do this study, I wanted to understand how genetic 
research translates within and amongst each of these contexts: the laboratory, the clinic, and 
the homes of individuals and families living with autism. I wanted to tell a story about autism 
genomics as it is assembled and reassembled in these different spaces. But how should I do 
this? How do I tell a story about the translations between these places? Stories are often 
linear affairs, with a beginning, middle, and an end. The audience is gently coaxed along a 
particular trajectory until they arrive at a conclusion. Much of the messiness, the collisions 
between voices and the branching off of alternative trajectories, is left untold.  
 In reading this dissertation, its organization might be interpreted in several different 
ways. Upon first glance, the chapters appear to conform to the standard layout. An 
introduction and background gives way to some new findings and a conclusion is reached. A 
single story is made to unfold. There are other ways of reading this, however. Each chapter is 
also its own story containing its own trajectories and voices. For example, the ways in which 
the notion of translation is registered varies amongst the chapters in the body of this 
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dissertation. In Chapter Four, translation is described as a process of transformation as I 
follow the enactment of an individual diagnosed with autism, and then blood, then DNA, 
computational outputs and graphical representations, PowerPoint slides, reports, feedback 
diagrams, scores on clinical assessments, and then back to the individual and his/ her family. 
In Chapter Five, translation in autism genomics is described as a predominantly political 
process in which human and nonhuman actors are enrolled in a network and mobilized or 
fronted by spokespeople. In Chapter Six, translation is again reassembled; here I explore the 
idea of translation as coordination amongst different enactments of reality. While each of 
these chapters is ostensibly about autism genomics, on another plane of analysis I am also 
critically engaging with the concept of knowledge translation; each of the chapters highlights 
aspects of translation (i.e., transformation, the political, coordinating multiplicity) that are 
largely absent in the KT discussions found in the Canadian health sciences literature.  
There are connections and coherences percolating amongst the chapters.  They 
interfere and interact with each other. There are philosophical and theoretical stories 
entwined within these pages as well. There are also ruptures, deep crevices that hint at the 
friction among various voices and trajectories.  A break in chapter headings might signify a 
break in the cartography of assumptions, and with it the landscape of autism genomics 
changes, multiplies. Again, on another plane of analysis, these frictions and ruptures are also 
the spaces that hold the potential for new possibilities for imagining knowledge translation. 
 In reading this dissertation this way, I hope to not only describe multiplicity and 
difference within the context of autism genomics, I also want to perform this multiplicity. 
The word I is very important here. It is my performance. Each chapter enacts another way in 
which I have come to understand autism genomics. All of the accounts are mediated and 
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performed through my own body. Some researchers include a separate section or story 
describing how the topic of study relates to them personally. I have chosen not to do that. To 
do so might risk the creation of a binary opposition between that which is personal and 
subjective and that which is impersonal and objective. Such distinctions would be 
inconsistent with the constructionist assumptions underpinning this research.  
1.2. Research Questions 
According to Eakin and Mykhalovskiy (2003) in qualitative inquiry the research 
question often "functions more as a compass than an anchor, and is sometimes not really 
known until the end of the research. The following questions are those that I have attempted 
to address in this dissertation: 
1. Within the context of recent findings about copy number variations, how is genetic 
knowledge about autism constructed through the various practices, places, and spaces 
in the laboratory? 
2. How is this genetic knowledge translated amongst the laboratory, autism clinic and 
families involved with autism genetics at Hospital X?  
Drawing on constructionist, practice theories, this research adopts the view that knowledge is 
inseparable from the practices through which phenomena are known. Knowledge does not 
merely reflect the world, but also constructs the world. Different knowledge practices 
construct different objects.  In the context of my research, it is not only knowledge about 
autism that is being constructed and translated within and amongst the laboratory, clinic and 
home, but also autism itself. Knowledge is viewed as a practice, entangled in the material 
reality of the world. Following from this assumption, several other research questions have 
emerged in this research: 
1. How is autism constructed in the laboratory, clinic and family homes involved in the 
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autism genetics research at Hospital X? 
a) Who/ what are the actors that are assembled around "autism" in the laboratory?  
b) Who/ what are the actors that are assembled around "autism" in the clinic? 
c) Who/ what are the actors that are assembled around "autism" in the home? 
2. How is "autism" coordinated/ translated throughout the Autism Genetics Study?  
a) Where are there controversies/ discrepancies in the practices of "autism" across the 
autism genome research at Hospital X? 
b) What are the strategies for coordination between scientists, clinicians, and parents of 
individuals diagnosed with autism?  
c) How is "autism" practiced in the shared/ hybrid spaces within the autism genetics 
research?  
1.3. Purpose 
  The purpose of this research is to re-conceptualize knowledge translation within the 
particular context of autism genomics, considered from a constructionist philosophical 
position and as informed by actor-network theory. It is a descriptive agenda. My hope is not 
to prescribe a set of rules or steps to follow when engaging in KT. Rather, I will explore how 
knowledge translation can be described and explored when approached from this theoretical 
and philosophical position. Description in this context is simply empirical enquiry persuasive 
to scientists as well as to participants in the study whose work it hopefully informs.  
 The need for a broader conceptualization of KT has been suggested by Greenhalgh et 
al (2004), with specific calls for more theory-driven approaches (McWilliams, 2007; Reimer 
Kirkham, Baumbusch, Schultz, & Anderson, 2007). Following these critiques, the purpose is 
to demonstrate how KT can be re-conceptualized and re-positioned within a broader range of 
theoretical and methodological approaches, which could complement (or potentially disrupt) 
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the current understanding and models of KT predominant in the health sciences literature. In 
this way, I hope to ignite a discussion about the limitations of existing orientations to KT, 
and offer an alternative approach, thereby expanding the philosophical and methodological 
breadth of the Canadian KT agenda.   
1.4. Autism or ASD? 
Throughout this dissertation I have chosen to use the word “autism” rather than Autism 
Spectrum Disorder (ASD).  ASD is a complex and heterogeneous diagnosis, a spectrum with 
an enormous range of clinical manifestations. In the practice of autism genomics, however, 
the complexity of this diagnosis is reduced. As I observed and formally and informally 
interviewed members of the laboratory, autism was referred to in a binary manner. In 
practice, the complexity of the spectrum is reduced to a binary phenomenon: individuals 
diagnosed with autism, siblings, parents, family members in an extended pedigree were 
either on or off the spectrum, diagnosed with autism or not. This is not to say that the 
complexities of diagnosis and differences and variation within the spectrum were not 
discussed and practiced within specific circumstances and locations within the clinic and 
home. However, as autism pertained to genetic testing, the complexity and diversity of the 
spectrum was reduced.  
 To some degree, this simplification and reduction of the autism spectrum is also being 
reflected in changes being made to the Diagnostic and Statistical Manual V (DSM-V), 
forthcoming in May 2013.  Particularities and sub-classifications are being reduced. This also 
reflects my experience of how clinicians and scientists talk about and think about ASD in the 
context of genetics. Participants frequently used the word “autism” to stand in for everything 
on the spectrum. In almost all of the conversations and observations I had, participants talked 
about autism in a binary way, either you have it or you do not.  
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Furthermore, my research is not focused on how autism is clinically diagnosed. 
Throughout my fieldwork I never observed a clinical diagnosis being given. The issue of 
variations and the differences within the autism spectrum are an entire other realm of 
complexity that warrants its own empirical investigation that is well beyond the scope of the 
focus of the present research.  In all cases that passed through the unit and laboratory that I 
observed, the individual already arrived with a diagnosis of ASD. Thus, if I have reduced the 
complexity of the autism spectrum to a simple binary opposition in my interpretation and 
representation it is because that is the way autism was practiced by those whom I observed 
and interviewed in the context of autism genetics. Put in another way, my use of the word 
“autism” reflects its emic construction (how it is used and practiced by the people I observed 
within the specific contexts of autism genetics), which may not reflect the formal definition 
of autism found in medical text books. For example, one clinician described autism in this 
way: 
Now, the tools that we use, you still need to use clinical judgment. Because the 
tools, like for example, you’re either on the spectrum or you’re not. But it 
doesn’t mean, sometimes you need to use your clinical judgment to determine, 
is it autism, is it Asperger’s, is it PDD-NOS, which is going to be irrelevant 
with the next DSM. So it’s going to be ASD or not. So there won’t be those 
classifications any more. It’s changing. That’s why sometimes the clinical 
diagnosis and the research diagnosis may or may not be the same. But typically 
you’re either on or not on the spectrum.  
 
Thus, there are many areas in the autism clinic in which much attention is focused on sub-
classifications within ASD.  Certainly, clinicians spend a great part of their day arriving at 
specific diagnoses within the spectrum. The clinic that became my field site was a research 
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clinic with a wide variety of research studies. Some of the projects the clinicians were 
working under were not connected to genetic research, while other studies were intimately 
tied to genetics. Throughout the day, clinicians had to shift between opening up or black-
boxing the complexity of ASD as they moved between activities that were not part of genetic 
studies and those that were. Within the specific context of autism genomics, which is the 
focus of my present research, the distinctions and particularities within the diagnosis tended 
to be re-scripted as a binary classification. Following this, I have adopted the word autism 
throughout the text. In the few spaces of my descriptions and interpretations where sub-
classifications on the spectrum are evoked, I consciously turn to using the term ASD. 
1.5. Doing Fieldwork 
a) Location 
This research took place within a hospital in a Canadian city. In order to preserve the 
anonymity of participants, all names of places and people have been altered. The hospital 
will be referred to as the Hospital. Within this hospital, data collection was carried out in an 
applied genomics laboratory and in an autism research clinic. The laboratory will be called 
Laboratory X and the clinic will be referred to as the Autism Clinic.  
b) Timeline 
Final ethics approvals from The University of Western Ontario and from the hospital 
research ethics board were granted in February of 2011. As I was on a maternity leave, data 
collection did not commence until June of 2011. Much of the data was collected throughout 
the summer months between June and September in which I tried to travel to the field sites at 
least once or twice a week. Much of the observational data was collected in this time. 
Between October and March, many of the interviews were conducted with less emphasis on 
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observational data collection.  During these months I would travel to the field site a few 
times each month. Data collection was completed in March 2012. However, following this, 
several key informants were contacted to review the written sections of my dissertation for 
feedback. I wanted to ensure that the descriptions of the activities in the laboratory and clinic, 
in particular the descriptions in Chapter 4, were being described accurately. I state this, 
however, recognizing at the same time that the descriptions are partial and contain less 
technical detail than “native” inhabitants of the laboratory or clinic would use.   
c) Participants 
Participants at Laboratory X had a variety of educational backgrounds including 
molecular biology, genetics, zoology, and bioinformatics. They represented a variety of 
positions at Laboratory X including post doctoral fellows, PhD students, project coordinators, 
laboratory technicians, facility managers, assistant directors and the director. These 
participants varied in the amount of time they had been working at the laboratory, from 
eighteen months to fifteen years. The laboratory scientists whom I recruited into this study 
were purposively sampled. In order to be able to follow DNA as it moves through the 
laboratory, I approached people who were experts at each stage of the genomic experimental 
process from DNA extraction to report writing. 
 In the autism clinic, participants included psychology PhD students, psychologists, 
developmental paediatricians, project coordinators, a parent liaison, genetics counselors, and 
clinical geneticists. The participants from the autism clinic had been working there for a 
range of one year to ten years. The clinicians who participated in this research do not 
represent a sample. They are an entire population as I interviewed and observed everyone in 
the clinic who carried out clinical work as part of the autism genomics project.  
 Parents of children with autism had all participated in genetic testing at the hospital 
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and had received feedback about the results of those genetic tests. In total, six parents 
participated in an interview, five mothers and one father. Genetic results varied for each of 
the families. While each child had been reported to have a copy number variation (CNV), the 
location of the CNV was different amongst families; different genes were affected from one 
family to another. Moreover, while five of the families received genetic feedback indicating 
the genetic variant was inherited, one family had results indicating a de novo (or spontaneous 
and non-inherited) variant. All participants were at least 18 years of age and all of them 
spoke English. When children were in the room while I was observing at the autism clinic, 
for example when I observed the Autism Diagnostic Observation Schedule (ADOS) and 
intelligence testing, parents signed consent forms on the child’s behalf. When possible, 
children signed an assent form. The parents were chosen based on a convenience sampling 
strategy in which I approached anyone whom I was aware of being given genetic feedback 
during the time I was in the field. 
1.6. Methods 
Data collection included document analysis, participant observation, and interviews 
with three groups of people: basic scientists working at Laboratory X, clinical researchers 
working through at autism clinic, and parents of children diagnosed with Autism Spectrum 
Disorder who were participants in the genetic research taking place within Laboratory X and 
the autism clinic. All of the people working or studying as part of the Laboratory and autism 
clinic were also part of the same hospital.  
a) Types of Data Collected 
i) Laboratory X 
  I conducted seventeen semi-structured interviews with eleven people at the 
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Laboratory over the course of data collection. All of the semi-structured interviews were 
digitally audio recorded and transcribed verbatim. Interviews ranged from fifteen minutes to 
over two hours, with most lasting approximately 45 minutes. I also carried out several 
informal interviews, chatting in the hallway before or after meetings or asking quick 
questions during observations. I also went down to the cafeteria with participants for lunch 
on several occasions which prompted further opportunity for discussion. None of these 
informal interviews were recorded or transcribed. Instead, I took field notes either during or 
directly after these interactions.  
Data collection also included participant observation, or “deep-hanging out”, in which 
I followed participants around and made notes on what I was observing as they went about 
their daily routines and tasks in the laboratory. I observed different kinds of meetings, 
including Monday morning meetings, laboratory meetings, and Exome sequencing meetings. 
I was able to observe laboratory experiments taking place such as PCR, microarray and Next 
Generation Sequencing (NGS). Almost every time I conducted a semi-structured interview 
with someone at the Laboratory, they walked me through the laboratory, taking me through 
the various steps in an experiment and showing me the instruments used or the various data 
print-outs produced along the way.  
Several types of documents were included in analysis, such as PowerPoint 
presentations, NGS protocol, meeting agendas and meeting minutes, as well as peer-reviewed 
publications that were either authored by Laboratory X members or discussed at meetings. 
Email was often used to announce interesting articles being published in the scientific 
literature. In addition, several of the web-sites used in the Laboratory X for genomic analysis 
were scrutinized for this research, for example, The Database of Genomic Variants 
(http://dgvbeta.tcag.ca/dgv/app/home) and the 1000 Genomes Project 
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(www.1000genomes.org). 
ii) The Autism Clinic 
I conducted nine semi-structured interviews with nine participants at the Autism 
Clinic. All of these interviews were digitally, audio recorded and transcribed verbatim. 
Interviews varied in length from 30 to 60 minutes. I also informally chatted with clinicians 
while walking to and from meetings or while eating lunch in the lunchroom. I observed 
meetings, presentations, intelligence testing, ADOS testing and assessment scoring and 
genetic feedback sessions. I also analyzed various documents, such as patient consent forms, 
PowerPoint presentations, peer-reviewed articles authored by Autism Clinic employees, and 
ADOS assessment forms.  
iii) Parents of Individuals diagnosed with Autism 
Data collection with parents included observation of genetic feedback sessions as 
well as subsequent semi-structured interviews, which were digitally audio recorded and 
transcribed verbatim. I was able to observe four feedback sessions with parents, individuals 
diagnosed with autism (called probands), and siblings. In addition, I conducted semi-
structured interviews with parents at least 2 months after they received the genetic feedback. 
These interviews were between 25 and 40 minutes in length.  Ideally, I would have liked to 
engage in participant observation within the homes of these individuals and families. 
However, in discussions with my supervisor and the director of the autism clinic, it was 
decided that this form of data collection in the home would be too intrusive and burdensome 
for families.  
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b) Limitations to Data Collection 
i) Laboratory X 
One of the biggest limitations was my ability to observe inside the laboratory. Several 
of the experiments have steps that require intense concentration for the person running the 
experiment. They cost up to twenty five thousand dollars per run and I was told, 
understandably, that certain steps would not be open to observation because of this.  As a 
result, I was reluctant to casually walk into the laboratory and observe without setting up a 
formal appointment for being there. I did not want to walk up to a participant working over a 
lab bench unannounced and inadvertently introduce error into an experiment. 
ii) Autism Clinic 
As with the laboratory, there were limitations in my ability to casually “hang-out” in 
the Autism Clinic. The area is small with most employees working in cubicles. Telephone 
conversations with parents were being conducted in these spaces and so any talking or 
informal interviewing would have been distracting for employees trying to carry out their 
daily activities. There was physically nowhere for me to stand that was out of the way as 
hallways were unusually narrow in this space. The large lunchroom was the only open space 
where I felt I was not in the way. The other problem with casually dropping in to observe at 
the autism clinic was that a locked door stood between the front waiting room and the rest of 
the clinic. On the few times I tried to drop-in to causally observe, I ended up waiting for 
hours in the waiting room before anyone realized I was there. This is because there are some 
days when there is no receptionist sitting at the waiting room sliding window. If patients are 
not booked for a morning or an afternoon on these days, there is no reason to check if anyone 
is in the waiting room. Observations, therefore, took place at pre-arranged times such as for a 
specific assessment, feedback session or meeting.  
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This limitation to accessing participants, to conducting participant observation, is 
faced by many anthropologist, but is perhaps particularly characteristic of research that 
attempts to engage relatively elite people and institutions. As Gusterson  (1997, pp., 115) has 
noted, “participant observation is a research technique that does not travel well up the social 
structure”. As such, Gusterson called for anthropologists to break with a “fetishistic 
obsession with participant observation” (Gusterson, 1997, pp., 116) and instead adopt a more 
“polymorphous engagement” of participants which entails collecting data eclectically from 
dispersed sites, and across disparate sources. Following this vein, in my own research 
participant observation was not hierarchically positioned as more valuable or insightful than 
interviews or document analysis. 
iii) Family Home 
One of the limitations of recruiting parents into my study was that there were very 
few parents receiving genetic feedback regarding ASD. In the first three months of fieldwork 
only two families received feedback and I was only able to observe one of these. (The 
research coordinator forgot to tell me about the other feedback session. So I did not know it 
had occurred until after the fact.)  Fortunately, there were a few more feedback sessions that 
occurred between November and January. Thus, while my sample of parents might appear 
small this is because the entire population from which I was recruiting was extremely small. 
Indeed, two of the parents interviewed had been given genetic feedback over a year earlier 
but had heard about my study through their ongoing involvement with the autism clinic. With 
so few families receiving genetic feedback during my fieldwork, I chose to interview these 
two mothers as well. Important to note, many of these families had been waiting for nine or 
ten years since their blood was first collected for genetic testing. It is only with recent 
technological advances that clinically significant variants are being detected. 
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Overall, the most significant limitation in my ability to collect data was the distance 
between where I live and where Laboratory X and the Autism Clinic were located. It took a 
two hour train ride as well as a subway ride or half hour walk in order to get from my house 
to my field site. As a result, I could not participate in the kind of day-to-day, deep hanging 
out that typically characterizes ethnographic field work. I also had a young, nursing infant as 
well as a toddler at home throughout this fieldwork. While there were weeks when I 
commuted back and forth every day, I typically went in only once or twice a week.  
1.7. Process of Interpretation and Representation 
In the social sciences there is only interpretation. Nothing speaks for itself.  (Denzin, 
2004) 
 
 The ongoing process of interpretation and representation consisted of a constant 
manoeuvring back and forth between books and articles I was reading and the data I was 
collecting in an effort to make sense of what I was learning in the field. All of the data I 
collected - interview transcripts, documents, participant observational field notes - were 
gathered together in QSR Nvivo 9. This software is purely an aid to organization and allowed 
me to hold together, in one place, all of the data I was amassing. From a constructionist 
standpoint the researcher is intimately involved and implicated in the interpretation of data. 
In the interpretation process relations are made between literature and data. The conceptual 
tools, the theoretical assumptions adopted by the researcher precede the doing of 
ethnography and shape what is seen in the field and written in a text (Van Maanen, 2004). At 
times it is about reading through the data with the literature in mind and at other times it is 
about reading through the literature with the data in mind.  
I found the train rides to and from the field sites to be particularly productive times, in 
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which I would reflect on the relationships between what I was reading and observing and 
hearing. My field notebook contains many jottings and bursts of insight that often raised 
further questions. These entries came to be known to me as Train Thoughts. The train ride 
was a liminal place, between the spaces in which data was collected and the formal writing 
space of my “office”. By reading back over these train thoughts I can trace the various 
trajectories of my thinking and follow which lines of inquiry were left as loose ends, 
questions unexplored, and which I ended up pursuing within this dissertation. As it is for 
many, the interpretation was done through the activity of writing (Richardson, 2004), 
whether this writing took the form of expanded field notes, jotting in Train Thoughts, or 
more formal attempts to solidify my ideas in drafts of this dissertation.  As Denzin asserted, 
“a situated, writing self structures the interactions that take place among the writer, the text, 
and the reader” (2004).  
Through interpretation, the researcher imposes an order on the world being studied. 
Denzin outlined four phases in the process of moving from the field to a written text:  sense 
making, representation, legitimation, and desire. Sense making concerns how the researcher 
moves from field notes to the actual writing process. I used the time riding on the train to 
write out descriptions of how what I had just experienced in the field related to particular 
concepts or ideas I was reading in the science studies literature. It was in these “Train 
thoughts” that I began to try out theoretical orderings on my field notes.  Representation, 
according to Denzin, deals with the issue of voice, and reflexivity as the author positions 
herself within the text. At the end of this chapter, I describe in more detail the issue of 
reflexivity. Legitimation concerns how a text makes claims for its own authority. Reliability, 
validity, and generalizability are typical hallmarks of legitimation in post-positivist texts but 
are not appropriate in constructionist texts. Verisimilitude or truth is established through 
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detailed descriptions of field experiences. Denzin stated, “authentic understanding is created 
when readers are able to live their way into an experience that has been inscribed and 
interpreted” (2004). I have dealt with this issue of legitimation in further detail in the section 
below on quality criteria. Desire pertains to the issue of making a reader enjoy a text, making 
it vital and gripping.  I have tried to make the text readable by attempting to portray vivid 
descriptions of the places and people I encountered. 
The codes I developed were not seen as inherent within or emerging out of the data 
itself but rather as signposts to the ideas and concepts about which I was reading. I interpret 
codes as a nexus between author, data, and influential literature.  I developed coding schemes 
for each of the three sub-groups (laboratory, clinic, family) within my study. I was then able 
to compare across these three coding schemes to look for similarities and differences 
amongst them. I further coded the instances and circumstances in which the actor-networks 
of these three sub-groups came together. As such, the coding scheme and the way the data 
were approached is directly related to the research questions, with three coding schemes 
focused on each of the spaces (lab, clinic, family home) as separate actor-networks and 
another coding scheme focused on the hybrid spaces in which networks became entangled. 
What I have written is a complex entanglement of field notes and memories that have been 
assembled and reassembled through the art of interpretation. The theoretical ideas presented 
in this dissertation are not new; there is nothing original in writing about post-humanist 
constructions of scientific knowledge; these concepts are borrowed from the published 
literature. My contribution is to take these ideas and to begin to relate them to another arena 
of discussion in which I have not seen these ideas surface before, that of Knowledge 
Translation (KT).   
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1.8. Reflexivity 
According to Kinsella & Whiteford (2008), reflexivity "goes beyond pragmatic 
reflection to embrace a critical dimension and to carefully interrogate the very conditions 
under which knowledge claims are accepted and constructed. Reflexivity recognizes the 
sociality of the process of knowledge generation".  With this definition in mind, science 
studies or the sociology of scientific knowledge (SSK) is synonymous with a reflexive 
endeavour; the raison d'être for this field of study is to explore how science actually works, 
its assumption and practices on the ground which contribute to the making of scientific 
knowledge.  
Lynch (2000) asserted that there are actually many different meanings and uses of 
reflexivity, depending on who is doing the reflecting, on what they are reflecting and what 
are the intended outcomes or goals of reflecting. In Lynch's words, each kind of reflexivity 
"involves some sort of recursive turning back, but what does the turning, how it turns, and 
with what implications differs…" (2000). 
Reflexivity is utilized by Latour (1988) to indicate "any text that takes into account its 
own production and which, by doing so, claims to undo the deleterious effects upon its 
readers of being believed too little or too much" (Latour, 1988). Infra-reflexivity, supposes 
that no amount of layering of self-consciousness will ever bring a text closer to a referent. 
For Latour, infra-reflexivity is a process of "displaying the knower and the known and the 
work needed to interrupt or create connections between them" (1988). Since any account is 
always a story, Latour proposes that we add as many genres and styles of narration as 
possible. He stated (1988) "the reflexive character of our domain will be recognized in the 
future by the multiplicity of genres, not by the tedious presence of 'reflective loops'". In this 
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way, the knower or the writer is pushed off stage and the spot light is turned once again to 
things in themselves.  
According to Latour the Actor-Network Theory (ANT) account "has to be able to 
register differences, to absorb multiplicity…" (Latour, 2005), much the same way that 
Woolgar calls for sustained uncertainty and the juxtaposition of multiple interpretations.    
The text itself is a mediator in ANT. Here, then, more recently Latour has recounted his 
claim that all we can do is write stories. He laments the claim that just because there is no 
absolute Text, all texts are relative. Instead, he contends that "textual accounts are the social 
scientist's laboratory and if laboratory practice is any guide, it's because of the artificial 
nature of the place that objectivity might be achieved…" (2005). The artificial and the 
objective, truth and fiction are not set in opposition to one another but instead are intimately 
mixed together. Latour continues by stating: 
 A good text is never an unmediated portrait of what it describes - nor for that 
matter is a portrait. It is always part of an artificial experiment to replicate and 
emphasize the traces…The simple act of recording anything on paper is already 
an immense transformation that requires as much skill and just as much artifice 
as painting a landscape or setting up some elaborate biochemical reaction 
(2005). 
As described previously in this chapter, this dissertation attempts to perform 
multiplicity, to register differences in the ways that I experienced, approached, and 
interpreted the activities I encountered during field work. I have tried to keep myself, as 
author, in focus, to show how I was entangled in the activities amongst the different spaces I 
entered.  My feelings, anxieties, naivety break through the surface of various descriptions and 
interject, in an italic font, another voice. My body, clumsy and unfamiliar with the 
choreographed rhythms and movements of the laboratory or the clinic, offered another 
vehicle from which to register and compare the practices in these different spaces. As such, 
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data was not only gathered through listening or observing but also through my body as a 
physical object that had to squeeze between, hover around, had to become partially 
disciplined in the fashion of these various spaces so as not to bump into temperamental 
machines, for example. I had to learn when I could ask questions and when I needed to 
remain silent. Thus, as will be explored in the following chapter, knowledge production was 
experienced as a fleshy, corporeal event rather than a mental bi-product. From this 
perspective, knowing becomes a practice, an activity intimately tied to the material world. 
Reflexivity, then, is about keeping those connections and ties in focus and refusing to allow 
insights to be black-boxed and severed from the bodies, machines, feelings, and tools through 
which they are constructed.  
I can not claim to offer the story of autism genomics. This is because the interactions 
and activities I observed cannot be reduced to a single story. Moreover, the observations and 
conversations I entered into were confined to a single year and doubtless some of the actors 
have changed already. It is not a story about what autism genomics is, but instead, I aim to 
tell a story about the tensions and differences in the way that autism genomics is becoming. It 
is a story of the doing of autism genomics.   
1.9. Quality Criteria 
 
The whole point of 'evoking' rather than representing is that it frees ethnography 
from mimesis and the inappropriate mode of scientific rhetoric that entails 
'objects', 'facts', 'descriptions', 'inductions', 'generalizations', 'verification', 
'experiment', 'truth' and like concepts that, except as empty invocations, have no 
parallels either in the experience of ethnographic fieldwork or in the writing of 
ethnographies. 
 (Geertz, 1988, p. 136)  
 
How does one assess the quality of research? What are the standards or criteria for discerning 
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a high-quality versus a low-quality text? As will be described further in the following chapter 
on Philosophical Background, I argue that actor-network theory is a methodological 
approach very much akin to ethnography. As such, I put forward two key criteria for 
assessing the quality of research, which are typically associated with ethnographic works. 
These two criteria are authenticity and ethnographic validity. In addition, I propose an ANT-
centred quality criteria, that of deploying actors as networks. 
a) Authenticity 
Ethnography is about trying to "persuade readers….that what they are reading is an 
authentic account by someone personally acquainted with how life proceeds in some place, at 
some time, among some group" (Geertz, 1988). The quality or 'author'ity of an ethnographic 
text rests in its claim to authenticity. The ethnographic text must persuade the reader that "I 
was there". This can be done in different ways. Geertz is often quoted for his example of 
thick description (2001). Similarly, Atkinson describes the rhetorical device called 
hypotyposis as a key means of establishing a narrative contract. Hypotyposis is: 
the use of a highly graphic passage of descriptive writing, which portrays a 
scene or action in a vivid and arresting manner. It is used to conjure up the 
setting and its actors, and to 'place' the implied reader as the first-hand witness 
(P. Atkinson, 2001, p.98).   
 
Thus, one criterion for a good ethnographic account is authenticity - the ability to persuade 
the reader that "I was there". 
 Chapter four is a detailed account of the activities that I observed in the various 
spaces of the laboratory, clinic and family home. I have tried to leave the reader with my 
sense of what these spaces are like and what it is that people do in these spaces. There are, 
without doubt, huge gaps in my understanding of what is going on in these spaces. My 
interpretations of the practices that occurred as DNA passed through these spaces are based 
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on my understanding as someone who is not a genetic scientist, not a clinician, and not a 
parent of a child with autism. Many of the complexities and details with which insiders might 
be grappling in their daily work remain beyond my understanding. And yet, with the 
fundamental, basic insights that were shared with me in each of these spaces I am able to 
offer descriptions which begin to open up the complexity of translation. 
b) Ethnographic Validity 
 The issue of validity is one discussed amongst post-structuralist social scientists with 
much ferment (Lather, 1993).  The positivist definition of validity rests on a correspondence 
model of truth. This view of validity does not resonate well with a research project 
underscoring ontological multiplicity and non-coherence. Instead, validity must be 
repositioned as “multiple, partial, and endlessly deferred” (Lather, 1993, p.675). Richardson 
(1993), for example, describes a “transgressive validity” using poetry to “make visible both 
context and labour” (Richardson, 1993, p.696). Validity, then, involves illustrating the 
process through which a researcher comes to construct a particular representation.  
According to Sanjek (1990) there are three canons on which ethnographic validity rests: 
theoretical candour, the ethnographer's path, and field note evidence. These all point to a 
reflexive stance in which the researcher engages with the process of constructing a textual 
account of the field site(s).  
i) Theoretical Candour - A good ethnographic account will discuss how theory 
guides the process of fieldwork. The ethnographer cannot attend to everything at once while 
in the field. The ethnographer makes choices about what he/she attends to and these choices 
are guided by theory. In order to establish validity, an ethnography must be explicit about the 
theoretical reasoning behind these choices (Sanjeck, 1990).  
 In my research, I am interested in how autism is practiced and translated through the 
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assembling together of human and nonhuman actors in the laboratory, clinic and home 
settings. Thus, participant observation is integral to my research. Semi-structured interviews 
alone would not allow me to describe the mundane day-to-day practices of autism in the 
laboratory and clinical contexts.  In my research, practice theory has implications for my 
choice of data collection methods. The interpretation and representation of the data that I 
have presented is also influenced by several theoretical concepts such as multiplicity and 
difference.  
ii) The Ethnographer's Path - Ethnographic validity, according to Sanjek 
(1990), is also established by a detailed account of how the ethnographer was introduced to 
various people and contexts. The ethnographer's path is a kind of road-map to the fieldwork 
process, allowing the reader to follow along from point of first contact through to exiting 
fieldwork. The path brings the reader along, exploring how the ethnographer became 
connected to the people and places explored in fieldwork.  
iii) Field note Evidence - The third canon of ethnographic validity requires the 
ethnographer to be explicit about the relationship between the field notes and the written text.  
Like the Ethnographer's Path, the issue of field note evidence is concerned with explicitly 
stating how the notes of the field inform the final text. This third canon might also draw on 
what Ottenberg called 'headnotes': "the notes in my mind, the memories of my field research" 
(Ottenberg, 1990, p.144). As Sanjek explained,  
[W]e come back from the field with fieldnotes and headnotes. The fieldnotes stay 
the same, written down on paper, but the headnotes continue to evolve and change 
as they did during the time in the field…the headnotes are more important. Only 
after the anthropologist is dead are the fieldnotes primary (1990, p.93). 
 
Ethnographic validity, according to Sanjek, requires that the ethnographer reflect on this 
process of how hundreds of pages of hurried scratches jotted in the field amount to the 
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chosen impressions and examples unfolded in a text.  
In this dissertation, the various chapters draw from different experiences and 
interpretations of field work. For example, the story that unfolds in chapter four in which I 
map out and follow the route of genetic information as it is translated amongst laboratory, 
clinic and home is one way of ordering my fieldwork experiences. However, chapters five 
and six draw on particular theoretical concepts such as Callon’s (1986) notion of translation, 
Mol’s (2003) idea of multiplicity, and Law’s notion of coordination. Thus, each of these 
chapters pulls out different experiences, allowing me to present different ways of assembling 
or ordering the data. 
c) Deploying Actors as Networks  
A good ANT account will deploy actors as networks (Latour, 2005). This means that the 
account must follow the translations and transformations of actors as they move in and out of 
various networks. An actor and the networks through which actors become associated are not 
conveyed as rigidly bounded or stable but rather are imagined as moving, changing, and in 
flux. Heterogeneity and complexity proliferate as the ANT account re-constructs the 
pathways through which actors move, subverting certainties about what any actor is. In my 
own research, I have attempted to trace the transformations of actors as they move through 
the networks of laboratory, clinic and family home in the context of autism genomics.  
 
In the next chapter, I unfold the intricate layers of philosophical assumptions which have 
guided data collection, interpretation, and representation.  
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Chapter 2 
Groundwork: Philosophical Footings 
 
"It is not a matter of looking harder or more closely, but of seeing what frames our seeing" 
(Lather, 1993, pp. 693).  
 
2.1. First Layer: Theoretical Position 
 a) Theories of Practice 
2.2. Second Layer: Methodology 
 a) Actor-Network Theory (ANT) 
 b) Criticisms of ANT 
 c) How does ANT as a Methodology relate to Ethnography? 
2.3. Third Layer: Epistemological Mooring 
 a) Constructionism 
 b) Epistemology or Ontologies?: Practiced Knowledge, Practiced Realities 
 c) Both Constructed and Real 
2.4. Relating my Philosophical Position to Knowledge Translation 
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Plate 2.1: Situated Author 
 
In this chapter I will attempt to position myself and make explicit the assumptions 
underpinning each stage of this research. These assumptions have informed the questions I 
have asked, the methods for data collection, the theories influencing the analysis of the data, 
and the way I have performed and presented the research in this written text. In this chapter I 
have organized these assumptions into three layers. To be sure, there are issues and debates 
which cut down through these philosophical strata, at times overlapping and folding these 
layers like the convoluted striations on a mountain rock face. As I work down through these 
philosophical layers in this chapter, these percolating issues and debates will be followed and 
mapped out as well.  
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Plate 2.2: Rock Strata 
The top strata I will address are theoretical. Theories of practice have influenced this 
research. If we dig down a little deeper, we find the second layer, which is methodological. 
Although the word theory is embedded within Actor-Network Theory, I argue that this is 
actually a methodological stance. I will also discuss how this research relates to another 
methodological approach, that of ethnography. I argue that ANT and ethnography are 
overlapping methodologies.  Finally, digging further, we find the third layer, which is 
epistemological. A description of the epistemological position I have adopted, 
constructionism, reveals assumptions about knowledge and the relationship between the 
knower and that which is known, subject and object.  
2.1. First Layer: Theoretical Position 
 
32 
 
2.1a Theories of Practice 
Practice theories are a heterogeneous response to structural determinist theories 
(Ortner, 2006). Ortner (2006), for example, traced the history of practice theories and 
described how practice theory emerged as an alternative to three major paradigms (symbolic 
anthropology, Marxist political economy, and French structuralism) which were all 
essentially theories of constraint. Through these three paradigms human behaviour was seen 
as shaped by external cultural forces. Practice theory, as it emerged in the late 1970’s and 
early 1980’s sought to explore the processes that produce these cultural constraints. Early 
practice theorists attempted to define a “dialectical, rather than oppositional relationship 
between the structural constraints of society and culture on the one hand and the practices of 
the social actors on the other” (2006). Ortner described practice theory as evolving over the 
last few decades, addressing the issue of power and the situatedness of practices in a 
historical context.  Furthermore, the concept of culture is reworked through practice theory 
(Ortner, 1999). Culture is “loosened up” and tied less to geographically defined groups of 
people, acquiring a geographic and temporal mobility. 
There is no single, unified approach underlying practice theory.  However, while 
there are important distinctions between various theories of practice, at the core these 
theories all insist that human action is both constrained by a social or cultural order and that 
human action makes, reproduces, and transforms that socio-cultural order (Ortner, 1996). As 
such, practice theories tend to reject the dichotomy between macro and micro, structure and 
individual, instead reformulating these positions as mutually constituting one another through 
practice. It is through practice that dichotomies between subject and object, micro and macro 
might be described as being mangled (Pickering, 1995). It is through the central issue of 
agency that some of these dichotomies will be explored in this section.   
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Before delving into these issues and distinctions within practice theories, I first 
consider what is meant by practice. According to Schatzki (2001), “practices are arrays of 
human activity”. These activities are embodied and materially mediated. The embodied 
nature of practice is crucial as it is the body that is assumed to be the meeting place, the point 
of connection between the individual and the social, the micro and the macro. The material 
nature of practices is taken up by some more than others. In particular, Latour and those who 
engage with actor-network theory are especially concerned with a focus on non-humans in 
the study of practices. Most practice theorists also approach practice as shared, collective 
actions. A distinct social ontology has arisen in which practice theories approach the social as 
“a field of embodied, materially interwoven practices centrally organized around shared 
practical understandings” (Schatzki, 2001). The social then, can be understood by exploring 
how humans (and non-humans) interact with one another through shared practice.  Barnes 
(2001) stressed that practice theories are not compatible with individualism, noting how 
humans “cannot be understood as independent calculative social agents, they stand revealed 
in their practice as profoundly interdependent, mutually susceptible social agents”.  Thus, 
practice theories aim to show both how the social influences individuals and how individuals, 
through practice, make the social.  
i) Where does agency lie?  
Pickering (2001) outlined how agency is situated in a post-humanist theory of 
practice. Distinct from most social theory in which key concepts revolve around humans, a 
post-humanist position “recognizes from the start that the contours of material and human 
agency reciprocally constitute one another” (A. Pickering, 2001).  In The Mangle of Practice 
(1995), Pickering sets out to describe how science is practiced in real-time. Rather than 
exploring how science represents nature, Pickering prefers to adopt a performative idiom. He 
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starts from the position that the world is constantly doing things; it is filled with agency. 
Science is a means of coping with this agency. Scientists, as human agents, build machines to 
“capture, seduce, download, recruit, enrol, or materialize that agency, tamping and 
domesticating it, putting it at our service” (1995). Through examples from old and new 
particle physics, Pickering describes the reciprocal process of “tuning” between human and 
non-human agency. He further describes this process as a “dance of agency”, which is 
elucidated in this quote: 
Scientists tentatively construct some new machine. They then adopt a passive 
role, monitoring the performance of the machine to see whatever capture of 
material agency it might effect. Symmetrically, this period of human 
passivity is the period in which material agency actively manifests itself. 
Does the machine perform as intended? Has an intended capture of agency 
been effected?  Typically the answer is no, in which case the response is 
another reversal of roles: human agency is once more active in a revision of 
modelling vectors, followed by another bout of human passivity and material 
performance” (1995).  
 
This dance between agencies is a dialectic of resistance and accommodation. The world 
initially resists some human attempt to capture it and in turn humans accommodate this 
material agency and modify their instruments and machines. It is through this dialectic, this 
constant shifting back and forth between human and material agency, that Pickering’s post-
humanist position on agency emerges. This dialectic which he calls the mangle of practice, 
attempts to keep in view simultaneously human and non-human agency. In this post-
humanist space human and material agency are intertwined and reciprocally defined. This 
post-humanist space is one in which “the human actors are still there but now inextricably 
entangled with the nonhuman, no longer the centre of the action and calling all the shots” 
(1995). 
Knorr-Cetina (2001) has further elucidated the post-humanist position in the context 
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of epistemic practices. According to Knorr-Cetina, epistemic practices are based on a form of 
relationship, a relationship between subjects and objects. Scientific objects, objects of 
knowledge are those things that are at the centre of investigation, that are in the process of 
being defined through research. They “are characteristically open, question-generating and 
complex. They are processes and projections rather than definitive things” (Knorr-Cetina, 
2001). In this way, knowledge objects are different from objects that we encounter in 
everyday life, such as tools or goods that can be characterized as a closed box. Conversely 
knowledge objects are characterized by their lack of completeness as they are in the process 
of being materially defined. She describes epistemic objects as having an “unfolding 
ontology” which highlights changes in these objects over time. She states that inquiry tends 
to increase rather than reduce complexity of knowledge objects.  
Moreover, epistemic objects often exist in a variety of forms simultaneously. For 
example, in her field of high-energy physics, Knorr-Cetina notes how the detector 
“continually circulates through a collaborating community of physicists in the form of partial 
simulations and calculations, technical design drawings, artistic renderings, photographs, test 
materials, prototypes, transparencies, written and verbal reports” (Knorr-Cetina, 2001).  
Knorr-Cetina approaches epistemic practices as a type of relationship between subject 
and object. When epistemic objects are in the process of being materially defined scientists 
attempt to capture the object, to represent it. Through initial experiments an object is partially 
defined and the representations often imply what is still missing, suggesting directions from 
which to approach the object in future. Knorr-Cetina describes this desire to capture the 
object as a “chain-of-wanting”. This structure of wanting between the scientist and the 
epistemic object offers a view of practice that is embedded in relational dynamics. Through 
practice objects and scientists are mutually engaged: “objects provide for the chain of 
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wanting through the signs they give off and what they still lack and scientists (subjects) 
provide for the possibility of the unfolding of the objects through experiment. In this way, 
practice is oriented toward the future as the nature of an epistemic object unfolds through the 
successive attempts of experts to pin it down. Knorr-Cetina points to the emotions, the 
excitement and pleasure, involved in epistemic practice through which subject and object are 
mutually engaged.  
The issue of how agency emerges in this dichotomy between individual actors and 
over-arching structure is addressed by Latour more recently through the idea of scripts 
(Latour, 2012). Individual actors are involved in several competing scripts simultaneously. 
At times our actions are guided by scripts and at other times we write those scripts. At time 
we live under the script; here the script delegates instructions to us to be carried out. At other 
times we live above the script and as such we insert instructions into the script. Latour 
proposes, however, that we are “never simultaneously but always sequentially fabricators and 
fabricated, and we shift roles at specific deadlines that are themselves scripted” (2012). The 
individual-structure dichotomy is made more complex here as Latour interrogates the 
concept of the individual, instead highlighting the possibility for a single actor to take the 
form of many characters inscribed into different, and often contradictory, scripts. The 
structure is nothing more than what is written in these various scripts. The relations between 
individual and structure are registered through flip-flopping below and above the scripts over 
time. 
In this research, I have adopted a theoretical position based on practice theories. In 
particular, I have been influenced by post-humanist theories of practice, which acknowledge 
the agency of both humans and nonhumans in the activities of science. This dissertation 
adopts the position that individuals make the social and that the social influences and 
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constrains individuals. Thus, practice theories enable one to simultaneously focus on 
divergent ends of the individual-social and subject-object dichotomies. As will be explored 
more fully in the discussion of methodology and epistemology, this bi-focal perspective is 
achieved by foregrounding nonhuman actors. While practice theories ideally illustrate both 
how the social constrains the individual and how individuals make up the social, this research 
has focused on the latter. The methodological approach found within actor-network theory, 
explored below, details why only one half of the practice theory agenda has been dealt with 
in this research, as the social (or cultural) is viewed as a category that needs to be explained 
rather than one that is used to explain other things.  
2.2. Second Layer: Methodology  
2.2a Actor-Network Theory 
Methodology denotes how the would-be knower, the researcher, can go about finding 
out whatever he or she believes can be known (Guba & Lincoln, 2004).  As Crotty (1998) 
explained, methodology is “the strategy, plan of action, process or design lying behind the 
choice and use of particular methods and linking the choice and use of methods to the desired 
outcomes.” Actor-Network Theory (ANT), I argue, can be considered a methodology, one 
that shares similarities with ethnography.  ANT surfaced in the 1980’s in the field of the 
social studies of science. It was initially put forward by Bruno Latour. Law (1999) has 
described ANT as the semiotics of materiality or relational materiality; “It takes the semiotic 
insight, that of the relationality of entities, the notion that they are produced in relations, and 
applies this ruthlessly to all materials – and not simply to those that are linguistic” (1999). 
Further, ANT proposes that these relations between materials are not inherent by themselves 
but that these relations have to be performed. It is through semiotic materiality and 
performativity that ANT becomes a methodology informing how researchers approach a 
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research question and the desired outcomes of research.  
In this section I will outline some of the main components of ANT: actors, networks, 
and the tension between actors and networks. I will discuss how this methodology informs 
one’s plan for carrying out investigations and the intended outcomes of using this 
methodology.  I will also briefly address one of the key criticisms levied against ANT 
regarding its ability to address issues of power and politics. Finally, I will briefly address 
how an ANT methodology might be described as overlapping with ethnography. 
i) Actors 
 Anything that modifies a state of affairs is an actor. In actor-network theory, the 
activity of acting is spread widely; it is not only humans that act. For example, in the context 
of genetic research on "autism", actors might include equipment, tools, tests, statistics, print-
outs, journal articles, blood samples, and granting agencies along with technicians, 
administrative personnel, and scientists. Each of these could be considered a potential actor 
depending if and how they are drawn into controversies. Thus, ANT studies often describe 
both human and non-human actors as they are entangled with one another.  Instead of 
assuming objects are passive, ANT focuses on how the material world pushes back on people 
(Latour, 1992). This is not to suggest that ANT confers intentionality to non-living objects, 
but rather that action loses any humanistic assumptions. Nonhuman actors can be anything 
that forces others to do something. For example, the flashing or beeping seatbelt signal that 
warns a driver to put on his/ her seatbelt when starting a car could be a nonhuman actor (B. 
Latour, 1992). The same language of agency is used to describe objects on either side of the 
traditional dichotomy between things that belong to nature and things that belong to society. 
This is arguably one of the most defining characteristics of ANT - the inclusion of non-
human actors.  
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 Latour wrote about the "underdetermination of action…the uncertainties and 
controversies about who and what is acting when 'we' act” (2005). Just as an actor on a stage 
in a theatre is never alone (there are props, backstage crew, lighting, audience reactions, a 
script, a playwright…the list could go on), the word “actor” in actor-network theory indicates 
a dislocation of action. Latour suggested that we should "remain puzzled by the identity of 
participants in any course of action" (2005) instead of deciding too quickly who and what is 
doing the acting. Latour has described ANT as "a very crude method to learn from the actors 
without imposing on them an a priori definition of their world-building capacities" (1999b). 
It is in this sense that ANT can be approached as a methodology rather than a theory. As 
Latour stated, it is “simply a way for the social scientists to access sites, a method and not a 
theory, a way to travel from one spot to the next” (1999b).  
 ANTs approach to studying non-human actors is not without its critics. There have 
been several arguments and discussions within the field of science studies addressing this 
inclusive definition of the "actor". For example, Yearly and Collins (1992) questioned how, 
as humans, we can speak for non-human agents who cannot speak for themselves. They 
chastised Latour for what they called his "absence of methodological control over fantasy" 
(1992). Moreover, they were concerned about the essentialist implications of taking non-
human actors too far: 
If non-humans are actants, then we need a way of determining their power. 
This is the business of scientists and technologists; it takes us directly back to 
the scientists' conventional and prosaic accounts of the world from which we 
escaped in the early 1970s (Yearly & Collins, 1992). 
 
Thus, Yearly and Collins, along with Bloor (1999) and those in the Edinburgh school, 
prefer to adopt a humanist approach. Jensen recapitulated Yearly and Collins's position and 
stated: 
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On the one hand the epistemological realist position of science is granted, but 
it is then doubled by the position of the sociologist who is able to really point 
to how realism is the result of the open and negotiable work of scientists (but 
notably not the open and negotiable work of natural entities) (Jensen, 2004, p. 
239).  
 
Thus, for Yearly and Collins it is the sociologists who are really able to provide an 
account of science and how it works.  
 Latour's aims are different, choosing to trace the networks between human and non-
human actors, all of whom have agency. Similarly, Pickering (1995) has portrayed the 
practice of science as a "mangle" in which "the dance of agency…takes the form of a 
dialectic of resistance and accommodation" (1995). He elaborated on his concept of the 
mangle by noting that from this perspective science is seen as an "evolving field of human 
and material agencies reciprocally engaged in a play of resistance and accommodation in 
which the former seeks to capture the latter" (1995). Thus, contrary to the Edinburgh school 
which, for the most part, obfuscated the role of non-human agency in science, Pickering and 
Latour call for a gaze that captures both human and non-human agency simultaneously.  
Actors become Black-Boxed 
 One of the difficulties with following actors is that many actors quickly become 
black-boxed once a controversy is resolved or an innovation is taken for granted. Black 
boxing is a process in which an idea/ knowledge is rendered "distinct from the circumstances 
of its creation" (B. Latour & Woolgar, 1986). This process of black-boxing is also referred to 
in the ANT literature as 'punctualization' (Akrich, 1992). As an example, we might say that 
the double-helix model of DNA is a black box. It is taken for granted. All the actors - 
discussions, models, alternative hypotheses, people, tools, and tests - that were part of the 
context in which the double-helix model was developed have dropped from the description. 
DNA is a double helix: order is created out of disorder.  In other words, as a network 
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becomes stronger and more stable a network can be treated as a point or a node rather than a 
network.  
 When phenomena are black-boxed it is tricky for the ANT analyst to unpack those 
boxes and recover all the important actors. In this light, Latour (2005) has offered a few 
suggestions on how to attune oneself to situations in which actors are more likely to become 
visible. For example, one suggestion is to study innovations (e.g., the scientists' laboratory), 
where objects are not yet taken for granted and are made visible through meetings, plans, 
sketches, and regulations. A second setting in which actors become more visible is in 
accidents or breakdowns. At these times, objects that were a moment before taken-for-
granted, automatic, and invisible are suddenly scrutinized and quickly made visible.  
 In my research on knowledge translation in the context of autism genomics I have 
adopted this approach. Autism as a genomic object is still in the process of being constructed 
and in this sense its construction is visible. It has not yet become black-boxed, allowing me 
to trace how it is assembled in the networks of the laboratory, clinic, and family home.  
ii) Networks 
"…[T]he elements bound together in a network (including people) are 
constituted and shaped by their involvement with each other" (Lee & Brown, 
1994, p. 775). 
 
In ANT, the actor is not explored in isolation. Rather, actors act in relation to other 
actors within a network. The word network in ANT has a very specific meaning that was 
intended to convey two key attributes: instability and transformation. Deleuzian concepts 
such as the “fold” and the “rhizome” underpin the ANT notion of the network (Jensen & 
Rodje, 2010). "Network" is a common-place word today and has lost the meaning that was 
intended when actor-network theory was first named. Specifically, Latour explained: 
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At the time, the word network, like Deleuze's and Guattari's term rhizome, 
clearly meant a series of transformations - translations, transductions - which 
could not be captured by any of the traditional terms of social theory. With 
the new popularization of the word network, it now means transport without 
deformation, an instantaneous, unmediated access to every piece of 
information. That is exactly the opposite of what we meant" (Latour, 1999b). 
 
 Latour (2005) described "double-click" information which is associated with the 
internet. Double-click information travels from one user to another without change; inputs 
and outputs are the same. Unlike a network of highways which is stable and transports 
vehicles from one place to another without any change, in ANT, actors are modified by their 
involvement within a network. The second characteristic of networks in ANT is that they are 
unstable and ambiguous. Actors can have multiple ties to many networks simultaneously 
(Singleton & Michael, 1993).  If actors leave a network it will change or even fail altogether.  
 The work by Williams-Jones and Graham (2003) on genetic testing demonstrates two 
of the key attributes of the ANT network - transformation and instability. Williams-Jones and 
Graham (2003) demonstrated the ambiguity and instability of networks over time, 
underscoring the work needed to maintain the enrolment of actors. The network, in ANT, 
does not have to be composed in a certain way; it could always be different; networks may 
fail and fall apart. These authors mapped the networks of 'BRCA-testing' which included 
actors such as technicians, geneticists, counsellors, patients, families, reagents, sequencers, 
laboratories, corporate interests, and stockholders. For a time, Myriad Genetics was able to 
hold together one version of the BRCA-test network; key actors such as the British Columbia 
government were enrolled. For example, public testing was halted through cease and desist 
letters as the British Columbia provincial government laboratories stopped providing public 
testing, instead referring patients to Myriad. However, in 2003, after a period of two years, 
the B.C. government reversed its position on gene patenting and resumed 'in-house' testing. 
43 
 
Thus, the network that Myriad had attempted to stabilize eventually broke down and changed 
as key actors left to join other networks.   
 In the example above, the two key characteristics of the network in ANT are 
apparent. First, the network is unstable. The BRCA-test network that Myriad Genetics 
attempted to hold together eventually broke down and changed altogether when the B.C. 
government bypassed the pharmaceutical company. The transformative nature of networks is 
also emphasized; for example, a genetic test is modified into a commercial resource in the 
Myriad network.   
Networks and the Research Analyst 
 Networks do not just apply to the human and non-human actors brought together by 
the members of the groups we study. Consider Strathern's statement that the "theorists’ 
interpretations are as much networks as any other combination of elements" (1996). In an 
ANT account, the analyst has been typically situated outside the network being described 
(Schwartz Cowan, 1987). This warrants further consideration. How do the networks of the 
analyst and the networks of the field site interact in the written account? How does the 
analyst situate him/herself in relation to the networks being traced? Law (2000) explored this 
issue directly. He contended that there are many different ways of ordering what we describe 
in our fieldwork, with different aspects of the personal being drawn into the stories we tell. 
He urges researchers to consider what he calls "narrative interference", to pay attention to 
how we are performing the stories we tell about our research site. Attending to our bodies as 
a site for ordering, in particular at times when different orderings cannot be aligned into a 
coordinated, singular story, we "become sensitive to the multiplicities of the world" (Law, 
2000). As there are multiple ways in which the networks we study can assemble and change, 
so too can the network within which our account is situated. Thus, Law seems to suggest that 
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just as actors influence and are influenced by the other actors in a network, so too is the 
author/ researcher. We too become de-centred, located in different subject positions as we 
relate to different objects.   
 In other words, in ANT the analyst may be thought of as a network builder among 
network builders. Latour has stated, "the text, in our discipline, is not a story, not a nice story. 
Rather, it's the functional equivalent of a laboratory. It's a place for trials, experiments, and 
simulations" (B. Latour, 2005, p. 149). Here, Latour reframed Law's idea of performing 
narratives (2000); to Latour we are like scientists in a laboratory when we write. Considering 
Laboratory Life (B. Latour & Woolgar, 1986), by invoking a laboratory he implies that we 
very active in ordering our world(s).  
 One of the difficult decisions when adopting an ANT approach is in knowing when a 
network has been fully traced. How do we stop the network-tracing activity and declare data 
gathering and analysis to be finished? Strathern (1996) asked how to "cut" the network. She 
stated:  
the power of such analytical networks is also their problem: theoretically they 
are without limit…one can always discover networks within networks; this is 
the fractal logic that renders any length a multiple of other lengths, or a link in 
a chain of further links. Yet analysis, like interpretation, must have a point; it 
must be enacted as a stopping place (Strathern, 1996). 
 
Doubtless, there are probably many network-cutting possibilities. Ownership is one example 
offered by Starthern: "…[B]elonging divides and property disowns. So where technology 
might enlarge networks, proprietorship can be guaranteed to cut them down to size" (1996).  
She considers the example of an invention; the academic article outlining the invention may 
include 50 names, while the patent contains only six. The network is quickly cut and 
boundaries are inscribed through ownership. Thus ownership and authorship are one means 
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of truncating a network.  Others have suggested "promoting incompleteness and ambiguity 
[are] positive aspects of a theoretical strategy (Neyland, 2006, p. 43). Interpretation could be 
treated as a multiple, disputable, ongoing, fluid affair.  Moreover, the length of the 
dissertation also dictates when the network is cut. Latour stated, "you stop when you have 
written your 50, 000 words" (Latour, 2005, p. 148). Elsewhere, Akrich and Latour have 
commented, "It is never clear where the 'real' limits of a setting are even though it has 
inscribed precise walls to itself - a book does not end with the word 'end'" (Akrich & Latour, 
1992, p. 261). Perhaps the question to be concerned with is not where and how the network is 
cut but how the connections are traced within the part of the network explored. The text 
either does or does not capture the movement, activity, and translations in the actor-network 
being studied.  
iii) Holding onto the Tensions in the "Actor-Network"   
 
 Micro-macro, local-global, individual-collective: there are many possible 
dichotomous positions that could be held in the space-holder of the "actor-network".  The 
hyphen between actor and network in ANT implies that these two terms are brought into 
relation with one another. Law (1999, p.1) has described the actor-network as an 
"intentionally oxymoronic term".  
 This is perhaps the source of much confusion about just where an ANT approach is 
situated. According to Latour (2005), one of the main difficulties with these dichotomies is 
that they imply a change of scale. He described the tendency of social scientists to explain 
the local by jumping up to "social context", "frameworks" or "structure" and then later 
swinging back down to the individual setting.  For Latour, the question is "to decide whether 
the actor is 'in' a system of if the system is made up 'of' interacting actors" (B. Latour, 2005, 
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p. 169). In ANT, one is not led away from the local; the macro/ global/ collective are 
described by focusing on the interconnections between many local sites. "Macro no longer 
describes a wider or a larger site in which the micro would be embedded like some Russian 
Matryoshka doll, but another equally local, equally micro place which is connected to many 
others…" (Latour, 2005, p.176)  For Latour "there exists no place that can be said to be 'non-
local' (Latour, 2005, p. 179). The network half of the actor-network term does not denote a 
larger "context" but rather describes the connections between the actors.  
 In ANT a researcher does not attempt to decide whether a phenomenon or interaction 
is best described as micro or macro. Instead, "scale is the actor's own achievement" (Latour, 
2005, p. 185). The job of the ANT researcher is to trace how scale is achieved by following 
the actors themselves.  This means that the tensions between large and small, individual and 
collective, micro and macro are not overcome by ANT; rather, these tensions become even 
more emphasized.  The purpose of ANT is precisely not to overcome these dichotomous 
positions but rather to follow and describe how these positions are constructed through the 
process of translation.   
 In another example of how the tensions between dichotomous positions are held 
together in ANT, Law and Callon (1997) explained that anything can be thought of as 
simultaneously a point (an individual actor) and a network (a collective). This is because, 
according to these authors, an individual actor can be conceptualized as a black-boxed 
network. If we look closely at any actor, we begin to see the connections between a great 
number of elements assembled together. The authors explain that a black box: 
"translates the various materials that make it up. It translates them by co-
ordinating them, by fronting them, and by standing for them in a simple and 
coherent form. This means that for the moment the fronted network acts as a 
single unit" (Law & Callon, 1997, p. 170).  
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In this way, the actor and the network, the individual and the collective - each of these is 
understood in relation to the other. We do not want to have to choose one half of the 
dichotomy over the other as each is crucial to understanding the process of translation. ANT 
attempts to hold onto the tensions that emerge between two ways of seeing, simultaneously 
following both the individual and the collective, the actors and the networks. One does not 
replace the other; rather they are like two sides of a single coin.  
iv) Context 
   Law and Callon (1992) suggested that "the notions of context and content …may be 
transcended if projects are treated as balancing acts in which heterogeneous elements from 
both 'inside' and 'outside' the project are juxtaposed" (1992, p.22). Here Law and Callon 
move away from the idea of a determined actor and a determining structure; instead they aim 
to show how networks and actors are mutually shaped. They do this by exploring the 
development and eventual abandonment of a military aircraft called the TSR.2.  
 In the production of the TSR.2, the local network consisted of designers, designs, 
production teams, management, subcontractors, engine and wing positions, and the like. 
Initially, the global network included the Ministry of Defence, the Treasury and the Navy. 
New actors joined the global network, however, and threatened the success of the local 
network in carrying through with the construction of the TSR.2. For example, the Labour 
Party became a new actor, when they won an election over the Conservatives; moreover, an 
alternative aircraft called the F111 comparable to the TSR.2 was already in production in the 
US. Law and Callon (1992) point out that the success or failure of a technology rests on the 
ability to build and maintain local and global networks. Therefore, context amounts to the 
associations, the connections, between various actors in different networks. The context 
changes as new actors are introduced or old actors are called into question.  
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b) Criticisms of ANT 
 A primary criticism frequently levied against ANT is the claim that ANT is amoral 
and apolitical. However, there are many different ways of measuring politics. ANT perhaps 
captures the political in an unconventional way. According to Mol and Mesman (1996, 
p.436), "it generates new axes of difference. It creates new political categories". ANT pays 
attention to how a particular order is generated. By detailing the micro dynamics of how a 
particular order is achieved, ANT brings to the foreground places and times when alternative 
orderings could have arisen; the current ordering is not inevitable and networks of 
associations between actors can always fail. 
 Latour (1986) specifically addresses the issue of power, distinguishing between 
diffusionist and translational models of power. In the diffusion model, power rests on an 
initial force. In this model, one focuses on those who have power and those who do not. 
Power is used as an explanation. The translation model of power focuses on how power is 
shaped and transformed. It emphasizes the chain of actors needed for power to exist. For 
example, Latour proposed, "people who are 'obeyed' discover what their power is really made 
of when they start to lose it. They realize, but too late, that it was made of the wills of all the 
others" (1986, p.268). In this way, Latour understands power to be a consequence (a 
consequence of enrolling, convincing) rather than a cause of collective action. Thus, 
according to Latour, power is not something that can be possessed, but rather is practiced and 
made. The key point in moving from a diffusion model to a translational model of power is 
that power is not used to explain something else; instead, it is power itself that requires 
explaining.  
 Latour's account highlights the work involved in maintaining power; yet, ANT also 
records how some networks become robust, irreversible (M. Callon, 1991) and standardized 
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(Star, 1991). Star examined how stabilized networks exclude some actors. Specifically, she 
stated, "part of the public stability of a standardized network often involves the private 
suffering of those who are not standard - who must use the standard network, but who are 
also non-members of the community of practice" (Star, 1991, p.43). Star (1991) also 
acknowledged, however, that the multiple memberships any actor has in several networks 
simultaneously could be regarded as a mechanism for resistance.  Thus, contrary to 
criticisms of being amoral or apolitical, I interpret ANT as having the potential to offer novel 
ways of exploring power and politics.  Of particular relevance to this dissertation, I argue that 
the political is explicitly brought to the fore in an ANT-informed discussion of knowledge 
translation. The ANT notion of the political in the context of autism genomics and 
knowledge translation will be further explored in Chapter 5.  
c) How Does ANT as a Methodology Relate to Ethnography? 
“The only viable slogan is to follow the actors themselves” (B. Latour, 2005). 
ANT is a methodology in so far as it guides the inquirer as to how to approach a 
question. ANT proposes that we trace the inter-connections between actors and that it is these 
connections which constitute the social. Latour has described ANT as “simply an attempt to 
allow the members of contemporary society to have as much leeway in defining themselves 
as that offered by ethnography” (2005). Inquirers have to engage in the world-making 
activities of those they study without deciding in advance who the actors are and what makes 
them act (Latour, 2005). Much like ethnography, the ANT inquirer must follow the actors 
themselves, follow the natives. So the ANT inquirer has the task of tracing connections 
between actors, registering differences in the ways that actors come together around 
controversies.  
An ANT inquirer starts in the middle of things, in medias res. This methodology 
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points to certain methods such as conducting interviews, taking notes, leafing through 
documents, and clumsily loafing around (Latour, 2005). Through these methods the inquirer 
traces how actors become connected in different ways within different networks. In this way, 
the goal or intended outcome of an ANT account is descriptive rather than prescriptive. The 
task is to deploy actors as networks. A good account will perform the social, will bring 
together various actors into a collective (Latour, 2005).   
All of this is very similar to and compatible with ethnography. I would suggest that 
ANT and ethnographies are over-lapping methodologies. Ethnographer means, literally, 
“writing culture”. An ANT methodology similarly aims to write an account of the social. 
They have different vocabularies but in practice an ANT inquiry is very similar to an 
ethnographic study. Perhaps, it would be helpful to describe ANT as a particular type of 
ethnography, one that focuses on culture or the social as a network of materially 
heterogeneous related entities. Indeed, many of the leading proponents of ANT have claimed 
to be engaged in ethnography (Latour & Woolgar, 1986; Latour, 1987). Others have 
described this methodology as a type of “praxiography” (Mol & Law, 2003). While there are 
similarities between ANT and ethnography, to be sure, there are also instances in which ANT 
is distinct from ethnography. These instances are described in the following section. 
The Ambiguous Relationship between ANT and Ethnography 
Disciplines define and redefine themselves interactively and competitively. 
They do this by inventing traditions and canons, by consecrating 
methodological norms and research practices, by appropriating, translating, 
silencing and holding at bay adjacent perspectives. They articulate, in tactically 
shifting ways, the solid core and the negotiable edge of a recognizable domain 
of knowledge and research practice (Clifford, 1997). 
Ethnography and ANT are dynamic and changing methodologies. Neither of them is 
fixed and therefore it is difficult to outline the boundaries of one in relation to the other. 
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Further adding to the complexity, ethnography refers both to “the manner in which 
observations are made and to the process of compiling a description” (Strathern 2000, 
accessed at http://virtualsociety.sbs.ox.ac.uk/GRpapers/strathern.htm). In presenting an 
argument that ANT can be a distinct methodology, I am not proposing that ANT and 
ethnography are necessarily mutually exclusive in all circumstances. Certainly, many, 
perhaps most, scholars engaged in ANT research propose that they are simultaneously 
engaged in ethnography (Bruni, 2005; Heath, 1998; Hine, 2007; Latour & Woolgar, 1986; 
Neyland, 2006; Williams-Jones & Graham, 2003). I merely want to pause before making the 
knee-jerk genuflection to ethnography and ponder; can ANT stand on its own legs as a 
distinct methodology? I argue that while there are ways in which ANT and ethnography 
coincide, there are also tensions between the two methodologies; ANT can push hard against 
the limits of ethnography, compelled me to situate my own research within ANT specifically 
and more tenuously in relation to ethnography.  
There are two principal reasons why I am uncomfortable with claiming the 
ethnographic label. The first is the centrality of prolonged participant observation to the 
ethnographic endeavor. While the role of participant observation as a necessary element of 
ethnography has been challenged over the last few decades, deep hanging out over and 
extended time remains an iconic right of passage for the ethnographer. The second reason 
why ethnography does not fit well with the approach I have taken to my research is the 
emphasis on meaning-making at the core of ethnography. Each of these tensions (long-term 
field work, and meaning-making) is discussed below.   
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i) Long-Term Participant Observation and the Ethnographic Psyche 
Ethnography is not an easily bound methodology. Indeed, Atkinson et al (Atkinson, 
Coffey, Delamont, Lofland, & Lofland, 2001) celebrated the idea of “unity in diversity”.  
The borders of ethnography are being stretched and blurred with a growing proliferation of 
ethnographic sub-types (auto-ethnography, critical ethnography, cyber-ethnography, 
institutional ethnography, multi-sited ethnography, etc.), which each have their own 
particular emphases and contexts. The practice of ethnography typically conjures up images 
of prolonged contact with research participants in which the method of participant 
observation is paramount. Classic ethnographies such as Malinowski’s Argonauts of the 
Western Pacific (1922), Margaret Mead’s Coming of Age in Samoa (1928)(1928) or Evans-
Pritchard’s Witchcraft, Oracles and Magic Among the Azande (1937) reinforce long-term 
participant observation as a requirement to claim the identity of ethnographer. However, 
since Nader’s (Nader, 1969) call for increased ethnographic research on the powerful (such 
as corporations, federal bureaucrats, political leaders), this expectation for prolonged 
participant observation as an integral aspect to ethnography has been challenged. Such 
expectations are not feasible in many of the field sites that arise when one chooses to “study 
up”.  For example, the power dynamics and gate keeping involved in Gusterson’s (1997) 
study of a nuclear weapons laboratory presented significant obstacles to participant 
observation. While deep hanging out and prolonged engagement with research participants 
may be typical, ethnography cannot be reduced to a particular method. However, the focus 
on prolonged and deep engagement with a field site has left some science and technology 
scholars who “study up” more sensitive and less confident in their assertions that they are 
doing ethnography. Some have found it necessary to describe their studies as having 
“ethnographic sensibility” (Star, 1999). Meanwhile, Hine (2007) somewhat tongue-in-cheek, 
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described her methodology as “a methodologically eccentric historico-ethnographical 
autobiographically-inflected thematic analysis of the material and communicative cultures of 
systematics rather than simply ethnographic”(Hine, 2007). My own disciplinary movement 
from anthropology to health sciences has left me with less confidence in claiming the label of 
ethnographer given the way in which I have engaged with my topic of investigation, pushing 
hard against and perhaps transgressing what traditionally counts as ethnographic.  
ii) Meaning-Making 
The dynamics of doing fieldwork in private and privileged spaces, “studying up”, has 
perhaps loosened the grip that participant observation traditionally held around ethnography. 
Long-term participant observation may be an example of what Clifford (in the quote above) 
has described as the “negotiable edge” (1997) of research practice. If ethnography is not 
merely participant observation, then what is it? I argue that central to an ethnographic 
methodology is the practice of describing meaning-making, often in relation to the notion of 
culture. Geertz’s Interpretation of Culture (1973), for example, explores culture as semiotic. 
He wrote,  
Believing, with Max Weber, that man is an animal suspended in webs of 
significance he himself has spun, I take culture to be those webs, and the 
analysis of it to be therefore not an experimental science in search of law but 
an interpretive one in search of meaning (Geertz, 1973).  
Thus, meaning-making is perhaps an example of the “solid core” (Clifford 1997) of 
ethnographic research practice.  
Why ANT is not necessarily Ethnographic 
The primary tension between Actor-Network Theory, as I have engaged with it, and 
ethnography is this fundamental aim of ethnography to describe “meaning-making” through 
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the notion of culture. From my perspective, where ethnography and ANT rub up against each 
other with some friction is in how “culture” or the “social” are imagined. Through the 
interpretive turn, led by Geertz, culture came to be recognized as socially established 
structures of meaning embodied in symbols (1973).  
The thing to ask about a burlesqued wink or a mock sheep raid is not what 
their ontological status is…The thing to ask is what their import is: what it is, 
ridicule or challenge, irony or anger, snobbery or pride, that, in their 
occurrence and through their agency, is getting said (Geertz, 1973) 
 
 Thus, meaning, meaning-making, the meaning-ladeness of cultural life are central to 
the ethnographic agenda. By claiming that ANT and ethnography are overlapping, I am, 
perhaps, pushing hard against this ingrained meaning-centredness of ethnography. This is 
because I have not explicitly focused on what autism genetics means to those in the 
laboratory, clinic, and family home. I have instead focused on how it is done, enacted, 
practiced in the material world. Even as I write this I am uncomfortable with this, as 
obviously meaning is intimately related to and tied up in practice. I stress however that in this 
dissertation I am more concerned with the objects themselves - DNA, autism, the patient - 
and how they are done through practice rather than focusing on the meanings that humans 
attach to these phenomena.   Contrary to Geertz’s (1973) assertions in the quote above, I 
propose that the (multiply emergent and sometimes ambiguous) ontological status is 
precisely the thing to ask about autism!  Thus, I have chosen to focus on ANT as a distinct 
methodology, albeit a methodology that shares many similarities with ethnography.  
2.3. Third Layer: Epistemological Mooring  
 
[W]e are not denying the existence of real, painful stress and suffering. 
There is, of course, a biological reality, but the moment that efforts are 
made to explain, order, and manipulate that reality then a process of 
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contextualization takes place in which the dynamic relationship of biology 
with cultural values and the social order has to be considered.  
(Lock & Gordon, 1988) 
  
Epistemology is concerned with knowledge, how we come to know what we know 
about the world and how this knowledge relates to nature. The dichotomy that comes to mind 
in the context of epistemology is that between realism and idealism. If one imagines various 
epistemological positions as being stretched out along a single axis with realism at one end 
and idealism at the other end, constructionism would be somewhere in the middle. Also 
central to a discussion of constructionism is the dichotomy between subject and object, and 
natural and social. Indeed, these dichotomies are intimately related to one another. I have 
tried to tease them apart in the discussion that follows. 
a) Constructionism 
Constructionism is often preceded by the word “social”. According to Hacking 
(1999), the underlying aim of social constructionist arguments is to raise consciousness. 
Specifically, these arguments critically examine how whatever it is that is said to be socially 
constructed is not inevitable; “that X as it is at present, is not determined by the nature of 
things” (Hacking, 1999) and it could always be different. Social constructionist arguments 
usually appear when X is taken for granted and seems to be inevitable. Hacking identified six 
grades of constructionism ranging from historical, ironic, reformist, unmasking, rebellious to 
revolutionary. In the historical vein, X is contingent upon historical events. Those who adopt 
this position are usually noncommittal about wither or not X is good or bad. The ironic 
commitment to constructionism follows that X is a contingent product of history but yet X is 
something that we cannot, at present, avoid in our interactions. Reformist feel that X is quite 
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bad and by demonstrating how it is constructed and not inevitable we might be able to 
change some aspects of X. The unmasking commitment to constructionism seeks to expose 
the function of X and thereby strip it of its authority. A rebellious constructionist believes 
that X is not only constructed but that X is bad and we would be better off without X. 
Finally, a revolutionary commitment tries to change the world in respect of X (Hacking, 
1999).  
 In examining Hacking’s six categories of commitment to constructionism, I find that 
my own position does not fit anywhere. While I would describe this research on autism to be 
perhaps most akin to Hacking’s ironic category, it does not quite work. This is because, as 
Hacking states, “X, which we thought to be an inevitable part of the world or of our 
conceptual architecture, could have been quite different” (Hacking, 1999). Approached from 
within theories of practice, however, I feel that there is perhaps another category of 
constructionism that could be teased out: multiplicity. A multiplicity category explores how 
X is contingent and not inevitable. It also aims to show that not only could X be quite 
different, but that X is quite different. In a commitment to constructionism as multiple, the 
aim is to unpack how different constructions of X exist and interact with one another, how 
they might resist, conflict and at times relate and borrow from one another.  Thus, 
approached from theories of practice and a methodological stance of actor-network theory, I 
am committed to construction as multiple.    
i) What is it that is constructed?  
 Again, I draw on Hacking (1999) to clarify what I mean when I position myself in a 
constructionist epistemology. Hacking distinguished between objects, ideas, and what he 
calls “elevator words”. The boundaries between these three classifications are tenuous and 
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slippery but the distinction is helpful, I think, in clarifying what precisely I am referring to as 
being constructed. The first category of objects are in the world, according to Hacking. 
Autism can be examined as an object, as can DNA and individual people. The second 
classification is called ideas and includes ideas, concepts, beliefs, attitudes to and theories. 
Ideas can be shared or private. Autism could also be approached as an idea; one could study 
how the idea of autism has been constructed differently over time or in various contexts. For 
example, disability rights constructions of the idea of autism differ greatly from the ideas of 
autism held by some parent-driven groups such as Autism Speaks, which seek to cure autism. 
The third category is elevator words. Elevator words include facts, truth, reality, and 
knowledge. These words, suggested Hacking, are not objects in the world but say something 
about the world and the way we think about the world. One could, for example, study the 
construction of knowledge within a particular context, like autism genomics.  
 Throughout the chapters of this dissertation that which is being explored as 
constructed differs. For example, in chapter 3, I describe how the idea of autism has been 
constructed through technological advancements in genomics. In chapters 4 and 5, I explore 
how knowledge is constructed within the contexts of autism genomics. In chapter 6, I unpack 
how the nature of autism, its ontology, is constructed multiply in the laboratory, clinic and 
family home.   
ii) Can something be Constructed and Real? 
 I am very concerned that in taking a constructionist approach this research might be 
misinterpreted as taking the position that autism and the objects of science under 
investigation are not real. I want to make clear my position - that I hold autism to be real, 
very real. I contend that it is, however, both real and constructed. To say that the idea of 
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autism or knowledge about autism is constructed is perhaps less risky. However, in chapter 6, 
I also explore how the nature of autism, its ontology, is constructed. It is here that I must be 
most clear in how I relate and connect a multiply-constructed object to one that is also, in no 
uncertain terms, real.  
 Here, I want to draw on Pickering and Latour again to help me elucidate what I mean 
when I say that autism is both constructed and real. The issue of realism, as has been 
discussed above, is usually problematized by knowledge on the one hand and the world or 
nature on the other hand. The central question is whether or not and to what degree 
knowledge is able to represent or correspond to the real world. Pickering (1995) enlists his 
concept of the mangle of practice in a position he calls pragmatic realism. In my reading of 
Pickering, scientific knowledge is real in so far as scientist are engaged in this dialectic of 
resistance and accommodation with nature, in so far as knowledge is finely tuned to the 
world.   
The problem is that humans can be engaged in this dance of agency with the world in 
different ways. The various tools, the technologies, and the machines that are used by 
humans allow us to become entangled with the world in different ways. As will be 
demonstrated in this dissertation, for example, autism is constructed in the laboratory through 
a process in which scientists use various machines, tools, and objects (e.g., DNA) to explore 
the world. Here, not only knowledge about autism but in certain instances autism itself is 
constructed in terms of genes and DNA.  At the same time, autism is constructed in the clinic 
through a very different process in which clinicians use tools and technologies (e.g., tests and 
observation schedules) to engage with the world. Through practices of the clinic autism is 
constructed behaviourally. Both of these constructions are at once real; knowledge from the 
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laboratory and knowledge from the clinic can both be described as particular ways of 
practicing or ordering autism.  
In this way the world can simultaneously support multiple entanglements and 
dialectics of resistance and accommodation. Even though, at times, these constructions may 
in certain ways conflict with one another. Two constructions may actually be 
incommensurable; that is, there may be no common yardstick from which to measure and 
compare two constructions, two different ways of approaching and engaging with the world. 
Yet, they both may be real. Sometimes these constructions coexist temporally and in other 
examples one way of engaging with the world overtakes another. I feel that it is through the 
process of knowledge translation that we shift and maneuver between and amongst various 
entanglements with the world.  
Like Pickering, Latour also focuses on nonhumans as central to dismantling the 
dichotomy between subjects and objects, culture and nature. By considering associations of 
humans and nonhumans in a state of uncertainty, Latour attempts to end the volleying back 
and forth between subject and object (2004). I draw on Latour also as he points out that once 
an object becomes a fact, once it is given a name, once it has been probed and prodded 
through various tools and practices, it becomes real; it assumes an ontological weight, so to 
say. In this way ontology is intimately related to practice. The nature of an object is 
determined through practice, through various “socio-technical assemblages”. At this point we 
must take it for granted as being real. It becomes a closed box. Latour, for example, analyzed 
a scientific experiment by Pasteur (Latour, 1993a) and contends that an experiment is "an 
action performed by the scientist so that the non-human will be made to appear on its 
own…The experiment creates two narrative planes: one in which the narrator is active, and 
one in which the action is delegated to another character, a nonhuman one" (Latour, 1993a). 
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We constantly shift between frames of reference. Latour described how Pasteur acted so that 
the yeast could act alone. Depending on which of these two actors is stressed, the same text 
becomes constructivist or realist (1993). 
When an object comes to be defined through various trials in the laboratory, an act of 
ventriloquism arises. At first, when the contours of the object are still uncertain, the scientists 
speak for the object. Later, after the object has been established as fact, the object speaks for 
itself (Latour, 2004). It is real.  If and when a new controversy opens up around an object, a 
new paradigm or new technology is developed that allows the object to be probed and 
prodded in different ways, the question of its constructed nature opens up once again. The 
arena in which it is come to be known, the technologies, the field of practices that constrain 
how scientists accommodate nature’s resistance – all of this becomes visible again. After a 
while some agreement is reached and the apparatus of practice fades away again leaving 
nature to seemingly exist independently of the tools and practices through which we engage 
with the world.  
2.3.b Epistemology or Ontologies?: Practiced Knowledges, 
Practiced Realities 
 David Bloor, a sociologist in the Science Studies Unit at the University of Edinburgh, 
has been a major champion of the Strong Programme in sociology. The key idea attributed to 
the Strong Programme is the symmetry postulate. Bloor has explained this postulate as 
follows: 
Both true and false, and rational and irrational ideas, in as far as they are 
collectively held, should all equally be the object of sociological curiosity, 
and should all be explained by reference to the same kinds of cause. This 
requirement was formulated in opposition to an earlier prevailing assumption, 
still defended in many quarters, which has it that true (or rational) beliefs are 
to be explained by reference to reality, while false (or irrational) beliefs are 
explained by reference to the distorting influence of society (Bloor, 1999, p. 
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84). 
 
This postulate marked a radical shift in science studies. As a result, all knowledge and beliefs 
could be explained in the same way. The concern for Latour, however, is that this postulate is 
limited to epistemological concerns. It proposes symmetry of knowledge and ideas about the 
world, but continues to uphold the traditional view that the world (reality) itself is out there, 
untouched. The world (reality) is not within the purview of social science; only descriptions 
of the world should be subjected to sociological scrutiny: 
The important point is to separate the world from the actor’s description of the 
world. It is the description that is the topic of enquiry, and the proposed 
separation is one of our resources. This is all just another way of saying we 
must respect the distinction between the object of knowledge and the subject of 
knowledge (Bloor, 1999). 
 
 The preceding quote points to Bloor's modern separation between subjects and 
objects, human representations and things-in-themselves.  As such, Bloor restricted his 
research to scientific knowledge, rather than the broader domain of science itself.  Scientific 
knowledge could be explained by society. As the following passage suggests: 
All knowledge always depends on society. This is because, as I have argued and 
as case-studies demonstrate, society is the necessary vehicle for sustaining a 
coherent cognitive relation to the world (Bloor, 1999). 
 
 Meanwhile, Latour claimed that Bloor and other champions of the Edinburgh school's 
Strong Programme assume "unequally the sources of uncertainties, so that all the 
uncertainties reside with humans, while the sensory inputs remain utterly neutral" (Latour, 
1999a, p.117). Latour aimed to problematize nature itself. Latour claimed, "Bloor aligns 
himself with the most reactionary philosophers of science who insist that science studies is 
all very well as long as it sticks to epistemological questions and leaves entirely aside—that 
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is to the scientists!—the ontological ones" (1999a, pp.122). Alternatively, Latour insisted that 
instead of leaving aside nature, we should focus squarely upon it. He stated, "the alternative I 
would prefer is to engage in a complete reworking of the origin of the notion of ‘nature’. 
Nature is the concept to topicalize. It is through nature that the whole history of absolutism 
has been developed" (1999a, p.127).  
For Latour, nature and society can be explained by things themselves if we follow, 
step-by-step the chains of association, which include "psychological, ideological, cognitive, 
social, and material entities, many of which are non-human agents. Along these chains, each 
element takes the meaning given to it by the adjoining elements in the series" (B. Latour, 
1999a). Latour depicted Bloor, the Strong Programme and those in the Edinburgh unit of 
Social Study of Scientific Knowledge as subjectivist (emphasizing the role of society or 
culture) and at the same time realist (not questioning the ontological status of things in 
themselves). In this way, it is assumed that there are different types of causalities attributed 
to different types of reality; a wedge is driven between nature and society, object and subject 
and each side of the chasm is explained according to different standards. Latour, on the other 
hand, aspired to push the symmetry postulate one step further, eschewing this divide between 
subject and object, a relic from the modern project. His aim was to illustrate how this divide 
is produced. For example, Latour and Callon aimed to introduce an alternative ontological 
axis, one that would break the tug of war between natural realism and social realism. They 
contended: 
Our general symmetry principle is thus not to alternate between natural realism 
and social realism but to obtain nature and society as twin results of another 
activity…network building…we have to make ninety-degree turn from the SSK 
yardstick and define a second dimension" (Latour & Callon, 1992).  
 
Thus, instead of starting with nature and society, for Latour and Callon, these divisions were 
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an end result of the activities and networks of humans and non-humans. Later, Latour 
(1993b) further explicated this alternative ontological dimension. This north-south dimension 
"registers variations in the stability of entities from event to essence" (1993b). In other 
words, the vertical dimension traces the historical process through which a thing becomes 
stabilized. The essence of the thing is the trajectory that links all of the events in the thing's 
history.  Thus, Latour's project is to focus on the process and practices through which things 
become stabilized.  Latour later offered a more sophisticated explanation of his deviation 
from the traditional subject-object dualism (Latour, 2008, p.105). He stated: "in the first 
frame, all the attention is concentrated on two loci: the object intact ‘out there’ and the 
subject that has shifting versions ‘in there’. In the second frame, the two anchors have 
disappeared: there is no longer one subject and there is no longer one object. Instead there are 
threads woven by the crisscrossing pathways."  Thus, he was interested in "successive 
temporally marked versions of the objects and subjects" (Latour, 2008). In this way, Latour 
has granted ontological status to knowledge activity. Truth becomes an event and knowledge 
a trajectory.  
The notion of time becomes paramount. When one takes a synchronic snapshot of the 
relationship between subjects and objects, they appear frozen, hardened in opposition to one 
another. The subject looks outward at objects as they are already recognized. In a diachronic, 
historical view, we can see how the "things" (not necessarily subjects or objects) are 
continuously shifting in relation to one another.   
 Likewise, according to Pickering, pragmatic realism subverts the realist/ idealist 
debate, claiming instead that "the world will support an indefinitely diverse set of ontologies 
and bodies of knowledge" (1995). In this way, Pickering, like Latour, is at once realist and 
relativist. What Pickering highlighted within this pragmatic realist perspective, is the 
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importance of time. For example, Pickering described the "irremediable historicity of 
scientific knowledge (and culture in general): what counts as knowledge now is a function of 
the specific historical trajectory that practice has traced out in the past" (Pickering, 1995).  
 Latour echoed this emphasis on time and went so far as to position facts and 
knowledge as having ontological status or weight; they are events that can be marked and 
traced through time.  Thus, what counts as an object or a subject is a result of a particular 
stabilization of practice over time.  In this way, it seems to me, that ontology can only be 
understood in relation to epistemology. To say that something is ontologically multiple, is to 
say that the nature of that thing is multiple. But nature is only apprehended through 
interaction with the world and that interaction, I am arguing, is in the form of practice. 
Ontology is practiced; it is not given a priori. This is how it can be said that an object exists 
ontologically in multiple ways, because it exists through multiple practices. This is not to say 
that the object is not real. Its existence can only be understood through practice, through our 
interactions with the world, and these interactions are mediated by and through tools, 
technologies, and practices.  
In exploring multiple ontologies, I am exploring knowledge. Ontology and 
epistemology are conflated. How so? They are conflated through the idea of practice. 
Specifically, the notion that knowledge is practiced upsets the dualistic opposition between 
inside and outside, subject and object. Instead, when knowledge is regarded as practice rather 
than understood as something which lives in the human mind, knowledge becomes a 
materially heterogeneous activity. Knowledge is thus imbued with an ontological status.  
Casper Bruun Jensen (2004) further explores this move in ANT, emphasizing the comingling 
of humans and nonhumans, subjects and objects as challenging traditional epistemology: " 
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because activities such as observing or representing are not seen as distinct from intervening 
or constructing…in this way epistemology collapses into ontology and the sciences are 
reformulated as practical activities aimed at rebuilding the world by adding new elements 
with new capabilities and new relationships to it" (Jensen, 2004). As Latour has suggested 
"we have abandoned, as illusory, the demarcation between ontological and epistemological 
questions" (Latour, 1999c).This is a crucial point, that realities and knowledges of realities 
are constructed together. As Law has recently stated, “we need to replace an attitude of 
innocence with the recognition that our knowledges are complicit and collusive in the 
real…knowledges are embedded in and enacted alongside and together with realities that 
they purport to describe” (Law, 2012). Similarly, Latour describes knowledge as a “mode of 
existence” (2008). 
Mol (1999; 2000; 2002) in her work on the ontological politics of atherosclerosis, 
described how a disease is enacted differently through different practices in the same 
hospital. The different realities of atherosclerosis butt up against one another, sometimes they 
are held within one another, and other times they are contradictory. The key point is that 
there is no single coordinated network to support a singular reality of atherosclerosis. There 
are actually multiple modes of ordering reality. So the construction metaphor no longer 
works. Reality is much too tentative and fragile, too fluid and relational to be described 
through images of concrete and steel conjured up by the word “construction”. The project is 
no longer to describe the construction that could have been constructed otherwise, but rather, 
to describe the ways in which several simultaneous realities being performed at once hang 
together. Ontology is multiplied along with ways of knowing and doing. As Law has 
similarly stated, “if practices and knowledge practices are performative, then…reality is also 
heterogeneous: it, the real (or they, the reals), is (or are) simply being done differently in 
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different places” (2012). 
Mol (2002) described how the different practices and enactments of atherosclerosis 
are distributed over different local spaces. When they do run into each other, when traffic 
between sites forces one reality to come up along side another, there are forms of 
coordination. They manage to coexist together. Mol, for example explores two different 
technologies and how they are coordinated. An angiographic image shows the vessel lumen 
while a duplex gives information on blood velocity; the objects of these two techniques are 
different but they are made comparable. There are ways to translate them. Velocity increase 
is translated by a technician into loss of vessel lumen. Thus, as Mol (2002) contends "the 
threat of incommensurability is countered in practice by establishing common measures. 
Correlation studies allow for the possibility (never friction free) of translations." 
Mol explained,  
the knowledge incorporated in practice does not reside in subjects alone, but 
also in buildings, knives, dyes, desks…This then may be a way out of the 
dichotomy between the knowing subject and the objects-that-are-known: to 
spread the activity of knowing widely…Instead of talking about subjects 
knowing objects, we may then, as a next step, come to talk about enacting 
reality in practice (Mol, 2002, p. 50). 
 
A turn toward practice and activities precludes knowledge from living in the mind. 
Knowledge is done - it becomes a fleshy, corporeal affair of the bodily world in which we 
move. 
Reality, for Mol, is performed in a variety of practices and is therefore multiple. She 
writes of ontologies rather than ontology; the distinction is made, however, between multiple 
and plural, setting her viewpoint apart from those who espouse a perspectival or 
constructionist approach. According to Mol, perspectivalism" broke away from a 
monopolistic version of truth. But it did not multiply reality. It multiplied the eyes of the 
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beholders…And this in turn brought pluralism…While in the centre the object of the many 
gazes and glances remains singular, intangible, and untouched" (Mol, 1999). Alternatively, 
constructionist stories articulate the possibility for alternative constructions of reality that 
might have been by unpacking the processes through which accepted "facts" were produced 
and other potential facts were lost along the way.  
 Instead, Mol's description of multiple ontologies is contingent on the ideas of 
performance and practice: reality is "done and enacted rather than observed" (Mol, 1999). In 
this way, there are multiple versions of the object, multiple forms of reality itself. However, 
"[t]hese are not perspectives seen by different people - a single person may slide in her work 
from one performance to another…So they are different versions, different performances, 
different realities, that co-exist in the present" (Mol, 1999). She explained further that while 
these various realities may clash at some points, different performances of an object also 
depend on and collaborate with one another. Thus, they do not necessarily co-exist 
independently and side-by-side, but rather might be found inside one another. 
 While Latour emphasizes how constructions of reality could be otherwise, tracing 
how particular constructions arise through time, Mol concentrates on how reality is 
performed or practiced multiply in the present. Considering all the emphasis on time by 
Latour and Pickering, this dissertation is noticeably atemporal. Despite my indebtedness to 
Latour’s ideas, it is Mol’s concern for multiplicity and ontological politics in medicine that I 
find particularly relevant and generative in my pursuit to explore the concept of knowledge 
translation from a constructionist position. In this dissertation I seek to take up the issues of 
multiplicity and coordination as integral to a new way of framing the practice of knowledge 
translation.  
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c) Both Constructed and Real 
In Science in Action (Latour, 1987) Latour unfolds the story of how objects are 
slowly made into being, first a fuzzy thing on which the tests must be conducted to define its 
edges, figuring out what it does what it doesn't do. Nature or objects do not come into being 
until after they are "isolated from the laboratory conditions that shaped them, things with a 
name now seem independent from the trials in which they proved their mettle" (Latour, 
1987). Through this process, reality becomes reified. Thus, Latour alludes to the two-faced 
Janus. On the left side of Janus, Nature is cause, on the right side consequence. On the left 
side scientists are realists, on the right side relativists. On the left side science is cold, hard 
and certain. On the right side, science is warm, soft, and unsettled. Stengers (2010) 
reinterpreted the two-faced Janus as consisting of what she calls “bearded science” on the left 
and beardless youth on the right. She describes a:  
“struggle for a less dissociated or amnesic personality than the Janus figure, for 
a bearded old man who would remember and celebrate the adventurous, 
intricate constructive processes that any scientific achievement entails, instead 
of  describing the achieved result as the direct consequence of a normal, 
rational method” (Stengers, 2010). 
 The suggestion to shift between frames of reference allows Latour to adopt a realist 
perspective without absolutism.  Things are real; they exist, whilst also being constructed.  
i) Construction as Process 
When we talk about a construction, we often imply a maker, an architect. What 
Latour wanted was to think not about an all-powerful creator, but rather the process of 
construction. He proposes that we think of engineers instead of architects; "learning how to 
become responsive to the unexpected qualities and virtualities of materials is how engineers 
will account for the chance encounter with practical solutions: they will never think of 
describing themselves as little kids moulding reality at will" (Latour, 2003). In other words, 
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by using the word “construction”, agency must be shared across a wide variety of actors and 
uncertainty introduced into the final construction. Adopting a constructivist position, 
according to Latour, means "to learn how to become sensitive to the contrary requirements, 
to the exigencies, to the pressures of conflicting agencies where none of them is really in 
command" (2003). A potter, for example, may throw a pot with a particular shape, but she is 
constrained by the properties of the clay (is the clay uniformly wedged, is it too wet or too 
dry), the speed of the wheel, or gravity’s effect on abrupt curves. As any fledgling potter 
knows, certain shapes hold up better than others (pots collapse and fold at weak spots - so we 
learn which shapes are possible and which can be maintained). Thus, the potter constructs a 
pot, but not without the constraints of the material world.  
 Latour views constructivism as the only way to bypass the dichotomy between an 
unconstructed world that is "already there" and a world made purely of subjective value 
claims (Latour, 2005). Elsewhere, Latour (1993) has described science studies as situated in 
a no-man's-land between the two cultures of sciences and humanities, between absolute 
realism and absolute relativism. In the no-man's-land, relativism is relative and realism is 
more realistic.  In this no-man's-land relationism comes to replace both terms (Latour, 1993). 
Empiricist notions of knowledge remain deeply cognitive and cerebral; detached minds gaze 
out at the world.  Conversely, Latour and ANT hope to plug the wriggling brain back into 
the body; he stated in Pandora's Hope (Latour, 1999), "we no longer have a mind dealing 
with an outside world, but a lived world to which a semi-conscious and intentional body is 
now attached." In this way, the outside world is granted a warm, human, historical existence, 
a more realistic realism or relative relativity.  
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2.4. Relating my Philosophical Position to Knowledge Translation 
Practice theories, actor-network theory and constructionism provide a set of concepts 
and ideas from which to draw upon when exploring knowledge translation. In closing this 
chapter, I would like to briefly outline how knowledge and translation (the two fundamental 
components of KT) are informed by the particular theoretical, methodological, and 
epistemological positions I have adopted. 
a) Knowledge 
 In this research I have approached knowledge as a practice. Specifically, following 
practice theories, I suggest that knowledge is a materially heterogeneous practice with an 
unfolding ontology. Actor-network theory has been described as the semiotics of materiality, 
emphasizing how things are produced in relation to other things. An ANT methodology 
allows me to decentre knowledge and trace the connections between the various human and 
non-human actors that make up a particular enactment or practice of knowledge. 
Constructionism brings to the foreground the idea that knowledge is entangled with the way 
the world is enacted. Knowledge is conceptualized as a particular way of ordering the world. 
Different knowledge practices rebuild the world anew. In a constructionist approach, 
knowledge does not only describe reality but creates it. Thus, knowledge practices are not 
treated as distinct from ontological practices.  When knowledge practices change or multiply, 
so too does reality.  
 This particular conceptualization of knowledge, informed by practice theories, ANT, 
and constructionism, can be contrasted with the conceptualization of knowledge that is 
typically found in the health science literature pertaining to KT. In my reading of this 
literature, I interpret knowledge to be predominantly conceptualized as a representation of 
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reality rather than a practice or construction of reality; a reified possession rather than a 
process; a black-boxed actor, rendered distinct from the circumstances of its creation, rather 
than a network of connections relating many actors to one another. This typical 
conceptualization of knowledge will be further explored though the example of the 
Knowledge-to-Action (KTA) model promoted by the CIHR in the final chapter of this 
dissertation.  
 Thus, in re-conceptualizing knowledge through a philosophical lens informed by 
practice theories, ANT, and constructionism I am altering what it is that is being considered 
as undergoing translation. The knowledge that I am considering in this thesis bears little 
resemblance to the knowledge that is considered in the health sciences KT literature. That 
which is under investigation differs from what is typically included in KT research.  
b) Translation 
Following these changes in the conceptualization of knowledge, my understanding of 
translation is also markedly different from the dominant conceptualization of translation in 
the health sciences literature. Informed by practice theories, ANT, and constructionism, my 
view of translation implies a process in which different knowledge practices are related to 
one another. Following ANT methodology, in describing translation I am describing how 
actors change as they enter new networks. An ANT-informed understanding of translation 
requires that I register differences in the way that actors come together as they move amongst 
different networks. In my conceptualization, translation and transformation are synonymous. 
As my conceptualization of knowledge relates knowledge practices to the construction of 
ontological realities, it follows that translation also entails creating connections between 
multiple ways of enacting reality.  Drawing on the notion of multiplicity, following Mol, I 
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will suggest that hidden within the process of knowledge translation is an ongoing process of 
ontological politics.  
It is in this notion of ontological politics that my conceptualization of translation 
differs from the translation that is discussed in the health sciences KT literature. In this 
literature, translation is not generally approached as a political process. Further, while many 
models discuss the need to adjust knowledge so that it can be adopted to a particular context, 
translation is not typically defined by change and transformation of knowledge. Rather, it is 
assumed that at its core knowledge being translated remains constant and unchanged when 
moved from producers to users. Finally, as implicated in the previous sentence, translation 
often entails two distinct groups of people: those who produce knowledge and those who use 
it. In the health sciences literature the translation process implies an intentional and directed 
attempt to move knowledge from producers to users.  
In relating my philosophical position to a discussion of KT I have highlighted the 
differences between the ways in which I have approached knowledge and translation and the 
ways in which they are conceptualized in the health sciences KT literature. The body of this 
dissertation, which draws on my field work experience, explores autism genomics as a case 
study in which to examine KT using particular conceptualizations of knowledge and 
translation that are informed by practice theories, ANT, and constructionism. I argue that 
developing theory-driven approaches to KT, as I have done in this dissertation, will enable a 
larger network of KT researchers to think critically about what is typically included and 
precluded from investigation and open up possibilities for re-configuring what KT entails. 
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Chapter 3: Research Ethics 
 
 
 
 
 
 
 
 
 
 
At the end of a Monday morning meeting on March 6th 2012 a genetic counsellor 
relayed to the group that in a recent feedback session one of the probands had withdrawn his 
consent and no longer wished to participate in the autism genetics research. This proband 
happened to have a particularly interesting copy number variation. A discussion ensued about 
how to best go about the withdrawal process. One person in the room, a post doctoral fellow 
in bioethics who had been invited to work with the group, noted the impossibility of 
retrospectively taking data out of past compilates. Others noted the need to trace where the 
proband’s information had gone as it had been part of a central public repository used by 
other scientists internationally. Still others noted the implications of his withdrawal, that they 
could no longer publish the results. This conversation led to the above statement made by the 
director of the laboratory:  
“You can see that ethics is overtaking the science now”  
(Director, Laboratory X – March 6, 2012, Monday morning meeting). 
In this chapter I would like to take this statement made by the Director and apply it 
3.1. Approaching Anonymity 
7.1a Anonymity of individuals diagnosed with autism and 
their family members 
 7.1b Anonymity when "studying up" 
3.2. Tensions in the research process: Anonymity? "Thick         
description"? Or somewhere in between? 
3.3. Expectations of Research Participants 
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specifically to an ethical quandaries that emerged from my research, that of providing context 
of the research participants while at the same time providing anonymity in the context of 
knowledge translation of genomic science from the laboratory to the clinical setting and back 
again.  
3.1. Approaching Anonymity  
The word “anonymity” has been used to specifically describe the protections to prevent 
the identifiability of participants (Walford, 2005; Tilley & Woodthorpe, 2011). Tilley and 
Woodthorpe (2011, p.198), for example,  make the distinction  between confidentiality and 
anonymity stating, “confidentiality refers to the management of private 
information…anonymity refers specifically to removing or obscuring the names of 
participants or research sites, and not including information that might lead participants or 
research sites to be identified”.  Confidentiality is a broader concept that entails more than 
merely protecting the identity of research participants and sites. For example, confidentiality 
also includes issues pertaining to security measures for protecting data, and foreseeing legal 
reasons to disclose information to third parties (TCPS, 2010). These broader issues 
associated with confidentiality are not being challenged in this chapter. Rather, following 
Tilley and Woodthorpe (2011), this chapter specifically focuses on the issue of anonymity in 
the context of qualitative inquiries. Anonymity, according to Walford (2005, p.85),  
[M]eans that we do not name the person or research site involved, but, in 
research, it is usually extended to mean that we do not include information 
about any individual or research site that will enable that individual or research 
site to be identified by others. 
 
In the Canadian research context, the Tri-Council Policy Statement (TCPS) 2 2010 is the 
joint ethics policy guideline prepared by Canada’s three federal research agencies (Canadian 
Institutes of Health Research (CIHR), and Natural Sciences and Engineering Research 
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Council of Canada (NSERC). The TCPS2 is guided by three core principles: respect for 
persons, concern for welfare, and justice. In the TCPS2 (2010), the notion of anonymity is 
not defined and is instead subsumed within the concepts of privacy and confidentiality, 
which are important aspects of these three core principles. According to the TCPS2, “privacy 
risks in research relate to the identifiability of participants, and the potential harms they, or 
groups to which they belong, may experience from the collection, use and disclosure or 
personal information” (2010, p.55). Confidentiality refers to the obligation to safeguard 
entrusted information; specifically, ‘researchers shall safeguard information entrusted to 
them and not misuse or wrongfully disclose it” (2010, p.56). While the TCPS2 does not use 
the word anonymity, it does acknowledge, however, that confidentiality “can be a particular 
challenge in qualitative research because of the depth, detail, sensitivity and uniqueness of 
information obtained” (2010, p.143-44). Here the TCPS2 demonstrates sensitivity to the 
unique challenges involved in protecting anonymity for highly descriptive research 
methodologies. 
 
Anonymity of research participants are commonly demanded across Research Ethics 
Review Boards at Universities and other institutions (Giordano, O'Reilly, Taylor, & Dogra, 
2007). However, the orthodoxy of anonymity is beginning to be questioned in qualitative 
research (Kaiser, 2009; Kelly, 2009; Snyder, 2002; Van den Hoonaard, 2003; Walford, 
2005). Van den Hoonaard (2003, p.141) argued that anonymity “is a virtual impossibility in 
ethnographic research” and pointed to the marked differences between the “front-stage” 
promises of anonymity made to REBs and the “back stage” reality of research in practice. 
Complicating the issue of anonymity, Walford (2005) argues that while the identity of a 
particular site or community might be concealed, pseudonyms will probably not conceal the 
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identity of individuals in relation to others from that same site or community.  For example, 
there have been studies in education research (Burgess, 1985) in which pseudonyms did little 
to protect participants from colleagues and principals discerning individual identity.  Walford 
(2005, p.88) warned,  
The head teacher and other teachers will know which teachers were involved in 
the research and few details may be sufficient to identify the person being 
quoted…Moreover, the people who are in a position to identify individuals are 
exactly those to whom exposure has the greatest potential risks of harm or 
embarrassment. 
 
Scheper-Hughes (2000) has written similarly: 
 
I have come to see that the time-honoured practice of bestowing anonymity on 
‘our’ communities and informants fools few and protects no one—save, 
perhaps, the anthropologist’s own skin. And I fear that the practice makes 
rogues of us all—too free with our pens, with the government of our tongues, 
and with our loose traditions and interpretations of village life (Scheper-
Hughes, 2000), p.128. 
 
Thus, the typical way in which anonymity is preserved (pseudonyms) ensures what 
Tolich (2004) has described as external confidentiality (to the outside world). However, as 
Kaiser (2009 pp.1636) has noted, “this approach does little to ensure that persons with whom 
respondents have relationships such as spouses, coworkers or neighbors will be unable to 
identify respondents”.  Meanwhile, Tilley and Woodthorpe (2011) raised concerns about the 
challenges of maintaining anonymity amidst increasing pressure to disseminate and translate 
research findings in an on-line era. These authors suggested, “it is now common practice for 
a lot of information about research activities to end up in various places, especially on the 
internet…the sheer volume of this information can challenge the principle of anonymity in 
identifying sites” (2011, pp. 205). 
Nespor (2000) has identified other problems with anonymity. In particular, he 
suggested that strategies to improve anonymity, such as glossing over details, invite the 
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reader to generalize the findings of a particular study to any place and time. Readers might be 
more apt to apply findings to other situations or sites, without considering important and 
unique socio-historical contextual factors. Concerned for the anonymity of participants in my 
own study, I considered the idea of removing any traces of the particular context of autism 
and instead using [       ] in place of the world autism throughout my dissertation. Nespor’s 
(2000) concerns regarding the decontextualizing of findings and the risk for readers to 
generalize findings into other contexts influenced my choice to remain close to the particular 
context in which my research was situated.    
My research involved engagement in a genomics laboratory and autism clinic. While a 
pseudonym might hide the identity of the participants in the short-term, any description of 
the spaces and the technologies in those spaces narrow the range of possibilities 
immeasurably, such that the laboratory and by extension the clinic are quickly identifiable. 
Such description, however, is essential for a serious discussion of the construction of 
genomic knowledge and its translation amongst the various participants in the laboratory and 
clinic. Moreover, actions taken to hide or gloss over the particulars of the research site in the 
interest of preserving anonymity would simultaneously impede my ability to demonstrate 
authenticity (showing the reader that I was there) and thereby threaten my own claims to 
research quality. In my research, the challenges associated with anonymity differed between 
and among individuals diagnosed with autism, family members, scientist, and clinician 
participants and are explored separately below.  
3.1a Anonymity of individuals diagnosed with autism and their family 
members 
 One of my primary concerns is ensuring that individuals diagnosed with autism and 
their families are not identifiable within my writing. This was actually more difficult to 
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achieve than I had initially anticipated. The main difficulty in ensuring anonymity of the 
families that participated in my research is that there have been so few families given genetic 
feedback in the Autism Genetics Study, as it moves from the basic science laboratory to the 
clinic. In order for social science to accompany rather than follow cutting-edge basic and 
clinical research, as has been argued (Timmermans & Berg, 2003), social research must 
begin with a small group of participants, and thus strategies to address the related 
complexities of anonymity should be pursued. Feedback has only been given in the last three 
to four years with less than a total of twenty families actually involved. This is because 
parents only receive feedback when a genomic variant is found which is of “clinical 
significance”. Most of the genomic variants that are found in the laboratory are either not 
clinically significant (these variants are common in control populations) or, increasingly, 
they are what are termed “unknown clinical significance”.  
Trying to provide anonymity increases in complexity when one considers the many 
different people for whom a research will seek anonymity. For example, in my research I 
hope to ensure the individuals diagnosed with autism and their family members are not 
identifiable. This becomes complex in relation to other family members, friends, co-workers, 
or acquaintances as well as from the researchers and clinicians in the autism genetics study.  
To promote anonymity I have used pseudonyms and modified demographic information as 
much as possible.  However, pseudonyms do little to protect the anonymity of individuals 
with autism and their family members from the clinicians and scientists in the autism 
genetics research. With so few parents involved in my study, and so few families having 
received genetic information from the Autism Genetics Study, clinicians would quickly be 
able to identify who said what.  This concern is further complicated by the fact that these 
scientists and clinicians were listed as co-investigators on my research project, as per 
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research ethics board requirements; as such, they have access to signed consent forms clearly 
identifying the parents who participated. The parents were aware of this, as the information 
letter and consent form has the names of the clinic and laboratory directors at the top. In parts 
of my dissertation, parents may offer concern regarding the clinical genetics feedback 
process, offering potentially useful suggestions about the need for continued opportunities for 
follow-up meetings with the genetic counsellor. In the interest of increasing anonymity from 
the scientists and clinicians in the autism genetics research, I have tried developing 
composite descriptions, based on stories from several research participants that have been 
combined. For example, when I describe the process of meeting with a genetics counsellor to 
receive genetic feedback, the story is told from the perspective of a mother. The experiences 
and feelings recounted here are morphed together from several different mothers I 
interviewed and from the four different feedback sessions that I observed. I have thus 
collected data verbatim but to promote the anonymity of the research participants I have 
brought together, and reassembled it.  
3.1b Anonymity when “studying up”? 
While I had anticipated the challenges to anonymity for individuals diagnosed with 
autism and their families early on in the research process, the difficulties related to 
anonymity for the scientists and clinicians became increasingly apparent as I began to write 
descriptions of the spaces in which they were working. There are few people involved in 
autism genomics research in Canada with the resources and infrastructure to carry out the 
types of cutting-edge experiments I describe, let alone on such a large scale. The laboratory 
and its director have an impressive public presence in the world of autism genetics research 
and, as such, are highly visible. With a little effort, anyone who reads my dissertation could 
probably figure out the group I was studying if they really wanted to. Considering this and 
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that there is only one director of the laboratory and one director of the clinic, anonymity 
becomes difficult, if not impossible, to achieve.  
Over forty years ago, Laura Nader (1969) called for anthropologists to “study up”, to 
focus on the elite individuals and institutions with power. She identified four factors which 
contributed to the paucity of studies focused on those with power: access, attitudes, ethics, 
and methodology. Traditionally, in many anthropological studies, the researcher traveled to a 
distant country and had relatively more power than the research participants. Participants 
may not have spoken the same language in which the anthropologist would eventually 
publish findings and would have little opportunity to scrutinize the interpretations made by 
the researcher. While anthropology “at home” has become increasingly common in the last 
few decades, many researchers continue to focus their studies on relatively marginal or 
disenfranchised people.  As Gusterson (1997) has noted, “In many cases, anthropology’s 
traditional taste for the marginal and exotic has not so much been transgressed as imported 
and transposed upon American society, leaving us with more studies of scientologists and 
crack dealers than of federal bureaucrats and corporate executives” (1997, p.114).  
Recently, Edwards (2007) focused squarely on the challenges that emerge when 
“studying up”. Edwards (2007) conducted an ethnography of the Japanese women’s soccer 
team and the broader issue of corporate sports. She quickly found herself dealing with 
corporate scandal involving Japanese mafia and some of Japan’s most powerful and elite. 
The taken-for-granted power imbalance that traditionally favours the anthropologist was 
reversed creating complex new ethical questions that were not yet explored in the literature. 
“What happens”, Edwards (2007, p.564) has asked, “when the power vector points in the 
other direction?” The novice researcher is left in uncharted waters, with little guidance on the 
ethical or methodological issues pertaining to researching those with more power than 
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ourselves. My aim is to contribute to the nascent conversation about the ethical challenges 
that may arise when one engages in this activity of studying up, across, and down. In 
particular, I explore some of the issues I confronted in the context of doing a multi-sited 
study with a heterogeneous mix of participants who had varying degrees of power vis-à-vis 
myself as researcher.   
 Arguing against the automatic adoption of anonymity of research participants, 
Walford (2005) suggests a process in which the participants are themselves given a platform 
in which to present their interpretation alongside the researcher, an idea previously put 
forward elsewhere by Lawless (1992). Such an exchange, in which the researcher and 
researched present ideas alongside one another, would indeed be another source of data and 
might possibly lead to ongoing interpretations.   
 Giordano el al (2007) considered the possibility of allowing participants the choice of 
maintaining anonymity and confidentiality. These authors describe the debate between 
retaining anonymity of participants and revealing identities as a collision between different 
constructs of agency. Giordano et al raise several important questions in the debate whether 
or not to offer the choice to refuse anonymity to participants. For example, is the participant a 
vulnerable participant who needs to be protected or is the participant also an individual, 
separate from the study, who may benefit from giving voice to their own experiences? Can a 
participant recognize and predict the implications and ramifications of choosing to be 
identified as a research participant? 
 The issue of choice regarding anonymity is made more complex when considering 
research with multiply positioned participants who are linked by association with one 
another. There is often an unspoken assumption that research participants in a single study 
are a homogeneous group (Edwards 2007). However, when purposefully including a diverse 
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range of participants is integral to your research questions, what might be ethical research 
practice for some participants may in fact confer risk, harm or stress on other participants 
within the same study. In my research on autism genomics, for example, allowing scientists 
to waive anonymity and naming the laboratory might, by association, implicate the few 
families who have received genetic feedback pertaining to autism involved in my research. 
While conducting fieldwork I came to realize that the scientists and clinicians who 
participated in my research had the expectation that they would be co-authors on publications 
that arose out of my dissertation. Journal articles in genetics begin with lengthy lists of 
authors, name after name, sometimes filling an entire page. Anyone who has contributed in 
any way is included as an author. Thus, of course, I came to realize it was natural for them to 
assume that by letting me hang out in their facility and clinic, interview them and generally 
take up their time they would expect to be authors on publications related to this project. I 
realized it would be a cultural faux-pas not to include them as co-authors and I would 
probably be regarded by them as “not playing by the rules”.  
 So the scientists and clinicians expect to be named, along with the laboratory and 
clinic sites. But what risk would their identification confer on the few families who have 
received genetic information from this laboratory and clinic? While some parents I 
interviewed had no problem being identified, indeed they openly appeared in journal articles 
previously published by the autism genomics researchers, there were other parents and 
families for whom anonymity was important. The issue of waiving individual anonymity 
reveals tensions and complex dynamics, not only between different groups of participants 
(scientist/clinician or family) but also within single families. One family, for example, had 
several adult siblings involved in the genetic testing process and two of these siblings were 
identified as being on the autism spectrum. During one of my observations, one sibling 
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revealed to the genetic counselor that he no longer wanted to be a part of the research. During 
this observation in which feedback was being given to the family, this individual looked very 
unhappy and had in fact been several hours late for the appointment. It seemed to me that he 
was attending the feedback session under duress, as other family members were very keen on 
the project.  
How would offering choice of anonymity work in this case, in which participants are 
related. Let us say, hypothetically, that one sibling chooses to be identified, waiving their 
right to remain anonymous. However, let us suppose that the other sibling does not want to 
be identified and wishes to remain anonymous. When the topic of the research is genetics, 
entire families are implicated by association with an individual who might choose to be 
identified. Identifying oneself as having a genetic marker associated with autism is also by 
extension opening the doors for speculation about one’s family members. While for one 
sibling, being identified might be an empowering and positive experience in the research 
process, for the other sibling identification may confer risk, harm or stress. Thus, the concern 
over offering participants the right to waive anonymity is more complex in the context of 
genetics as a tension could arise between an individual participant’s wishes and the 
preferences of other family members who may be implicated.  Nisker and Daar (2006) have 
suggested increased precautions and protections for individuals and family members in the 
context of genetics-based narratives. Likewise, the TCPS (2003) stated in Article 8.2,  
Because the potential for gathering genetic knowledge about biological 
relatives or groups by studying only a few individuals is unique to genetic 
studies, an individual may not be assured of privacy within the group, unless 
extra precautions are taken. 
 
Many of the scientists and clinicians who participated in my project expected to be 
identified, while some individuals diagnosed with autism and families expect to remain 
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anonymous. However, identifying scientists and clinicians (and therefore the particular 
laboratory and clinic) could also identify the individuals with autism and their families, of 
whom there are so few who have received feedback to date.  Again, the Tri-Council Policy 
Statement (2010) offers some help.  
In some instances, participants may waive anonymity (e.g., if they wish to be 
identified for their contributions to the research). Researchers should obtain the 
consent of these participants, and negotiate agreements with them that specify 
how they may be identified or recognized for their contribution. Where an 
individual participant waives anonymity but other members of the participant 
group object because identification may cause harm to the group, researchers 
shall maintain anonymity for all members of the participant group (2010, p.58).  
 
The implication of this TCPS statement for my research is that, despite scientists’ and 
clinicians’ expectation to be identified, I should maintain anonymity of all participants since 
some expect to remain anonymous. With so few people being given clinically significant 
genetic feedback to date, I feel that I must at least refrain from divulging the actual names of 
the hospital, laboratory, and clinic. Likewise, I have chosen not to include the names of 
participants, whether they are people working in the laboratory, clinic, or the names of 
individuals diagnosed with autism and their family members. While the descriptions of the 
spaces in which I carried out my research might be identifiable to those within the Canadian 
autism genetics community, and indeed the international community of genomics 
researchers, it is unlikely that anyone outside of the autism research group I studied would be 
able to identify specific families from the descriptions I provide in this dissertation. 
Moreover, sensitive to this issue of ensuring anonymity, this dissertation was printed out and 
couriered to examiners so as not to risk electronic transfer of information.  
What is more challenging, however, is trying to maintain anonymity of participants 
amongst each other. In practice, using a pseudonym alongside descriptions of the activities of 
participants does little to hide their identities from each other when there may be only one 
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project coordinator or a few psychology PhD students. What are the ramifications for 
“Claudia” who questioned the possible end uses of the genetic results or for the liaison who 
condemned the “cure speak” of the laboratory director? These participants talked about 
important issues that have yet to be openly discussed amongst members of the laboratory and 
clinic and dissemination of these findings could potentially instigate fruitful discussions 
therein. Alternatively, these questions raised by some participants could perhaps contribute to 
a straining of relations between these participants and the directors, their employers. While 
my consent form clearly stated that data and findings would be accessed by members of the 
research team (including the directors of the laboratory and clinic listed on the consent form), 
did the participants understand the ramifications of this, that their anonymity vis-à-vis their 
co-workers would be difficult to preserve?  
3.2 Tensions in the research process: anonymity? "thick 
description"? or something in between? 
Thus far in this chapter, I have tried to unpack some of the challenges to anonymity in 
the dissemination of qualitative research findings that include descriptive nuanced accounts 
of highly identifiable people and spaces. The process of working through the issues 
surrounding anonymity has brought into relief the inherent tensions in the research process, 
tensions between doing everything one can to protect anonymity of participants (such as 
using square brackets rather than the word autism) on the one hand and on the other hand, the 
value of in-depth, rich or "thick" descriptions of the particular contexts in which fieldwork is 
carried out. In anthropology, the discipline in which I feel most at home (although I have 
been nomadic in my PhD), there is great value in providing detailed and nuanced accounts of 
particular spaces and events and to unpack the complex socio-historical particularities of 
those spaces and events. Moreover, an Actor-Network Theory account requires descriptions 
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of the local assemblages of actors as they move from site to site. Maintaining anonymity 
could be difficult when recounting the detailed minutia of a setting in which actors come into 
contact with one another. As social scientists travel into new domains of research, including 
cutting-edge genomics, ethical issues, such as those surrounding anonymity, may require us 
to reconsider those practices which have traditionally defined us.  
 In Table 3.1 I have taken excerpts from my dissertation and considered how these excerpts 
might be re-written to strictly protect participants’ identities. The first example in Table 7.1 
illustrates how anonymity might be better protected by removing the name of the particular 
condition (autism) from the dissertation, such that the easily identifiable people and places 
associated with autism genomics research in Canada might remain anonymous.  A generic 
condition [-] is made to stand-in for the actual context in which field work was conducted. In 
the second example, details of the physical space in which my field work took place are 
truncated in order to hide the identity of Laboratory X from those within the broader autism 
genomics research community who have visited Laboratory X for annual meetings. In the 
third example, the types of activities and work that occur in the Laboratory are deleted as is 
the number of employees, as the fee-for-service facility and the magnitude of the staff may 
be another way for readers to figure out where the research was conducted.  
Table 7.1 
Anonymity Protected Description and Contextual Information 
Preserved 
1.   i) Individuals diagnosed with [        ] and 
their family members give blood in the 
blood lab located on the main floor of the 
hospital. The genetics project 
coordinator, Claudia from the [       ] 
Clinic, typically walks them over to the 
triage area in the new atrium of the 
hospital. 
 
1. i) Individuals diagnosed with autism and 
their family members give blood in the 
blood lab located on the main floor of 
the hospital. The genetics project 
coordinator, Claudia from the Autism 
Clinic, typically walks them over to the 
triage area in the new atrium of the 
hospital. 
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ii) Thus, the genetic variation in one 
individual with [    ] is likely to be 
distinct from the genetic variance of 
another individual with [    ]. In 
reviewing the literature, several genomic 
loci were described as contributing to 
susceptibility for [    ]. 
iii) I often wonder does that gene 
impact on, my question, I have a 
number of questions. So what it 
does is it brings forth more 
questions about myself. So 
because I have the gene I am the 
carrier or do I have [      ] on a 
lower part of the spectrum? What 
does it exactly mean is my 
question?  
 
 
 
 
ii) Thus, the genetic variation in one 
individual with ASD is likely to be 
distinct from the genetic variance of 
another individual with ASD. In 
reviewing the literature, several genomic 
loci were described as contributing to 
susceptibility for ASD. 
iii) I often wonder does that gene impact 
on, my question, I have a number of 
questions. So what it does is it brings 
forth more questions about myself. 
So because I have the gene I am the 
carrier or do I have autism on a 
lower part of the spectrum? What 
does it exactly mean is my question?  
 
2. i)The laboratory is housed in a Medical 
Research Centre. It’s on my right as I 
walk along Rainier Street now. A 
beautiful old building sits stalwart on my 
right. A shadow is cast down on the 
rugged stone bricks by a tall, smooth, 
modern tower now joined at a seam onto 
the far end; this is the Medical Research 
Centre. As I approach, a custodian is 
cleaning the glass of the revolving doors 
so I push open the swinging door. The 
noisy street is shut behind me and my 
footsteps echo in the vast foyer as I walk 
through toward the elevators. To my right 
is a set of stairs that leads down into the 
food court, the underbelly that joins the 
research tower to the hospital. I know if I 
head down the stairs the tables will be 
full with groups of people huddled 
together around laptops, chatting over 
morning coffee from Timmies. 
 
ii) Several framed photos hang from the 
walls at regular intervals. On closer 
inspection, they are not just photos but 
actually the covers of journals related to 
2   i)The laboratory is housed in the Medical 
Research Centre. It’s on my right as I 
walk along Rainier Street now. As I 
approach, a custodian is cleaning the 
glass of the revolving doors so I push 
open the swinging door. The noisy street 
is shut behind me and my footsteps echo 
in the vast foyer as I walk through toward 
the elevators. 
 
 
 
 
 
 
 
 
 
 
 
 
 
ii) 
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genomics or the first page of articles 
published by Laboratory X employees. 
One of the frames contains a photo with 
humans: two children – twins – one 
with the phrase “I’m with Nature” and 
the other with the phrase “I’m with 
Nurture” written in block letters on 
their matching T-shirts. 
 
 
3. About one hundred people work here at 
the Laboratory X, with the vast majority of 
those working in the service facilities. This 
is the business part of the facility which 
conducts fee-for-service genomic work. 
Only about ten or fifteen people are part of 
the academic team, which consists of 
principle investigators, post-docs and 
graduate students. 
 
3. Only about ten or fifteen people are 
part of the academic team, which consists 
of principle investigators, post docs and 
graduate students. 
 
The purpose of this table is not to indicate how descriptive social science research 
should proceed with regard to protecting anonymity. Rather, my aim is to highlight the 
competing tensions in the research process that emerge when studying easily identifiable 
people and places. In my own case, it took time for me to gain an understanding of how the 
research site is positioned in relation to the broader national and international context. Upon 
entering the field I was not aware of how special and unique my particular field site was and 
thus I did not anticipate in advance the challenges involved in maintaining anonymity. It was 
only through the process of writing detailed descriptions (Richardson, 2004) that I came to 
understand the complexity involved in maintaining anonymity within descriptive social 
science research about easily identifiable participants. The two research ethics boards from 
which I obtained approval to carry out this research also did not probe me to think about this 
issue. 
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The statements in the Letters of Information indicate that no personal information 
about participants will be published and yet through the descriptions and contextual 
information about the field sites made throughout my dissertation personally identifying 
information could be figured out. In the lengthy ethics protocol submitted to the hospital 
ethics board I indicated that only pseudonyms would be used in place of the actual names of 
Laboratory X and the Autism Clinic. However, the data sharing agreement between the 
hospital where my research was carried out and my university ethics board contains back-to-
back contradictory statements that underline the difficulty in safeguarding anonymity while 
meeting expectations for authorship. This data sharing agreement demands that I: i) not 
include personally identifying information, and ii) include investigators (lab and clinic 
directors) as authors in publications (thereby disclosing their identity as well as their 
institutional affiliation). Figure 3.1 illustrates that exact phrasing pertaining to confidentiality 
that was used in the Letters of Information and Data Sharing Agreement. 
Figure 3.1: Ethics Documents Statements Pertaining to Confidentiality 
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 Thus, the Letters of Information and REB submission promise to protect the identity 
of participants. However, descriptive details about the study sites along with nuanced 
accounts of the activities carried out by particular individuals may reveal the identity of 
participants to some readers. Furthermore, the data sharing agreement undermines these 
precautions being taken by suggesting that some participants (Directors of the laboratory and 
clinic) should be named as authors on publications, thereby revealing the names of the 
particular field sites.  
As descriptive social science moves into field sites such as cutting-edge genomics 
where participants may be easily identified how can the friction between a descriptive 
methodology and the need for anonymity be lessened? What steps should be taken to satisfy 
Letter of Information for Families 
We will respect your privacy. No information about who you are (your child is) will 
be given to anyone or be published without your permission, unless required by 
law. 
Letter of Information for Scientists and Clinicians 
We will respect your privacy. No information about who you are will be given to anyone 
or be published without your permission, unless required by law. 
REB Submission 
As an additional precaution to uphold confidentiality, the name and location of the 
laboratory and clinic will not be given in JB’s dissertation or any written presentations 
of this research; instead pseudonyms will be used. 
Data Sharing Agreement 
RECIPIENT shall not include any personally identifying information in any publication 
or presentation. [Hospital] Investigator’s contribution to the Study and authorship 
contributions, as applicable, shall be acknowledged appropriately in any such 
publication or presentation in accordance with academic standards. 
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these documents and at the same time provide the nuanced descriptions and depth which 
make the research meaningful within a particular context? How do I comply with 
expectations for confidentiality and anonymity while at the same time meet the academic 
expectations surrounding authorship? Does the consent process need to change in order to 
inform participants about the limitations to anonymity in descriptive research that “studies 
up”? My research brings to the foreground the complex implications of engaging in 
descriptive methodologies amongst highly visible or easily identifiable participants with 
regard to anonymity and the need for a greater awareness of this issue amongst research 
ethics boards.  
3.3. Expectations of Research Participants 
While anonymity is my primary concerns in this chapter, there is one other issue to 
briefly address in relation to “studying up” that provoked my discomfort and concern at 
various times throughout my research. At times, I struggled with the interrelated issue of 
loyalty to my participants and “for whom is this research being written?” (Priyadharshini, 
2003).  For example, I have a particular interest in knowledge translation, specifically in 
developing new conceptual models of KT based on a constructionist philosophical 
foundation. Approaching KT from this lens has enabled me to interpret my field notes about 
observations and interviews in a way that is probably unfamiliar and unanticipated by the 
participants. For example, exploring knowledge as being constructed rather than discovered 
might be received as a critical attack on the values and assumptions underlying much of the 
work in the laboratory and clinic. I worry that not only might the participants not agree with 
my interpretation but that they would also not find such discussion valuable.  
Priyadharshini (2003) has previously discussed this issue. He stated. “subtle constraints 
imposed on my research from the point of gaining access to the end of fieldwork contained 
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my natural inclinations and made it harder for me to wear the badge of critical researcher…” 
(2003, p.426).  These subtle constraints about which Priyadharshini writes were present in 
my fieldwork experience as well. For example, early on, while establishing the laboratory 
field site I had a meeting with the director of Laboratory X. He made a passing remark at 
some point in our brief meeting that they did not need another theoretical or philosophical 
piece but rather he felt the findings should be “practical”. This brief statement caused me 
great concern over the course of my research. Will he find this dissertation “practical”? To 
me, thinking through knowledge translation from a different philosophical position is 
practical. It has practical implications for how KT is approached. I feel that my integrity as a 
researcher would be compromised if I were not able to critically explore the assumptions 
underpinning much of the work currently being done in the area of KT.  On the other hand, 
those who participated in my project gave their time generously and I feel an obligation and a 
desire to have them appreciate the work I have done. I would hope that my research would 
have some meaning or use to the participants. What kind of loyalty or allegiance is assumed 
when you are allowed access to a field site?  What responsibility do I have as a researcher to 
ensure that my findings have some sort of practical utility, that they reciprocate in some way 
for the many hours the scientists and clinicians have given me as research participants? These 
are questions that are equally important to researchers who are not “studying up”. Further, 
knowing that your participants can and probably will engage with what you have written and 
that they have the power to respond in an articulate and scholarly way is a sobering thought 
that makes these questions about loyalty and expectations all the more poignant to the 
fledgling researcher.   
In this chapter I have discussed the concept of anonymity as it relates to multiple sets 
of research participants in new and emerging sites of inquiry where "studying up" brings to 
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the foreground a tension between methodological rigor and research ethics.  In addition, 
questions surfaced regarding loyalty to participants and negotiating participants’ expectations 
alongside a researcher’s individual interests and aims. This chapter raises more questions 
than it answers and I suspect many of these issues will be ongoing in the future as I prepare 
sections of this dissertation for journal publication.  Far from presenting tidy answers and 
conclusions, this chapter merely opens up a discussion about some of the ethical complexities 
that have emerged through an anthropologically-inspired study of genomics. 
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Chapter 4 
Inside-Out and Upside-Down: Tumbling into the World of 
Autism Genomics 
 
In this chapter, I will first briefly familiarize the reader with how autism is diagnosed 
today and some of the statistics pertaining to prevalence and incidence. While my research 
was not focused on issues of diagnosing autism (all of the proband participants had been 
previously given a clinical diagnosis of autism before engaging in genetic research) the 
clinical tools and technologies engaged in the process of diagnosis were very important 
actors in the network of the autism clinic in so far as they were used to establish an 
individual’s phenotype. Thus, this initial introduction of the diagnosis of autism will be 
followed in later chapters by a more in-depth description and discussion of some of the tools 
involved in the diagnostic process.  
 The second aim of this chapter is to provide the reader with a background 
understanding of the current genomic practices within which autism is being constructed 
today. An overview of the current genetics literature related to autism will prepare the reader 
with a baseline understanding of autism genetics to facilitate in following the descriptions 
presented in the subsequent chapters.  
4.1. Diagnosing Autism Spectrum Disorder 
4.2. Genomic Constructions of Autism 
 a) Research Paradigms 
 b) Linkage and Association Studies 
 c) The “Multiple Hit” Model 
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4.1. Diagnosing Autism  
According to the DSM-IV, the umbrella term of Pervasive Developmental Disorders (PDD) 
is comprised of five related clinically defined categories. Three of these categories compose 
what is commonly called the autism spectrum, including: Autistic Disorder, Asperger's 
Syndrome (AS), and Pervasive Developmental Disorder Not Otherwise Specified (PDD-
NOS).  Rett disorder and childhood disintegrative disorder (CDD) are less common but 
included within PDD. Moreover, a broad autism phenotype (BAP) has recently been applied 
to label subtle cognitive or behavioural attributes that are similar but less severe than those 
exhibited in Autism Spectrum Disorder (ASD) patients (Freitag, 2007). The diagnosis of 
ASD has become standardized with two instruments: the Autism Diagnostic Interview-
Revised (ADI-R) (Lord, Rutter, & Le Couteur, 1994) and the Autism Diagnostic Observation 
Schedule (ADOS) (Lord, 1989). 
Leo Kanner first identified autism in 1943 (Kanner, 1943). Originally, Kanner 
defined "autism" based on two criteria: "autistic aloneness" and "insistence on sameness" 
(Kanner & Eisenerg, 1956). Recent diagnostic criteria for autism, as it is described in the 
American Psychiatric Association's DSM-IV (American Psychiatric Association, 2000) and 
the World Health Organization's International Classification of Functioning, Disability, and 
Health (ICF) (World Health Organization, 2001), are structured around the three core areas 
of social impairment, communication difficulties, and rigid and repetitive interests and 
activities. Typically, onset occurs before age three (Gillberg & Coleman, 2000). Asperger's 
syndrome is diagnosed when individuals meet the criteria, but without showing language 
deficits or "mental retardation"2 (Lord & Spence, 2006). Many people with Asperger's 
syndrome may be regarded by their peers as odd, but not perceived as psychiatrically 
abnormal (Gillberg & Coleman, 2000). A diagnosis of PDD-NOS indicates milder 
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difficulties (Lord & Spence, 2006).  
 Nadesan (2005) has traced the historical changes in the classification of "autism", 
drawing attention to recent broader and more inclusive criteria for diagnosis which has led to 
the notion of a continuum or spectrum. Kielinen et al (2000) described a striking variation in 
the rates of "autism" that result when different diagnostic criteria are applied to the same 
survey data. It behoves us to bear this in mind when comparing measurements reported 
across time; different diagnostic criteria can result in radically different epidemiological 
statistics.  For example, incidence (the number of new cases in a population over a period of 
time) is difficult to determine with diagnoses on the "autism" spectrum as several variables 
(i.e., changes in diagnostic criteria, increased public awareness and improved service 
availability) have not remained constant over time. Fombonne (2005) warns that upward 
trends in prevalence (the proportion of individuals in a population with a disorder) cannot be 
attributed to increased incidence because of the aforementioned variables. The prevalence 
estimates of Autistic Disorder is approximately 13 / 10 000 (Fombonne, 2005). Prevalence 
rates for Asperger's is about one fifth that of autism, approximately 2.6/ 10 000; however, 
epidemiological studies of Asperger’s are very sparse, as it was only recently acknowledged 
as a separate diagnostic category (Fombonne, 2006). Meanwhile, PDD-NOS has a prevalence 
rate of about 20.8 / 10 000 (Fombonne, 2005). Most of the available statistical data which 
support prevalence rates are based on surveys conducted in urban areas (Fombonne, 2006). 
There is also a marked sex differentiation in autism, with a 4:1 male to female ratio 
(excluding Rett syndrome which is more common in females) (Bartlett, Gharani, Millonig, & 
Brzustowicz, 2005). 
 Comparing measurements of an ASD diagnoses is further complicated by the possible 
political ramifications of attaching this label or code to a child. Grinker (2007), for example, 
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highlights that an ASD code will usually get your child more services that benefit him - more 
hours of speech therapy, more aide support, more of almost everything the school has to 
give" (2007, p.267). Thus, a diagnosis may be sought in some situations. Defining and 
measuring "autism", therefore, is a complicated endeavour with many factors to be taken into 
consideration.  
4.2. Genomic Constructions of Autism 
 
In the 1970s, the first twin studies were conducted showing a significant difference 
between monozygotic and dizygotic concordance (Rutter, 2000). A major shift in the 
conceptualization of autism and its causes began to occur. Twin studies replicated these 
findings in the 1980s and 1990s presenting a 60% concordance rate for autism in 
monozygotic twins compared to a 5% rate in dizygotic twins (Rutter, 2000). Current 
heritability estimates for ASD are ~90% (C. Marshall et al., 2008), suggesting that "autism is 
one of the most heritable neuropsychiatric disorders" (Bonora, Lamb, Barnby, Bailey, & 
Monaco, 2006, p.51).   
 While there have been major advances in the study of genetics over the last decade, 
for example the mapping of the human genome and new technologies such as micro array 
analysis, there remains much to be explored in the aetiology of "autism" (Bonora et al., 
2006). According to Pickler and Elias (2009) there are currently over two dozen genetic 
syndromes (e.g., Fragile X syndrome, Angelman syndrome and Rett syndrome) that have 
been associated with "autism", likely because "autism" is defined by such a heterogeneous 
mix of behaviours. Given this heterogeneity it is most likely that a large number of genetic 
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variations and possible epigenetic occurrences are involved in the development of ASD 
(2006).  
4.2a Research Paradigms 
 Genetic research in the area of autism is typically conducted within one of two 
paradigms: common disease-common variant and common disease-rare variant (Cook & 
Scherer, 2008). The common disease-common variant model is oligogenic in that it assumes 
disease results from "the combined action of multiple interacting genes" (Abrahams & 
Geschwind, 2008, p.342). In this model, it is assumed that multiple alleles that are common 
to the general population each contribute small effects to the phenotype. Distinct 
characteristics of ASD (e.g., communication difficulties or repetitive and rigid behaviour) are 
related to independent genetic factors (Happe & Ronald, 2008; Ronald et al., 2006). This 
model has been supported by linkage studies indicating different locations for various traits 
or characteristics of "autism" (Schellenberg et al., 2006). Risch et al (1999), for example, 
argue for at least 15 susceptibility loci. Happe and Ronald (2008) described the idea of the 
"fractionable autism triad"; the idea of fractionability suggests that "different genetic loci 
may be associated with the different core behaviours that currently define the autism 
diagnosis" (Happe & Ronald, 2008). These authors raise the question of whether autism 
should really be conceptualized on one continuum, "or whether each individual should be 
mapped in a three dimensional space along three, perhaps orthogonal, dimensions: social 
interaction, communication, and RRBIs [rigid and repetitive behaviours and interests]" 
(Happe & Ronald, 2008, p.299). The implications of the common disease - common variant 
model of autism are that genome-wide association studies which look for susceptibility genes 
would be more successful if they geared their search towards specific behaviours within the 
autism triad rather than searching for genes underlying autism as a whole.  One of the key 
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challenges is the difficulty to define the phenotype, especially considering the broad 
spectrum of autism. Such a diverse and variable set of characteristics and behaviours would 
likely involve genetic heterogeneity, as well as epigenetic factors. Bartlett et al (2005) have 
considered this difficulty and stated: 
While phenotypic heterogeneity does not necessarily imply genetic 
heterogeneity, the breadth of phenotypic variation, which cannot solely be 
accounted for by any one etiological theory, and the linkage findings converge 
on the same conclusion, that autism is not a unitary phenomenon (Bartlett et al., 
2005, p.224). 
 The task is complex as genetic effects may operate on components of autism rather 
than at a syndrome or diagnostic level (Rutter, 2000). As Abrahams and Geschwind (2008) 
have suggested, "diagnostic categories used in clinical practice might not properly represent 
underlying genetic risk". Thus, the clinical diagnosis of autism can be thought of as a 
grouping of characteristics or traits which are not necessarily held together by the same 
genetic and biological markers. 
 Conversely, the alternative common disease-rare variant model emphasizes 
overlapping risk factors (Pritchard, 2001). This rare variant hypothesis posits that many 
alternative rare variants underlie susceptibility to common complex conditions (Cook & 
Scherer, 2008; Pritchard, 2001). Recent work in the area of ne novo (spontaneous) copy 
number variations (CNVs) is rooted in this model (PGCC Committee, 2009). (This common 
disease-rare variant model was the model that guided the research in Laboratory X, where I 
conducted my fieldwork for the present dissertation.) Copy number variations may include 
deletions or duplications of DNA segments. Several studies have examined whether copy 
number variations are more frequent in case subjects versus comparison subjects. For 
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example, Sebat et al (2007) found increased rare de novo (spontaneous) copy number 
variants in case subjects (10%) versus comparison subjects (1%). Several studies have also 
reported an increase in deletions or duplications on chromosome 16p.11.2 in case subjects 
versus comparison subjects (Kumar et al., 2008; C. Marshall et al., 2008; Weiss et al., 2008). 
While researchers typically work within one or the other model (common disease - common 
variant or common disease - rare variant), Abrahams and Geschwind (2008) have 
commented on the necessity for the integration of findings from each of these models. 
I learned, when talking with a post-doctoral fellow in Laboratory X, that this distinction 
between  theoretical approaches is also accompanied by a slight difference in language. 
Whereas those using the common disease- common variant hypothesis tend to talk about 
“polymorphisms” (single nucleotide polymorphisms or SNPs), scientists who adopt the 
common disease- rare variant model tend to use the word “variant” (SNVs). During my 
fieldwork it seemed that people were using these terms interchangeably. When I asked a 
post-doc if there was any real difference between SNPs and SNVs this was her response:  
Ahhh!  This is something that I find very irritating because many people are 
rather loose in their use of polymorphism and variant. It’s all about frequency; 
so a polymorphism (ie a SNP) is generally taken to be a position that varies 
commonly in the population usually with a given minimum frequency (eg 1%, 3% 
or 5%). Whereas a variant is something that is more rare and may never have 
been described before. 
4.2b Linkage and Association Studies 
 An alternative way to unpack the genetic construction of ASD is to examine how 
genetic-related conditions are explored. Linkage studies and association studies are two 
primary means of analyzing the relationship between genotype and phenotype (observable 
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expression of genes). The purpose of linkage studies is to map genes in families in order to 
locate susceptibility genes. Linkage studies concentrate on affected sibling pairs in multiplex 
families (Abrahams & Geschwind, 2008). Linkage is defined as "the tendency for alleles 
close together on the same chromosome to be transmitted together, as an intact unit, through 
meiosis" (Freitag, 2007, p.7). Lander (1996) proposed that most single nucleotide 
polymorphisms (SNPs) are ancient and common to most people in a population. SNPs 
become common because they are neutral or favourable to survival and get passed down to 
the next generation; however some may have harmful effects. Linkage analysis, then, starts 
with a particular phenotype found in families and then tests genetic locations on the genome 
to find linkage between genes and phenotype (Bartlett et al., 2005). Linkage has also been 
called reverse genetics, as the scientist moves from the phenotype back to the genotype 
(Bartlett et al., 2005). Several chromosomal regions have been linked to an ASD phenotype. 
Some linkage studies have stratified their sample of individuals with regard to phenotypic 
traits. From these studies, chromosome 2q and 7q35 appear to influence language 
development, while 1q is linked with obsessive-compulsive behaviour (Freitag, 2007). Thus, 
according to linkage studies, different components of autistic behaviour may have different 
underlying causal factors. The difficulty with linkage studies is that any one gene has a small 
overall effect size. Thus, it may be difficult to achieve statistically significant results.  
 Association studies start with the genetic or genomic information (genotype) and then 
search for associations with phenotypes. In other words, they are genotype-driven rather than 
phenotype-driven. Association studies use high-resolution microarray technologies to detect 
balanced and unbalanced structural variants or copy number variations (CNVs) (C. Marshall 
et al., 2008). CNVs involve segments of DNA that are at least 1 kb in size. Balanced 
variations involve no loss or gain of genetic material (Buchanan & Scherer, 2008). 
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Unbalanced variations included deletions or replications. Locus 1q21.1, for example, is 
associated with duplications in a form of ASD (Cook & Scherer, 2008). CNVs can be de 
novo (spontaneously arising rather than being transmitted by a parent) or they can be 
inherited. Adding to this complexity, the position or context of CNVs within the genome can 
influence expressivity or penetrance (Buchanan & Scherer, 2008). 
 Marshall et al (2008) reported a 7.1 % and 2% rate of de novo CNVs in simplex and 
multiplex families compared with a <1% spontaneous CNV mutation rate in non-disease 
samples. These authors found that CNVs in ASD are often in loci with genes functioning in 
postsynaptic density and regions associated with mental retardation. SHANK3, NLGN4, and 
NRXN1-PSD are three genes involved in synaptic functions and have been shown to have 
CNVs in ASD probands. Berkel et al (2010) found de novo copy number variations in the 
SHANK2 synaptic scaffolding gene in patients with ASD and mental retardation (MR). Two 
loci for ASD CNVs overlap with mental retardation. In particular the 16p11.2 CNV region 
was found at almost 1% frequency in ASD samples and not controls (C. Marshall et al., 
2008).    
4.2c The “Multiple Hit” Model 
According to Leblond et al (2012), while there are many diverse causes of ASD, the 
“main category of genes associated with the disorder is related to development and function 
of neuronal circuits.” Genes such as neuroligens (NLGN), neurexins (NRXN) and SHANK 
are important for formation and stabilization of synapses and coding for scaffolding proteins. 
Mutations in these genes have been widely reported in patients with ASD. The “multiple hit” 
model suggests that the co-occurrence of deleterious variations in multiple genes could act 
together in the same pathway to increase the risk of ASD. For example, Leblond et al (2012) 
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suggested that the NRXN-NLGN-SHANK pathway and CNVs in the 15q11-q13 might 
together increase susceptibility to ASD. Recent data suggest that common genes/ pathways 
are being identified across a broad range of neurodevelopmental disorders. For example, 
ASD, schizophrenia, ADHD, and obsessive compulsive disorder all have overlapping 
susceptibility regions (C. Marshall & Scherer, 2012).  Lionel et al (2011) stated that there 
seem to be “common genes and pathways implicated in several disorders…[suggesting that]  
different human disease-phenotype groups might arise from overlapping molecular 
causation”. 
 Specific genes thought to be associated with "disease" are called candidate genes. 
There is no single gene for ASD; rather, there appear to be several different regions in the 
genome that may confer susceptibility to ASD when perturbed. For example, Levy et al 
(Levy & et al., 2011) stated: 
A striking finding of all the studies of de novo mutation in children with ASDs is 
the apparent number of distinct target loci. Even discounting 25% of events as 
incidental (based on a 2% frequency in sibs and 8% in probands), there are a 
large number of target regions and few recurrences. Only CNVs at 16p11.2 are 
present in more than 1% of cases (ten out of 858 children).  
 
Thus, the genetic variation in one individual with ASD is likely to be distinct from the 
genetic variance of another individual with ASD. In reviewing the literature, several genomic 
loci were described as contributing to susceptibility for ASD. For example, using extended 
family pedigrees from 42 extended ASD families, Salyakina et al (2011) reported twelve loci 
that co-segregated with disease which may be involved in ASD susceptibility. Screening for 
CNVs is often used as a method for identifying susceptibility regions in the genome.  
 One of the most recurring regions for variants in ASD is called 16p11.2. This region 
has been described by Čiuladait÷ et al (2011), Kumar et al (2008), Marshal et al (2008), 
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Weiss et al (Weiss et al., 2008) and Barge-Schaapveld et al (2011).  Ciuladaite et al (2011), 
for example, suggested that the 16p11.2 deletion is a recurrent genomic event and a 
significant risk factor for autism. However, a deletion in the 16p11.2 region is associated 
with a wide range of clinical phenotypes. Deletions in the 16p11.2 locus are risk factors for a 
variety of developmental and psychiatric conditions, such as MR (mental retardation), ASD, 
attention deficit hyperacativity disorder (ADHD), language delay and seizures (Ciuladaite et 
al 2011).   
Recently, CNVs have also been found in individuals with ASD at the x-linked 
PTCHD1 locus (Pinto et al., 2010). All of these variations were inherited from unaffected 
mothers. Marshall and Scherer (2012) have suggested that these X-linked variants may 
provide an explanation for the skewed male to female ASD diagnoses. Females, with two X 
chromosomes, are protected by CNVs in this region; whereas males, with only one X 
chromosome, are not protected.  
 Given the range of loci involved in ASD, a “threshold” model has been proposed to 
understand the role of CNVs in ASD (Cook & Scherer 2008).  Marshall & Scherer describe 
this threshold model as follows: 
Some CNVs have a large impact on ASD susceptibility and these are typically de 
novo in origin, cause more severe ASD symptoms, are more prevalent among 
sporadic forms of ASD, and are less influenced by other factors like gender and 
parent of origin. Other CNVs have moderate or mild effects that probably require 
other genetic (or non-genetic) factors to take the phenotype across the ASD 
threshold (C. R. Marshall & Scherer, 2012; C. Marshall & Scherer, 2012). 
Devlin & Scherer (2012) have suggested a possible multigenic threshold model for ASD in 
which multiple CNVs, smaller sequence variants, and variants in apparently non-coding 
105 
 
regions of the genome (intron) may all interact. This gene-gene interaction may work to push 
an individual over the ASD threshold.  
 The diverse phenotype and complex aetiology of ASD make replication of study results 
a difficult task. Bartlett et al (2005) explain two key concepts that have an enormous impact 
on the possibility for replication of findings. Locus heterogeneity describes a situation in 
which different genes may be involved in causing the same disease in different individuals. 
Allelic heterogeneity implies that different alleles of the same gene may confer susceptibility 
to the same phenotype. Thus, it is very difficult to achieve replication of a positive 
association between a candidate gene and autism. This challenge is compounded when one 
considers possible environmental exposures (Hertz-Picciotto et al., 2006; Lawler, Croen, 
Grether, & Van de Water, 2004) and multiple interacting genes.  
 The technology to assay the entire human genome has instigated a transition in the 
way scientists think about disease, highlighting the need to simultaneously integrate 
information from many sources. Paradoxically, while the sensitivity and resolution of new 
genetic technologies improve and enable scientists to interrogate specific alleles on particular 
genes, there is also an increase in uncertainty about the nature of disease.  According to 
Schaaf & Zoghbi (2011), rare de novo CNVs account for 7-20 % of individuals with ASD, 
single gene disorders account for 5-7 % and metabolic disorders account for approximately 
5% of ASD cases. This leaves at least 70% of all ASD cases for which a genetic cause cannot 
yet be identified. Schaaf & Zoghbi further stated, “It is very likely that there will be hundreds 
of autism genes and proteins; thus designing treatments for ASDs tackling one gene at a time 
will be a challenge” (Schaaf & Zoghbi, 2011). Marshall & Scherer (2012) have specified that 
the challenge is in the correct interpretation of the clinical significance of each variant. To 
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address this challenge, the International Standards for Cytogenetic Array Consortium has 
established a working group to develop an evidence-based process for evaluating and 
interpreting genetic finding so that they can be used to inform clinical practice (Riggs et al., 
2012). Moreover, knowledge translation amongst scientist, clinicians and the public is 
increasingly being recognized as an important aspect of genomic research (Zwaigenbaum et 
al., 2011). 
 In reviewing the complex genetic aetiology of ASD, the need for research describing 
the process of translation amongst basic science, clinical, and family milieus is made evident. 
Drawing on concepts such as ontological multiplicity and the mangle of practice, outlined in 
the previous chapter, the remainder of this dissertation will explore the processes involved in 
translating amongst the heterogeneous groups of people, practices, places and objects that 
partially connect through the overlapping networks of the Autism Genetics Study at the 
particular sites in which I conducted fieldwork.   
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Chapter 5: Translation as Transformation 
[B]ehind the texts, behind the instruments, inside the 
laboratory, we do not have Nature, not yet…what we have is 
an array allowing new extreme constraints to be imposed on 
'something.'"  
(Latour, 1987, p.89) 
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5.1 Setting the Stage  
 
The dry heat of the office building gives way to the cold November air as I push 
through the revolving doors onto High Street West. The wind feels crisp against my face as I 
step further out onto the sidewalk. Inhaling, I catch a brief hint of fragrant spices from the 
little East Indian restaurant across the road. A long line of cars stretches beside me as I walk 
quickly along the bustling, morning rush-hour sidewalk and round the corner onto Peele Ave. 
A large group of ESL students huddles outside the door of an International School. I weave 
through them and quicken my pace, hoping to catch the walk signal ahead. Just missed it. 
Standing at the corner waiting for the light to change, I can see the boney, finger-like 
branches of the trees reaching up around the hospital. As if misplaced by summer, two 
bronze women in sundresses hold down a bench, blossoming and rounded with their 
sculptured children playing at their feet. Four other hospitals huddle up to the street in this 
one small stretch of the block; if one was ever to find herself ill or injured, surely this would 
be the ideal location.  
Passing a half-empty bank of Bixi bikes, I walk a little further and turn right on 
Rainier Street. It’s 9:00 am and I’m heading to Laboratory X to find out if I can observe 
anything this morning. I’ve just come from the Autism Clinic and I have a follow-up 
interview scheduled in an hour from now with one of the genetics post-docs. The laboratory 
is housed in a Medical Research Centre. It’s on my right as I walk along Rainier Street now. 
A beautiful old building sits stalwart on my right. A shadow is cast down on the rugged stone 
bricks by a tall, smooth, modern tower now joined at a seam onto the far end; this is the 
Medical Research Centre. As I approach, a custodian is cleaning the glass of the revolving 
doors so I push open the swinging door. The noisy street is shut behind me and my footsteps 
echo in the vast foyer as I walk through toward the elevators. To my right is a set of stairs 
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that leads down into the food court, the underbelly that joins the research tower to the 
hospital. I know if I head down the stairs the tables will be full with groups of people 
huddled together around laptops, chatting over morning coffee from Timmies. Many of them 
have probably been working for hours already, taking a break before heading back to the 
hospital or up to one of the laboratories in the tall medical tower.  
Approaching the bank of elevators, I push the “up” button and see a poster 
advertizing an upcoming colloquium on stem cell research. The elevator dings and the shiny 
metal doors open. Several other people step into the elevator with me. There are sixteen 
floors and Dr Lorenz’s laboratory is on the fourteenth. All of the people in the elevator have 
name tags hanging around their necks, partially obscured by scarves and winter jackets. 
Some people are quietly talking about the snow forecast for later this week while three others 
appear to be deep in conversation about a recent conference. The elevator stops at several 
floors before the fourteenth. As the others step off the elevator they each pull out their name 
badge and swipe it across a security scanner to unlock an interior set of heavy beige doors 
before they can enter into the laboratories awaiting them.  
 The elevator dings for the fourteenth floor and I step out. It looks different from the 
other floors we’ve just passed through with their prosaic beige paint and uninviting locked 
doors allowing only a few to enter. Here, there is a black leather bench perched in front of a 
window as you step off the elevator and green leafy ferns in shiny black planters adorn the 
corners. It’s quiet. The clean foyer is bathed in natural light from the large square window, 
deeply recessed in the end wall. The heavy, security-protected double doors are wide open, 
inviting customers to enter. To the right of the double doors, slightly obscured by a plant, 
there is a sign warning that ‘This facility is under video surveillance’. The floor is glossy 
grey with a brightly coloured helix pattern winding through it, a subtle indication of the work 
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being done here.  
This is what Erving Goffman (1959)  would call the “front stage” of the laboratory. Clean 
and bright with carefully planned signs telling the client or visitor that this lab is well-
funded, high-tech and state-of-the art. All of the messiness of doing genomics takes place 
“back stage”, behind the glass wall of the laboratory or behind closed-door conference room 
discussions. 
I follow the helix pattern through the inner double doors and pass a large window 
with sliding glass doors on the left with a sign above that reads “DNA sample drop-off”. All 
the samples that will eventually end up in the lab have to first pass through this window. The 
samples come from a variety of places; some from the DNA extraction lab in the hospital 
down the street that I just walked past a few minutes ago. Other samples are mailed from 
cities across Canada or from other countries. They can be from blood, tissue, or saliva. With 
luck the samples have been stored properly in the little glass tubes as they have made their 
various journeys to this window. If caps were not screwed on tightly they might have spilled 
and technicians will have to try to collect any remnants remaining in the surrounding 
package.  
I look at the clock on the wall inside the small office on the other side of the drop-off 
window: 9:15. Brittany looks up and sees me. I wave and she smiles before turning back to 
her computer screen. Brittany is in her late thirties and has a PhD in molecular biology. She 
is thin, angular, but her soft, quiet voice bends in an unexpected way. She is precise, detailed, 
meticulous in the way she manages all of the records, accounting for all the samples that 
have been dropped off and delegating them to the various technicians in her the lab. She 
spends most of her time in this little office, receiving samples and managing the workflow of 
the microarray facility. One of her main tasks is to organize and keep track of all the orders 
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coming in on the Laboratory Information Management system, or LIMS. She is busy at this 
time of morning, as many samples have been dropped of by technicians as they begin their 
work day. The samples will continue to pass through the drop-off window all day. I continue 
to walk past the window. 
 If you were standing here beside me and looking straight ahead, you would see the 
laboratory, through a huge transparent glass wall. On the door leading to the laboratory there 
is a Biohazard sign that says “containment level 2”. There is also a sign informing 
sequencing costumers to proceed to aisle N. Through the glass, you would see rows and rows 
of machines with people wearing white lab coats and safety glasses standing bent over their 
work benches or perched atop stools gazing at computer monitors. The walls are white and 
the ceiling is made from white ceiling tiles interspaced with florescent lights. You would see 
that the laboratory is very bright, that the opposite side of the laboratory is also made of a 
large wall of windows letting in ample natural light even on this grey November day.  The 
main part of the lab is just one large room divided by several aisles. Each aisle seems to 
loosely correspond to a certain activity; for example, there is an aisle where all the 
microarray data is done and another for Next Generation Sequencing (NGS).  
Figure 5.1: Wet Laboratory 
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Now, if you were to turn your head to the right and look down the hallway, 
immediately to the right you would see a swipe card machine for people to clock in and out 
as they start and finish their work day. About one hundred people work here at the 
Laboratory X, with the vast majority of those working in the service facilities. This is the 
business part of the facility which conducts fee-for-service genomic work. Only about ten or 
fifteen people are part of the academic team, which consists of principle investigators, post-
docs and graduate students. Beside the swipe card machine there is also a magnet board with 
the academic’s names on it and In/ Out beside them. Each person moves their magnet to “In” 
when they arrive and “Out” when they leave. I’ve frequently seen people doing this. 
 A little further down the hall to the right there are rows of grey lockers with locks 
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dangling. This is where lab technicians store their lab coats and other laboratory 
paraphernalia. Indeed, the aisles between the workbenches in the laboratory are quite 
narrow. I always felt a bit like a bull in a china shop when I would come to the lab to do 
observations or interviews. I never knew where to place my backpack holding my laptop, 
books, notebook, as well as a coat or sweater.  Beyond the lockers is the large conference 
room that holds the regular Monday morning meetings, which I have often attended. Beside 
the door is a keypad entry. There is also a bulletin board which hangs on the wall beside the 
conference room. Here there are advertisements for all manner of instruments used in the lab. 
Everything from refrigerators that keep the samples cold, to reagents, to little gel dots. There 
are posters advertizing conferences and upcoming talks. Some of the talks are actually 
information sessions hosted by the companies that make the instruments for the lab.  
 On the other side of the conference room door, there is a large, four foot by four foot 
brightly coloured red sign against the white wall. The sign reads: 
Finding disease-causing genes in DNA is 100,000 times harder than finding the 
white pins in this wall. We did it. Can you? Hint: use the microscope. Hospital X. 
 
There are double helix images all over the sign.  Further beyond the conference room is a 
section of cubicles and a few offices.  A washroom is located a little further on and then 
beyond that are the offices of some other labs, not associated with the Laboratory X. I have 
heard that Laboratory X has, in the past, acquired some office space down there as other 
researchers have moved out of the building. Space is highly coveted.  
Now, if you were to turn your head around to the left, looking down the hallway in 
the opposite direction, you would see a kitchen at the far end. This is a busy room with a 
fridge, microwave, sink, cupboards, table and chairs. It is morning and as I walk down the 
hallway toward the kitchen I am greeted with the smell of freshly brewed coffee. Several 
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framed photos hang from the walls at regular intervals. On closer inspection, they are not just 
photos but actually the covers of journals related to genomics or the first page of articles 
published by Laboratory X employees. One of the frames contains a photo with humans: two 
children – twins – one with the phrase “I’m with Nature” and the other with the phrase “I’m 
with Nurture” written in block letters on their matching T-shirts. Just to the left of the 
kitchen, near the end of the hall, is the door to the academic offices. Tyler, one of the senior 
research coordinators here, used to sit at the first cubicle but has recently been moved into his 
own office. He is still unpacking boxes. Penny, the main administrative assistant has an L-
shaped desk in the middle of the room. Beyond this desk are more cubicles, primarily 
housing the bioinformaticians. The director of the whole laboratory has an office to the right 
of the admin desk. His office is fairly small, the size of a typical university academic office, 
but is adorned with a beautiful view out a large picture window.  
For the most part, people in the academic office are sitting at their cubicles working 
on laptops.  They do not have telephones (something I learned when trying to set up a 
telephone chat with one of the post-docs). The people who inhabit the research office do not 
wear lab coats or safety glasses. Everyone is dressed very casually, not surprising since many 
of these people are students of one sort or another. Jeans and a long sleeve jersey or sweater 
seems to be the preferred attire.  There is beige carpet on the floor in here and the office 
somehow feels warmer and more relaxed than the rest of the facility. 
 I can hear Dr. Lorenz approaching the academic office. He is telling someone that he 
took the subway to work and was surrounded by people more sick than he. He is wearing a 
red sweater with a dress shirt collar neatly folded over the top along with blue jeans and 
black shoes. A large black leather shoulder bag/ brief case is slung over one shoulder, 
bulging. His brown hair is cut short and he looks tired this morning. He sneezes. There is a 
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group of people standing in the hallway. Tyler and Brittany are among them. Dr. Lorenz says 
jokingly, “I thought the meeting wasn’t happening until 9:30”.  A woman approaches him 
and tells him that she is having a problem with someone who has not been showing up on 
time. Dr Lorenz and this woman disappear around the corner into his office. 
 So far you have met a few of the people that will become important in my recounting 
of the travels of DNA as it moves throughout the laboratory. I have given you a general 
description of the spaces that make up the Laboratory X, as you might see them upon 
entering the facility for the first time.  Now, I will shift gears. I want to give you a more 
detailed account of a sample of DNA as it moves through the facility. I will move from 
describing not only what you would see with your eyes but also what is being done, with 
hands and robots and computers. I warn you, the number of actors you are introduced to is 
about to magnify significantly as we zoom in on the trail of a single DNA sample.   
5.2. From Individual to Blood 
And I think for their lab it’s a lot more biology and science and that kind of stuff, 
not clinical like it is here... sometimes they don’t understand what we’re doing or 
why it takes us so long to do things. So for us, I feel like we have to balance that a 
lot around here versus them, they just look at the data, they look at the blood. It’s 
more straightforward, cut and dry. (Excerpt from interview with psychology 
student/ research assistant at the Autism Clinic) 
5.2a Collecting Blood 
Just prior to the start of my data collection, the protocol for the genetics study 
changed. Previously, every participant was first “deep phenotyped” and then their blood was 
taken and sent onto the lab for genetic testing. The deep phenotyping included all the 
psychological assessments (i.e., ADOS, ADI-R) and took two days to complete. In the new 
protocol, however, only a brief phenotypic profile is gathered before blood is taken. The 
limited phenotypic data collected includes a photograph of the individual and the parents, as 
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well as having some questionnaires filled out by the parents. Deep phenotyping is now 
reserved for only the very few participants who have “interesting” genetic findings. In the 
new protocol, genetic testing comes first with phenotypic assessments after for select 
participants. I was told that this change in protocol was implemented in an effort to reduce 
costs, as phenotypic assessments are time-consuming and expensive.  
Individuals diagnosed with autism and their family members give blood in the blood 
lab located on the main floor of the hospital. The genetics project coordinator, Claudia from 
the Autism Clinic, typically walks them over to the triage area in the new atrium of the 
hospital. I will recount one of the blood draws that I observed early on in my fieldwork; at 
this time everything was new to me and my notes are particularly detailed about this event.   
Through revolving glass doors, we arrive at the new atrium with a mother named 
Jane, a father named Bruce and their teenage daughter, Alexis, who was diagnosed over ten 
years ago on the autism spectrum. Claudia takes Jane over to the desk where she has to fill 
out some paper work. A woman behind the desk takes all of their health cards and runs them 
through her computer. While Claudia stays with Jane I sit down with Bruce and Alexis on 
one of several green leather padded benches scattered in the waiting area. Alexis leans her 
head against her father’s shoulder while he puts his arm around her. Nestled against her 
father, her red hair pulled back in a pony tail, she begins quietly humming to herself. I can 
not tell if her eyes are closed or if she is just looking down. There are large glass windows all 
along the wall and plenty of natural light. The walls are painted green and yellow and lively 
murals depicting beach scenes surround the upper walls around us. This is the new part of the 
hospital. Lots of people come and go through the revolving doors behind us. From where we 
are sitting the reception/ check-in area is off to my right and to the left is a cafeteria. A large 
stairwell ascends to the second floor and a glass walkway spans the atrium above us, leading 
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to another part of the hospital.  The ceiling is very high and everything echoes. I can hear the 
sound of water falling, coming from a fountain in the cafeteria. While we wait, I tell Bruce a 
little more about my study. After a while, Claudia comes back to our bench and asks Bruce if 
he could roll up Alexis’s sleeve so that Claudia can rub a small amount of numbing cream 
onto her arm at the spot where the needle will later be inserted. 
Claudia asks them to wait here where their daughter is comfortable while we rush 
ahead to the blood lab to make sure they are ready. We return to the atrium, bringing a wheel 
chair with us for Alexis. While we walk out of the atrium and down the hallway leading to 
the blood lab, I can tell that the mother and father are feeling a little anxious. Being poked by 
a needle in order to fill six or seven tubes is not fun for any of us, to say the least. For people 
with autism it can be extremely frightening and disturbing. Bruce must be anticipating this 
while we approach the blood lab because he reminds me that this is a very stressful event for 
them. He says I can observe but if Alexis gets very agitated I should leave the room. He 
might have to hold her down in order to do the blood draw. 
There is an ethical issue here that I faced repeatedly throughout this research. Although I 
had obtained informed consent from each participant,I was constantly aware that observing 
these very intimate, private and stressful events (such as feedback sessions or blood and 
tissue collection) was an unbelievable privilege. I was a complete stranger to all of these 
people and they allowed me to follow them into highly emotional and private events. What 
right did I have to be there? Was my presence contributing more stress in an already 
stressful situation, just so that I could collect data for my PhD?  I was constantly on the 
verge of apologizing for even asking to be there. In these situations I tried to make myself as 
small and unobtrusive as possible. 
The hallway outside the blood lab is very busy and often noisy, as there is a constant 
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stream of hospital employees and patients walking past the lab in order to reach a bank of 
elevators located nearby. The canteen is also located down the hall from the blood lab.  
Once in the lab, Claudia gives the paperwork to the administrative assistant behind a desk. 
We all wait in a small, grey-walled waiting room with a television playing in the corner. The 
television helps to distract Alexis while Bruce and then Jane are taken out into the main 
room. A curtain is pulled around so that there is some privacy for the parents while their 
blood is drawn. Alexis is sitting in a wheel chair watching Toopy and Binoo on the television 
in the corner. She grows a little anxious when, for a few minutes, her mother and father are 
both out of the room getting blood samples collected.  She holds on tightly to a small Fisher 
Price children’s tape player. It sounds familiar: Raffi. Periodically she bends down to tap her 
fingers on one of her neon pink running shoes. She probably doesn’t understand who we are 
or why she’s here or where her parents have gone.  Claudia reassures her that her mother and 
father will be returning to the room very soon.  
After a few minutes her parents are finished with their blood draws and we all file 
into a small room. A hospital bed stands immediately to the left of the door. Rows of tubes 
are lined up across the starched white sheets pulled tightly across the bed. The tubes are each 
labelled and capped. The caps are different colours. Some are for clinical testing and others 
will be passed on to Laboratory X for genetics research.  
It struck me that these tubes were significant. They marked a demarcation between the 
individual as a human body, whose emotions, behaviours and personal characteristics were 
perceptible and the individual as a number, a tag on a tube. Without that labelled number, 
the blood inside the tube would be unidentifiable from any other blood. The patient ID 
number becomes a place holder for all the individual characteristics that make a human an 
individual. In the language of actor-network theory, the ID tag is made to ‘stand in’ for the 
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individual, temporarily suspending a whole network of actors.  
Alexis is wheeled into the centre of the room. There are six of us jammed in around 
her in this tiny space. One nurse brings over a DVD player to try to distract Alexis. Jane says 
“no thank you”; it probably won’t work for the needle. It’s better if her daughter can just 
listen to her mom’s voice. Alexis remains sitting in her wheelchair while a large, friendly and 
confident nurse rolls up the sleeve of the girl’s sweater and inserts a needle. Alexis pulls 
away slightly but is calmed by her mother who stands directly in front of her. The nurse 
keeps a friendly banter going. Alexis is doing very well. Her agitation was noticeable only 
through the noises she makes which grow louder and by the tears welling up in her eyes.  
Both her parents are touching her and talking to her to try to keep her calm. I edge back 
closer to the doorway behind me, ready to leave if things start to escalate. I can feel that my 
heart is beating faster. I feel like such an intruder.  It only takes a few minutes to fill all of 
the tubes with dark red blood. After all of the tubes are filled, Jane gives Alexis a croissant as 
she has not eaten since dinner last night. It had been a fasted blood draw for her. The cheerful 
nurse reassures Alexis that it is all finished and praises her for doing so well. We all quickly 
walk back to the new atrium and say good-bye. Alexis is tired and needs to eat and go to bed. 
The parents had to medicate her with Ativan prior to arriving today. I am exhausted after just 
observing the event as a “detached” outsider. I can only imagine how tired the parents and 
child must be feeling.  
We walk the family back to the atrium of the hospital. While they drive away in a 
grey sedan, their collected blood remains behind. For the family, the ordeal is over for now. 
They go home to recuperate. Their work is done. For the little tubes of blood, the journey is 
just beginning. At this point, the tubes with different coloured caps go their separate ways. 
Some of the tubes go to the clinical lab at hospital where information is collected pertaining 
121 
 
to iron or thyroids but unrelated to the genetics investigation. Another set of tubes that was 
collected will go to the Laboratory X for biobanking. Here an “immortalized” cell line is 
established and refrigerated indefinitely, a back-up source of DNA.  Still a third set of tubes 
will first move through the DNA extraction lab before making their way into Laboratory X 
for genetic testing. It is this third set of tubes that I followed. 
5.3. From Blood to DNA  
The DNA extraction lab is located in the hospital in the Department of Paediatric Lab 
Medicine.  DNA extraction for the autism genetics project is performed by a robot, an 
automated machine called Autopure, made and distributed by Ciagen (formerly Gentra). The 
Autopure is the size of a large laboratory refrigerator, perhaps five feet tall and four feet 
wide. One of the laboratory technicians explained the extraction process from her 
perspective: you just “pour your blood into barcoded tubes, scan them, load them and then 
when it comes off in about an hour and a half, it’s DNA!” When pressed to describe what she 
and the robot do with the blood in more detail the story unfolded in this way:  
First, the DNA extraction lab receives one eight millilitre tube containing the blood 
from an individual with autism. If the blood is fresh and “uncompromised”, they log it into 
their database and assign it a DNA number. They check the identifiers on the tube to make 
sure they match with what is written on the requisition form. For clinical bloods they require 
two identifiers. For research, however, they allow just one identifier, a study number, to 
accommodate the concerns over confidentiality enforced by the ethics review board. The 
Autopure extracts DNA in batches of sixteen. At the front of the machine there is a rack of 
sixteen large 50 ml red-capped tubes, two rows of eight, each with a small barcode on the 
top. The technician scans the barcode and matches each one with the DNA sample number. 
The blood is poured into the barcoded tubes, the lids are closed. Next, an uncapper comes 
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down, a vacuum manifold, and lifts up the red tube caps. It holds onto them in rows of eight 
at a time. The tubes are lifted up on a rack and slid over under a pumping dispenser. The 
pumping dispenser has tubes that run back to large four to ten litre jugs of reagents. An 
appropriate volume of reagent is pumped into the tubes and then they are re-capped, 
transferred to the back of the robot and locked into a rotator where they are inverted. The 
machine can gently rock the tubes or vigorously vortex them. This is what I can see with my 
eyes. What is not visible is what is happening to the blood at the cellular level. The Autopure 
isolates the white cells because there are no nuclei, no DNA, in red blood cells. The nuclei of 
the white blood cells are ruptured and the DNA is released. The proteins are separated away 
from the DNA and then several washes in ethanol rid the DNA of any contamination. At this 
point, when the machine is doing the washes, the DNA in the tubes looks a little like cotton 
baton, white and fluffy. The DNA is “pelletted down” and put into a blue-capped tube, 
inverted so the ethanol evaporates off. The DNA has now been extracted but it still needs to 
be put in a hydration solution and rotated over night. The solution contains a buffer to protect 
the DNA from degradation. The samples are then stored at four degrees and every two weeks 
the lab technicians generate a “send out”.  A technician pulls all the samples and checks that 
the DNA number, aliquot volume and concentrations match. The technician signs off on this 
and then puts the samples in a basket. At this point, Lisa from Laboratory X walks over and 
picks up the extracted DNA tubes. 
Since the blood was taken from the child’s arm it has been given a patient number, a 
DNA number and a barcode number. Poured from one tube into another, white blood cells 
have been isolated from red, nuclei shattered, proteins separated from DNA. It has been 
washed in ethanol, dried and alluted into a buffer solution and stored in a refrigerator at four 
degrees. The blue-capped tube containing extracted DNA now sits in a basket, waiting to be 
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picked up and walked over to the Laboratory X.   
5.3a Into Laboratory X 
Lisa is a project coordinator in her mid-forties. She has a Bachelor’s degree in 
microbiology and has been working at Laboratory X for fifteen years. She works four days a 
week here and one day a week at the autism clinic. When Lisa walks over to the DNA 
extraction lab to receive the tubes of blood they usually already have a unique identifier tag 
or label on them. Back at her own desk, she inputs these data into a database, which 
generates a spreadsheet. She double checks to make sure that all the data are correct (e.g., 
date of birth). The tube of extracted DNA is kept in storage until the coordinator of the 
academic section is ready to run experiments on it.  
There are three main types of genetic experiments that occur in this lab, each 
associated with a different scale or resolution of detection. At one end of the spectrum there 
is cytogenetics, which focuses on microscopically visible cells. Karyotyping or fISH are 
examples of cytogenetic experiments. For autism cases, these experiments associated with 
cytogenetics are primarily reserved for validation of other findings. At the other end of the 
spectrum is Next Generation Sequencing (NGS). This technology is used to find single 
nucleotide polymorphism or SNPs (pronounced snips). NGS is able to detect a change in a 
single base (e.g., a T that is now a C). In between cytogenetics and NGS is a technology 
called microarrays.  Microarrays, frequently referred to as arrays, are able to detect deletions 
or duplications in stretches of DNA. These deletions or duplications are called copy number 
variations or CNVs.  
After arriving in Laboratory X, an autism DNA sample flows through these various 
experiments and technologies. The first line of investigation is a microarray followed by its 
associated cytogenetic validation experiments. Based on certain criteria, the sample might 
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then move through an NGS experiment. If an interesting mutation is found along the way, the 
case might be discussed at one of the laboratory meetings before being written up in a report 
to be given back to the clinician. What arrives in the laboratory in a little glass tube will leave 
the laboratory as words on a research report. Below, I will try to describe all the work, the 
activities, the ways of seeing, probing, investigating, the various and multiple conversions 
and representations that occur within the laboratory. I have pieced together a story that 
follows what happens to the DNA in a little glass tube: from microarray to NGS to 
computational analysis, until eventually it exits the laboratory as words on a research report.  
5.4. The Microarray Process: From DNA to CNVs 
Much of what I learned about the details of the microarray process came from a 5th-
year PhD student named Ankit working under the supervision of Dr Lorenz, the director of 
Laboratory X. I interviewed him several times and interviews would often last for two to 
three hours. We also had lunch together on several occasions when I would learn about the 
more informal, behind-the-scenes operating of Laboratory X. During his undergraduate and 
Master’s training in microbiology Ankit used to spend a lot of time in the laboratory but now 
his time is almost exclusively devoted to analysis and interpretation of results.  
Consequently, he was able to talk me through the entire process. I was also able to interview 
the manager of the microarray facility and to observe the two technicians who run the 
Illumina array platform on several occasions. The entire experiment can take several days to 
complete with different activities occurring on different days of the week.  Through these 
various observations and interviews I have pieced together below the microarray process.  
5.4a Clinical vs. Research Microarrays 
 Before describing the microarray process, a distinction must be made between clinical 
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and research microarrays. The microarrays run at Laboratory X are research microarrays. 
They are high-resolution, meaning that they interrogate the human DNA strand at many 
points allowing for a more detailed view in more locations along the genome. In comparison, 
the clinical microarray probes the genome in only a few places. It targets only those areas in 
which genetic variation is already known to be associated with pathogenic outcomes. The 
linkage between the clinical array lab at the hospital and the research arrays at Laboratory X 
is a strong one. I frequently saw members of the clinical array laboratory at the Monday 
morning meetings at Laboratory X. Many of the cases that were discussed at these meetings 
were originally from the clinical lab. If the clinical lab is unable to find any CNVs on their 
clinical array platform but they still suspect a CNV to be involved, they will send the sample 
on to Laboratory X so it can be run on a higher resolution research array.  
 Significantly, just prior to the beginning of my field work, effective March 1st, 2011, 
the Ontario Ministry of Health and Long-Term Care began funding post-natal clinical 
microarrays for children with intellectual delays. The cost of the clinical array is now 
covered by OHIP, the Ontario Health Insurance Plan. Now, if a family doctor or 
paediatrician wants to refer a patient to a clinical geneticist because the individual has a 
developmental delay or autism, a clinical microarray must first be ordered before the referral 
can be made. There are two things that are important about this change. First, since March 
2011, any physician can order a microarray (a family physician or paediatrician, for example) 
and not just a clinical geneticist. This also means that the results of the array are being sent 
back to and interpreted by the family physician or paediatrician. This is important for a 
discussion on knowledge translation as, according to the participants in this project, there is 
much concern over whether or not the referring physician will be able to interpret the results 
of a microarray. In particular, arrays with results of “unknown clinical significance” can be 
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confusing and tricky to interpret for even the savviest of clinical geneticists. Secondly, 
important for theoretical consideration, the clinical microarray has now been made a 
mandatory step in the referral process. The micro array is one of the criteria that must be 
fulfilled prior to being seen by a clinical geneticist. In the language of actor-network theory, 
the array has become a significant actor, an “obligatory passage point”. 
5.4b Running a Research Microarray 
We are at the far end of the laboratory. When you first take in the scene it is 
overwhelming, visually exhausting. There are so many things to take in at once; my eyes 
don’t know where to land.  There are bottles, boxes and machines crowding the rows of black 
benches. Every inch of space seems to be packed with labelled jugs of solutions with names 
that are unfamiliar, glass beakers, boxes of tubes, fridges, and many different machines. Two 
long, scratched up canisters stand at the end of the bench, for oxygen or some other gas I 
guess. They seem to me like they might be relics unearthed from a long ago submerged 
submarine, faintly reminiscent of a sepia-toned wartime photograph I might have seen. I have 
no reference for many of the items around me. For someone who has never stepped foot in a 
laboratory before, it feels as though I’ve stepped into another world. I recognize almost 
nothing. The only thing that looks familiar is a white fridge that appears very similar to the 
one that stands in my kitchen at home. The similarity stops there as the contents inside are 
alarmingly different. No milk jug or yogourt in here; instead, there are stacked up plates with 
rows and rows of tiny labelled tubes containing DNA extracted from hundreds of individuals. 
The air in the laboratory is warm from all of the heat given off by the machines.  A constant, 
loud humming sound drones on in the background.  
Today I am watched two different technicians, Mitsie and Chang. Mitsie tells me to 
set my backpack and coat on one of the chairs against the wall. She wears a long white lab 
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coat, her jeans and running shoes poking out the bottom.  Light green plastic gloves are 
stretched over her hands. Her black shoulder-length hair hangs loosely around her neck. The 
aisle where she is working today is about three feet wide. On one side is an Illumina 
microarray machine. It is about three feet by three feet and two feet deep, essentially a big 
box sitting on the top of the black bench. It has a dark grey, opaque, plastic shell. There is a 
monitor attached at eye level and a keyboard sits in front. A large metallic arm is located to 
the side of the machine, the auto-loader which moves the plates carrying the prepared 
microarray chips inside the machine. Across the aisle sits another computer. Beside this is a 
large robot, about four feet long and three feet high and three feet deep. It too sits atop the 
bench. It has a glass front which can be raised up or down and a slit cut out along the bottom 
where the technician can reach her hands into the machine. There are other machines near by 
as well, a centrifuge for spinning samples, a hybridization oven, and more computers. There 
are a few spaces between machines and equipment so that I catch glimpses of the man 
working on the other side of the bench, bent over a computer. I see him glance at me 
quizzically a few times. Strangers are an anomaly in the laboratory where an intimacy 
develops amongst technicians over years of working side by side with each other. Hands and 
bodies seem to effortlessly slide into well-choreographed, predictable movements. Although 
I try to stand out of the way, try to be aware of the movements of the other scientists in the 
aisle, as I concentrate on capturing the details of the practices surrounding the microarray I 
am often encumbering somebody’s pathway.  
Before the array can be run, the lab technicians have to wait until there are enough 
samples collected because arrays are run in batches. Typically there are ninety-six samples 
on one plate. The tubes that Lisa picked up from the DNA extraction lab are sitting in the 
fridge. Mitsie takes them out and lets them sit so that they will be brought up to room 
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temperature before being loaded onto the microarray chip. There are several different 
machines and robots involved in the whole process of a microarray experiment. The first step 
is to scan the barcode numbers on each of the Illumina chips. The chips come in an orange 
box. Inside the box are maybe ten chips, each individually wrapped in a metallic package. On 
the front of each is a label with a barcode. Illumina makes each of its chips slightly different 
so that the probes on one chip are not identical to the probes on another. The barcode tells the 
robot where to look for the position of the probes along the genome. She scans each package 
into the computer using a little hand-held scanner. It reminds me of a price scanner at a 
department store. On the computer screen in front of Mitsie, there is an Excel spreadsheet 
open and every time a package is scanned a number appears in one of the boxes on the 
screen. She is meticulous about checking the order of the packages. The order she scans them 
in is telling the computer the order they will appear on the plate. There are specific loading 
patterns and each chip needs to be positioned in a specific place on the plate. Before scanning 
them she numbers the outside of the foil package. When I first observed I was not sure what 
she was doing and asked her a question. She ignored me for several minutes and answered 
later; I quickly learned that this was not the time to be asking questions. She joked that if she 
makes a mistake in the ordering of scans, a sample that is from a female may be switched 
with another and could come out as a male. “Then you know you’ve screwed up!” Each of 
these chips cost three thousand dollars. Today they are preparing twenty four chips.  It takes 
her about twenty minutes to scan all of the chips. Inside each foil package is a small chip. It 
is about the size of my second (“peter pointer”) finger. The barcode that was on the outside 
of the package is also on the bottom of the chip. As Mitsie explained, “every chip has a map 
of where the probes are”. On this particular chip there are two and a half million probes. The 
chip she is using has eight different bands across it and each band will hold a different 
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sample. She calls these different bands “grids”. At this point, each chip only holds the 
probes, beads that were loaded on by the Illumina company. The patient sample has not been 
added yet, that comes next in the hybridization stage of the experiment.  
Before the patient samples can be added to the chip, the samples first go through a 
stage called “amplification and digestion”. At this point, there is a clear plastic 6” square 
plate with 96 little wells in it, arranged in a grid. Each of the little wells holds a small amount 
of DNA, each a different sample from a different individual. Various reagents are added to 
each well and left for a twenty hour incubation. Then it is pelletted down during a 
purification step, leaving only the material that they want. The pellets are then dissolved into 
a solution again. Enzymes are added to the DNA to “de-nature” them. This was explained to 
me in the following way: 
PhD Student:  So what you do is they first chop up the patient’s DNA so it’s not 3.1 
billion base pairs together. It’s sort of fragmented into different…I 
don’t know if you know about restriction enzymes? 
 
Julia:    No. 
 
PhD Student:  It’s not very important. Restriction enzymes, it’s a reaction mix that 
helps you slice up ‘DNA.  
 
Julia:    It kind of loosens them up or something?  
 
PhD Student:  So it actually slices them. Slices a large chromosome into smaller 
fragments. So it slices it up into small pieces. 
 
After the samples are “de-natured” (sliced up), they are hybridized. During hybridization, the 
probes on the Illumina chip are attached to the DNA sample from the patient. In the entire 
human genome there are approximately 3.1 billion base pairs. The array company designs 
chips so that they target specific areas of the genome. Each probe is twenty-five base pairs 
long. On the particular chip they are using today, the company has built two and a half 
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million probes. The more probes, the greater the resolution and the greater the ability to 
detect smaller deletions or duplications. If ten thousand probes are stretched across the 
human genome the variation has to be much larger in order to be detected. If 2.5 million 
probes are stretched across the genome the array has a greater ability to detect smaller CNVs.  
 For hybridization to occur, the sample of patient DNA has to be physically added to 
the chip. I observed as Mitsie did this for 192 samples one day. The technicians have to be 
extremely organized, knowing where each sample is being loaded. It takes two technicians 
working in tandem along with the hybridization robot to load the samples on the chips. First, 
Mitsie opened up the glass front door on the machine and fit in the first of two 96-well plastic 
plates containing the 96 DNA samples in eight rows of twelve. This plate was fit snugly in on 
the left of the machine. On the right side of the machine Mitsie places nine black containers, 
each holding a glass chip (each chip will hold eight samples). Dangling from the machine 
there is a little arm which holds eight thin needle-like prongs (called pipettes) pointing 
downward in a row. These pipettes are spaced apart so that they fit exactly into the wells of 
the sample plate. The arm moves back and forth a few times to orient itself and then lowers 
into the sample plate, dipping into the first eight wells and sucking up the DNA. (I looked in 
the plate later and saw that a small amount of DNA is left behind in each well as a back up in 
case there is a mistake and the hybridization needs to be repeated.) After the DNA is sucked 
up, the arm then moves up and over to the right so that it hovers above the top of the first 
chip. Two of the eight pipettes lower down and touch the chip at exactly the spot where two 
of the bands run across. Mitsie has reached her hand in through the slit in the glass front of 
the machine to help guide the pipettes, making sure that they drop the DNA sample at exactly 
the right place. The needles move up and the next two needles move down hitting the next 
two bands on the chip. Again, Mitsie guides the robot so that the DNA enters the band on the 
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chip at exactly the right place. This is repeated until the chip is filled. The robot arm then 
moves back to the left of the machine and dips the eight pipettes into an ethanol solution, 
cleaning them so that they can then be dipped into the next eight wells of DNA and the 
process can be repeated on the next chip. 
 While the robot cleans itself, Mitsie takes the black cartridge out of the machine and 
passes it to Chang. She takes the slide out of the black cartridge and places it in another black 
cartridge. Using a pipette, she adds a small bead of water to each band on the chip. This is to 
make sure that the DNA does not dry. If it dries, the DNA from the patient sample will not 
bind to the Illumina probes. I can see that the little bands have changed colour slightly now 
that they have DNA in them. At one point Chang told Mitsie they need to do one of the bands 
again; not enough DNA sample was added and it hasn’t gone all the way across the band. 
They will manually add more of that particular sample at the end. A top cover is secured over 
the chip and from here it will be placed in the hybridization oven at 44 degrees Celsius for 
eighteen to twenty hours. While the chip sits in the oven over night, the Illumina probes align 
and bind to specific regions of the DNA sample.  
 I imagine the hybridization process is a bit like a grade six school dance. The oven doors 
are closed on the microarray chips. I imagine that Queen starts playing or perhaps in 
today’s ovens it would be some sort of techno music with a booming bass. At first all of the 
rna probes are lined up against one wall while the sliced up fragments of patient DNA self-
consciously chit-chat across the chip. With the heat of the oven, like the music in the gym, 
rna probes and DNA fragments begin to mix. Eventually, couples pair off and begin to dance. 
A frantic flurry of activity begins as DNA fragments try to bind with an rna probe. There are 
far more DNA fragments than rna probes. Anxiety sets in as more probes and fragments bind 
off together. Everyone is jostling and bumping around on the dance floor. A shorter fragment 
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is dwarfed by some of the other larger fragments. Suddenly, the shorter fragment bumps into 
a probe. They circle around one another first, checking each other out. They realize they fit 
together. They align! Their hydrogen molecules begin to bond.  Eventually, all of the rna 
probes are aligned to the corresponding DNA fragments. The remaining DNA fragments 
bump around for a while, relentless in their search for a probe with whom they might bind. 
Eventually these remaining fragments settle down and enjoy the warm heat of the oven, 
perhaps chatting together in small groups and comparing stories about the previous ordeal 
of being extracted from their intra-cellular friends a few days or weeks earlier. 
 I came back to the laboratory the following day and watched as the chips were 
removed from the oven. At this point the chips need to be washed. The washing will get rid 
of all the bits of patient DNA that did not bind to a probe. The only thing that is left on the 
chip after washing is the segments of DNA that have bound to a probe. Below, are my notes 
describing the washing process: 
Chang tells me to come closer and stand by her. She has placed several chips, 
horizontally, lying on their side, into a little wire basket and she is vigorously dipping it in 
and out of a clear buffer solution. She does this for a few minutes. Bubbles are forming at the 
top. At times one of the chips will become dislodged from the basket with the force of her 
moving the basket up and down. She stops and carefully puts it back into the basket and 
continues dunking it. The buffer is washing away all the non-binding DNA.  
While Chang is doing this, Mitsie dumps the buffer out of a black container sitting on 
top of the bench in front of her where the four chips were resting that she has now moved 
aside. Chang pulls out the chips she has just been dunking and puts them into little black 
cartridges. Mitsie puts on a rubber strip around the perimeter of the chip. Chang pours in 
more buffer and Mitsie then puts on a glass slide. While Chang is dunking the next batch of 
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chips, Mitsie is taking scissors and trimming away the excess plastic strips that hang over the 
edge of the black metal cartridge. I can still see the little bar code on a white sticker sticking 
out from the bottom of the black cartridge. Once these are trimmed they are put into a 
container that holds four chips.  
Chang and Mitsie are working silently, passing things back and forth without asking 
or signalling to one another. It is obvious that they have done this many, many times together 
and they have a carefully planned out rhythm and detailed choreography of their movements. 
While their legs are standing still, if you were to watch just their arms and hands it does 
almost seem like a duet or a dance of some sort that is being performed together.  
At one point, when Chang is washing the next batch of chips, Mitsie walks over to the 
next aisle. I follow her. She is loading all the black cartridges into the glass-fronted 
“Freedom Evo” machine, the same machine that added the patient sample to the chips 
yesterday. This time, the chips are placed vertically in a large black metal box. This is the 
space in the machine to the right of the area where the hybridization took place yesterday. So 
the same robot is capable of doing different tasks in the different spaces within the machine. 
She closes the glass front. She walks over to the computer beside the machine and clicks the 
mouse on a window that has popped open on the screen. A green light turns on at the top of 
the machine. And immediately the little row of 8 needles/ pipettes goes down at the left and 
submerges in a clear solution. There are a few different plastic wells along the back. One of 
the wells is labelled RA1. The needles suck up some of the solution and then move up and 
over to the right of the machine above the vertically placed chips. At this point Mitsie shows 
me how each of the glass slides, which she had clipped on over the chips, has a little slant 
descending toward the chip. The pipettes drop the solution into this little divot and it slowly 
sinks down across the chip, moving across all 8 samples on the chip. Mitsie says she does not 
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have to use her hand to guide the robot pipettes for this washing stage as she did for the 
hybridization. This is because the divot in the slide is the entire width of the chip and as long 
as the pipette hits it somewhere in that little well it will be fine. She just has to be sure she 
has put the slides in the right way or the solution will just run over the top and not have a 
little well to sink into. The pipettes go back to the left of the machine and dip themselves into 
another solution. She shows me the different buffers it goes through and then says that the 
last two, on the right, are the stains. These stains are dropped into the chips in the same way 
as the buffers. The stains are what allow the DNA to become florescent when they are 
imaged in the microarray machine. After that, all the slides and clips are removed from the 
chips and they are washed once more and then a coating is put over top of the chip. They are 
dried and then they are ready for the array machine.  
From here, the chips are loaded into the microarray machine. It takes about an hour 
and a half for each chip to run through the machine. Because there is an opaque plastic cover 
on the microarray machine, I can’t actually see what is happening inside. To the side of the 
machine several chips are stacked up waiting to be put through the array. There is a coat on 
the top of them that Mitsie says she would not want to touch. She always wears gloves at this 
point. She says I should ask Chang to show me the image on the computer monitor. Chang is 
just putting out the garbage, a clear plastic bag filled with various empty bottles that they 
were using this morning for washing. She places the garbage just outside the door of the lab 
and comes back in. She nudges the mouse and the microarray screen lights up. The upper 
half of the screen is full of green and black dots. The lower half of the screen is full of red 
and black dots. Chang tells me that if a location is green and red it is heterozygous. If a 
position on the chip appears as only green or only red, then it is a homozygous call.  A runner 
along the left edge of the screen displays a rectangle for each of the 8 samples that are 
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currently passing through the machine on one chip. A blue box sits on top of the sample that 
is currently being scanned. It is on the 4th sample right now. As the machine finishes a chip 
the rectangle on the left side of the screen becomes coloured. The top sample, that has 
already been scanned looks different from the others that have already been scanned. The 
others are all green. Each square, representing a sample, is divided into four horizontal bands. 
On the top sample rectangle, there are alternating red and green bands. Two of the bands that 
should be green are red. This means that something has gone wrong. Chang tells me that it 
could be the decode data that was downloaded. Sometimes they have to download the decode 
data again and it will be fine. Alternatively, it could be the sample. I talk with Mitsie about it 
later and she thinks it’s not the decode data; it’s the sample because all of the other sample 
rectangles seem to be coming up fine. Sometimes the sender gives them enough DNA to do a 
re-run, but sometimes they don’t and they have to go back to the sender and ask them for 
more sample to trouble shoot.  
Although I cannot see what is happening inside the microarray machine, the process was 
explained to me in this way: 
PhD Student:    These probes are sort of fluorescent and when they bind to something they 
light up. So every probe that’s bound to something, it lights up with a 
certain intensity. You take a picture through a fluorescent scanner and you 
get an idea of the intensity of each probe. So each probe will be a dot in this 
picture. The chip itself is very small but it has 1.8 million probes on it and 
you have data from 1.8 million points in this picture.  
 
At this point the DNA has been converted to little green and red dots on an image. The 
computer file is then sent out of the lab to one of the post-docs or graduate students in the 
academic office. This is another significant conversion. The material being worked with from 
here on is no longer the physical substance of the human body. It is computer generated 
graphs and numbers that make their way out of the wet laboratory and into the research 
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office. Of course, these computer files are carefully linked to the DNA through patient 
identification numbers.  
Although, for simplicity, I often describe this research as following DNA as it is translated 
between three locations (clinic, lab, home), each one of these locations is actually a complex 
arrangement of spaces and networks. What I call “the lab” could also be described as 
several distinct locations, spaces within spaces.  For example, there is the “wet lab” where 
patient materials – DNA – is sliced, buffered, hybridized, warmed in an oven, washed, dried, 
and photographed. Gloves, goggles, lab coats, bottles, pipettes, tubes, and a lot of different 
chemicals are all integral to the network of this space. The academic office, or “dry lab”, 
however, contains none of these artefacts. Computer files, spreadsheets, mathematical 
algorithms, journal articles are the property of this space. There is movement between these 
spaces and their close proximity is important. People from the dry lab might periodically 
move into the wet lab, checking on a procedure if a result does not seem quite right. For the 
most part, technicians from the wet lab do not, however, move into the dry lab. In the wet lab 
patient materials are translated into computer files. In the dry lab, the computer files are 
interpreted, graphed, written up into reports. So while “the laboratory” may be described as 
a unified whole, a single place when it is discussed by clinicians, it is also a complex 
arrangement of distinct, highly differentiated but related spaces for those who work inside it. 
Figure 5.2: Flow Chart Depicting CNV Interpretation Process 
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Once the microarray data is moved from the array machine in the laboratory to the 
computer of one of the academics, it is actually a binary code to a text file called a .cel file. 
This file contains the probe intensity information.  The scientists take this binary information 
and load it into the company software, which then converts the information to text. There are 
different microarray companies (Illumina, Affymetrix, and CGH), and each company 
produces its own proprietary computational software. However, academic lab groups also 
develop their own open-source software for analyzing microarray data. The scientists I talked 
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to explained that they used multiple tools (software) in interpreting microarray data, 
combining the results to increase specificity. A PhD student explained: 
If you used just one tool to identify CNVs on your microarray, you’ll find that 
there’s a false-positive rate, which can be as high as thirty or forty percent. So, 
for example, if you get an array from a lab for a patient and use a single tool, it 
tells you there are like a hundred CNVs. But if you actually went to the lab and 
tried validating them by quantitative PCR you would find that only 60 of them 
would be real and forty of them would be false. This would be a case for any 
tool. So if you take three different tools and you take only the CNVs that were 
detected by at least two of the three, those tend to be real. So the validation rate 
for those is like ninety percent. This is actually a big deal because we have too 
many patient samples to go and validate all of them together. So we just stick to 
the stuff that is more likely to be real.   
 
There is another reason why combing results and increasing “true-positives” are important. It 
not only saves time by allowing lab techs to run validation experiments on fewer samples; it 
also is important because CNVs have to be reported back to the clinic. Ankit explained in an 
interview, “It reduces the chance of them being false, which is a big deal when you’re 
reporting results to a patient. So, you need to make sure it’s true before they make any 
clinical decisions or something based on that.” 
  The software provides a visually friendly format from which to analyze the data. The 
microarray information can be plotted on an intensity graph. The intensity of a probe is 
directly related to the amount of DNA that has bound to it.  If more DNA binds to a probe, it 
lights up more. If no DNA binds to a probe it won’t light up at all. If there is no light signal 
from it then it will show up black. This can all be captured on an intensity graph, which has 
an X-axis as the central line. Most probes cluster at this central line. This line corresponds to 
a copy number of two. Usually a person has two copies of every base, one inherited from the 
father and one from the mother. When the probes on this graph dip below the central line it 
means there is less genetic material binding to this probe and only a copy number of one. 
This means that there has been a deletion of genetic information. The microarray has “called” 
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a deletion.  
Ankit clicked on the program and was able to zoom in and out on the chromosome, 
quickly changing scale and allowing him to analyze the data in different ways. With another 
click, the program showed him the “break points” for the deletion which told him the exact 
position of the deletion. It also showed him which genes were located there. This is the first 
indication that there might be a deletion in this region. However, the person interpreting the 
graph is not certain. The intensity graph cannot be trusted on its own. This is because 
sometimes probes fail because of technical problems. If a probe fails, it would look like a 
deletion on the graph, but it’s not real. A PhD student explained: 
PhD Student:   So this is why you have to validate everything the array calls with something 
else before you report to patients or to clinicians. You’ve got to show that it 
exists. So this is why we use either fISH which I showed you before or we 
use something called quantitative PCR, qPCR, which is sort of the same 
thing. It’s an independent experiment with confirmation of a deletion or a 
duplication. 
 
Once the CNV has been validated with qPCR, the next step is to identify whether this 
deletion or duplication is in a region (usually a gene) that is already known to be associated 
with autism.  
 In addition to the graphical view of intensity information, the microarray software 
program produces something called a CN segment summary. This provides a list of all the 
CNVs that the software found for each sample run in a batch on a microarray. The segment 
summary shows several columns including: sample name, copy number state (whether it’s a 
loss or a gain), chromosome number and coordinates within the genome. For each sample 
there will usually be about forty or fifty CNVs found. However, most of these are found in 
the general population. The scientists need to distinguish between those CNVs that are rare 
(and most likely contributing to the phenotype) and those that are common in the general 
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population. In order to do this, there is a comparison between patients (called cases) and 
controls.  
When talking with me about the analysis process, Ankit switched on his laptop and 
brought up something called the DGV, the Database of Genomic Variants. It’s a free on-line 
database, which I later looked at more closely at home. Throughout my fieldwork, this tool 
was repeatedly used in meetings to discuss variants. The DGV allows you to zoom in on any 
region of the human genome. There are various tracks that can be turned on or off. It 
distinguishes between exons and introns. An exon is the part of the genome that codes. It is 
made up of genes. An intron is a region of DNA that does not contain any genes, but 
sometimes it is important for regulating genes. It used to be called junk-DNA but scientists 
are realizing that it might actually have important epigenetic functions. On the DGV, the 
exons are represented as vertical bars and the introns are horizontal bars. So, for example, 
you could look at the NRXN gene on chromosome 2. The DGV will tell you that you are on 
Chromosome 2 and give you the coordinates. Chromosome 2 is approximately one hundred 
fifty megabases long. The position on the DGV might zoom in to display between fifty and 
fifty one. It will also show you the probe distribution in this region. The green bars show you 
that there are plenty of probes in this location. So if there is a CNV, it should be picked up. 
The DGV is also an amazing resource for interpreting CNVs. This is because the DGV also 
compiles all the information published in academic papers that report CNVs. For example, 
according to Ankit, in the last seven years there have been about one hundred studies of 
CNVs in the general population. One study might look at CNVs in a thousand Europeans and 
another might look at CNVs in a thousand Africans. The DGV builds up all this information. 
This is important because all people have CNVs and so the people looking at patient samples 
have to interpret whether or not these are rare in the general population, if they are primarily 
141 
 
seen in cases and not in controls. For every gene, the DGV tells you what deletions or 
duplications have been commonly found in the general population. A blue line would show 
you a duplication and a red line a deletion (the colours sometimes change). So if a deletion 
has been validated using qPCR the PhD student will then go to that exact region in the DGV 
to see if that same deletion is frequent in the general population. If there are very few 
deletions or duplications in that region amongst controls that information also supports the 
significance of that genetic variation as potentially related to the variation in phenotype.  
 Another way to determine if a particular CNV is found in the general population is to 
look at the CN segment summary. Here, there is a column titled “percentage overlap”. This 
column indicated how much of the sample CNV overlaps with CNVs already found in the 
DGV, which are found in the general population.  Most CNVs that are called overlap 100% 
with the DGV, meaning they are common in the general population. So, you only investigate 
further the ones that say zero percent. These are the CNVs that are not found in the DGV and 
are therefore not found in the general population. This means that they are rare deletions or 
duplications. Roughly one CNV from each sample will not overlap with the DGV. At this 
point you can further filter out the CNVs that do not touch on genes; these ones are intronic 
and are less likely to be significant.  
 Ankit opens up PubMed and types in the name GPHN, the gene symbol for Gephrin. 
Immediately, fifteen papers appear in which this gene has been described. Some of the papers 
describe a particular disorder in which GPHN is involved and other papers describe 
functional information, telling the reader what the particular protein does. This is useful for 
new genes. However, when a gene has been well described over time Ankit uses the OMIM 
database. OMIM stands for On-line Mendelian Inheritance in Man. He stated: 
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So, there are twenty thousand genes in the human genome, give or take a few 
thousand. A certain fraction of those have been reported in disease before. If you 
run a genetic test on somebody and certain genes come up you want to know if 
the genes that you found have been reported with a particular phenotype before. 
So, essentially they compile papers together and they come up with lists of genes 
that have been reported as mutated in specific disorders.  
 
 Thus far in the process of detecting CNVs, a microarray was run and a deletion was 
found by looking at an intensity graph. Then this was validated using qPCR. Following this, 
the region was compared to the DGV and found to have no similar mutations in this region in 
controls. At this point, the PhD student needs to learn more about this CNV. Was it inherited 
or de novo? De novo CNVs are deletions or duplications that are not inherited. They arise 
spontaneously in individuals and often seem to be more likely to be associated with 
phenotypic variations indicative of autism. If the laboratory already has DNA collected from 
the mother and father of the case (called the proband) then a micro array can be run on them 
separately. The PhD student told me that autism was particularly successful at getting trios 
(mother, father and child DNA) because diagnosis tends to happen early on and the child is 
accompanied by his or her parents at clinic visits. (In comparison, in schizophrenia it is much 
more difficult to acquire complete trios because patients are often in their thirties or forties 
and sometimes their parents are no longer alive.) Once you have all three samples plotted on 
an intensity graph you can easily see if the mutation is de novo. If the probes on the mother 
and father’s graphs are all clustered along the central axis, then they both have a copy 
number of 2. The dip in probes below the axis on the proband’s graph is not inherited from 
either mother or father. 
 There are other ways that CNV data are interpreted and analyzed. The PhD student 
explained: 
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PhD Student:     So they run the microarrays and they give us the data, like, the fluorescence 
data. So obviously the CNV data is computational because you can’t go 
through probes individually. So the array that they are currently running is 
from this company called Ilumina. So they give us this software called 
Genome Studio. So it sort of streamlines the whole analysis procedure. So 
the arrays are fed into this software, like the information on the arrays, like 
the intensity information.   
 
He showed me how Genome Studio worked. He was able to change chromosomes in the 
browser and to zoom in and out. Here is another excerpt from one of our conversations:  
PhD Student:     So that’s SNP data. This is intensity data. Now how does this CNV look? A 
NRXN1. So this is zoomed in [moving the mouse around], Chromosome two, 
zoomed in. [Clicking with the mouse]  So if you want to see the [clicking] so 
this is the whole of chromosome two. Like it’s generally along this baseline. 
But you’ll see at some of the positions, some of the probes are lower. These 
could be deletions. In fact, the NRXN1 is here. So if you zoom into this 
position, it looks like this. So this is just the NRXN1 locus, it shows you 
where the gene is. And here is your baseline which corresponds to copy 
number 2. So you see that they always cluster around the baseline. So most 
of the regions of chromosome two, the person has two copies. This is what 
you’d expect. Except here you suddenly see these probes fall off a cliff.  
 
Julia:      Right. 
PhD Student:   So that is where your deletion is expected to be. And the interesting thing, you 
can sort of see a pattern in the genotypes as well. So if two copies are 
present, of DNA, you’d expect there to be three combinations, right. 
Homozygous for one base, homozygous for the other base or heterozygous. 
So you can see that the heterozygous was present when there was two. It can 
be homozygous, heterozygous or homozygous. But in the deletion region 
there’s no heterozygosity possible. So it calls it homozygous so this sort of 
supports the intensity information. 
 
At this point, after examining the CNV through the DGV and the Genome Studio software, 
the case might be discussed at an upcoming Monday morning meeting as an interesting 
finding.   
5.5. Validation – From CNVs to Real CNVs 
Several times in my field work I heard people talking about fISH or qPCR. These are 
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techniques that are used to validate microarray results. fISH stands for fluorescent in situ 
hybridization. When a technician finds an unbalanced rearrangement of genetic material (a 
deletion or duplication) they cannot be sure that it is real. Microarray results can be “a bit 
noisy”. Investigators need to add another layer of evidence, another independent test to 
confirm the variation. Ankit explained it this way: 
You’ve got to show that it exists. So this is why we use either FISH which I 
showed you before or we use something called quantitative PCR. qPCR. Which is 
sort of the same thing. It’s an independent experiment with confirmation of a 
deletion or a duplication.  
 
With an array, you put the DNA on a slide and see right across the human genome. With 
fISH or qPCR, you have to know the specific region you’re testing. For example, an array 
showed that there was a segment on Chromosome 16 that was duplicated in an individual 
diagnosed with autism and Ankit needed to have that verified.  
5.5a fISH  
fISH is within the purview of cytogenetics. The cytogenetics office sits off to the side 
from the main lab, a small room, perhaps ten feet square in area. The walls are circumscribed 
by lab benches with a few work stations (designated by stools or chairs) in various places. 
There are two microscopes in the room. One day, when I was interviewing the manager of 
the cytogenetics lab she showed me around. A more junior cytogeneticist sat perched on a 
stool, clad in a white lab coat, bent over a microscope. Around the perimeter of the room, are 
a series of “chromosome paints” in bright colours. They’re quite beautiful actually, like 
modern abstract art. The manager of the cytogentics lab explained to me that the work carried 
out in her lab is considered quite obsolete compared to most of the newer technologies. The 
objects that are worked on in this lab, chromosomes, are microscopically visible.  The 
scientists who work in this lab are tuned to or oriented toward an entirely different object. 
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The landscape of the cell, interrogated through a microscope, is comprised of completely 
different components that the landscape of extracted DNA which is probed through 
microarrays or sequencing. There is very different work going on here in this small 
laboratory by these few scientists, sequestered off from the large main laboratory room.   
fISH was first developed in the 1990’s as a technique in which fluorescently labelled 
probes are hybridized to a patient’s chromosomes (George et al., 2011). If a florescent signal 
is detected, it indicates the presence and copy number of that region in the patient’s genome. 
To conduct a fISH experiment, the scientist needs to have live, growing cells. They cannot be 
frozen or prefixed. Depending on where they stop the cell growth, cytogeneticists can do 
different things. At interphase the chromosome fibres are more loosely packed than at 
metaphase. If there is a segment of DNA that is duplicated close by to the original segment 
you can see it better in interphase than in metaphase. The resolution is higher. If you want 
chromosomal positional information, however, cytogeneticists arrest the cell growth in 
metaphase. When checking for a duplication, the cytogeneticist will use interphase nuclei but 
will also use metaphase nuclei to check that the probe was in the correct position. The 
manager of the cytogenetics facility, a clinical cytogenetist whom I will call Gloria, 
explained the fISH process as follows: 
So you have your slide with your chromosomes on it and then you denature your 
chromosomes so that the DNA goes apart, like, separates. And then you have your 
probe which is your sequence of DNA with your little florescent tag. You denature that 
and then you put it onto the slide. So both of them are denatured and you leave them to 
renature and it will go to the targeted region, yeah. 
 
Once the probe has hybridized to the patient DNA the cytogeneticists can arrest cell growth 
in various stages of development and count the copy numbers of the florescent probe. Gloria 
showed me an example of a 22p11.2 deletion in an autism case. She opened up her laptop 
and found the image depicting the florescent signals. “So you see two reds and two greens. 
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And here you see two reds and two greens. And then, yes…see, over here, there is only one 
signal being picked up.” The green signals are from the control probe while the red is from 
the test probe targeting the 22q11.2 region. While the green control probe is consistently 
there, the red test probe is absent.   
5.5b Polymerase Chain Reaction (PCR) 
Rabinow’s book (1996), Making PCR, describes the development of PCR in detail. 
The story goes that Kary Mullis, the man awarded the Nobel Prize for his idea of PCR, while 
driving in his car to his cabin, starting thinking about DNA polymerases and DNA 
sequencing. Polymerases are enzymes that repair and replicate DNA. The first step in this 
process is to separate the double strands of DNA. While this is a normal part of cell division, 
in can be mimicked in the laboratory through heating. By adding a primer (a section of DNA 
that acts as a starting point) the polymerase builds on the primer along the template, 
following the principle of base-pair complementarity. Mullis realized that by iterative cycles 
of heating and cooling, a chain reaction could be started in which a defined and specific 
target of DNA sequence could be exponentially reproduced. The products would be of a 
defined length, the length between the outside ends of the two primers. This was Mullis’ 
“eureka” moment.  
Mullis and other scientists at the Cetus Corporation where Mullis worked had 
stumbled on a technique, PCR, which completely altered the practice of microbiology.  As 
Rabinow asserted in the mid-1990’s, “it is no exaggeration to claim that PCR is a 
fundamental tool that makes feasible such magaprojects as the Human Genome Initiative” 
(Rabinow, 1996). PCR was a ubiquitous component within many of the experiments I 
observed in Laboratory X. What follows is a brief description of one of the PCR experiments 
I observed in the summer of 2011.  
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I observed as Heather did a PCR this morning. She microwaved a liquid in a 
container, adding euthidium bromide (a carcinogenic substance) to the mix. After 
microwaving the liquid for a couple of minutes she took it out and brought it back to her 
bench space. The substance had turned into a kind of viscous gel. There are several small 
wells or indents along one edge of the rectangular container that holds the gel. With really 
tiny fragments of DNA, you need a very firm gel. Our DNA fragments today are fairly long 
so the gel does not have to be quite so firm. Heather told me to think of it like a sieve. She 
said, “So imagine you’ve got a big bag of frozen peas that are all different sizes. Some of 
them are really tiny and some of them are really big. So it’s like a sieve to sort out the 
different sizes of peas that you’ve got”.  She’s not sure how large her DNA fragments are 
because she doesn’t know the break points. She guesses the fragments are between two and 
ten kilobases. She’s trying to amplify across a deletion of unknown size and she’s not 
actually positive it is actually deleted.  
To run the PCR she needs to put a dye in the gel. It’s coloured and lets her see. The 
dye is also heavy and pulls the DNA down into the wells so it doesn’t float around. At this 
point there is no DNA in the wells yet. The DNA is still in a row of little plastic tubes. The 
tops of the little plastic tubes, each filled with sample DNA, are bent over from melting a 
little in the heating cycles of the PCR machine. Heather shows the guy sitting at the bench 
beside her and says she will not use these tubes again. It’s tricky to fit the end of the pipette 
in them. There is a little dial on the pipette that changes the amount of liquid that will be 
sucked up. She rotates this with her thumb. There is a tiny amount of liquid in the tubes, 
about five microliters. We put the gel in the fridge to wait for it to set.  After ten minutes we 
take it out of the fridge and load the DNA sample. Alongside the sample DNA there is 
something called a ladder. It contains many DNA fragments, all of known sizes. So you can 
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compare your samples and the ladder. Each of the little wells or holes in the gel along one 
side has a buffer solution. When the DNA is added it sinks into the well. Heather sets her 
timer for thirty minutes. A current runs through it on an electrophroesis, a small machine that 
sits beside her on her bench.  Heather tells me that because DNA is charged, it will separate. 
The small fragments will move through the sieve faster than the big ones. After the gel and 
DNA has sat in the electrophroesis for about half an hour, we come back. Taking the 
rectangular container with us, we walk to the end of the aisle and toward the wall by the door 
of the laboratory. Here there is a UV light box called a UV transilluminator. Heather puts the 
container into the box and waits while it takes a picture. The euthidium bromide that she 
added to the gel makes the DNA glow. After a minute a black and white photograph is spit 
out of the machine. It shows the ladder along the side, basically a line of vertical bands going 
down the photograph. There are other rows of vertical bands beside the ladder. These are 
running down from the wells where the sample DNA was dropped. With the photograph in 
hand, we walk out of the laboratory and back to Heather’s desk in the research office. Several 
black-covered lab books are line up at the back of her desk. They look much like the black 
notebook I carry around and scribble in during fieldwork. Heather is involved in so many 
different projects; she juggles between five lab books. She describes her lab books as a 
“historical recipe book with everything I’ve cooked”. Each of the pages is filled with detailed 
notes of all the steps of each experiment she has done, along with taped in print-outs 
generated along the way. She opens one of the books to the last used page and tapes in the 
black and white photograph of the PCR. 
I asked Heather what the next step would be. At this point, she would repeat the experiment. 
She said, “in the words of my old supervisor – anything real will happen twice”.  
149 
 
5.5c PCR to real-time quantitative Polymerase Chain Reaction (qPCR) 
 The description above is about the PCR process. The PCR process in not used for 
validation but it led to another technology, real time quantitative PCR or qPCR that is used in 
validating microarray results. While a cytogenetic experiment called florescent in situ 
hybridization (fISH) can be used to detect and verify microdeletions and duplications, fISH is 
usually only used when the region in which the CNV is located is already known. Moreover, 
fISH is time-consuming, costly and sometimes does not have the resolution to detect small 
CNVs (Weksberg et al., 2005). PCR is used to amplify DNA fragments, with 20 cycles 
producing a million-fold increase in DNA. This amplification, however, introduced the 
potential for a lot of error, as all fragments may not amplify with the same efficiency. 
Eventually, the PCR cycles no longer produce an exponential increase in DNA fragments, 
with some cycles generating more than others. This is called the “plateau phase”. Real-time 
PCR, (VanGuilder, Vrana, & Freeman, 2008) first described in the mid 1990’s, plots the gain 
in florescence against time (the number of PCR amplification cycles). Real-time qPCR 
allows one to measure the PCR products as they are accumulating. Therefore, the scientists 
can determine the amount of florescence while the experiment is still in the exponential 
range.  It is only during this exponential phase of the PCR experiment that the scientists can 
extrapolate back to calculate DNA copy number measurements of the starting sample.  
After the microarray and qPCR validation, the little tubes of extracted DNA 
frequently move on to another place in the laboratory, continuing on their journey, to be used 
for sequencing. Not all samples continue, however. There is a prioritization that occurs. An 
academic project coordinator explained the prioritization to me, with the caveat that as prices 
start to come down all samples will be run on Next Generation Sequencing in the future. For 
now, samples are sequenced if they have:  
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1) high resolution array data 
2) a known CNV of interest (to see if other variants were detected) 
3) high quality DNA from blood  
4) good phenotype information with family members available for follow up 
He explained that the second point is a bit counter-intuitive but they want to find out if other 
variants could explain or at least contribute to the phenotype. What follows is a description of 
the sequencing experiments that I observed and talked about with scientists in Laboratory X. 
5.6. From CNVs to SNPs - Next Generation Sequencing 
Next Generation Sequencing (NGS) is a technology that can detect all types of 
variation in the genome but is most often used to find a variant called a single nucleotide 
polymorphism or SNP (pronounced ‘snip’). Compared to CNVs, SNPs are much smaller. 
They might be only one or two base pairs in length. For example, if a length of DNA in the 
human reference genome reads A, C, G, T, C and a length of DNA in a sample of DNA reads 
A, C, T, T, C, then this could indicate a SNP at the third base. Where there is a G in the 
reference there is a T in the case sample. In order to detect SNPs, an entirely different 
technology is used. Whereas microarrays were used to detect CNVs, sequencing is used to 
detect SNPs. Traditionally, sequencing was carried out using Sanger biochemistry and was 
limited to smaller, targeted investigations. Recent Next-Generation platforms are able to 
sequence whole genomes. There are three different NGS sequencing platforms used in 
Laboratory X (454 sequencing, Solexa, and SOLiD platform); each has specific uses 
depending on a customer’s budget and the size and quantity of the samples being processed. 
Each of the platforms has specific advantages and disadvantages (i.e., read length, types of 
error, and cost).  According to Shendure and Hanlee (2008), “Although these platforms are 
quite diverse in sequencing biochemistry as well as in how the array is generated, their work 
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flows are conceptually similar”.  During my fieldwork the SOLiD 4 machine was updated to 
a SOLiD 5500. My observations are based on experiments using the SOLiD platform.  
There are several steps involved in a NGS sequencing experiment. In the lab where I 
conducted my fieldwork, the scientists were involved in exome sequencing rather than whole 
genome sequencing. In exome sequencing, only the exonic parts of the genome are captured 
and explored with the intronic stretches of nucleotide bases being washed off in the process. 
The first step is to prepare the library. The second step is called hybridization where the 
DNA is captured. The final step involves adding barcodes and doing an emulsion PCR.  The 
barcodes are added if DNA is being pooled during the experiment. In this section, I will 
describe the NGS process for an exome sequencing experiment. This description has been 
pieced together based on five different interviews with two post-docs and a manager, as well 
as three different observations of sequencing in the laboratory.  
The first step for Heather to do is to prepare the DNA. Other people have already 
extracted the DNA from a blood sample. What matters is the quality of the DNA. All she 
needs is the extracted DNA. She reaches into her fridge and pulls out a tube containing clear 
liquid. This is DNA in solution. I’m quite fascinated and ask her if she can tell that this is 
DNA in here. She says, “It’s just a tube. It’s not very exciting. If you know what you’re 
looking for you can tell. If it’s really high concentrations you can tell because it’s gloopy.” 
She lets me pick up a tube and look more closely at it. At the bottom is a tiny bit of clear 
liquid. I gently wiggle the tube but the liquid doesn’t slosh around at all. She says this is 
because the tube has been stored at such a cool temperature. So she takes her DNA in a tube 
and does an enzymic reaction to purify it. The next step is the hybridization. This is 
important because they are not doing whole genome sequencing for the Autism Genetics 
Study; they are doing exome sequencing. This means that they only want to capture the 
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exome, the genes, and not all of the intronic bits. So she needs to capture the exome and 
wash away all the rest of the genome. This is called hybridization. This step is done early in 
the morning, while the lab is quiet and nobody is there to interrupt her.  She explained the 
process like this: 
So, what we have is a little sequence, little RNA baits basically that 
correspond to the exons and so we attach these to the DNA in our sample. We 
shatter our sample into tiny fragments, prepare those and repair them and 
stuff. And then we bind those with the RNA bait that corresponds to the exon 
so they stick. And then capture the RNA bait using magnets. So then with the 
magnet we can pull out the DNA fragment and wash off everything that 
hasn’t stuck to a fragment. 
 
The fragments are very small, approximately 200 bases long. The RNA baits are about 120 
bases long. She adds the RNA baits to the extracted DNA sample and leaves them at 65 
degrees Celsius for about twenty four hours. Hydrogen bonding occurs between the 
corresponding fragments during this time. After this, the washing process takes about five 
hours of adding solutions (like ethanol), mixing it, pulling the beads to the side with a 
magnet, sucking out the solution and putting in another solution. Over and over.  
In the first part of this step the RNA baits bind to the DNA sample. A fishing analogy is 
often used in the lab to talk about this process of capturing regions of the genome. Heather 
explained,  
 I need baits because in some of my experiments I’m only interested in some 
of the genome. So if you imagine a fishing experiment, I go in and fish out 
the bits of genome that I’m interested in. So to carry on this kind of fishing 
analogy, they call them baits. So the baits represent a complementary 
sequence to the sequence I’m interested in. So you use the baits to fish out the 
bits you want. 
 
Then the rest of the DNA is washed away with various solutions. So all she is left with are 
the exons.  
The next step is to give each sample of extracted DNA a bar code. This is because she 
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runs six samples at the same time and needs to mix them together. The barcode on each 
sample will enable her to figure out which fragments belong to which sample at the end of 
the sequencing. The barcode is a short stretch of sequence included within a primer. A primer 
is a sequence of base pairs that is unique to a very specific region of the human genome. 
Most of the primer is the same for each of the samples but at the end of each one is a little 
sequence tag. This is attached to each fragment. So the first thing that is sequenced is the 
little tag which tells the scientist who the fragment belongs to. 
Below is an excerpt from my field notes when I observed the hybridization and adding the 
barcodes: 
  Heather holds onto a long magnet with red handles at either end.  Hanging over the 
length of the magnet are eight tubes. The lids of the tubes have tiny patient ID numbers hand-
written in green marker. Each of the tubes is quite small, about half the length of my baby 
finger. They each contain a clear liquid. At the side of the tubes resting along the magnet 
there is a small brown line. Heather explains that these are actually tiny magnetic beads being 
pulled over to the magnet. The DNA fragments are attached to these beads. She spins the 
tubes on a round centrifuge and the liquid turns brown as the beads become dispersed or 
resuspended in the solution. Then when she puts them on the magnet they are pulled to the 
side and the solution becomes clear again. This way she can fill the tubes with different 
solutions and then take her pipette and suck the liquid out again without sucking up the 
beads. She does this several times with different solutions.  The pipette seems to be almost an 
extension of her gloved hand, as she quickly presses a button at the top of the pipette with her 
thumb to draw up the solution. A self-proclaimed “techno-nerd”, she explains that she has 
been doing this for over ten years. She thought it was funny that I didn’t know what a pipette 
was because she has worked with them almost every day of her adult life.   
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She is adding the barcode tag. She sets the timer which is stuck to her workbench at 
eye level when sitting. There are lots of plates in front of her on the work bench. After a 
while the timer beeps as she is adding primer to each sample. She has lots of tricks to make 
sure that she doesn’t make a mistake when adding the primer. Finally, she takes a pipette and 
draws liquid out of one tube and drops it into another plate which contains several small 
holes. The holes in the plate are numbered along the top from 1 to 12 and there are letters 
going down the side from A to H.  She is removing the water and DNA and leaving the beads 
behind and then adding the DNA to the primer that is already in the holes in the plate. 
She is using rows C-F and columns 3 -10 on the plate. These are tiny amounts of 
liquid that she is moving around, only 50 microliters. She can’t talk to me right now. It is 
very important for her to concentrate and make sure that the she doesn’t add two different 
samples of DNA to the same hole in the plate. She has lots of little tricks to remind her which 
of the holes she has already added the DNA.  Each of these experiments costs several 
thousand dollars to complete. Once all of the holes in the plate are filled she presses on a 
clear, thin plastic sheet which looks like a big square sticker, to prevent any of the liquid 
from spilling or evaporating during the PCR. We walk over to the end of the aisle and open 
the lid of the PCR machine and lay the plate inside. She pushes several buttons on the display 
at the front and the machine starts. She says it will take about an hour.  
Once the samples are in the SOLiD machine, it takes about two weeks to run. The 
SOLiD machine is basically a robot. She describes the machine in this way, “They’re like 
children. They have tantrums like children. The one I’m running at the moment, you can’t 
touch it. It crashes as soon as you touch it.” When she took me on a tour of the lab she 
showed me a few of their NGS machines and there was a hand written sign on a piece of 
paper saying ‘do not touch!’ on one of the sequencers. Once the samples are put into the 
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SOLiD machine for sequencing a light is emitted for each base and the machine then 
photographs each one of these lights. Each base pair has a different colour light. The absolute 
raw data from these machines are the millions of photographs taken of each of these lights. 
This is called “colour-space”. This then gets converted to nucleotide letters. After this the 
nucleotide letters are aligned to the reference genome.  
What actually happens is you get reads that look like someone’s thrown some 
Smarties on them because there are so many errors. Most reads, or a lot of reads, 
have an error in them. So you’ll get a load of position that match to the reference 
and then on nearly all the reads there’ll be one base scattered around and 
different. But basically you get a pile of reads that all correspond to your region. 
(Heather, post-doc) 
 
These Next Generation Sequencers are “high through-put” meaning they can process a lot of 
data. However, they are also very error-prone. According to Shendure & Hanlee (2008, 
p.1137) “base-calls generated by the new platforms are at least tenfold less accurate than 
base-calls generated by Sanger sequencing”. If she finds any mutations that she thinks are 
interesting she has to validate using a second method of sequencing. This second method is 
called Sanger sequencing. She explained, “This is just traditional Sanger sequencing. This is 
how sequencing was done before Next Generation Sequencing and we use it for validation of 
NGS because it’s cheap and cheerful and you can do a small targeted region for not much 
money very quickly.”  Sanger sequencing does the same thing as Next Generation 
Sequencing except that it does a very small, targeted region. If she finds a variant in a 
particular exon in the NGS data, she will only Sanger sequence that particular exon. It might 
be about 300 base pairs in size. It takes about four days to do the Sanga validation and at the 
end “you get very nice, clean data”. She went on to describe the data that she gets from the 
Sanger, 
So you know exactly what it is; you know exactly where it’s coming from. 
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It’s very simple to interpret and it doesn’t require massive amounts of 
bioinformatics and huge quantities of data storage and stuff like that. It’s all 
just really simple. 
 
5.6a The Computer Pipeline 
 The NGS machine produces several spreadsheets. All of the data runs through a 
computational pipeline. Intense interest and concern over the quality scoring of the generated 
sequences gave way to lively discussions at weekly lab meetings. There are a variety of 
different software and data analysis tools available for processing and interpreting data. 
Different software have different functions in the data analysis process, such as aligning the 
sequence reads to a reference genome, base-calling or polymorphism detection, de novo 
assembly from paired or unpaired reads, and genome browsing and annotation (Shendure and 
Hadlee 2008). SHRiMP, for example, is an algorithm used for alignment of SOLiD data. At 
one point in my fieldwork, I interviewed the bioinformatician who developed the pipeline. I 
also observed an exome sequencing meeting in which she delivered a one-hour presentation 
about the pipeline. A young Asian-Canadian woman in her late twenties, she had a calm, 
quiet voice and smiled easily. When she began to speak about her work on the computer 
pipeline it was like she was speaking another language. Despite, or perhaps in spite, of my 
father making my siblings and I work through computer programming books in Quick Basic 
when I was seven and eight years old, I have not taken an interest in computer languages or 
taken any computer science classes in University.  The description of the pipeline process is 
limited by my lack of familiarity with computer science. 
The NGS data in its most raw form is actually a huge series of photographs. These take up 
three to four terabites of disc space for each run and are almost immediately converted into 
colour space. Once the bases are “called” in colour space, the image files are erased. Each 
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colour corresponds to a different nucleotide and along with the colour the SOLID machine 
will also give a quality score, indicating how confident the machine was in calling each 
colour. So the colour space is actually based on numbers from 1 to 4. If the machine is unable 
to make a call about a base it will insert a dot. Colour space is then quickly converted into 
nucleotide space (e.g., T, C, G, A). All of this data is taken off the sequencer and put on the 
computer cluster, where the bioinformaticians access it and analyze it. Once it has been 
converted into nucleotide space, the data is then put into the “Pipeline”. There are several 
steps to the pipeline process. The first step is to align the nucleotides to the human reference 
genome. When there are differences between the sample and the reference genome it could 
indicate a SNP or it could mean there is an error. If there is a “true SNP” there will be two 
colour changes. If there is only one colour change, it is most likely a sequencing error. In this 
case, the pipeline will insert a base from the reference genome at this point. This, however, 
introduces something called “reference bias”.  
The next step is to remove duplicates or PCR “artifacts”.  The problem is that if one 
allele has an artifact and the other has a true SNP, they both get thrown out. There are various 
complicated algorithms that recalibrate the sequence. For example, if a reference base was 
inserted in an earlier step, it gets recalibrated to N at a later step. The whole pipeline is 
designed to try to increase the number of true SNPs and decrease the number of false 
positives. There are all sorts of scores and statistics used to estimate the probability that when 
a SNP is called it is true. They want to be sure that if they are “calling” a SNP that it is really 
real. For example, during a meeting someone suggested that they could adjust one of the 
computer filters to give Tyler more SNPs and Tyler responded, “We don’t want more SNPs, 
we want more real ones!”  The entire pipeline is very complicated and involves a lot of 
computer science to understand. However, as the NGS facility manager stated, “Basically 
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what’s important for people is two types of data. One would be the sequences themselves. 
And the quality scores associated with those sequences”. Sequencing technologies are 
changing quickly and were described by several people in both the laboratory and autism 
clinic as a “constant moving target”. What seems clear is that the challenges likely to face 
this area of research in the coming years are those associated with how to interpret and make 
clinically relevant all of the masses of data that are generated by these high through-put 
technologies. As Shendure & Hanlee stated,  
Analogous to microarrays, we also expect that the challenges will quickly 
shift from mastering of the technologies themselves to the question of how 
best to go about extracting biologically meaningful or clinically useful 
insights from a very large amount of data” (2008, p.1143). 
I feel I should briefly interject in the description here to make a point about agency. In 
Chapter 2 I discussed the notion of agency and how it is problematized within practice 
theories and actor-network theory. Particularly relevant here is the idea of the dialectic 
between the social structure and the individual or the actor and the network. Each constructs 
the other. Through my research in Laboratory X, this post-humanist, dynamic relationship 
between different agencies is witnessed in surprising places, even at the very core of how 
science itself is practiced. The human genome, micro array testing, PCR and all the tools, 
robots, protocols and material entities that are implicated in these technologies are in fact 
pushing back on the scientists. The scientists are not only involved in their creation but are 
also created by them. For example, since the human genome and technologies such as the 
micro array which have been developed to probe the human genome, the way in which 
scientists conduct research in the field of molecular genetics has been completely altered. 
Whereas research used to be hypothesis-driven, the paradigm has shifted to a discovery-
driven model. Hypothesis driven research is no longer realistic or productive with the unruly 
multitude of actors now opened up by these new technologies for mapping and probing the 
genome. As one scientist explained to me:  
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PhD Student:  But now we have access to pretty much the whole genome so that helps a great 
deal in finding disease genes. So previously before the sequence of the 
genome was known, say you wanted to find a gene for a disorder, you were 
restricted to a handful of genes for which function is known. And so you go 
and look at only those genes, any sequence with those ten genes and then see 
if they have any mutations. So this is what’s called a candidate gene 
approach. So you are obviously restricted by what you know. Because there is 
no other way to approach that. But now that you have sequence from the 
Human Genome you can sort of look at everything in one go and you might 
find a mutation in an unknown gene and it could be interesting, it could not be 
interesting; it’s hard to interpret, especially if the gene is of unknown 
function. But it’s opened the door to a whole other level of detection. Now 
we’re not restricted by what we know anymore. We’re sort of moving from 
hypothesis driven research into discovery driven research. So they are sort of 
two different approaches. Like, hypothesis driven would be like if you took a 
single gene and you think it’s involved in a certain disorder because it has a 
known function and say my hypothesis is that this is involved and we want to 
look at this. That’s hypothesis driven. Discovery driven is, you’re just going to 
take a patient’s DNA and put this on a whole genome micro array and see 
what’s going to fall out. (interview) 
 
So scientists are influenced by, constructed through, the technologies which they create. They 
developed the human genome, microarray, and sequencing machines and in turn these 
technologies are forcing scientists to completely alter how science is ordered, organized, 
practiced. Scientists do science differently because of the agency of these technologies; 
hypothesis-driven research is no longer always manageable or desirable. The scientific 
method, at the core of science, is changing as technologies change. The world is approached 
differently now because of these new technologies.  Agency is shared in a dialectical dance 
among human and non-human actors. 
5.6b Monday Morning Meeting 
The door is locked to the conference room. I’m early as usual. A few minutes later, 
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Tyler comes along and opens the door, propping it open with a chair he’s pulled from along 
the wall. He’s wearing blue jeans and a black long-sleeved shirt. His dark hair is starting to 
grey at the temples. He must be about forty. We talk for a few minutes while he sets up the 
laptop and projector. After a few minutes, others start to walk into the room, finding seats 
and quietly chatting. Some wear coats, indicating they’ve made the trek here from other 
buildings. Others have already shed their jackets and instead carry coffee. Felicia, Claudia, 
and Loren walk in, arriving from the Autism Clinic. They sit down beside each other at 
chairs near the head of the table. 
The Monday morning meetings are held every second Monday in the conference 
room of Laboratory X. The conference room is large, at least 25 feet long, with one big 
wooden table running the length of the room. There is a white board at one end of the room 
and windows at the other end. There are two doors through which one can enter the room, 
both automatically locking. Black chairs hug the edge of the table and a second ring of chairs 
flank the outer walls of the room. I have been to meetings with as many as forty people are 
crammed into this space. Monday meetings begin at 9:30 and run for an hour. An agenda is 
circulated by email ahead of time and electronic PowerPoint slides are distributed early on 
Monday morning. The meeting is organized and chaired by Tyler, the main project 
coordinator in the academic lab. Dr Lorenz often attends but the meeting is not cancelled if 
he is going to be absent. Only academics attend this meeting. Technicians are not invited. 
From Laboratory X, there are post doctoral fellows, PhD students, bioinformaticians, and 
other lab directors involved in autism genomics. From the Autism Clinic, the director who is 
a developmental paediatrician, the genetics project coordinator, and one of the psychologists 
are present. There are also clinical geneticists and genetic counsellors present, although they 
sometimes have their own clinics to run and can not always attend the Monday morning 
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meetings. As well, there are often a few people from the clinical laboratory at Hospital X 
who attend this meeting. Typically, there are about twenty people in the room, although the 
numbers were sometimes fewer over the summer months.  
Since the Autism Genetics Study is a large, multi-site project, there are always people 
who phone into the meeting. From the other geographically dispersed groups who are 
involved in the Autism Genetics Study are project coordinators, psychologists, clinical 
geneticists and co-principal investigators.  
Tyler opens the meeting by going over the agenda, which appears in point form on 
the large screen behind him. He reviews the minutes from the last meeting and then passes it 
off to the first person to present. Presenters at these meetings are almost always from 
Laboratory X. In other words, the PowerPoint slides primarily convey information about 
genetic experiments and findings. The clinicians in the room tend to be observers, sometime 
interjecting to add phenotypic information pertaining to a specific case. (In the eight months 
that I observed these meetings, only two presentations were made by someone who did not 
work at Laboratory X – my own presentation to recruit them into my project and presentation 
by a woman from the federal Ministry of Health who was setting up an autism surveillance 
program.) I was told that occasionally, in the past, a clinical geneticist has presented cases. 
Usually, however, it was the scientists who presented genotype information and then asked 
the clinicians for more phenotype information from which to interpret the genetic results.   
Typically, the agenda would contain three or four cases to be discussed. Some might 
be results from the micro array and others from Next Generation Sequencing. There might 
also be informal discussion about a conference or discussion about a research ethics board 
(REB) application. Often they discussed the protocol that was being developed for a newly 
funded project, which was really just another way of acquiring samples for the Autism 
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Genetics Study.  
At the beginning of the meeting, the case studies to be presented would be listed by patient 
number. For example, one Monday meeting contained the following list: 
H1243/H5204 (NRXN1 nonsense mutation) – report sent  
H3980 (IL1RAPL1 maternally inherited intronic deletion) – 5M analysis?  
H5763 (NRXN1 intronic deletion) – Ankit to get report  
H1376-03 – 19p12 and 4q32.1 gains (report sent)  
As the presenter introduces the case, I can hear the clinicians whispering to each other, 
conjuring up the people represented by the patient number. “Is this the Fuller kid? The boy 
from [Y]?” Loren asks in hushed tones. “No, this is the Stevens family. His sister was 
diagnosed first and he is part of the sib study.” Claudia has brought a stack of patient charts 
with her. The email from Tyler the previous day has given her time to pull the relevant 
charts, ready to offer more detailed information if asked by a presenter.  
The presenter, usually a post doc or grad student, first describes the type of mutation 
found and offers a brief description of the function of the particular gene in which the 
mutation was found. Here they might show a slide with a list of scientific articles that have 
already published about this gene. Then they indicate which type of experiment was used to 
find the mutation and how it was validated. If the mutation is a CNV found with a microarray 
then the next slide is often a screen shot from the Database of Genomic Variants.  
A slide from the Monday meeting on October 17th was laid out in the following 
manner. At the very top of the slide is a chromosome overview which looks like a striped 
ruler. It is divided into segments. Each segment denotes ten megabases (ten million bases) of 
the human genome. At one point a red line crosses the ruler perpendicularly. Under this is 
says, for example, “4q32.1 - 14kb gain”. This tells the audience the location of the mutation 
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and the size of the mutation and whether it was a loss or gain (deletion or duplication) of 
genetic material. Under this there is a second line that runs across the width of the screen. 
This line is divided at regular intervals so that it looks like a ruler. This is illustrating a 
particular region of the chromosome. It is at a different scale that the top line above, showing 
just the portion of the chromosome where the perpendicular red line intersected the first line. 
This zoomed-in ruler, for example, might increase by ten thousand base pairs with every 
notch, spanning a total of fifty thousand base pairs across the slide. Under this line are 
various blocks of coloured lines that indicate where particular genes are located in the human 
genome relation to the ruler across the top. These are called RefSeq Genes.  Under this are 
another set of coloured lines which indicate where OMIM genes are. OMIM is a database 
which contains all of the known disease-causing genes. Directly under the coloured OMIM 
lines there is also a brief description. For example it could say, “FGA Afibrinogenemia, 
congenital, 202400, (3) Amyloidosis, hereditary renal, 105200…”  In this way, the slide 
allows you to compare the location of the CNV found with the location of other known 
disease genes. (See Figure 5.3 for an example) 
Figure 5.3: Example of a DGV slide 
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Following this screen shot, the presenter would often then show a slide with a pedigree. The 
pedigree is a particular type of family tree. At the top of the pedigree is the family 
identification according to the patient number. Different levels of the pedigree correspond to 
different generations, just as with a family tree. A circle is used to depict a female and a 
square is used to illustrate a male. On the pedigree, if the circle or square is coloured in 
black, this means they have been given a diagnosis of ASD.  If the circle or square is 
coloured in grey it means they have been diagnosed with another neurodevelopmental 
disorder. The pedigree also gives information about any deletions or duplications associated 
with a particular circle or square. For example, it might say “de novo NRXN1 deletion”. 
Sometimes there are several deletions or duplications listed under a single circle or square. 
Some circles and squares have deletions or duplications listed under them but they are not 
coloured in black, meaning they do not have a diagnosis of autism.  
 Some pedigrees are small, containing just two levels or generations. A trio (mother, 
father, and proband) is a frequent pedigree that appears. Others are large and expanded 
pedigrees. The pedigree shows visually who has autism, who carries a CNV, whose blood 
has not yet been collected and it can also indicate other phenotypic traits that are not 
standardized. For example, some pedigrees contain information yielded through 
conversations with the parents of the proband. One pedigree contained information below a 
square that stated “very shy when younger” another square stated “quiet and reserved, keeps 
to himself”; several other circles had the word “scoliosis” written underneath them. One 
pedigree went so far as to indicate below a square “organizational difficulties, recites 
Shakespeare”. There was some discussion about this particular inclusion on the pedigree, 
with the director of the Laboratory X stating with exasperation, “but maybe he was a high 
school English teacher! I can recite the 1984 statistics from the Montreal Canadians hockey 
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team but that doesn’t mean I have autism”.  
 Needless to say, the pedigree is a site where information from the laboratory is joined 
with phenotypic information gleaned from the clinic. (Sometimes the junior members of the 
laboratory are not clear on which phenotypic information is appropriate for a pedigree.) 
Indeed, very frequently the presentation of the pedigree segued into a discussion in which the 
scientists would ask the clinicians present at the meeting if they had or if they could obtain 
any other phenotypic information about members of the family. This information could help 
the scientists further interpret their data, determining if the phenotype segregated with the 
same distribution of the genotype.   
In addition, the pedigree was often followed up with a discussion about whether or 
not there was a need to try to contact the family to get more blood from other relatives. If 
more blood samples were needed a research report would first have to be written and given to 
the clinical geneticist to explain that there had been a new finding. From there a feedback 
session would be booked with the family to explain the finding and to ask if they would be 
willing to contact extended family members for purposes of obtaining a blood sample. The 
decision of whether or not to write up a research report is a common outcome of these 
Monday morning meetings. Minutes from these meetings commonly contained statements 
about which reports were to be written and by whom.  
5.7. From Data to the Report 
Reports are written by several different people at the Laboratory X. For one of the 
post-docs, this seemed to be one of her main duties. A PhD student who was heavily 
involved in microarray analysis was also responsible for writing research reports. At the top 
of the report is the date, the physician’s name and the sample ID number. The CNVs are then 
categorized into four different classes. The following excerpt details a particular report that 
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the PhD student named Ankit showed me: 
PhD Student:    So class four is CNVs that are in controls as well, Class three is CNVs that 
are not in controls but don’t overlap any genes, Class 2 are not in controls 
and they overlap some genes but we’re not sure what they mean. Like, they 
could be significant or they might not be. And class 1 is it’s a known 
syndrome or a known pathogenic locus. So for this particular patient the 
array computational analysis programs spat out a list, in this case, there 
were 37 copy number variants. So they are listed in this table. So we give 
the physician the position, the start position and the stop position, size of the 
variant. The type, loss or gain, and each of them is given a class.  
 
Julia:     Wow. 
 
PhD student:    So you’ll see that of the 37 copy number variants [scrolling with his mouse], 
31 are class 4. They were seen in controls. So two of them are class three 
which don’t overlap any genes. We don’t know what they mean. Two are 
class two. They overlap some genes but for these particular genes there is 
not much functional evidence in the literature. Not much is known about 
their function. So they call it class 2. And there are another 2 which are 
class one. So, one of these is the NRXN deletion. So we say that ‘one class 
one deletion overlaps NRXN1 and there is evidence in the literature for the 
[?] of exonic deletions.” And we also say “this deletion was detected in 
samples from the dad and sister but not in the mom by qPCR”. So it sort of 
summarizes.  
 
The report then leaves the laboratory and moves the genetic information back into the clinic. 
This report speaks for all the work that was done in the laboratory. Since arriving in the 
laboratory in a little glass tube, the DNA has been sliced, put on a slide, washed, 
photographed with a florescent scanner, magnified, plotted on graphs, turned into pedigree 
diagrams in power point presentations, and now categorized into four different classes. What 
came into the laboratory in a tube has been converted and transformed many times and now 
leaves the laboratory on a research report. All of the work that took place in the laboratory is 
behind the scenes, or backstage. For the clinician, it is the report that matters. Just as the tube 
of blood seemed somehow significant for me so too did the report. In the same way that a 
tube of blood “stands for” a person, a report is made to “stand for” all the work of testing, 
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discussions, conversions and representations that are done in the laboratory. Weeks and 
months of work are summarized in a few typed paragraphs on a page. 
During my fieldwork I witnessed a lot of discussion concerning whether or not a 
report should be written and if so, the precise wording of the report. Several times, a research 
report would be written up to the frustration of the clinical geneticists who would remind the 
scientists that if a report is written there has to be a feedback session with the family. This is 
because once a report is written it becomes part of the patient chart and the patient needs to 
be properly informed about the information. The clinical geneticists indicated that it would 
be best if reports were only written for cases that had “clinically significant” findings.  
The issue of the wording of reports is exemplified in another interaction that I 
observed. I was sitting in on a monthly meeting between two post-docs from the laboratory, 
two clinical geneticists, a genetics counsellor, and the main research coordinator for the 
genetics research at the Autism Clinic. The conversation was not recorded but I captured the 
discussion in detailed notes. The conversation unfolded something like this: 
Research Coordinator:  Normally we don’t give the research report to the parents at the 
feedback session. But these parents have requested a copy of it. 
They want to leave with it in their hands at the end of the 
feedback. 
 
Clinical Geneticist:         You can give them a service report but not the research report. 
 
Genetic Counsellor:        Why can’t they have the research report? 
 
Clinical Geneticist:         It’s too complicated for them. 
 
Genetic Counsellor:       But the wording is appropriate. 
 
Clinical Geneticist:   Alright, but we need a statement at the bottom of the report that 
says it’s a snapshot at this date. It needs to be explicit that the 
interpretation and the technologies could change over time.  
 
The biggest difficulties arise when clinical significance is uncertain. These are sometimes 
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termed “fence cases”. These are difficult to communicate to families in feedback sessions 
because they are so complicated and often much of the information is not there. The literature 
is inconclusive. The interpretation of the data is uncertain and couched in several modifying 
hedge words when discussed in meetings. There is a tug-of-war between not wanting to 
cause the individual undue anxiety and frustration and wanting to make sure that the 
individual has all the relevant information with which to make clinical decisions.  
The issue of ambiguity is a growing concern among the clinicians. In a meeting at the 
autism clinic I listened as Dr. Morten explained how previous versions of their consent forms 
stated that the genetic testing would help to reduce ambiguity and uncertainty. They have 
now taken this statement out of the consent forms because they find that genetic testing 
actually increases uncertainty and ambiguity; it opens up more questions than answers as the 
technology continues to change.  
This issue of ambiguity is well described in the science studies literature. Hedgecoe & 
Martin have described the impact of genomics on the reclassification of disease, for example. 
Even cystic fibrosis, one of the most simple, monogenetic disorders, has endured complex 
expansion into neighbouring conditions (Kerr 2000; 2005; Hedgecoe 2003). Genetic 
classification of disease is messy, unpredictable, and can lead to increased ambiguity rather 
than clarity. 
When results are clearly clinically significant the research report is then written up 
and sent to Dr Morten at the autism clinic. The project coordinator phones the parents and 
schedules an appointment for a feedback session. Often, it has been several years since the 
individual gave blood. Then, out of the blue, the telephone rings and the parents are told they 
need to meet with a genetic counsellor as there is new information about their DNA that 
could be contributing to their child’s autistic behaviours.  
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5.8. Exit the Laboratory: The Feedback Session 
 
 Once a report has been written and sent back to Dr. Morten at the Autism Clinic, the 
family is contacted and asked if they would come in as there have been clinically significant 
findings from the genetic testing. Dr. Morten or Claudia usually makes the phone call. For 
some families, it has been years since they’ve had contact with the Autism Clinic. The phone 
call takes them by surprise. “We’d like to make an appointment to talk with you. We have 
some interesting genetic findings about your son and we’d like to update you.” An 
appointment is made; a date and time are set. At the meeting there will be a genetic 
counsellor and often either a clinical geneticist or Dr Morten, a developmental paediatrician. 
During my fieldwork, I was able to observe several feedback sessions. In addition, I 
interviewed six parents about their experiences in receiving genetic feedback. The story that 
follows is an amalgamation of stories based on the various feedback sessions I observed and 
my interview conversations with parents. The story is told from the point of view of a mother 
as most of my interview participants, within families of children with ASD, were mothers.  
 They weren’t sure what to expect after receiving the phone call. Dr. Morten didn’t go 
into any detail about what the “interesting findings” were or how they might impact the life 
of this family. The mother lay awake all night. She was excited to finally have an answer. It’s 
been nine years since their blood was collected. Could there be a major breakthrough, some 
new findings with therapeutic implications? Technology has changed a lot in that time. So 
has this family. When they first brought little Davey into the clinic he was just two years old. 
Despite already suspecting there was some sort of developmental delay, the diagnosis of 
autism was still an overwhelming shock for the mother and father. Their imagined lives that 
lay ahead, talked about with excitement, suddenly crumbled before them.  Since then, they 
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have adjusted their expectations. They have learned to go on in their daily life with their son, 
whom they love dearly and whom they can not imagine living their life without.  There have 
been difficulties along the way but routines were established and a new normality quietly 
settled around them long ago. The phone call has stirred it all up again. While she has been 
content and enjoyed her life these past years since her son was diagnosed, the mother can’t 
help but feel her heart beat faster when she thinks about the news they might receive. She 
tries not to let herself get too excited or hope for too much. Still, lying in bed on the night 
before the meeting, in the quite minutes before sleep finds her, she imagines how their son’s 
life might change with the news they are about to receive.  
 They left home with plenty of time to get to the Autism Clinic, but traffic was 
unusually slow and they find themselves walking off the elevator only a few minutes before 
their scheduled appointment. They have both taken the day off work, he a sales manager and 
she a dental hygienist. On most days off work they dress in casual comfortable jeans and 
sweatshirts. Not today. She looks at her husband. He’s wearing freshly ironed Dockers and a 
dress shirt and tie. The tie is what gives it away, the importance of the day. She wears her 
dark green skirt and cashmere sweater, a silk scarf hanging loosely over her shoulders. They 
approach the reception desk and give their name. “I’ll let her know you’re here”, the friendly 
receptionist smiles and tells them to take a seat before she disappears down the hall. A few 
minutes later a diminutive, middle-aged woman approaches them, a younger woman 
following behind.  The first woman extends her hand toward them, “Hello, I’m Donna”, a 
genetic counsellor. She introduces the young woman who stands slightly behind them. The 
mother and father are told that she’s a student who would like to observe the meeting. 
Glancing at each other, they nod in acceptance. The student pulls out a piece of paper which 
describes her study. They quickly read it over and sign the consent form.  They follow Donna 
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down the hallway and into a conference room.  
 The conference room is fairly small with two couches and two chairs placed in a 
circle around a small central coffee table. Along one wall is a large window which looks out 
onto a busy street six floors below. It is grey outside today but the sun keeps trying to break 
through the clouds and for a moment sunlight beams through the window, spilling across the 
dark grey carpet.  A brightly coloured painted canvas depicts a part of the large mural that 
adorns the walls of the waiting room. The woman and her husband sit down beside one 
another on one of the small couches and the genetic counsellor, Donna, sits across from 
them. The younger student sits off to the side. Donna starts by telling them that there has 
been an explosion of research in the last five to ten years. Their son’s sample has been in the 
laboratory a long time, as it was collected almost ten years ago. There have been recent 
advances in the technologies used to explore genetics and that is why we are here today. She 
asks how much background they have in genetics. The couple respond that it has been a 
while, since high school biology probably. Donna pulls out a thick, white, three-ringed 
binder. “We have over thirty thousand genes. As you know”, she says, “our genes are like a 
blueprint of instructions. Genes are everywhere in our bodies and we can get at them through 
a blood test to look at chromosome structure”. She flips the binder open to a page with 
several little black and white worm-like squiggles on it. “Our genes are on chromosomes. 
You can think of these chromosomes like a necklace and the genes are like the beads”. She 
explains that in previous technology scientists could look at a blood sample under a 
microscope and see each of the chromosomes. She shows them that there are 23 
chromosomes and that there are two copies of each chromosome. One copy is from your 
mother and one copy is from your father. “With new technologies, we are able to look for 
subtle changes. We can detect missing or extra pieces that are very small”. She says you can 
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imagine that the chromosomes are like a map and the new technologies are like the little 
blown up insert on the map that shows one area in more detail.  With your son’s blood 
sample, we blew up each chromosome to look for missing or extra pieces. Donna then takes 
out a sheet of blank white paper and begins to draw. First she draws two vertical lines and 
marks a small x on one of them. She then writes “16” underneath the lines. Donna explains, 
when looking at your son’s chromosomes with this new technology we have found that there 
is a small piece that is missing on chromosome 16. She writes the word “DELETION” in 
capital letters on the piece of paper. “When we look at the literature to see what other 
scientists have found in this region of chromosome 16 we find that there are two different 
sizes of deletions here, one larger and one smaller.”  She then draws two horizontal bars, one 
smaller and one larger. She explains that there are about 50 people reported and described in 
the literature with the larger deletion in this region but the smaller deletion is not as well 
understood. It seems to be more variable. There have not been any other reports in the 
literature with individuals with this deletion who are on the autism spectrum. However, some 
individuals have been described as having learning or behavioural difficulties. Donna draws 
another line and above it writes “range of difficulties”. She explains that some genes are 
cause and effect and you can almost be sure that they will be on the spectrum if these genes 
are interrupted. Other genes, however, seem to be risk factors but are not totally responsible. 
At this point Donna stops and asks if the mother and father have any questions. The woman 
asks, “What does this mean for us?” Donna responds, “At this point in time we cannot give a 
more effective intervention. It is just information. But knowledge is power and we felt that it 
is important for you to know what we have found so far. There will be lots of new 
information in the next few years as technology continues to advance”.  
 The meeting continues with Donna collecting information about both the mother and 
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father’s family history. She asks if there have been others in the family diagnosed on the 
spectrum or with any other neurodevelopmental diagnoses. She creates a kind of family tree 
with circles and squares, writing in all the information about grandparents, aunts, uncles, 
cousins, and siblings. She also asks if there were any learning difficulties, speech problems 
or quirky behaviours in any of the extended family members. After several minutes, Donna 
explains that they would like to get a blood sample from the mother and father to understand 
if the deletion on this chromosome was passed down or if it arose spontaneously in their son.  
The woman and her husband look at each other and nod, saying they would be interested and 
willing to participate in this. From the stack of papers in the binder Donna produces two 
consent forms and leaves the room while they read through them. Donna and the younger 
student return about ten minutes later and Donna asks if there are any questions about the 
consent forms. The woman and her husband do not have any questions and they have already 
signed their names at the bottom. With this in hand, Donna leads them out of the office and 
directs them to the blood lab on the first floor of the hospital.  
 The couple walk silently out of the office. Waiting at the elevator in the hallway the 
father says he is a little disappointed that all they received was information, that it doesn’t 
really change anything for their son Davey at this point.  The mother agrees and says she had 
been hoping for more. “But” she says, “it is really interesting and hopefully some day it will 
make a difference, maybe not for Davey, but for some other family in the future”. The 
elevator door dings as it opens and the couple walk in, heading down to the blood lab below. 
5.9. Back into the Clinic 
 5.9a Diagnoses: Clinical and Research 
When a family first arrives at the autism clinic to give blood for genetic testing, they 
174 
 
arrive with a previously given clinical diagnosis of ASD. This diagnosis will have been given 
by a paediatrician or family physician or perhaps even a neurologist. It is usually based on 
brief examinations of the individual and information gleaned from parents about the medical 
history and development of the individual. This clinical diagnosis is a criterion for being in 
the genetics study in the first place. When the family returns to the autism clinic for deep 
phenotyping sometimes years after their initial visit, following the genetic testing in the 
laboratory and the feedback session, they are involved in much more rigorous assessments. 
When the assessments are completed the individual will get a research diagnosis, which 
usually confirms the clinical diagnosis of ASD.  
As I stated earlier, the protocol for the genetics study had recently been changed prior 
to my fieldwork. Previously, everyone received the rigorous deep-phenotyping assessments 
before the genetic work-up. According to the clinicians at the Autism Clinic, many of the 
participants wanted to participate in the genetic research because these diagnostic 
assessments are so difficult to obtain otherwise. There are long wait lists for these gold-
standard tests. Children often remain for up to a year on waiting lists of educational 
psychologists to be tested. If a family is wealthy, these tests can be paid for and obtained 
privately. For many families this cost of private testing is out of reach and so they must wait. 
Participating in this genetic research, with its accompanying battery of clinical assessments 
included, was a means of obtaining assessments and was a big incentive for families to 
become involved. As the research coordinator stated, “I have never had to go out and actively 
recruit patients. In the nine years that I’ve been working here, there has always been a 
waiting list of people wanting to be in our study.” There was some concern, therefore, that 
the change in protocol would see a marked decline in families willing to participate in this 
research. During the following year, while I conducted my field work, they did not see a 
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decline in participants on the waiting list. There must  be other motivations for people to be 
involved in this research, as the deep clinical assessments are no longer guaranteed, given 
only to those found to have clinically significant genetic variants.  
After the family has received the genetic feedback another appointment is made to 
come back to the autism clinic at a later date in order to do all of the clinical testing or “deep 
phenotyping”. The purpose of these clinical assessments is to help interpret the genetic 
information by developing a more detailed picture of the physical and behavioural 
characteristics of the individuals in the family. Here I will discuss three important types of 
formal assessment along with informal conversations, which contribute to the phenotype 
information. These three assessments include the Standford-Binet Intelligence Test (5th 
Edition), the Autism Diagnosis Observation Schedule (ADOS) and the Autism Diagnostic 
Interview Revised (ADI-R). These are gold-standard assessments for the diagnosis of ASD. 
These are primarily conducted by a practicing psychologist or psychology PhD students.  In 
addition to these assessments, a digital photograph is taken of the patient and the parents in 
order to be used for a dismorphology exam, performed by a trained clinical geneticist. All of 
the deep-phenotyping takes place at the autism clinic. 
5.10 Setting the Stage: The Autism Clinic 
 
The large foyer of the grey office building contains a glass-covered desk with a list of 
all the offices and their floor numbers. Within the list, there are government offices, lawyers, 
and several offices and clinics associated with the hospital. A coffee shop bustles with 
activity as professionally-dressed people line up for coffee or muffins. The building is tall 
with twenty-four floors. As I step on the elevator several other people squeeze in beside me. 
Some are wearing hospital name tags around their necks but many are not. I step off the 
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elevator at the sixth floor. To the right is a law firm. I head to the left. A sign on the wall 
indicates that this is the Autism Clinic. An arrow below the sign directs me to continue down 
a smaller hallway to the right to find the door to the waiting room. I follow the arrow. 
Stepping through the door to the waiting room, the florescent lights shine brightly. The room 
is about eight feet by twelve feet in area. There are green, vinyl padded benches pushed 
against two of the walls for people to sit down. On the wall opposite the entrance is a large 
sliding glass window. Small Smurf figurines and a little wild-haired troll are poised on the 
ledge of the window, inviting little hands to reach up and play with them. The friendly 
administrative assistant sits at her computer behind this window. The walls are light blue. 
There is a bulletin board reserved for articles and notices that pertain to ASD in adolescence 
and adulthood. On the far wall, there is a large bookshelf containing binders and pamphlets 
as well as videos. Some of the pamphlets are several years old. A shelf with several small, 
labelled cubby holes holds various toys and puzzles. A child-size table and two small chairs 
are placed in the centre of the room. Artwork drawn by children hangs in black frames along 
one wall.  One frame hangs askew on the wall, empty. There is a recess in the wall beside the 
reception window where another locked door is located, always closed. On the back of the 
door are posters advertizing various research studies inviting individuals with autism to 
participate.  
 The administrative assistant has seen me and opens the locked inner door to let me 
through to the back. I’m here to observe some assessments today. The inner door opens and 
to the right is the administrative office. The carpeted hallway is narrow and leads past a few 
offices on the right. The first office is where Mary sits. She is a psychology PhD candidate 
and she does a lot of the testing for the infant sibling study as well as for the genetics study. 
She shares her office with another psychologist who is currently on a maternity leave.  The 
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next office on the right is Dr. Morten’s. It is much larger and holds a large desk as well as a 
round table and chairs. There is a window that runs across the length of the office. Filing 
cabinets and book shelves are crammed in against the walls. Across from these two offices, 
on the left side of the hallway are two other rooms. One room is used for testing and contains 
a small table and chairs as well as a brightly coloured play mat and lots of different toys. The 
adjacent room is very small and is used for observations.  
 Continuing down the hallway, there is a section with dividers. Claudia and Don sit to 
the right of the hallway (Don is a summer student in microbiology and hopes to go to 
medical school one day) and Florence often sits in one of the cubicles to the left. Florence is 
a research coordinator for one of the non-genetic studies but during my fieldwork she started 
working on phenotypic assessments for the genetic study. There are large beige coloured 
filing cabinets lining the walls. I’ve seen them being pulled open, the heavy drawers holding 
tightly packed patient files. There are well over two thousand patient files in this office. 
Further down the hall is another office on the right. This is where Loren sits. Finally, at the 
end of the hall is the large kitchen area with a large square table. This room also serves as the 
conference or meeting room. In addition to fridge, tea pot, toaster and microwave, this room 
has a white board and projector screen at one end. Windows at the far wall let in natural light. 
At lunchtime employees come in this room to sit and eat together.  
 Compared to the Laboratory X, the autism clinic space occupies a much smaller 
footprint. There are also far fewer employees here. At most, there are ten people who work 
here. I sit down at the table and wait until they are ready to do the ADOS testing that I will 
observe today.  
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5.10a Assessments: ADOS, ADI-R, and Intelligence Test 
 There are numerous assessments, both standardized and non-standardized as well as 
questionnaires that are filled out during the process of the deep-phenotyping individuals who 
have been involved in the genetics study. The three assessments I will present here are 
hallmarks of a research diagnosis of ASD and are considered by the clinicians I talked with 
to be gold-standard assessments.  
i) Autism Diagnostic Observation Schedule (ADOS) 
 
 I am sitting in a very small room. With me are two other women. One is a PhD 
psychology student and the other is a project coordinator who has a Master’s degree in 
psychology. There are three chairs in the room on which we sit down. Around me in this 
room are another desk and three other computer monitors and a recycling bin. Several boxes 
are piled up. At the end of the room, the wall is lined with a floor to ceiling bank of blue 
filing cabinets. In front of us, perched atop a desk is a video monitor, a panel with buttons 
and what looks like a joy stick. We are watching the interactions between the developmental 
paediatrician and a young three-year old boy in the room beside us. They hand me two paper 
booklets, two versions of the ADOS assessment. They are each holding these forms in their 
hands and writing on them every time the boy on the screen engages in any type of social 
interaction. At first, they are not sure which ADOS forms to use. There are different forms 
that correspond to different levels of child development (preverbal, early verbal, or later). 
The development paediatrician has never met this little boy before and has to determine 
through his interactions which of the measures she should use. She is “blinded” as to whether 
he has been previously diagnosed with autism. She will initiate a different set of interaction 
and play activities depending on where she thinks the child is positioned developmentally at 
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this point in time. At first the child is alone in the room with the paediatrician. The first part 
of the observation is called “free play”. The paediatrician sits in a small chair at the table 
while the young boy explores the various toys on a brightly coloured mat on the floor. He 
picks up some blocks. The paediatrician watches him and asks if he can build a tower. He 
ignores her, drops the block and moves onto a different toy. The paediatrician writes 
something down in her ADOS form at the little table. He flits around from toy to toy for a 
few minutes, picking them up, looking at them and then dropping them again. The 
paediatrician is trying to engage the boy and get his attention. She calls his name but he 
doesn’t look or respond. The boy finds a figurine that he seems particularly interested in and 
holds it up for the paediatrician to see. She writes in her ADOS form again. The paediatrician 
gets down on the mat too. She shows him a bubble machine. It blows bubbles out and the 
little boy loves it. He is squealing with delight and chasing the bubbles. He wants to try it 
too. He says the word “bubbles” and everyone in the room with me, hovering around the 
video monitor, quickly writes this down. The boy is making eye contact and interacting a 
little more now with the paediatrician. She is laughing with him.  
The child’s mother enters the room and sits on a chair at the far wall.  The boy runs to her 
and she gives him a hug. “Come see bubbles” he says. He is speaking a little more now that 
his mother has arrived. Everyone in the little room writes this down and they all seem to be 
switching to a different ADOS form, one that is targeted toward children who use phrase 
speech rather than the pre-verbal/ single word module. The boy comes back to the 
paediatrician while the mother sits on a bench against the wall. The paediatrician asks the 
boy to come sit at the table with her. They sit across from each other in small child-sized 
chairs. The table is not very wide and their hands can easily touch. The paediatrician asks 
him to pretend he is getting ready for bed and brushing his teeth. She asks what he usually 
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does. The boy is having difficulty sitting in his seat. He wants to use the bubble machine 
again. He ignores her when she asks about brushing his teeth before bed. He gets out of his 
chair and walks around to where she has placed the bubble machine. He wants it. The 
paediatrician says he can use it in a minute as a treat once they have played a little more at 
the table. The boy sits back in his seat, reluctantly. The paediatrician brings out a picture and 
puts in on the table. She asks him what the picture is about. From the little observation room, 
we cannot see what the picture depicts. The boy sits rocking in his chair and says something 
quietly. The paediatrician asks him if he likes horses. (It must be a picture of a horse that she 
is showing him.) She asks him what else he likes. He doesn’t say anything. She gets out a 
picture book. She opens it up and asks him what is going on. He reaches up and turns the 
pages. He briefly describes what is in each picture. Again, he gets out of his chair and tries to 
reach the bubble machine. She lets him use it briefly. He is laughing and chasing the bubbles 
around the room. The paediatrician directs his attention 
 “Here’s one. Try to pop it!” The boy follows her gaze and runs over to pop the bubble. His 
mother is laughing too and the boy is clearly enjoying himself. After a few minutes he is 
directed back to the table and the paediatrician takes out a small doll. She says it is the doll’s 
birthday party! She has little plates on the table. The boy is uninterested. He says something 
about blowing out the candles on her cake. He sits back in his chair and doesn’t seem to want 
to play. She asks if he wants to take a break and have a snack. No, he is not ready for a snack.  
 Once the ADOS is finished, the boy and his mother leave the room. This boy has 
participated in the ADOS as part of the infant sibling study, another study being conducted 
out of the Autism Clinic. He has siblings who have been diagnosed with autism and so he has 
been monitored closely at intervals since birth. Now they are going into the hospital to have 
their blood drawn for the genetics study. This is quite common at the Autism Clinic; a single 
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family participates in several on-going research studies and the researchers share tests across 
studies. It reduces duplication and saves time and money. If a child has an ADOS performed 
through the infant sibling study the genetics study can use this clinical (phenotypic) 
information to later help interpret genetics results.  
 We say goodbye to the little boy and his mother and then we all head down the 
hallway toward the kitchen at the back. We sit around a large table and compare our notes 
and scoring in the ADOS booklets. The coding is organized into five groups: language and 
communication, reciprocal social interaction, play, stereotyped behaviours and restricted 
interests, and other abnormal behaviours. The child is scored on several items in each 
category. He can receive a zero, one, two, or three for each item. For example, one item 
under the Language and Communication section is Overall level of non-echoed language. A 
zero is given if the child uses three or more words per utterance and some grammatical 
marking such as plurals or tense. A score of three is given if the child uses single words only 
or no spoken language.  I listened as they talked about what tenses the boy used, pointing, 
looking, visual referencing. They said that vocally he would not get a zero. He whispers a lot. 
They went through the list of different items for each of the groups to be scored, comparing 
what they heard and saw and then giving a score. At one point one of the students who was in 
the room said she was having difficulty deciding between a score of one or two for some of 
the items. The developmental paediatrician who had experience doing the ADOS said that 
the way she decides between a score of one or two is she mentally tries to think through the 
list of things that the patient did well and then a list of things that are off. She then compares 
these mental lists and it gives her the distinction between a score of 1 or 2. A score of 1 has a 
longer list of good things and a score of 2 has a longer list of things that are off. 
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 ii) Autism Diagnostic Interview – Revised (ADI-R) 
The ADI-R is a detailed interview with the parents, which often takes about two or 
three hours to complete. The interview is historical in nature, asking intimate and involved 
questions about everything from the pregnancy, birth, early development and into school 
experiences, depending on the age of the child being clinically investigated. On three 
occasions I planned to attend and observe an ADI. I would make the 2 and a half hour 
journey to the Autism Clinic, however, each time the parent cancelled or did not show up to 
the appointment. Consequently, my description of the ADI is based on interviews with a 
psychologist and a psychology PhD student who conduct the ADIs at the Autism Clinic, as 
well as document analysis of the ADI-R questionnaire guide.  
The ADI questions are divided into several topic areas: background, early 
development, acquisition and loss of language/ other skills, language and communication 
functioning, social development and play, interests and behaviours, and general behaviours. 
The background questions are designed to give the person doing the assessment an overall 
picture of what the “subject” is like. For example, questions are asked about family 
composition, past playgroups and schooling, or any current concerns. Early development 
questions deal with the onset of symptoms. For example, the examiner asks “how old was 
[subject] when you first wondered if there might be something not quite right with his/her 
development?”  This section also contains questions related to motor milestones, toilet 
training and bladder control. The acquisition and loss of language/ other skills section 
contains questions such as: “How old was s/he when s/he first used words meaningfully, 
apart from ‘mama’ and ‘dada’?  What were her/his first words? How did s/he show that s/he 
knew their meaning? [Get Examples]” Other questions try to understand whether the 
“subject” experienced a regression, losing a skill that he/she once had. For example, ‘Was 
183 
 
there ever a time that s/he stopped speaking for some months after having learned to talk? 
The next set of questions relates to language and communication functioning and contains 
questions such as: “How much speech does [subject] have now?” Other questions are 
designed to illicit information on stereotyped speech patterns, social chat (small talk), 
reciprocal conversation, intonation, volume, rhythm, rate, pointing, nodding, imitation, and 
imaginative play. Social development and play questions ask the parent to describe the 
“subject’s” use of direct gaze, social smiling, directing attention, sharing, sharing enjoyment, 
offering comfort, facial expressions, favourite activities and toys, group play with peers, 
friendships. The interests and behaviours questions ask about unusual preoccupations, 
repetitive use of objects, compulsions, unusual sensory interests. For example, “Does s/he 
seem particularly interested in the sight, feel, sound, taste or smell of things or people? For 
example, does s/he tend to sniff toys or people inappropriately?” This section also asks 
questions about negative responses to specific sensory stimuli, difficulties with minor 
changes in routines or personal environment, hand and finger mannerisms. The section about 
general behaviours includes questions related to gait, aggression toward care takers or family 
members, self-injury, hyperventilation, and special, isolated skills. Special isolated skills 
include abilities that the subject has such as visuospatial ability (puzzles, patterns), memory 
skills, musical ability, drawing skills, reading ability, or computational ability.  
The ADI is 85 pages long. On the top of each page is a brief summary of the purpose 
of the question or in some cases an operational definition will be given here to clarify what is 
meant by the question. For example, item 51 on page 45 is about social smiling. At the top of 
the page it says “defined as spontaneous smiling directed at a variety of people, including 
smiling back at someone smiling at her/him, smiling during an approach, and smiling as a 
response to what someone does or says to her/him”. On each page, below the purpose of the 
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question and operational definitions, are the question and a few probes that can be used to 
further specify behaviour. To the right hand side there is a scoring system. The interviewer 
scores each question in real-time, as s/he is going through the interview questions with the 
parent. Question 58, for example, is about inappropriate facial expressions. The scoring 
system is listed as follows: 
0 = facial expressions almost always appropriate to mood, situation and context 
1 = facial expressions slightly or occasionally inappropriate or odd 
2 = facial expressions obviously inappropriate in several different situations 
(SPECIFY) 
8 = N/A (almost no variation in facial expression, appropriate or inappropriate) 
9 = N/K or not asked 
At the far right side of the page are two tick-boxes, labelled “current” and “ever”, used to 
determine if the behaviour being described is current or has ever occurred in the past.  
 Included in the ADI interview protocol is also an ADI-R Comprehensive Algorithm 
Form. A PhD student in psychology who conducted many of the ADI-R interviews explained 
the scoring system in one of our interviews:  
Julia:   How does the algorithm work for the ADI? Is there a scoring system? 
P:  There’s a scoring system and you have to be trained and get reliability on that. 
And the scores go from 0 where there’s nothing that indicates autism or any 
kind of developmental issue, to a score of one or two. Two or three are usually 
the highest you can get. So the diagnostic algorithm only uses scores of 0, one 
and two. So, a three turns into a two. There are other, in certain questions, in 
language or motor movement where if a kid has a severe physical disability or 
has a different type, like a stutter or something then you would put a different 
type of score. So each question indicates which number you should be putting 
in… They do give descriptions about what each score would mean and then 
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you’re supposed to be scoring as you go along with the parent. So if there’s 
anything that you’re not sure about you have to really probe deeper. 
 
On the Algorithm Form, the interviewer copies down the score given for specific questions. 
These scores are added up for each section and a total is arrived at. For example, section A is 
called Qualitative Abnormalities in Reciprocal Social Interaction. It is comprised of four 
sections with each section drawing on various questions from the ADI-R interview protocol. 
Different questions pertain to different subject ages, so that the questions involved in the 
algorithm for a two-year old are different than those included in the algorithm for a five year 
old. On the front page of the Algorithm Form there is a space for the score summary. The 
interviewer writes in the sum of all the scores corresponding to the questions in section A, for 
example. There is a diagnostic cut-off given for each section’s total score. For example, 
section A has a cut-off of 10. If a “subject’s” scores were above the cut-off scores for each of 
the sections, then the ADI-R would be interpreted as indicating ASD. This ADI information 
would be compared with scores for the ADOS and other questionnaires as well. Moreover, 
the clinician meets with the patient to get an overall impression. Several of the psychologists 
I interviewed suggested that clinical judgement is an important component of diagnosis.  
iii) Intelligence Testing – Stanford-Binet 5th Edition 
 Another standard assessment that is conducted at the Autism Clinic is Intelligence 
Testing. The same PhD student who did many of the ADI’s was also responsible for much of 
the intelligence testing at the Autism Clinic. I observed him conduct the testing and 
interviewed him about the process. In addition, several of the other people I observed and 
interviewed in the Autism Clinic described various aspects of the intelligence testing.  
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 The first functional intelligence test was developed in France in 1905 by Binet and 
Simon. Initially, the test was not well received. Lewis Terman, from Stanford University 
bought the publishing rights from Binet for the sum of one dollar and in 1916 the first 
Stanford-Binet Intelligence Scale was published, translated and adapted from its original 
form (Viney & King, 2003). The Stanford-Binet Intelligence Scale, 5th Edition, was released 
in 2003. It is a one-on-one, individually administered test in which an examiner uses various 
cognitive tasks to assess the intelligence of an individual. The test is used or a broad range of 
ages (from two years to 85+ years) and can be used to test a wide variety of disabilities and 
exceptionalities. Intelligence is broken down into five categories or factors underpinning 
cognitive ability: fluid reasoning, knowledge, quantitative processing, visual-spatial 
processing, and working memory.  Some of the advantages of the 5th edition over earlier 
editions are its game-like qualities with more colourful artwork, toys and manipulatives and 
its balance of verbal and nonverbal content. The game-like qualities of this newest edition are 
especially important considering the pervasive concern for examinee fatigue. Indeed, the 
testing that I observed at the Autism Clinic was often punctuated by several breaks as young 
examinees would often begin squirming in their seat after a little while.  
 As with the ADOS testing, I watched the Intelligence testing from an adjacent room 
through a video monitor. The intelligence testing room was quite different compared to the 
room set up for the ADOS testing. Two chairs were arranged on either side of a small table 
pushed up against one wall of the room. A round clock was mounted on the wall. The room 
was painted in a neutral colour and was, with the exception of the table and chairs, empty 
with no stimuli to distract the examinee from concentrating on the tasks presented to him or 
her. The testing consisted of various cognitive tasks that were worked through across three 
different booklets. The various factors (ie., working memory) contained different items or 
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tasks for the examinee to respond to or perform. The items would begin more simply and 
increase in difficulty. The books were set up like a tent on the table between the examiner 
and the examinee, with one page facing the examinee and the backside of the previous page 
containing scoring information and instructions facing the examiner. As the testing was in 
progress, the examiner recorded the scores for each item.  In the exams that I observed, the 
child being tested was alone with the examiner while his or her parents waited in the waiting 
room.  Once each of the three testing booklets had been worked through the psychologist 
would apply an algorithm to interpret the scores gleaned from the testing process. This 
information is then combined with scoring from other assessments and taken together they 
form the basis of a research diagnosis. 
At this point, I have followed DNA as it has moved through many different places 
and spaces within the laboratory and clinic, being translated and transformed many times 
along the way. From blood, to extracted DNA it moved into the laboratory. Here it was 
sliced, washed, photographed, amplified, plotted on intensity graphs, compared to reference 
genomes, compared to other findings in the literature, displayed in PowerPoint presentations, 
run through a sequencing experiment, tagged with a barcode, validated through PCR, and 
written up in a research report. Out of the lab, the DNA was discussed in a feedback session 
with parents, represented in photographs of chromosomes, through metaphors of necklaces 
and beads, and blueprints. Moving into the clinic, the DNA is combined with phenotypic data 
gathered through standardized observations, interviews, and intelligence testing. A clinical 
report is written and given to the parents.  
There have been several different humans involved in translating and transforming 
the products that have moved through these spaces: the patient and his or her family 
members, the developmental paediatrician, and project coordinator, the nurses in the blood 
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lab, the laboratory technicians in the DNA extraction lab, PhD students, post docs, 
technicians, and a wide variety of scientists at the Monday-morning meetings, genetic 
counsellors and medical geneticists in the feedback sessions, psychologists and paediatricians 
in the clinical testing.  
There have also been a large number and variety of non-human actors that have 
connected to the DNA along the way as it has moved through the laboratory and clinic. 
Arms, hands, numbing cream, needles, blood, tubes, robots, slides, chips,  ovens, pipettes, 
magnets, buffers, computers, mathematical algorithms, statistical pipelines, intensity graphs, 
research reports, clinical reports, diagrams and doodles, PowerPoint presentations, peer-
reviewed manuscripts, consent forms, standardized observation schedules, scoring sheets, 
video monitors, toys, bubble machines and databases are but a few.  
Thus far, I have not described what DNA or autism means to individuals but rather 
have focused on describing how autism is done through the interaction of human and non-
human actors.  
5.11 Entrance: Into the Family Home 
 
Unlike the story I have recounted from the laboratory and the autism clinic, the story 
that I want to tell about the families involved in genetic research are based on interview 
conversations only. I was not able to observe these families as they went about their daily 
routines. I could not see with my eyes how autism was done in the family home. Through 
interview conversations, however, I was given glimpses of how autism and the genetic 
information these families have received is enacted in everyday life. I have tried to unfold the 
different ways that autism is materially enacted by these families. I wanted to at least offer a 
glimpse of how the genetics of autism is reassembled beyond the walls of the hospital.  
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 5.11a Demographic Information of Parents 
The people interviewed included parents from six families who had participated in 
genetic testing and received genetic feedback about autism. The interviews were conducted at 
least 8 weeks after the families received the genetic feedback. Five mothers and one father 
were interviewed. Four of the mothers who were interviewed described themselves as single 
parents. All of the participants had completed at least some college or university. When 
asked about ethnic background each participant described his/herself as Canadian. The 
current age of the child diagnosed with autism in each family ranged from eleven to twenty 
one. The age of the child at the time of the original diagnosis of autism ranged from three to 
eleven. Three of the six families had more than one child diagnosed on the autism spectrum. 
The specific genetic findings varied with each family, such that across the families a number 
of genes had been identified as associated with autism including: NRXN, SHANK, 
PTCHD1, and SH2B1. Some parents were not sure of the gene involved but were aware of 
the location, for example chromosome 16. All of the genetic findings involved copy number 
variations (deletions or duplications) found through microarray testing. In the following 
section I would like to discuss how autism is constructed in relation to daily routines and the 
process of diagnosis. After exploring how autism is enacted or done through daily routines 
and the process of diagnosis, I will then be able to describe how genetic information becomes 
entangled with the enactment of autism in the daily life of families.  
During the feedback session, genetic information about autism is given to parents. At 
this point, this information enters entirely new networks as it becomes entangled with all 
kinds of human and non-human actors that make up the daily life of the family. The networks 
into which genetic information enters are elucidated by exploring the daily routines of 
children and families living with autism. All of the families described the importance of 
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keeping a routine. In the description that follows, I have cobbled together the daily routines 
gathered from each of the parents and presented them in one short account of a day in the life 
of “Bobby”. I have created an amalgamation of the stories, condensed into a single character 
named “Bobby” because I am concerned with the anonymity of participants and their family 
members. Bobbie’s routine is recounted in the third person, from a mother’s perspective.  
 5.11b Bobbie’s Daily Routine as Told by His Mom 
Bobbie has always had a strict routine. From the time he was a tiny baby I became a 
single mother and so I always had to work to financially support our family. I had to get up 
and go to work every morning so the kids always had to get up early too. Bobby wakes up in 
the morning around 7:00 am. He is often in a bad mood and swears at me or picks on his 
brother or sister. I do my best to make a nutritious breakfast: pancakes or French toast, fruit, 
and milk or something like that. I make milkshakes with berries a lot because I think the 
berries are good for Bobby’s brain. I want to know that I’ve done my best to start him off on 
his day in the best way I can. Often, when I’m racing to get breakfast ready for everyone and 
to get myself ready for work Bobby will have a meltdown about something. This morning, 
for example, he demanded that I come to his room at once because he did not like the 
particular socks I had laid out for him to wear. “I don’t care what you’re doing mom; I hate 
these socks and I want you to get me new ones, now!”  Eventually, we all scarf down some 
breakfast and I drive Bobby to school. My two older children take the bus to their school but 
I’ve always been nervous about putting Bobby on the bus. He can get taken advantage of 
easily. So I drop him off at his school. He is in an LD (learning disabilities) class but it is 
partially integrated. So he does take some of the usual subjects that other kids take, like 
drama or computers. I usually get called by the school, most days. Bobby spends a lot of time 
in the principal’s office and sometimes they let him practice being the secretary to give him 
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something to do. Sometimes Bobby gets sent home from school because he is acting out. So 
I’ve had to change my job, rearrange my work life so that I can have the flexibility to come 
home and be with him if I need to. Even though Bobby acts out and gets in trouble at school, 
I know he really enjoys it. It is the only place he has any real friends. He doesn’t have any 
friends anywhere else. He goes to an amazing school with an army of people taking care of 
him.  
 So at the end of the school day I pick him up. School ends at 3:00 but I pick him up at 
2:30 so he can avoid the commotion of the hallways when all the students get out of class. As 
soon as we get home he immediately goes onto his computer in his room. He likes Facebook 
and has thousands of “friends”. My other two kids try to track him on Facebook; they’re 
worried someone might try to take advantage of him.  Around 4:00 he starts to talk about 
food. We have dinner. Then it’s time for a shower. At 7:00 pm we watch Wheel of Fortune. 
At 7:30 we watch The Simpsons. At 8:00 he goes up to bed. He doesn’t go to sleep then but 
he always went to bed at 8:00 and he can’t get over that. He has to be in bed by 8:00 then 
even if he’s not tired yet. That’s how it goes, over and over, Monday to Friday.  
 In this short description about Bobby’s routine, a slew of new actors are introduced 
that are not part of the actors of the genetics laboratory or the autism clinic. The description 
is very shallow and does not relay the kind of thick description gained from participant 
observation. Even so, one is introduced to socks, fruit milkshakes, school buses, principal’s 
offices, Facebook, Wheel of Fortune, parents, siblings, teachers, and friends. The networks of 
the family home are further elucidated when the diagnostic process is considered. 
5.11c Becoming Diagnosed on the Autism Spectrum 
Although my research was not focused on constructions of ASD within the diagnostic 
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process, the diagnostic process was referred to by several parents in relation to their 
motivation for participating in genomic research. Two of the parents described getting a 
diagnosis quite quickly, by the time their child was three years old. For these children, early 
intervention was a possibility. For four of the parents I interviewed, the process of getting 
their child diagnosed with ASD was a long and arduous journey which was fraught with 
challenging encounters with physicians and school boards as well as misdiagnoses along the 
way.  For these children, early intervention was not possible. Several of the parents knew 
very soon after their child was born that something was wrong. Severe colic and non-stop 
crying for hours at a time was described by some. Difficulty talking or walking was 
described by others. In these stories of diagnosis the binary opposition of either being on or 
off the spectrum began to crumble and fragment into particular sub-classifications within 
ASD. One parent retold the story of her son’s diagnosis with Asperger’s in the following 
way: 
Mother: So he was eventually diagnosed in grade eight. So what happened was 
we had suspected it in grade four. He was identified as gifted, LD in grade four. 
And then a doctor, a paediatrician gave me a book about autism and I read it 
and if fit [my son]. You see he was very eccentric since he was little and he was 
brilliant, absolutely brilliant. At two and a half he could recite the Night Before 
Christmas. And he would tell me when to turn the page and it was word-for-
word. So we knew. And he always had difficulty socially and sensory and then 
in grade four when he got identified gifted LD, like I said, the doctor gave us 
this book. But he didn’t suspect it. You see we’re both into sports and music. 
Well, I was into the arts. So our son was always involved in sports when he was 
little.  So his gross motor was a little bit more developed. But he still had, he 
was still a bit of an awkward walker. But he was still very good at sports, 
especially football. So then, as the years went on, we found out more about 
him. Like in grade six I knew that he had a writing disability. He had difficulty 
doing things. But no one did anything about it so I finally took it upon myself 
in grade six to find out that he did have a writing disability. I had him tested. 
And then in grade eight they had ‘Toonies for Autism’ at his school. So they 
had somebody from the autism foundation come in and talk about autism. And 
he came home to me and he said, ‘You know what mom, I have a lot of those 
traits’.  
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Julia: So he identified it himself! 
Mother: Yeah. So then there were huge sensory difficulties and social 
difficulties in grade eight and his grade eight teacher didn’t pay attention to his 
IEP. So he literally shut down before Christmas. So that’s when we phoned a 
specialist, a child psychiatrist, and we got him in and he was diagnosed.  
 
Another mother recounted the long and frustrating route to a diagnosis of Autism for her son 
in this way: 
Mother:  It was a long road. Right after he was born, everybody knew there was something 
different but nobody could put their finger on it. Of course, it took us eleven years 
to figure out is was the chromosome 16 deletion, right. But we noticed issues in his 
development, issues with tolerating formula when he was an infant and once he was 
around a year or so there were some issues with some milestones…But when I went 
to the doctor he opened up my file and said, ‘you had post-partum depression after 
he was born, right.” And I said are you kidding me? Like he was telling me that I 
was crazy! So we continued to see developmental milestones not being met and we 
really started to see the stickiness, like he couldn’t handle change. Change the 
colour of his socks and he’d freak out. He had this hat he had to wear. A hundred 
degrees and he still had to wear a wool hat.  
   I really had to kick down our family doctor’s door to get a paediatrician 
involved. So we went to the paediatrician sometime between two and three, closer 
to three. And I had done my own research and I went in there and said I think he 
has autism. And the paediatrician gets out a list and he goes through and he checks 
them off and he goes, ‘well the problem is he only has fifteen out of sixteen 
characteristics’. And I looked at him and said are you kidding me? And I asked 
what one is he missing and he said, ‘well according to your statements he seems to 
sleep through the night’. And I said he screams for eighteen hours a day, of course 
he’s going to sleep! …So I had to fight the whole hospital board and this took 
another year and finally they came back and said they would do it. But by this time 
early intervention had also got us a referral to [Hosptial X]. And I said I feel more 
comfortable going to [Hosptial X] because other parents at our local hospital would 
go in for an assessment and they said we’d be in the waiting room and the staff 
would be arguing and then they’d compromise; one thought it was autism and one 
didn’t so they’d call him Asperger’s. It was a compromise. So I said, I feel better 
going to [hospital X]. I’m so glad we did. So we didn’t actually get in there 
[hospital X] until [my son] was six and he was seen and given a diagnosis of 
autism. 
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5.11d How Does Genetic Knowledge about Autism Relate to the 
Daily Routines and Experiences of the Diagnosis Process? 
In practice, the genetic knowledge that parents learn in the feedback session at the 
autism clinic does not change the routines of these families at all. As one mother said: 
I found during that process, where you’re all excited, like, ‘wow, we have an 
answer’ and it’s like, nothing’s different. Okay, we know what’s causing it but it’s 
going to be years before they can figure out if there’s any treatment or anything 
else. 
For all of the participants interviewed the genetic knowledge was practiced in an orientation 
toward the future. Some of the parents had difficulty getting their child diagnosed with 
autism and it is this experience that they hope to prevent for future generations through 
advancements in genetic testing.  
I think the thing for me is you absolutely feel helpless. All you want to do is 
help your child and they sit there going we don’t know what to tell you. 
Everything is a mystery. And I think at that point my hope was that some day 
they would be able to have some answers for parents. 
These families who participated in the genetics of autism research are aware that the benefit 
of the research will primarily be felt by future generations of families. One mother stated: 
How I feel is I know there is probably nothing that is going to help with my 
family but in future generations, putting my genes together with the others that 
they found had something in common. We could be part of the cure for the 
future. Finding out where this is happening in and what’s going on and maybe 
there could be a test in the future to say hey, if you are breeding with this 
person, there is a high chance that you could have a child with autism or you 
have the gene. And you might decide who you’re marrying. You would at least 
have the chance to say, hey I have the autism gene, we might not want to have 
kids. I don’t know.    
The ways in which the future is mobilized in expectations and motivations for engaging in 
medical technologies has previously been explored by Brown et al (2000).  The genetic 
knowledge that the families received in the feedback session was also described as important 
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and beneficial in relation to family planning for siblings of individuals with autism. One of 
the mothers whom I interviewed had two sons with autism and a daughter who was not 
diagnosed on the spectrum. She said she planned on telling her daughter about the genetic 
results when her daughter was older. She said: 
So if I said to my daughter, be careful [daughter] because you’ll probably have a 
child with autism. It would be helpful for anyone to know that, right, at a certain 
age. I don’t think they should know that before a certain age. I think if you knew 
that before a certain time in your life it could be very depressing.  
During one feedback session that I observed two “unaffected” siblings were present. Both of 
these siblings were over 18 years old. They told the genetic counselor that they wanted to 
have their own DNA tested. Specifically, they wanted to know if they also had the copy 
number variation as their diagnosed brother. They wanted to know if they might pass this on 
to their own children some day. This idea of family planning was also a concern for some 
participants. One mother described her son’s concerns about the possible implications of 
genetic testing: 
But one of his concerns, he voiced it with [Dr. Morten], was that he was worried 
that the information taken with the research, that he was worried, I think it was 
[the genetic counselor] had mentioned something about possibilities for down the 
line for interventions. And he was concerned that it would be a negative 
intervention. In that if somebody knew they were going to have a child with 
autism would they abort the child? So he was concerned about the moral 
implications of that.  
 Participants talked about other benefits of receiving genetic information. For 
example, one mother described always wondering if she had done something wrong when 
she was pregnant or when her son was a baby. Receiving genetic information enabled her to 
stop blaming herself for her son’s condition. She found out that her son’s genetic variation 
was de novo, in other words it was a spontaneous mutation and was not inherited from either 
his mother or father. She stated: 
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I think in some sense, you know, before we had this piece, you always have this 
sense of did I do something wrong? Is this my fault? You’re dealing with this 
child and you’re going to all these places and in the back of your head you’re 
wondering, what are they thinking? What did you do wrong? But, to realize the 
genetics of it all, you know, when you think back fifty years ago it was blame 
the mother, blame the mother. Those poor women. 
Another mother described feeling a similar anxiety about what had caused her child 
to have autism. She stated: 
I always often wondered what factors may have influenced it. If it was something 
in the environment, something I had done, blah, blah, blah.   And then when you 
hear finally, ok, there is a genetic component you think, well, OK. You know, so 
they’ve discovered something. I mean, I had always wondered how it had come 
to be and always thought there could have been some genes involved. I didn’t 
know. I had to figure out what it could have been. So I thought it could be 
environmental, did something happen in the womb? You know. 
Another woman whom I interviewed found out in the feedback session that her son had 
inherited the clinically significant genetic variant from her. She too carried this variant and 
passed it down to him. During the interview she talked about the complicated feelings she 
had about learning the genetic information, a sense of relief as well as feeling guilt: 
OK, I think at that point I felt bad in a sense, a certain amount of guilt. But I 
think also a certain amount of relief because now I could talk to my daughter 
and we need to really, and knowing now that there was something, it wasn’t 
just something that happened during pregnancy. There was some sense of relief, 
you know, there was mixed emotions. But at the same time you’ve lived with it 
for so long that you know you’re, whatever, this is the way it is.  
Genetic information was also expressed by some parents as giving them a long awaited 
answer to questions they had been asking for years. One mother in particular described the 
difficulties of getting a diagnosis and how she had felt belittled by family physicians and 
paediatricians. She recalled getting a call from the autism clinic at 10:30 at night. She was 
dozing off watching TV in bed. Dr. Morten told her about their findings: 
 She said that it turned out that [my son] was one of the children with the 
deletion. I remember she said, ‘so it’s official. You’re not crazy!’ All the issues 
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with his walking and his speech, they’re all related to that deletion on the 
sixteenth chromosome. I remember when she said it’s official I wasn’t crazy I 
asked if I could have it in writing. (laughing) … I didn’t sleep all night. It was 
kind of like all of a sudden the answer to everything. Like poof there it was. It 
was one simple thing that could explain everything. 
For others, genetic information opened up more questions: 
So my point is that I have more questions. So that’s something I’d be interested in 
pursuing is finding out more questions about the gene, answers to the questions 
and what does the gene, what does NRXN3 mean compared to NRXN1? So I did 
have the meeting with [the genetic counselor] and then my husband had the 
meeting with [the genetic counselor] but with one meeting you still have lots of 
questions.  
Thus, for families participating in autism genomics research, autism is, in part, constructed in 
relation to everyday routines and in relation to the experience of getting a diagnosis. 
Participating in genomic research and receiving genetic information, the parents who 
participated in interviews with me describe a variety of experiences. Some parents felt 
genetic information gave them long-awaited answers, while others felt the information 
opened up more questions. For some mothers, the genetic results relieved them of guilt, 
while for others feelings of guilt were sustained and reaffirmed.  All of the six participants 
who were interviewed described an orientation to the future, hoping that the genomic 
research of today would change the diagnostic process, opportunities for early intervention, 
and possibilities for family planning for people in the future.  
5.12 Summary 
 In this chapter I have attempted to follow DNA as it moves around the laboratory, 
clinic, and family home in the process of genomic testing in autism. Starting with blood 
collection and DNA extraction I then moved into the laboratory. From here DNA was sliced, 
amplified or “denatured”, aligned to probes and primers, tagged with barcodes, scanned, and 
photographed. Intensity graphs are made along with comparisons with a reference genome. 
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Described in the language of CNVs and SNPs, DNA is talked about via PowerPoint 
presentations at meetings and classifications are later made as research reports are written up; 
a genotype is established. Here the DNA has exited the laboratory and enters into another 
network of actors in the Autism Clinic. Children played with bubble machines, toys; they 
made eye contact or they do not. Talked or remained silent. Gestures were scrutinized by 
clinicians in a tiny room watching through a video monitor. Parents were interviewed about 
pregnancy, infancy, breastfeeding, toilet training, friendships, school and other intimate 
details of family life. Psychometric tests designed to measure intelligence were administered; 
questions were asked and answered. Assessments were scored. A phenotype was established. 
Through the Laboratory and Clinic, genotype and phenotype data were brought together, a 
phone call was made to parents. Here, the DNA entered another network in the family home. 
Routines, socks, school buses, siblings, friends, bedtimes were the actors found here. DNA 
became entangled in new associations with guilt, futures, diagnoses, divorce, relief, questions 
and answers.  
 I have tried to illustrate, by following the translations of DNA, some of the different 
practices of the laboratory, the clinic, and the home. Through the practices enacted in each of 
these spaces, DNA is constructed in relation to very different networks of human and 
nonhuman actors.  Knowledges that are produced within these spaces are intimately tied to 
materially heterogeneous actors. For the most part, this chapter has pushed down explicit 
discussion of the theoretical and philosophical ideas that informed my interpretations. I have, 
except for a few comments, attempted to describe events, activities, people and technologies 
in their own terms. The following chapters, however, will attend more explicitly to practice, 
constructionism and actor-network theory.  
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Chapter 6: From Problematization to Mobilization: An 
Actor-Network Theory Account of Translation 
 
In the previous chapter, I laid out a story following the production of genetic 
knowledge about autism as it moves between the family, the laboratory and the clinic. As I 
traced the route through which genetic knowledge flows, I described some of the most 
important actors (both human and non-human) along the way. As I re-read this last sentence, 
something strikes me as not quite right, not really reflective of what I experienced in my 
observations and conversations during field work. It occurs to me that the word flow is what 
bothers me. Does knowledge flow through a route? What is concealed by this verb, to flow? 
This is what the next section must elucidate, the work, the tensions, the non-coherence and 
the strategies for bringing disparate networks of actors together in order to make knowledge 
appear to flow.   
When I first thought through the layout of this dissertation, I imagined a general 
overview of the route through which genetic knowledge is produced in the first section and a 
deeper, more focused analysis in the second section. I realize, however, that it is not just a 
6.1. Overview of Callon’s Framework for Translation 
6.2. Problematization in Autism Genomics Research 
6.3. Interessment in Autism Genomics Research 
6.4. Enrolment in Autism Genomics Research 
6.5. Mobilization in Autism Genomics Research 
6.6. Conclusion 
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matter of looking more closely, zooming in. Instead, I need to unfold an entirely different 
story altogether. One that if layered on top of the first story will align in some places and not 
in others. There are points of connection as well as areas that will not cohere. In Chapter 
four, the story is recounted in a linear, chronological fashion. The blood is collected from a 
child diagnosed with ASD, DNA is extracted, an array is run, the DNA is sequenced, it is 
discussed in meetings, written about in reports, and then conveyed through different charts, 
graphs, and diagrams in a feedback session with clinicians and parents. However, much of 
my data is not captured within this linear story. In order to convey more of what I 
experienced during my field work, I need to tell another type of story, introducing a few new 
actors along the way. I need to add another narrative layer by describing what happens to 
knowledge as a story of translation.   
Translation, as it is captured in this chapter, has a very particular meaning, a 
historicity. It is situated within a specific place and time: 1980’s French science studies. 
Nestled within actor-network theory, translation was first unveiled by Callon in 1986 as a 
story of scallops, fishermen and scientists. Translation, in this specific instance draws on 
Actor-Network theory and describes an ongoing process in which one actor becomes the 
spokesperson for several other actors. When an actor (human or nonhuman) becomes 
translated it becomes black-boxed, represented, and fronted by another actor.  For example, 
when a scientist presents a Power Point slide that lists recently found candidate genes for 
ASD, there are several actors being translated within this slide, including: patients, DNA, 
microarray and sequencing technologies, journal publications, and distant laboratories and 
scientists involved in conducting experiments that discovered and validated each of the 
candidate genes. By invoking this specific notion of translation I am introducing a specific 
way of breaking translation down into four distinct phases: problematization, interessement, 
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enrolment and mobilization.  Unlike the previous chapter, the story of translation is not 
necessarily chronological. Each of the four components of translation requires constant 
ongoing work in order for the network to be upheld.  
6.1. Overview of Callon’s Framework 
One of the most often cited papers on the issue of translation in the science studies 
literature was written by Callon (1986). In this paper the authors outlined four components or 
'moments' of translation: problematization, interessement, enrolment, and mobilisation. This 
framework for translation is grounded in three basic principles: agnosticism (impartiality 
between actors in a controversy), generalized symmetry (which explains conflicting 
viewpoints in the same terms), and free association (abandoning distinctions between the 
natural and the social). Callon tells a story in which fishermen and scientists came together in 
an attempt to increase the production of scallops. The scientists came with a technique for 
cultivating scallops they had learned from the Japanese. Neither fishermen nor scientists 
knew much about the relationship between larvae and adult scallops. The fishermen were 
worrying about dwindling stock in St Brieuc Bay. Callon captured the interdynamics 
between these actors (scientists, fishermen, and scallops) with his four moments of 
translation.  
 The first moment, problematization, refers to the process by which a particular actor 
attempts to define the nature of a problem and thereby rendering itself an obligatory passage 
point for its resolution. Translation involves the imposition of a particular way of defining a 
situation for others.  The scientists in Callon's story set themselves up as an obligatory 
passage point by defining the problem; they want to know if the techniques used in Japan for 
cultivating scallops can be applied in France. Through this problem a network of alliances 
between actors is assembled: fishermen, scientist colleagues, and scallops themselves.  
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 Interessement describes how one attempts to capture others in particular roles.  In 
order to address the problem that they have identified as important, the scientists must 
convince the other actors to adopt certain roles and identities. The tools (towline) that the 
scientists put into the water in order to capture the scallops are an example of interessement. 
The scallop larvae are taken from their context and protected from predators. In order to 
convince the fishermen, the scientists hold meetings in which they show graphs representing 
the decline in stock in the Bay.    
 Enrolment depicts the scenario in which actors accept the roles assigned to them. Any 
of the actors may refuse. For example, the scallop larvae may not attach themselves to the 
towline device or the fishermen may decide to fish and capture all the scallops being 
preserved by the scientists. Enrolment highlights the negotiations that take place in order for 
actors to accept their identities.   
 Mobilization encompasses the methods used to ensure that the spokesperson for 
related collectives are not betrayed by the collectives or thwarted by competing spokespeople 
(Callon 1986). For example, it is not the fisherman themselves but their official 
representatives that sanction the research project proposed by the scientists. If all the actors 
are enrolled, the scientists are able to speak on behalf of all the fishermen and scallops. The 
scientists may go to a conference and present graphs and figures with numbers to a small 
group of experts. These diagrams and tables represent different populations of silent actors - 
scallops and fishermen - who have been mobilized, displaced, and translated into a graph. A 
host of alliances have been built up in order for the graph to exist. At any point the alliances 
may fall apart; the scientists may fail to enrol actors with their particular definition of the 
problem.    
 Callon’s (1986) framework emphasizes the work that is needed to keep disparate 
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actors together in a group or network. Put in the context of the day-to-day activities of autism 
genetics research this framework highlights the negotiations and the trials that a research 
project must survive in order to be translated. In the remainder of this chapter I will address 
each of Callon’s four moments of translation as they pertain to the various networks 
(laboratory, clinic and family) brought together in the autism genomics project. At the end of 
the chapter I will highlight how this framework might contribute to a discussion of 
knowledge translation.  
6.2. Problematization in Autism Genomics Research 
Problematization is a way of identifying and framing matters of concern so that the 
envisioned path to follow appears inevitable (Callon, 1986). Problematization does not only 
indicate the matters of concern but also sets up a particular network of actors as integral to 
the solution of the problem. There are always, however, other ways of framing a particular 
problem, alternative courses of action that could be pursued.  Each way of framing a problem 
rests on differing sets of values and assumptions. 
   There are several examples of Problematization that I observed and recorded in my 
field notes. The most prominent of these was an advertizing campaign distributed by a major 
Canadian newspaper.  This campaign was sponsored by Autism Speaks, a parent-driven 
NGO whose aim is to fund genomic research related to autism. Through this campaign, 
autism was problematized in a particular way such that the genetic research conducted at 
Laboratory X became a natural, obligatory passage point for a solution to be achieved. I will 
first describe the campaign and how a particular problematization was presented.  
  On a large four foot by four foot bulletin board on one of the walls at the entrance to 
the research office of the Laboratory X hang several full-page newspaper advertisements. 
The advertisements are dated from the summer of 2010. Along side some Christmas cards 
204 
 
from participants in the genetics project, these newspaper clippings have hung on this board 
throughout my field work. They are an example of a highly visible public articulation of a 
particular way to problematize autism. For several weeks, between May 2010 and July 2010, 
a national newspaper displayed full-page advertisements, sponsored by Autism Speaks. The 
advertisements depicted a jigsaw puzzle, almost fully completed. A final piece was missing 
and remained to be filled in. Across the puzzle was a photograph of a famous person’s face. 
Don Cherry, a legendary Canadian hockey commentator, for example, was presented in one 
of these campaign advertisements. On one day, the advertisement displayed a photograph of 
Dr. Lorenz (pseudonym), from Laboratory X, as the face in the puzzle. Along with his 
photograph was a quote, “I will not stop until a cure for autism is found”. Within the ad some 
information about Dr. Lorenz was given. By having his photograph and that quote appear in 
this ad, Dr. Lorenz and his research were (likely non-intentionally) aligned with a particular 
way of problematizing autism.  
In this problematization, autism is a disorder that needs to be cured.  Genetic research 
and in particular research on copy number variations are offered as a means through which 
the problem might be solved in the future. Autism is described as the problem and a cure as 
the solution with Dr. Lorenz and the Laboratory X as an obligatory passage point between 
problem and cure. A large network of actors are implicated in this problematization: 
individuals diagnosed with autism, genes, award-winning scientists, all the equipment and 
robots in the laboratory, the human reference genome, technicians, project coordinators 
recruiting patients, the list goes on. The challenge is to get all of these actors to align 
themselves with this particular articulation of the problem.  
6.3. Interessment in Autism Genomics Research 
In order to address the problem as it has been identified, each actor in the network 
205 
 
must be given a specific role to play. This designation of roles is called interessment, 
according to Callon’s (1986) framework of translation.  Among the scientists, clinicians, and 
families I observed, interessment took many forms, perhaps the most visible of which was 
the letter of information and consent form, written by the research investigators and handed 
to potential research participants.  
Early on in my field work, I observed a situation that highlighted some of the 
difficulties in getting actors to accept their defined roles. In this situation, a project 
coordinator was talking with a parent of a child on the autism spectrum. The parent was 
initially interested in becoming involved in the genetics research. She was eager to 
participate and had previously phoned the project coordinator several times in an attempt to 
get her child moved up on the waiting list. Claudia (pseudonym), the project coordinator, 
responded and a date was set for the child to come in and have blood drawn. Prior to this 
date, Claudia had sent the mother the letter of information and consent form for the research, 
so that the mother would have ample time to read over and consider the project. I attended 
the autism clinic on the day of the scheduled blood draw so that I could observe. When I 
arrived, Claudia explained that she had been on the phone with the mother all morning. After 
reading the consent form the mother was no longer interested in participating in the genetic 
research. She was concerned about the section in the letter of information that described 
implications for her or her child being able to get insurance. According to the project 
coordinator, this was a fairly typical concern: 
It’s one of those things that has to be in there to protect the hospital. And we 
don’t know that, even the mom today asked something about putting that in their 
medical records. I told her, right now I don’t have anything to put in your medical 
record, but if we find something that’s clinically significant then we’ll have to 
write a report and that possibly will go in your medical records. We’ve had 
families that have refused because of that. They don’t want to be involved 
because they don’t want it to affect their insurance. And we can’t guarantee 
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because we don’t know what’s going to happen. 
 
Each actor is involved in many different networks. In the scenario described above, the 
mother and her child are asked to play the role of patient. As part of this role they would be 
accompanied by another actor, the patient medical chart.  The mother, however, is already 
potentially enmeshed in a separate network, one set up by her insurance company. She 
refused to accept her role as patient in the autism genetics research because the potential 
findings, if included in her patient medical record, could adversely affect her or her child’s 
future insurance coverage.  
Several examples of interessment take place in the laboratory. Here, attempts are 
made to capture a non-human actor, the DNA, in a particular role.  First, blood or saliva are 
collected in a tube. The little glass tube is one way in which scientists try to physically 
capture DNA. Later on, microarray machines are brought into the lab, at great expense. The 
scientists try to make these machines play particular roles. For example, the hybridization 
machine must play the role of mixing genetic samples with Illumina probes. The array 
machine must be captured into the role of making florescent images. The human genome 
reference must be captured to play the role of representing the “standard” human.    
6.4. Enrolment in Autism Genomics Research 
 Enrolment describes the negotiation process through which actors are convinced to 
play their allotted role (Callon 1986). Actors may refuse. A complex and dynamic dance 
occurs amongst the actors in order to get all the actors to accept their role and continue to 
play that role over time. If enough actors refuse to enrol, the network will fall apart. In 
Callon’s article, the fishermen had to be enrolled in the network, agreeing to refrain from 
fishing the scallops in the bay during the experiment. The fishermen had been convinced by 
the problematization laid out by the scientists and had agreed to leave the scallop larvae 
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alone in order that they be further studied. The graphs and charts depicting dwindling scallop 
numbers had been presented to them by the scientists and had temporarily convinced the 
fishermen to suspend fishing.  One night, however, the fishermen dissented and drudged the 
bay with their nets within the towline. The network set up by the scientists failed to capture 
the fishermen as actors and as a result the scallops could not be captured either. The network 
crumbled. 
There are parallel examples of failed enrolment in the autism genome story as well. 
One of the crucial actors in the autism genome network is the proband (an individual 
diagnosed with ASD). Without probands the network could collapse.  In the clinic, there are 
many tools used to assess and confirm a diagnosis of ASD. The ADOS is one of those tools. 
In the ADOS assessment, children are asked to play with various toys and engage in 
conversation with the examiner. As one psychology student at the Autism Clinic explained, 
however, sometimes the ADOS fails to capture individuals in a diagnosis of autism. She 
explained: 
A lot of times, especially for the higher functioning kids, and especially girls, like 
girls with Aspergers, the ADOS does not capture autism very well. So, most of 
the time they will actually come out not autistic. They won’t meet the criteria. 
But that doesn’t mean they don’t have autism. So we have to figure out ways to 
support our decision in giving them a diagnosis…[O]n the ADOS you score for 
things like if they don’t talk a lot, but they’re very chatty. But those things aren’t 
what you score on the ADOS. They don’t score for that but that is social 
impairment. So the ADOS itself doesn’t capture those individuals very well.  
 
Other means of capturing particular social impairments are needed in order to enrol these 
individuals in the autism genome network. The phenotyping visit is a two-day affair, during 
which time several assessments and discussions take place. If the individual is not captured 
as a patient in the ADOS, there are other assessments, such as the ADI-R, which will help to 
include and enrol more people in the role of patient. Moreover, several participants described 
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the crucial role of clinical judgement. Built up over time, with increased experience, clinical 
judgement is what allows a psychologist to make diagnoses when the ADOS does not.  In 
this way, through multiple tools, the individual who eludes a diagnosis through the ADOS 
might still become enrolled in the network as patient.  
Part of the work of enrolment is to ensure that individual actors remain committed to 
a particular problematization. In the context of the autism genetic research, autism had been 
problematized as something that required a cure, a cure which could be reached through 
genomic research. During my interviews with some of the participants, it slowly emerged 
that some of the participants whom I interviewed were not entirely comfortable with this 
particular way of problematizing autism. Some were concerned that when autism was 
problematized as needing a cure, with the obligatory passage point of genetic research, future 
outcomes could include solutions that were, in their eyes, undesirable. One participant who 
worked in the autism clinic stated,  
Because you don’t really know because the technology keeps changing, which 
scares me a little bit too. I’m worried that I’m going to be old and grey and then 
realize this study I’ve been doing my whole life is doing prenatal tests on people 
and aborting kids because of this. It’s really going to bother me if that’s what it 
comes to. But I feel like it could come to that. But it’s going to be hard because 
it’s not going to be one gene and you don’t know. In one family two kids could 
have the same rare CNV, they don’t look anything alike. One could solve some 
crazy thing and be a genius. 
 
This research involves problematizing autism as something that needs to be cured through 
genetic research. The concern of the individual quoted above was the ambiguity of what the 
results of genetic research might lead to or be used for. In particular, she was concerned that 
genetic information might be used for prenatal diagnosis in order to prevent individuals with 
genes associated with autism from being born. (In deed, this participant’s concerns are 
similarly discussed elsewhere in a burgeoning literature that has grown up around the 
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concept of geneticization (Lippman, 1992; Lippman, 1998; Nelkin & Lindee, 1995) and the 
ethics of prenatal genetic testing (Lippman, 1994)(Asch, 1999). 
Another participant described her concern over the problematization of autism and 
specifically mentioned the newspaper campaign with the puzzle pieces. She stated:  
Participant:  The main concern obviously adults with autism have is what is 
the implication for this. What are you really . . . What is the 
purpose? Is it better intervention or is this going to go the way of 
Down’s Syndrome? And are you really saying that you want to 
understand the genetics for what purpose? Why are we doing 
this research? I am also very mindful about who funds research. 
Like genetics and their taglines of their organizations. So when I 
hear someone say Cure Autism Now by the leading scientists 
here at [the hospital], what does that mean, what does he mean 
by that? 
Julia:        Is this the [newspaper] thing? 
Participant:  Exactly. That is a very Autism Speaks driven mandate and 
Autism Speaks believes in that I think. 
 
She continued by explaining how she is involved in recruiting adults with autism to 
participate in the annual research conferences. She felt that they would no longer participate 
because they did not agree with this particular problematization of autism. She stated, 
I’ve always been in charge of bringing adults on the spectrum to talk and I don’t 
know if they’ll do it. Once [Laboratory X director] came out with that ‘cure’ 
thing, I know many of my adult contacts wouldn’t be comfortable now. 
 
Thus, competing problematizations can pull actors out of one network and into another. The 
quotes above indicate that this participant was simultaneously engaged in a different 
network, one that was sceptical of the word “cure”.  Advocates of disability rights do not 
problematize autism, but instead problematize a society that does not offer resources and 
opportunities to support families living with autism (www.neurodiversity.com).  Asch (2000; 
2005), has put forth a social paradigm of disability, questioning whether disease and 
disability are the problem or whether the challenges associated with disability stem from 
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particular social arrangements that are amendable to change. This alternative 
problematization, brings together a very different network of actors: accommodation 
resources, educational resources, respite care, employment opportunities, etc. In the 
problematization of autism disability rights advocates genetic research is not an obligatory 
passage point in the network.   
My research suggests that keeping a network of actors together requires constant 
work at every stage. Over the course of my field work, there were several instances in which 
the members of the autism genetics research at the Hospital publically articulated a particular 
problematization. Newspaper ad campaigns, radio and television interviews each contained a 
representation of the problem such that genetic research became an obligatory passage point, 
defining particular roles for various actors to play.   
 Another actor, integral to the autism genome network, is DNA. DNA must 
consistently be enrolled in order to be captured in the network. At any point along the way, 
through multiple experiments, DNA can refuse to be enrolled in the network. There are many 
examples throughout my field notes and interview transcripts that describe instances where 
DNA is not being captured and the scientists have to respond. For example, in order to 
acquire the DNA, a blood or saliva sample needs to arrive safely in the laboratory for 
extraction. I listened to a project coordinator describe in a Monday morning meeting an 
instance in which obstacles were met when trying to transport a sample. The lid had not been 
properly screwed on and the saliva leaked. The courier would not accept the package and 
refused to deliver it to the laboratory.  In response, the scientists found a company that 
developed padded packaging specifically designed for carrying genetic samples. If the 
sample leaked, the package soaked up the sample and a cell line could still be established 
from this in the laboratory; the DNA could still be extracted and captured in the network.  
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 Almost all meetings were, at least in part, devoted to enrolling DNA as an actor 
within the autism genome network. There were so many places in which the DNA could fail 
to be captured along the experimental pathway. One example that repeatedly arose in 
discussions between scientists was the issue of GC-rich areas on the genome. These are 
stretches of the genome that have a disproportionate number of G-C base pairs and fewer A-
T pairs. These areas are very difficult to capture in Next Generation Sequencing. 
Unfortunately, one of the gene families recently found to be associated with autism, the 
SHANK family, is highly G-C rich.  When I asked one of the molecular biology post docs to 
tell me more about the G-C problem I kept hearing about, this is what she said: 
Post doc:  SHANK 1, 2 and 3. So they have a really high GC content which 
means that a lot of the bases are G and C, not A and T. I don’t know 
how much genetics you have… 
 
Julia:     I understand that part. 
 
Post doc:  So A and T, when they bind together, they only have two hydrogen 
bonds. G and C have three hydrogen bonds. So a GC bond is stronger. 
If you have a high GC content that region of the genome will be more 
tightly bound than an A-T rich region. Um, and that can make 
sequencing really difficult because it’s harder to separate your DNA 
and it’s just harder to use, well, it’s hard to use data that’s AT rich or 
GC rich but for different reasons. So if you want something easy to do 
you want a good mixture of bases and you want them all mixed up as 
well. So even if it’s say 50-50 G and C but it’s all GGGGG, CCCC, 
AAAAA, that makes it difficult as well. So easy things are all kind of 
mixed and balanced. But the SHANK family have got a really high 
GC content so just doing any of the steps with them is more difficult. 
So, for a lot of the samples we’ve sequenced so far, we’ve got really 
bad data.  
 
The post-doc continued by explaining that she spends a lot of time tinkering with the 
experiments to overcome problems like the GC coverage issue. She calls herself a “techno-
nerd” because while other post-docs prefer to analyze the data, she enjoys figuring out ways 
of capturing more data and making sure it’s real. The GC problem is just one issue that can 
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affect coverage of the genome. There are some areas of the genome that are repeat-rich. All 
of these issues can result in “dirty” data. The qPCR experiment, used to validate microarray 
results was described as being “dirty”. One day while walking through the lab, I saw a hand-
written note taped to some machine (I’m not sure what the machine was for) that read, “This 
is a clean machine. Please, no pcr products!” I asked a participant why PCR and qPCR were 
considered “dirty” and this is how he responded: 
It’s quick, it’s fairly cheap, and it can give you an idea but it can be very 
ambiguous. Like some I was looking at yesterday for example, the results are half 
way between deleted and not deleted. So how do you interpret that? My control 
samples look beautifully not deleted. My actual samples are kind of half way 
between a deletion and a no deletion and I’ve done it three times and I’ve got the 
same result three times. So what does that mean? And that comes up time and 
time again. Because a lot of experiments are kind of specific to a region and if 
that region just doesn’t, it’s just riddled with problems. So sometimes it can be 
great, it can take a couple of days, you get a really clean result, you think ‘great, 
my deletion is beautiful. It’s inherited from dad and it’s in the unaffected sib or 
it’s not in the unaffected sib. Beautiful’.  The next day you do qPCR and you 
think, well what does that mean? 
 
 Thus, DNA has to be captured at several steps in several places within the laboratory. 
Even if it is captured by the microarray, it could still refuse to be captured in the qPCR, 
refuse to be validated. Certain regions of the genome are more difficult to capture than 
others. This has quite significant implications. At one Monday morning meeting, the 
scientists had just returned from a large international genome conference held in Montreal, 
attended by over 8000 people. On this Monday morning the scientists took turns around the 
table describing interesting talks or posters they had observed. One post doc complained that 
she felt there wasn’t anything new being presented at the conference, no new and exciting 
areas of the genome showing up. Another post doc responded. As usual, I was madly writing 
notes through this meeting and this is what I have captured about her response: 
Heather says that some genes just sequence really well compared to others - so genes they 
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[at conference] are talking about are found in these regions for technological reasons. She's 
not convinced it is not highly dependent on the technological limitations. Other genes don't 
sequence very well so people are not finding mutations there. 
In other words, some stretches of DNA are not being captured at various places in the 
laboratory. This DNA is failing to be enrolled, not only in the small, immediate network I 
observed at the Laboratory X, but these regions of the genome are not being captured by 
hundreds of other laboratory networks represented by posters and talks at the conference 
either.  
 As I stated earlier, much of the work being done in the laboratory can be thought 
about in Callon’s terms as “enrolling” the actors. It is a continuous, on-going process that 
needs to be managed across several steps and stages in each experiment. One particular way 
of measuring the quality of “enrolment” is through computational analysis. An entire team of 
computer scientists is employed in order to measure and ultimately increase the quality of 
what is being captured by the various technologies in the laboratory. In Next Generation 
Sequencing, for example, all of the data is taken directly off the machine and run through the 
Exome Pipeline. Each indel (insertion or deletion) is given a quality score which indicates 
the confidence in calling that mutation. When the sequencer fails to “read” a nucleotide base 
from the sample, the pipeline will insert a dot and this later becomes replaced with a base 
from the human reference genome. The concern is that the scientists don’t want data dumped 
because of one missing base in a read. Equally of concern, scientists also want to ensure that 
the SNPs they are reporting are real, that they are not artefacts of the technology.  
Complicated algorithms are applied in order to capture the most data, while still minimizing 
‘false positives’.  
 Callon’s (1986) framework describes the many trials that a network is put through 
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and the constant work that is done in order to maintain the enrolment of all of the actors 
along the way. In the network he described, the towline did not initially successfully capture 
the scallops. Many alterations had to be made in order to get the scallops to play the role they 
were supposed to play in the scientist’s network. Likewise, the fisherman had to be 
convinced and cajoled into accepting their role in order for the network to be maintained. 
Similarly, the autism genome network requires several actors to be enrolled. The proband 
and DNA, described above, are two of these important actors. The ongoing work of keeping 
actors enrolled was visible at every meeting and in each interview I conducted.   
6.5. Mobilization in Autism Genomics Research 
According to Callon’s framework, mobilization refers to the process by which actors 
are displaced and represented in some other form by a spokesperson (1986). All of the trials 
and work that has ensured the enrolment of the actors are bracketed off. In the case of the 
autism genome network, mobilization is frequently achieved in the form of the research 
paper, published in a peer-reviewed journal. The patients, the DNA, the machines, consent 
forms, assessments, blood, saliva, technicians, pipettes, glass slides, glass tubes, coloured 
caps, classification scales, protocols, and robots – all of these come to be subsumed within 
the article. The authors of the article speak for these actors, as long as the network has been 
maintained.  There are other examples of mobilization: a conference talk, a poster 
presentation, a PowerPoint slideshow.  What carries the most weight, however, what 
mobilizes these silent actors and makes them travel farthest is the journal publication. Once 
mobilized in the form of a journal article, these silent actors as represented on a graph or a 
table will be drawn into hundreds of other laboratory networks around the world, if even for 
a short time as competing or collaborating scientists read the article.  
All of these forms of mobilization, the journal article, poster presentation, 
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PowerPoint, are highly transportable, easily taken up and communicated. All of the work and 
effort done in the laboratory is represented in these mobilized forms. It is extremely time-
consuming (it takes decades to develop a laboratory on the scale of the Laboratory X) and 
expensive to hold together a network of actors such as the one in the autism genetics project. 
This is why these mobilized representations are so coveted, so valuable. There is often a race 
to publication between competing laboratories so that all of the effort, the work of keeping a 
network held together, is not wasted. Talking to some of the post-docs and PhD students in 
the laboratory, I learned about the scavenger-like behaviour of the drug companies who 
attend the scientific conferences. One post-doc described the drug companies as “predatory”. 
They run around between posters at poster sessions taking notes about any new gene that 
might be implicated in a disease, peppering the presenter with questions about the details of 
the genomic location. In one meeting, I heard the director of the lab state that conference 
presentations are precisely where you’re not going to describe your most interesting findings, 
exactly for that reason.  
 Journal publications are more likely the first place where new experimental results are 
announced. As I learned from one of the assistant directors at Laboratory X, the journal 
publication is also important because the number of articles produced by a laboratory is 
ultimately what gets measured by funding agencies, and thus journal articles become an 
important form of mobilization for the laboratory and the genetic research reported in each 
article. More articles will result in more funding, which in turn enables further future 
research. 
 The importance of mobilization in the form of journal publications was visible in 
several instances in my field work.  Often, PowerPoint presentations would include a slide 
with screenshots depicting several journal titles. For example, when trying to convey the 
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importance of the NRXN gene in autism research, one presenter flipped to a slide with the 
names of published articles that contained “NRXN” in their titles. The presenter could have 
just said, “I’m exploring this region of the genome where the NRXN gene is located because 
it is known to be associated with autism”.  But, what if an audience member were to disagree 
and argue that NRXN is not where this presenter should be focusing? Calling up all the titles 
of the related articles, however, gives weight to what he is saying. Each of the titles 
represents an interesting experimental finding from a laboratory. Subsumed within each title 
is a huge network of silent actors. By listing the titles, the presenter is calling up all of these 
actors that were brought together and maintained in a network through all the stages of 
various experiments in all of these different laboratories. By including this list of articles in 
the PowerPoint, it is as if the presenter is saying to the audience, ‘go ahead, challenge me. 
But you’ll have to challenge all of these networks and the hundreds of silent actors that have 
been mobilized behind me and represented in these titles’. Thus, publication is an effective 
way to mobilize diverse actors within the genetics network.  
 The genetics group on whom my research is based are proving to be very successful 
at problematizing, enrolling and mobilizing actors. With enormous grant funding, high-tech, 
cutting-edge technology, an ever-flowing line-up of patient samples to be processed - this 
network appears to be durable with strong associations amongst human and non-human 
actors. The framework provided by Callon provides a way of examining the work that is 
needed in order for a network of actors to be maintained. Future improvements in 
technology, for example, will be a vital means of enrolling non-human actors, such as 
particular G-C rich genes that are associated with autism.  
While an exploration of competing, alternative problematizations of autism is beyond 
the scope of my research, some participants suggest some ambivalence toward the current 
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problematization of autism in the genetics research project. Positioning genetics as an 
obligatory passage point is not what worries the individuals I interviewed. One could imagine 
a problematization in which genetic research is set up as the obligatory passage point to 
enable earlier interventions for children with autism. In deed, this was the problematization I 
often heard in the autism clinic. There seemed to be a flexibility in the way that autism was 
problematized within the different spaces of the laboratory-clinic network.  It was only when 
the director of Laboratory X made a very public articulation about finding a cure for autism 
that a few participants became concerned about enrolment.   
6.6. Conclusion 
The four stages outlined by Callon apply equally to human and nonhuman actors. 
This framework allows for an account of translation in which agency is shared. In this way, it 
resonates with Pickering’s dialectical mangle of practice. I am, in part, uneasy about 
including this chapter in this dissertation. In many ways, Callon’s (1986) framework 
underscores the political nature of the translation process, drawing attention to all of the 
enrolling, convincing, and ongoing negotiations that are necessary to keep disparate actors 
playing their allotted roles. Indeed, Callon (1986, p.199) described his article as providing “a 
better understanding of the establishment and the evolution of power relationships…the 
capacity of certain actors to get other actors – whether they be human beings, institutions or 
natural entities- to comply with them”. Doing fieldwork is itself a political process in which 
alliances were made between me, my supervisor, and the director of the laboratory field site, 
among other actors. In writing about the on-going work and negotiations that take place 
throughout the process of translation I have not conveyed the personal animosities between 
competing laboratories or competing scientists. While that may well be a part of the process 
of knowledge production, and this has been attended to elsewhere (e.g., (Latour & Woolgar, 
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1986)), I have tried to illustrate how the political transcends human-to-human interactions. 
The politics of translation is embedded in the non-human technologies, tools, protocols, 
DNA, probes, and reference genomes as well as the human actors assembled in the autism 
genetics network.  
I have included this chapter because it is this political nature of translation that is 
noticeably absent in the KT literature. For example, “identifying a problem” is one of the key 
components in the CIHR’s Knowledge to Action (KTA) model. (This model will be 
discussed in detail in the final chapter of this dissertation.)  In the KTA model the political 
dynamics of identifying a problem is not described. Similarly, the KTA model proposes 
stages such as “adapt knowledge to local context” and “select, tailor, and implement 
interventions”. In contrast, the notions of interessement, enrolment, and mobilization provide 
a new language and a novel entry point from which to critically approach the neutral 
representation of translation in the various components of the CIHR’s KTA cycle. The 
framework proposed by Callon (1986), which highlights translation as an inherently political 
process, may contribute to and enrich current understandings of the KT process in which the 
political is rarely addressed.   
219 
 
Chapter 7: Translations Amidst Difference and Multiplicity 
Medicine is not a coherent whole. It is not a unity. It is, rather, an amalgam of 
thoughts, a mixture of habits, an assemblage of techniques. Medicine is a 
heterogeneous coalition of ways of handling bodies, studying pictures, making 
numbers, conducting conversations (Berg & Mol, 1998). 
 
[M]edicine does not merely describe a pre-existing 
biological reality, but instead creates its own objects of 
analysis (Lock & Gordon, 1988). 
 
In this chapter I explore the idea that medicine is not a unity, that a phenomenon can be 
practiced quite differently within the same hospital. Through the concepts of multiplicity and 
7.1 Overview of Key Concepts 
 a) Difference 
 b) Multiplicity 
 c) Coordination 
7.2 The Practiced Individual with Autism 
 a) The Clinically Practiced Individual with Autism 
 b) Laboratory Practices of the Individual with Autism 
 c) The Individual with Autism Practiced at Home 
d) Strategies of Coordinating the Multiply Practiced Individual 
7.3 Autism(s) in Practice(s) 
 a) Practicing Autism in the Clinic 
 b) Practicing Autism in the Laboratory 
 c) Autism in the Family Home 
 d) Non-Coherence in the Practices of Autism 
 e) Strategies of Coordination 
7.4 Conclusion 
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coordination, I explore the tensions that arise when practices shape a phenomenon in 
divergent ways and examine what happens when these practices rub up against one another. 
In doing this I aim to explore the concepts of difference, multiplicity and coordination. The 
subsequent chapter will then consider how the concepts of difference, multiplicity and 
coordination  might inform the notion of knowledge translation.  
In order to consider these ideas I will examine two specific phenomena as they are 
practiced in the clinic, laboratory and home. The first phenomenon is the individual 
diagnosed with ASD. This may seem an unoriginal and over-worked choice. Social scientists 
have been complaining for years that medicine reduces the human body  in different ways, 
that the unified person becomes dehumanized and fragmented as various parts are 
sequestered off, counted, imaged, scanned (Casper, 1998; Lock & Nguyen, 2010; Martin, 
1987; Rapp, 1988). “Tsk, tsk” we might say as we read about the doctor who refers to a 
patient as the coronary in room B or the hysterectomy in the OR. This criticism, however, 
takes for granted the idea that there exists a patient as a whole. A unified person becomes the 
normative standard to which the reductions of medicine are compared. My research, 
influenced by scholars in the social study of science (Latour, 1992; J. Law, 2000; J. Law & 
Mol, 2002; J. Law, 2002; J. Law, 2003; J. Law & Mol, 2008; J. Law & Singleton, 2000; J. 
Law, 2007; Mol & Berg, 1994; Mol & Law, 1994; Mol, 2002; Mol & Law, 2003), starts 
from a different place. Following Berg and Mol (1998), I want to suspend the notion that the 
unified patient body exists as self-evident in the beginning, preceding the practices of 
medicine and instead focus on the practices that shape what counts as the individual with 
ASD. Through this examination the notion of a single unified patient body gives way to an 
image of a complex pastiche of bodies that are reduced in innumerable ways with various 
measurements, practices, habits, conversations, spaces and instruments. To say that the body 
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is reduced becomes uninteresting. What becomes important is to understand how these 
inevitable reductions that multiply with varying practices relate to one another, contradict 
one another, and coexist side-by-side one another. Understood in this way, the unity of the 
individual is an effect, a consequence of much effort and work to make differences cohere.  
The second phenomenon through which the notion of difference will be explored is 
“autism”.  Here, I want to compare how autism is enacted in the clinic, home, and the 
laboratory. This is a complex task as the multiplicity of practices that are found in the 
laboratory and clinic are layered with the complexity in the diagnosis of autism, a complex 
and heterogeneous diagnosis with a broad spectrum of clinical manifestations (Freitag, 
2007). In the practice of autism genomics, however, the complexity of this diagnosis may be 
reduced. As I discussed in previous chapters, in practice, the complexity of the spectrum is 
often reduced to a binary opposition: patients, siblings, parents, family members in an 
extended pedigree were either on or off the spectrum. Diagnosed with autism or not.  
Thus, in my analysis I will allow the binary reduction of the complexity and 
specificity within the spectrum to remain reduced and unproblematized, as that is how it was 
most often practiced by the participants in this study. Instead, I will focus on how autism 
(taken as a unified phenomenon) is practiced in the clinic, laboratory and home.  
7.1. Overview of Key Concepts  
Before attending to 1) the individual diagnosed with autism and 2) autism, as they are 
practiced in the context of autism genetics, I will first introduce a few ideas and texts that 
have influenced my analyses and interpretations presented in this chapter. Much of what I 
want to introduce here is intimately related to actor-network theory, previously explored in 
Chapter 2. Many of these concepts are rooted within and often extend actor-network theory 
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into new territory. In particular, I bring to the foreground the ideas of difference, multiplicity 
and coordination.  
7.1a Difference 
 While the idea of difference is at the heart of much of what I have been reading and 
writing pertaining to actor-network theory and knowledge translation, difference is often an 
unspoken assumption subsumed within other concepts or ideas. I did not come across a 
formal analysis that focused squarely on the notion of difference until I had already begun 
collecting data for this project. The idea of difference is so simple, so obvious, that it had 
escaped my attention. It was an assumption that was always already there, just beneath the 
words I was reading and writing. When I came across a book by Berg and Mol (1998) titled 
Differences in Medicine: Unravelling Practices, Techniques, and Bodies, it struck me that 
this was a fundamental concept underpinning what I was exploring.  In some ways, 
difference is at the very core of this dissertation.  Knowledge translation is needed because 
there are differences amongst those who inhabit the laboratory, the clinic and the homes of 
individuals with autism.  
 With the notion of difference, scholars have begun to tease apart the assumptions of 
unity in a variety of contexts. Berg and Mol (1998) explain how the unity of Western 
medicine, for example, unravels when one considers the various techniques, measurements, 
technologies, tools, and specialized vocabularies found within various fields of medicine. 
Likewise the unity of the patient dissolves when approached in this manner. Finally the unity 
of the present, as a time that breaks from the past, becomes problematic when approached 
from the notion of difference. The present often contains traces of the past. Moreover, there 
are differences in the times that make up the present such as the beginning and end of a 
consultation. Thus, with a focus on differences, what was once taken for granted as a unified 
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whole can be re-imagined as containing diversity. This diversity, state Berg and Mol (1998) 
is a feature of any complex practice and is neither inherently good nor bad. We can attend to 
the generative places where different practices are creatively coordinated as well as to the 
sites of conflict and tension. Diversity and difference are not something to overcome.  
 Willems’ (1998) work offers an example of how differences might be explored. He 
described and compared two cases of asthma. Willems suggested that the different treatment 
practices engaged in each case enacted different asthmas. Asthma is made different in the 
practices of Carl and Steven. Steven takes salbutamol, a bronchodilator which combats 
airway obstruction. Carl takes steroids which act against inflammation. Conventional wisdom 
might attribute these differences in treatments as reflecting different aspects of the same 
disease, distinctions between mild and severe asthma or differences in prescribing habits of 
the physician. Willems, instead, sets out to illustrate how drugs produce different asthmas 
and different lungs.  At times, a single patient may have to engage in two different treatment 
regimes. Willems (1998, p.17) asked “how is this to be imagined? Do people indeed switch 
from one disease to another, from one body to the other? Do their airways consist of 
muscular tubes in one moment and of inflamed mucous membranes the next?” Through this 
research Willems illustrates how lungs and diseases may be practiced differently as the 
patient enters into multiple treatments which imply different geographies of the diseased 
body.  
7.1b Multiplicity 
Multiplicity is related to the idea of difference. An object multiplies as it is practiced 
differently in different contexts. Mol’s work (2002), for example highlights the differences in 
atheroscleroses by comparing the practices of the clinical consultation and the pathology lab.  
In the clinical consultation, patients complain that their legs hurt when they walk and the pain 
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stops when they rest. A doctor might ask questions about where it hurts and how long the 
patient can walk. She might hold a patient’s feet in her hands to feel and compare the 
temperature. She might feel the pulsing of the arteries in different places along the legs. 
Down the hall, through the closed doors of the pathology lab, however, atherosclerosis is 
practiced quite differently. A leg has been amputated and refrigerated, a cross-section of an 
artery is made, and cells are stained. The lumen of the vessel wall is measured. Under a 
microscope, the pathologist sees arteries with thick intemas. This is what atherosclerosis is in 
the pathology lab. The objects of the clinic and the pathology laboratory might coincide. The 
patient with pain on walking and a weak pulse in the clinic might also be found to have a 
thick intema in the pathology lab. This is not always the case, however. In some instances, a 
post-mortem reveals extreme atherosclerosis in a patient who never complained.  
Through these examples of difference, Mol suggests that atherosclerosis, the disease, 
is not found within the body. Instead, it is performed through practices. As practices 
multiply, in different areas of the hospital, so too does a disease. According to Mol, it is not 
just that there are multiple perspectives of a single object. For her, more than that is going on. 
She is not interested in understanding the meanings or interpretations of atherosclerosis. 
When we focus on participants’ perspectives, the observers multiply but the object is left 
alone.  
A crowd of silent faces assembles around it. They seem to get to know the 
object by their eyes only. Maybe they have ears that listen. But no one ever 
touches the object. In a strange way that doesn’t make it recede and fade 
away, but makes it very solid. Intangibly strong (Mol, 2002, p.12).  
 
By foregrounding practices and all of the materials and activities involved, the disease itself 
is examined as something that is done or enacted, in practice. Thus for Mol, an object 
(whether it is a disease or a body) is allowed to multiply when we shift our attention from 
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differences in interpretations to differences in localized practices. 
Mol and others have gone to great lengths to describe how differences are made to 
relate to one another, how they are sometimes coordinated and made commensurable. 
Cussins (1996), for example, offered a thoughtful account of how women seeking services of 
infertility clinics actively participate in constructing themselves in multiple ways. She refers 
to a kind of “ontological choreography” which takes place when the body is constructed in 
relation to technologies. She stated “the subject is dependent on the constant ontological 
dance between ourselves and our environments that changes how many descriptions we fall 
under, of how many parts we are built, and how integrated we are or need to be” (Cussins, 
1998). The physical exam with the technology of the metal speculum brings into view the 
woman’s vagina, cervix, ovaries and uterus. The ultrasound allows follicles in the ovaries to 
be measured and counted. During a treatment cycle the woman is “rendered into multiple 
body parts” (Cussins, 1998). The patient actively orients herself in relation to the part of the 
body that is under scrutiny. If IVF treatment is successful the synecdocal relationship 
between objectified body parts and long-range subjectivity are maintained. Conversely, a 
metaphysical rupture ensues when treatments fail. In a single cycle a women moves “from 
one to many and back again” (1998, p.193). Thus, the body multiple is, as Mol suggests, 
“more than one but less than many”.   
It should be stressed, however, that this notion of multiplicity does not necessarily 
pose a problem for medicine. Different practices are distributed in different spaces and an 
object is transformed as it moves among sites of practice. Mol suggests, “that the ontology 
enacted in medical practice is an amalgam of variants-in-tension is more likely to contribute 
to the rich, adaptable, and yet tenacious character of medical practice” (Mol, 2002, p.115). 
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7.1c Coordination 
There are many ways in which differences and multiplicity are made to relate. Law 
and Mol (2002) describe what they call “fractional coherence”, in which things are drawn 
together but not centred. Law draws on this metaphor of mathematical fractals which are 
lines that occupy more than one dimension but less than two. For Law, single, coherent 
objects are the effects or products. Focusing on the TSR2, Law (2002) begins with a thought 
experiment in which the reader of a brochure is to assume a naïve position. The reader learns 
that the TSR2 is an aircraft on one page. That the TSR2 is a weapons machine on another 
page, a map-making navigational machine on still another page. A naïve reader who does not 
take the TSR2 as a priori a single object will learn from the brochure that there are many 
different objects held by the name TSR2. Law then outlines several strategies of coordination 
used in the brochure to connect and coordinate the various TSR2s described. The brochure 
itself wraps up all these different objects into one physically bounded place; the brochure has 
a table of contents which hierarchically relates different elements together, and 3-
dimensional perspectival drawings hold various elements together at different angles. Rather 
than starting with the assumption that an object is singular, Law suggests that we explore 
how various objects are made to relate and cohere. The singularity of an object is 
“precarious, uncertain, and reversible” (2002, p.36).    
7.2. The Practiced Individual with Autism 
 In this section I explore how the individual diagnosed with autism is practiced 
differently in the clinic, the laboratory, and the home. I illustrate how the body multiplies 
when one focuses on different practices which draw together different networks of human 
and non-human actors.  As such, I will recount many of the activities that take place within 
the different spaces in which autism genomics is carried out as they pertain to the individual 
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with autism. I also want to comment on the ways in which the body(ies) is/ are made to 
cohere and relate to one another. What I hope will become clear is that various technologies 
and non-human actors are integral to the differentiation of objects and to their coherence and 
coordination. The individual diagnosed with autism multiplies because s/he is practiced 
within different assemblages of actors that are brought together in various spaces and places.  
 Before continuing with my analysis of the various practices of 1) the individual with 
autism, and 2) autism, I would like to make a brief comment about the experience of treating 
these two epistemic objects as separate. That is, treating the individual as separate from a 
diagnosis. During the process of acquiring ethics approval from the Hospital X ethics review 
board, I first had to pass an internal scientific review in the autism clinic. For this internal 
review I had to present a research proposal. At one point in my proposal I used the phrase 
“autistic individual”. This was immediately jumped on by all four of the reviewers sitting 
around the meeting room table. No, no. The correct way to phrase this was “individuals with 
autism”. Intrigued by the importance of this wording I asked if they could tell me more about 
the preference for this particular phrasing. I learned that the clinicians felt the phrase “autistic 
individual” carried a meaning that the person is autistic, that autism is part of who they are. 
Conversely, they felt the phrase “individuals with autism” conveyed the meaning that autism 
is just something the person has but it is not who that individual is. Since the separation of 
individual and autism was clearly important to the clinicians, I have attempted to keep these 
two objects of analysis separate. In practice, these two objects of analysis were not as cleanly 
separable, or distinct as the clinicians suggested. The individual and autism are intimately 
entangled, with different practices of autism implicated in the different practices of the 
individual/ patient body. Autism and the individual are often co-constructed in relation to one 
another.  
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7.2a The Clinically Practiced Individual with Autism 
What I call the clinic is actually a research unit inhabited by various clinicians who 
perform clinical testing, monitoring and surveillance. The activities, technologies, and 
recordings that take place in the spaces that form the clinic perform the individual with 
autism in particular ways. Even within the clinic, a single human is performed in several 
different and sometimes conflicting ways.  
i) Practicing the Individual as a Social Being 
As has been described in Chapter 5, the clinical testing carried out in the autism clinic 
is highly standardized. These tests are conducted in relation to schedules or scales that are 
considered the “gold-standard” for autism diagnosis. In all of the observations, the paper 
documents were being closely followed and written on by the participating clinicians. In this 
way, the patient was being constructed or performed in relation to very specific guidelines in 
each of the different testing scenarios. These testing situations were highly controlled 
environments, such that the size, colour, objects and people found in the room would be 
similar in any testing situation. One of the first tests I came to observe in the unit was called 
the Autism Diagnostic Observation Schedule (ADOS). Clinicians must be trained 
(disciplined) in the ADOS to ensure that the test is being carried out and scored properly. In 
this test the child is placed in a room with toys. There are various versions of the ADOS, 
tailored for the developmental stage of the person being tested (pre-verbal, phrase speech, 
etc.). While the clinician is interacting with the child, s/he is also writing on the ADOS 
document, which is about 15 pages in length. Simultaneous to this, in another room 
connected via video monitor, other clinicians are marking in the ADOS schedule. On several 
occasions I was also given the schedule and expected to write in it as I observed.  
The ADOS for Phase II (phrase speech) consists of 14 different tasks including: 1. 
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construction task; 2. response to name; 3. make-believe play; 4. Joint interactive play; 5. 
conversation; 6. response to joint attention; 7. demonstration task; 8. description of a picture; 
9. telling a story from a book; 10. free play; 11. birthday party; 12. snack; 13. anticipation of 
a routine with objects; 14. bubble play. On the first page of the ADOS there is a box 
containing the child’s information including their ID, date of birth, gender, chronological 
age, the examiner, and the date of the evaluation. Subsequent pages are set up such that the 
tasks appear on the left hand side with a brief description and the right hand side is an empty 
space in which notes are to be written. All of the tasks afford a different way of evaluating 
the child’s social interactions.  Specifically, the ADOS rates five different areas: language 
and communication, reciprocal social interaction, play, stereotyped behaviours and restricted 
interests, and other abnormal behaviours.  
While watching the interaction on the video monitor the other people in the room 
with me were silent so that they could hear what the child was saying. The little camera lens 
could be moved by a joy-stick in order to orient our view to the movements of the child-
clinician interaction. In this little room we followed along the ADOS schedule, marking in 
examples of language use or play as they pertained to each task. Occasionally, someone 
would whisper, “what did he say?” At times one’s gaze would be directed at the schedule, 
writing in an example, instead of at the monitor observing the interaction. The room was 
often intense with concentration as the raters did not want to miss any interactions. The 
observers in the little room would write down examples of the child showing shared 
enjoyment (this was common in the bubble blowing exercise) or using facial expressions to 
communicate feelings, pointing, or engaging in imaginative play with figurines or dolls.  
Through the ADOS the clinician is oriented to the patient as a more or less “social” 
being. The patient is practiced as a social entity, one who navigates social interactions. The 
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patient is quite literally performed in this way, as an audience of evaluators observes the 
contrived interactions, the props of play things are placed on the stage, and the script of the 
ADOS is closely followed. 
ii) Practicing the Individual as the Thinker/ Knower/ Puzzle Solver 
Another test in the clinical unit, the Stanford Binet Intelligence test, was routinely 
practiced. Through this test the patient was performed as a cognitive being, a thinker/ 
knower/ puzzle solver.  Unlike the ADOS test, in the Intelligence test the eye contact or 
experiences of shared enjoyment for example, were not of relevance. The patient as a social 
being was bracketed off. The multitude of play objects included in the ADOS to provoke 
play and interaction between the patient and the clinician administering the test were 
noticeably absent in the physical context of the Intelligence test. In this scenario the room 
was bare except for a table and two chairs and the little flip charts that sat on the table 
between the clinician and patient. Whether the child whispered, yelled, or sang the answers 
was not important; with eye contact or without; in this context what mattered was whether 
the child answered the question correctly or not.  
As with the ADOS, the Stanford-Binnet Intelligence test is highly standardized. The 
examiner wrote down the verbal answers given by the patient while following along with the 
various components of the test. The test would sometimes take hours with the examiner 
allowing the patient to stop for breaks and snacks along the way. The test is divided up into 
different booklets, each focusing on a different task. 
 During one session I observed, for example, the clinician asked a boy who looked to 
be about ten years old, “which letter is missing from the picture?” Later he asked “what’s 
happening in this picture?” following this he said, “Tell me what each word is: apple, dress, 
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dog, hat, parrot, puddle, factory, allow, lend, eyelash, curiosity, skill”. The boy was not sure 
how to define curiosity. He sat in his chair wiping away tears, clearly upset that he doesn’t 
know the answer. When the clinician reassured the boy that he was not supposed to know all 
the answers and that the same sets of words are used for adults the clinician was responding 
to the boy as a social being. The boy was communicating, through tears and in his verbal 
responses that he was feeling upset. This would be a highly informative interaction in the 
ADOS test; I imagine the observers in the little room would be madly writing notes in the 
margins of the schedule trying to capture all the verbal and nonverbal details of this social 
interaction. In the intelligence test situation, however, the clinician did not write any of this 
down. All that is captured are the boy’s words that he has spoken in trying to define 
‘curiosity”. This is because the intelligence test practices the patient as a thinker/ knower/ 
puzzle solver. The social interaction in which affect is communicated is not relevant to the 
specific incarnation of the individual that is practiced through the intelligence test.  
iii) Practicing the Diachronic Individual through the ADI 
A third way in which the individual is practiced in the autism clinic was through the autistic 
diagnostic interview (ADI-Revised). This was a standardized interview that takes place 
between a clinician and the parents of a child on the spectrum, designed to elicit a detailed 
historical picture of the child. Through this interview, the individual is practiced as a 
temporally located being. The interview asks questions about when the individual achieved 
various developmental milestones (such as walking and talking); it also asks about school 
performance and friendships. In some ways, the ADI-R captures similar information as the 
ADOS and the intelligence testing, but it does so in a way that is diachronic. The individual 
with autism is performed as a changing, growing person who has inhabited different places 
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and situations over time. The ADI seeks to understand a more global historical overview of 
the individual from the parents’ perspective(s).  
 There are many other ways in which the individual with autism is practiced in the 
clinic. For example, the consent form practices the individual with autism as a voluntary 
research subject. The photograph taken of a individual’s face practices him/ her as a unique 
constellation of physical traits. The appearance of the patient’s photographed face is later 
interpreted and labeled by a trained clinical geneticist as dismorphic or not. Moreover, in the 
clinic patients come to be known as members of families. Clinicians may become aware 
when families are going through difficult periods, such as divorce. Personality traits of 
family members may be recalled when a patient is discussed. As such, in the clinic patients 
also often come to be practiced as members of an extended family.  
7.2 b Laboratory Practices of the Individual with Autism  
 I would like to turn now to some of the ways in which the individual with autism is 
practiced in the laboratory. In the spaces of the laboratory, through a variety of technologies, 
the individual with autism is translated many times. Each of the technologies goes about 
ordering the individual in different ways. At various points these orderings are brought 
together and made to cohere or relate to one another.   
i) Practicing the Individual with Autism as a Geographic Entity 
The individual with autism may be practiced in the laboratory as a geographic entity. 
Hanging prominently on the bulletin board inside the main office of the genetics laboratory is 
a collection of three world maps: the Hereford Mappa Mundi, the Mercator, and Wegener’s 
Theory of Pangaea. Below each of these world maps is a map of the human body: the 
chromosomal/ karyotype map, sequencing map, and CNV map. I learned that it was the 
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director of the laboratory who combined these maps on this sheet of paper, a creative 
signpost to the work being done within the laboratory: something akin to cartography. Just as 
each of the world maps portrays a particular kind of world, so too is the human body 
practiced slightly differently through the various maps constructed in the laboratory.  
Figure 7.1: Image of Maps Pinned onto Laboratory X Bulletin Board 
Figure 7.1 
 
Through several of the technologies in the laboratory the individual with autism is 
practiced as a kind of geographical entity, composed of genetic building blocks of various 
sizes and resolutions. Microarray and sequencing technologies in the laboratory reduce the 
individual with autism such that a string of nucleotide bases is made to stand in for the 
individual. At a slightly larger scale, in cytogenetics, the individual is practiced as a set of 
microscopically visible chromosomes. The particular components that are brought into view 
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by various technologies reassemble the individual with autism in different ways. Practiced as 
a geographical entity, there are many different tools in the laboratory that set out to map the 
individual with autism. Just as a geographer has tools that she uses to map a region of the 
earth (compass, GPS), so too does the scientist use a large number of tools to map the patient 
body (e.g., see Appendix B for list of tools needed for various stages of Next Generation  
Sequencing experiment). 
The individual with autism is at times collapsed within a geographical location. For 
example, a line from the minutes of one of the Monday morning meetings reads, 
 “ - 16q23.3 deletion who is on the waiting list to have an assessment so not 
100% autism at this time”. 
 The state of a particular location, whether the genetic material is deleted or duplicated or 
somehow rearranged in this single marked place, becomes the placeholder for the individual 
person. Practiced in this synechtocal way the individual is 16q23.3, the twenty third band on 
the short arm of the sixteenth chromosome. The part stands for the whole. In other instances, 
the body is practiced as a series of locations, each location with a particular address. The 
Next Generation Sequencing lab manager stated: 
So at the end the instrument will look at all these pictures and try to assemble 
the correlation. There’s actually a physical address. So the instrument knows ‘I 
have a bead here and that bead is on the same place in all those pictures 
(Interview with NGS manager). 
In the geographic body, the distance between locations is also important.  
 There might be other types of regulation that go on. In some cases it might be 
the actual physical distance between two genes that is important. So imagine, I 
don’t know this is just a hypothetical situation, imagine something has to bind 
somewhere to have an effect. If the effect is distance dependent and you delete 
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something in between then the distance will be wrong. So the regulation might 
not work (Post-Doc in Laboratory X). 
The practice of the body as a geographical entity also transforms the scientist into a kind of 
geographer of the body. In constructing the individual with autism as a geographic entity the 
scientist is also co-constructed. The body becomes a road of sequence and the scientist is 
transformed into someone who must map this road. One scientist explained: 
So say you have this, you line it up and it’s 3.1 billion bases long. You have 
this road of sequence in front of you.  
In mapping the geographic body, the scientist must become oriented to the different 
landscapes constructed through different technologies. For example, when looking at a 
Genome Browser together, a scientist explained what we were seeing on the screen in the 
following way:   
So when we say upstream and downstream, we mean relative to a gene. So, a 
gene is always transcribed or translated, that is, made into a protein in one 
direction. So the arrow on the figure will let you know which direction that is. So 
it’s made this way. So this is the first exon, second exon, third exon, fourth exon. 
So the PatchD1 actually just has two exons. And upstream of the gene, or sorry, 
downstream. So when we say, upstream is before the start. So in the case of the 
PathchD1 the gene was this way. (Ankit) 
The scientist-geographer is re-oriented in relation to a mapped patient body. The 
scientist is at once working above the genome map and also in the genome map. 
 Say you want to amplify a specific region of the genome, you would design what 
is called a primer, which would specify whereabouts in the genome you are. And 
then you can use the reaction to amplify that region from the primer. (Heather, 
interview 2) 
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The individual with autism when practiced geographically is an unknown territory, 
comprised of distinct landscapes depending on the technologies being used in its exploration. 
The scientist practiced as a geographer or cartographer approaches the patient landscape as 
something that can be mapped out in comparison to a kind of master map, the human 
genome. Prior to the mapping of the Human Genome, the human body contained huge tracts 
of territory that were uncharted. With the master-map of the Human Genome, however, any 
little region can be located. 
So after the whole genome sequence was known, if you have a sequence of DNA, 
like you isolated a particular sequence of DNA, you can kind of map it to that 
genome sequence and see which chromosome it lies on and which gene it might 
effect. So it sort of gives you a whole new context of location in terms of on a 
genomic scale. (Ankit interview) 
Practiced geographically, certain regions of the patient body are more or less elusive to the 
scientist-geographer. Certain areas refuse to be captured, ordered, and mapped out with the 
current technologies: 
But the issue there is GC rich exomes, they don’t sequence well. In certain 
places, if you have more than 80% GC, chances are you are not going to get 
coverage there, even if you keep sequencing.  
There are a multitude of examples that I have collected from the laboratory observations and 
interviews in which the individual with autism is constructed as a geographical space to 
which the scientist must orient herself with the aid of various technologies. In the laboratory, 
the mapped body is a socio-technical assemblage. It is materially heterogeneous; at times 
composed of cells and nuclei, at other times made up of chunks of nucleotide base pairs, and 
still at other times the body is practiced as a series of single nucleotide bases. The various 
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technologies construct the body as having different resolutions and orient scientists to the 
body landscape in different ways.  
ii) Textual Practices of the Individual with Autism  
In other instances in the laboratory, the individual with autism was also practiced as a textual 
entity. During an interview with a project coordinator in the laboratory, the textual practices 
of individuals were stated in this way: 
Project coordinator: [Describing a CNV] It’s a chunk, that’s exactly what it is; 
it’s a whole stretch of nucleotides that are either missing or duplicated. And the 
easiest analogy that I could say is if you summed up the genome as a book, a 
really large book with a bunch of sequence, these smaller nucleotide changes 
which we typically call a single nucleotide polymorphism or variant is just like 
a typo in the book. OK, and these can mean nothing, they can be a severe 
mutation; they can be anything. A copy number variation is like where you 
would have a piece, a page either missing or duplicated and so it’s a whole 
bunch of nucleotides involved. And some of these are just normal variation and 
everybody has them and they could be acting on something. And then in other 
cases we find these variations in genes that we think are involved in autism.  
This analogy between the human genome and a book has been dominant in this discourse for 
some time (Kay, 2000). It seems to be particularly prevalent when scientists explain genomic 
work to a lay audience. Certainly, the members of the laboratory did not talk to each other in 
this way. The excerpt above, for example, was taken from my first interview in the 
laboratory, when it was clear to the project coordinator that I was unfamiliar with the work 
and materials of the laboratory. It is a well-crafted analogy set aside to be pulled out and used 
when explaining laboratory work to non-scientists. 
238 
 
 The ordering or assembling of the individual with autism as a text, however, is not 
only practiced when talking to outsiders. When I open up Nvivo and read through my 
interview transcripts and observation notes, the practicing of the individual with autism as a 
text is present in almost every document. In particular, the technologies used in sequencing 
(in which the body is explored at the highest resolution) involve materials and procedures 
that when practiced together assemble the individual with autism as a text to be read. I 
became familiar with Next Generation Sequencing through interviews with two of the post 
docs running the NGS machines and analyzing NGS data, the manager of the NGS facility, 
and a bioinformatics specialist. I also observed various steps in the NGS experiments and 
read the protocol developed by the company that manufactures the technologies and 
materials required in these experiments. As I observed, listened and read about NGS, I 
became familiar with the textual practice of the human body. Obviously, in sequencing, the 
nucleotide bases are labelled A, C, T, G and as such the body is practiced as a string of letters 
to be read. One of the steps at the beginning of sequencing experiments is called “library 
prep”. Scientists create a specific library out of the individual patient’s sample. A participant 
from the NGS lab explained: 
So the library preparation is the step where we have to process the sample…And 
so for Next Generation Sequencing, you get the DNA, for the exome, what you 
need to do is you have to select all the exomes of that genomic library. So when 
you are sequencing what you need to do is to deep sequence all those regions. 
(NGS lab manager) 
This participant went on to explain: 
So when you are doing the library preparation you start with a lot of DNA and 
then you lose DNA as you go. So at the end, the reason you have to start with a 
lot of DNA is that you’re expecting that you’re going to be losing DNA 
239 
 
randomly. So you expect that in the final library you will have all of the DNA 
fragments that you need. (NGS lab manager) 
The individual with autism is practiced as a kind of textual entity through the activity of 
library preparation. Another way in which the individual with autism is practiced as a textual 
entity is in the concept of “read depth”. One of the common concerns raised in the weekly 
sequencing lab meeting was the issue of “read depth”. Read depth pertains to how many 
times a particular nucleotide base is captured in an experiment. A deeper read depth allows 
for more confidence when a particular nucleotide at a particular location is different than 
expected, different from the reference genome. 
So one of the reasons we need to have a lot of reads mapped to a particular 
region on the genome is because the error rates for some of those machines 
are higher than they are for Sanger sequencing. So usually we are expecting 
to see at least twenty reads mapping to a particular position. So when you are 
looking at something and you see a mutation for example and you say, ok, 
there are lots for reads here and I know, you can for sure say, this is really a 
mutation. But let’s say you only have five reads, and let’s say two of them 
actually point to a mutation and the other three are exactly the same as the 
reference then you have to make a judgment call there. Is this real? (NGS Lab 
Manager) 
 Some technologies allow the patient body to be read more deeply than others. A 
biostatistician was looking forward to receiving the first data set collected from a newly 
upgraded sequencing machine and stated, “The SOLID 5 is supposed to give us way more 
read depth. So a lot more reads are supposed to be sequenced”. This idea of read depth was 
further explained to me in an interview by the NGS manager: 
So basically what you are doing is, since you have millions and millions of 
fragments, let’s say, if you’re thinking about one exome. You maybe have one 
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fragment that will cover the whole exome, another that will cover just parts of 
it. So basically when you start aligning you have all these different fragments 
spread all over the exome. So when they are talking about read depth what they 
mean is on a particular position, how many reads are actually covering that 
position. (NGS manager) 
In the laboratory, the individual with autism is often practiced as a textual object. Depending 
on which aisle you find yourself standing in and depending on the technology being used the 
body is practiced as analogous to either the individual letters, words, or pages in a book. The 
body is quite literally read and scientists may be likened to copy editors, honing in on any 
typos that appear in the body as text. 
 Sometimes the body is practiced in different ways (as a geographical entity and as a 
text) in the same instance. These practices are made to cohere. Consider the following 
statement.  
I just pulled out how the intensity chart looks like. This is a good graphical view. 
So it’s P1428 [patient number]. So you can see the different chromosomes.  
In this single statement, the individual with autism is being practiced in several ways: as an 
intensity chart, a graph, a de-identified research subject, and a set of chromosomal building 
blocks. The various translations of the patient body constructed through various technologies are 
pulled together. 
 In other instances various technologies practice the individual in ways that do not 
necessarily cohere. During my fieldwork, I found that many of the different technologies 
were practiced separately. For the most part, researchers were either involved in microarray 
experiments or in sequencing experiments. Researchers would be aware of research going on 
through other technologies but an individual researcher tended to concentrate their research 
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in either sequencing or microarrays or cytogenetics. As a single sample traversed the 
laboratory, it was passed amongst different hands which were trained to practice a sample in 
ways quite different from one another. The human body as constructed through one 
technology did not always cohere with the body constructed through another technology. For 
example, I interviewed a post-doctoral fellow whose main interest was comparing microarray 
data and NGS data for a single patient. (Conversely, most of her colleagues in the laboratory 
were concerned with populations.) She found that there was not always a straight-forward 
relationship between the microarray and NGS data.  
The sequencing data is really new. So we’ve only reported out one family so far 
that had a single nucleotide variant which resulted in a stop-codon in an 
important gene. They had microarray data but the mircoarray data didn’t come 
up with any of the sort of normal suspects, the common things like the NRXNS 
or Neurolygens or SHANKs. They had other copy number variants but of 
unknown clinical significance. So it wasn’t until they did the sequencing that 
they could figure out, ‘ok, there’s actually something going on here’ it’s just at 
a different level of resolution. 
At one level of resolution, the CNV, a particular mapping of this individual did not 
distinguish between patient and non-patient, case vs control. Practiced in the laboratory 
through the microarray technology, this body is not constructed as diseased, pathogenic. 
When the body is constructed in another resolution, the NGS, the body is pathologized. Thus, 
the same individual body is constructed differently, in ways that do not overlap, by different 
technologies within the laboratory.  
7.2c The Individual with Autism Practiced at Home 
At home, individuals with autism are practiced through familial relationships - a son 
or daughter, a sister or brother – or in relation to particular roles they play or abilities they 
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might have – student, athlete, musician, scholar. The individual with autism constructed in 
the home is, again, entirely different from either the constructions of the laboratory or the 
clinic. In the laboratory the individual with autism is practiced as a geographical or textual 
entity and in the clinic the individual with autism is practiced as a cognitive or social entity. 
While the laboratory and clinical constructions of the individual are sometimes practiced in 
the home, there are many other ways in which the individual with autism is practiced here as 
well. 
There were a few instances in which the individual with autism was practiced as a 
patient in the home. For example, the individual is constructed as a patient when parents 
described their child in relation to a previously imagined non-patient child. One parent stated: 
I honestly think it’s an issue with coping. The one thing for me, I had difficulty 
coping and then it got to a point, I actually had a parent say to me, ‘you know, it’s 
OK to be angry. Just be angry’. I think you get to a point where you realize, you 
don’t have the kids you thought you were going to have. You have to grieve that 
and then in doing that you’re able to accept the one you’ve got.  
This mother described going through a period of mourning when their child received a 
diagnosis of autism; at this point she realized she did not have the child she thought she was 
going to have. Through a diagnosis of autism a child is transformed into a patient.  In this 
way, the individual with autism is constructed in an emotional process of coming to terms 
with the non-patient child that parents originally anticipated. Ironically, while the mother 
mourned for the child she thought she was going to have, she also simultaneously had to 
fight for her child to be recognized as a patient outside of the home. The mother who made 
the statement above recognized that something was medically wrong with her child and in 
this way constructed him as a patient in the home. She said: 
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I really had to kick down our family doctor’s door to get a paediatrician involved. 
So we went to the paediatrician sometime between two and three, closer to three. 
And I had done my own research and I went in there and said I think he has 
autism. And the paediatrician gets out a list and he goes through and he checks 
them off and he goes, ‘well the problem is he only has fifteen out of sixteen 
characteristics’. And I looked at him and said ‘are you kidding me?’ And I asked 
what one is he missing and he said, ‘well according to your statements he seems 
to sleep through the night’. And I said ‘he screams for eighteen hours a day, of 
course he’s going to sleep’!  
Thus, this participant described a situation in which her son was first constructed as a patient 
at home and only later, after much effort on her part, was he recognized and practiced as a 
patient in the clinic and laboratory. 
While the laboratory and clinical constructions of the individual with autism are 
sometimes practiced in the home, there are many other ways in which the family member 
with autism is practiced in the home as well. In the home, the family member with autism is 
also practiced as a biographical entity, with a past, present and future beyond that of a 
genetic map. This biographical nature of the patient is practiced in the clinic to some extent; 
through assessments such as the ADI-R the patient is constructed in relation to past events, 
language and motor milestones for example. Armstrong (1998) has described how medical 
records reconfigured the clinical patient as a biographical entity. Through medical records, 
such as the patient chart, “clinical problems were not simply located in a specific and 
immediate lesion but in a biography in which the past informed and pervaded the present” 
(D. Armstrong et al., 1998). In the feedback session, the individual with autism is also 
practiced in relation to the future; in particular, the individual is practiced as a possible future 
parent whose offspring may inherit genetic variants. In the home, however, the individual 
with autism is practiced biographically within a temporal trajectory that is deeply entangled 
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in the biographies of families and friends. The milestones that are captured in the clinic as 
aspects of an individual biography (captured in a single patient chart) are enmeshed in the 
life course of family members in the home. Parents quit jobs, change careers in order to 
accommodate the special needs of their child. The individual with autism at home is 
practiced through an entangled relational biography. This deep entanglement of the 
individual biography is not captured in the practices of the patient in the clinic.  
7.2d Strategies of Coordinating the Multiply Practiced Individual 
i) Feedback Session 
During the feedback sessions which I observed, the genetic counsellor first began by 
describing how the individual with autism is constructed in the laboratory. She enacted the 
individual as a geographical entity by describing recent technologies which look for subtle 
changes, missing or extra pieces at particular places on the genome. She showed parents 
black and white photographs of chromosomes. She used map analogies to help families 
understand how new technologies allow scientists to zoom in on particular locations on the 
genome, like an inset on a map. She told them that they have a deletion or duplication at a 
particular location and gave them details about the size of the deletion or duplication. She 
drew two vertical lines with the number 16 underneath and marked an “X” on one of the 
lines. She was orienting the family to the physical address, the place within the individual’s 
body where the deletion had been mapped. 
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She then described how there have been different sizes of this deletion found in 
various individuals diagnosed with autism. She draws two more vertical lines on the paper to 
indicate the size of the missing chink of DNA.  
 
 
Here she switched to clinical constructions of the individual with autism. The 
individual was constructed as a social being and a thinker/knower/puzzle solver as she 
described that those with the smaller deletion have been reported in the literature as having 
behavioural difficulties or learning difficulties. Finally, the genetic counsellor asked the 
family to help her construct a family pedigree, gathering information about extended 
relatives and any developmental or psychiatric problems they might have experienced. 
During the making of the family pedigree, I observed that families often began talking about 
the individual with autism as practiced in the home, in relation to school, friends, specific 
family gatherings or events, traits or idiosyncrasies that revealed themselves throughout the 
16 
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practices of daily living. They were practiced as deeply entangled relational biographies. 
 
ii) Patient Identification Number 
There are other strategies for coordinating the different practices of the individual 
with autism found within the laboratory, clinic and home. For example, the patient ID 
number labelling the tube of extracted DNA ensures that the geographical practices of the 
laboratory are kept in association with the clinical practices of the patient. This ID number is 
placed on the top of the research report and is carried into publications as well.  All of the 
information contained within a single patient chart carries the same ID number. In this way, 
all of the various ways of practicing the individual with autism in the different spaces of the 
hospital are made to coordinate with one another, to relate to one another.  
iii) Cases vs. Controls 
 The individual with autism was also practiced in the laboratory as a “case”, which 
was always practiced in relation to “controls”. Cases are samples that have a clinical 
diagnosis of ASD. The clinical practices of diagnosing individuals with autism were found 
within the laboratory practice of the individual as a case. In the practicing of the individual as 
a case vs. control the clinical constructions of the patient are made to relate to laboratory 
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constructions. They are coordinated. Controls are samples that do not have a clinical 
diagnosis. Practiced in this case-control relationship, patients are performed as a statistical 
entity in relation to a control population. The database of genomic variance, for example, is a 
technology which practices patients statistically, in comparison to a control population.  
So what we do, when we find something like this we interpret this variant in the 
context of the DGV. So this is from thousands and thousands of individuals in the 
general population and after looking at all those thousands and thousands people 
have reported only these many CNVs and there’s nothing similar to what you see 
in the two patients. 
In another interview, the case-control relationship was explained further: 
Now I told you that everyone has CNVs like even normal healthy people. But 
the difference is, what they kept finding is that patients with psychiatric 
disorders they tended to have these rare deletions or duplications which are not 
generally found in the normal population. Or even if it is found it’s really, 
really rare. So it would be less than 1 in 10 thousand people or one in twenty 
thousand. Whereas in cases, so they are rare in cases as well and they might be 
one in a hundred as opposed to one in twenty thousand in controls. So these 
rare deletions kept cropping up and perhaps most interestingly these rare 
deletions seem to affect genes in known brain function more often than not. So 
using this you sort of get an idea of which genes are being deleted. And this still 
only explains a very small percentage of cases. So if you took a hundred 
psychiatric cases and put them on arrays you’d probably get something of 
relevance 15 to 20 percent of the time. 
Through the Database of Genomic Variants, scientists can examine a single region of the 
genome and the program will tell them how often a variant at that location is found in 
controls and if a variant has been found in other cases. In this way, the individual body is 
practiced as part of a population. A PhD student in the lab explained, 
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These studies usually get a tonne of cases and they also get controls from the 
general population. So ideally when you say controls you want them to not 
have whatever disorder you’re studying. But that’s a little difficult to do in 
practice for something like autism or ADHD because a) it’s relatively common 
in the general population and b) it’s hard to find funding to actually phenotype 
controls. Because physicians are hard-pressed for time and there’s not enough 
money to line up a hundred people on the street and try to see if they have 
ADHD or Autism. So what people generally do is take a huge number of 
controls, like let’s say in the thousands, put them on arrays, but not phenotype 
them too well. Then take cases, these are phenotyped pretty well because they 
actually come to the hospital or their paediatricians. So they actually have 
problems and they come to the hospital so they are pretty well phenotyped. So 
they put them on microarrays or sequencing or whatever and then you see 
particular regions of the genome which have either point mutations which you 
can detect from sequencing or they have CNVs, like deletions or duplications 
and see, exactly like you said before, look at genes in which two or more people 
who are unrelated or two or more people with the same disorder who are 
unrelated genetically, they have mutations in those genes. Whereas in the 
controls you have either none or extremely few. So these might still be rare in 
the cases. Like out of a hundred only two might have them. 
 
In the above quote, several practices are juxtaposed in relation to one another. The 
individual with autism is a geographical entity with different genetic regions that can 
be mapped in different resolutions (point mutations or duplications/deletions). The 
individual with autism as a thinker/knower/ puzzle solver and as a social entity is 
held within the practice of clinical diagnosis, which turns the patient into a case. This 
individual is also a statistical entity and practiced in relation to populations. In the 
practicing of the individual with autism as a case vs a control, different constructions 
of the individual are coordinated and come together.  
7.3 Autism(s) in Practice(s) 
 In the previous section, I focused on the individual with autism as a site in which to 
explore multiplicity. The ways that the individual is practiced in the clinic and in the 
laboratory may or may not cohere. I now turn to another example in order to explore this idea 
of multiplicity: autism as an entity in itself.  In the context of the clinic, autism is invoked 
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through psychological tests (ADOS, ADI-R, intelligence tests) and through taking a “history” 
through discussions with parents and teachers. In the context of the laboratory, autism is 
invoked through alleles, the human genome, microarrays, PCR, and “next generation 
sequencing”. Each of these contexts has disciplined ways of focusing, centering on specific 
features, so that autism is either arrived at or ruled out.  In the clinic, various tests are scored. 
In the laboratory, a risk classification from one to four is given. These scores and 
classifications that are produced in the clinic and laboratory result from vary different 
practices in either context.  In each of the settings, autism is done in different ways. When the 
scores in the clinic correspond to the risk classification given in the laboratory, the different 
autisms practiced in each setting are made to cohere. In the following section I will describe 
how autism is practiced in the laboratory and the clinic. I will then provide examples of how 
these different enactments of autism are sometimes coordinated as well as instances in which 
the practices do not cohere, at least, not yet. 
7.3a Practicing Autism in the Clinic 
 “Nothing can replace clinical judgement. It all comes down to clinical judgment.” (Interview 
with psychology student at an autism clinic) 
In the clinic, autism is practiced as a nuanced and diverse phenotype. In the clinic, 
autism has a complex social, behavioural, linguistic nature. Autism is practiced through 
direct interaction between people. It is also practiced as something that unfolds over time. 
One of the assessment tools that are involved in the clinical practice of autism is the ADI-R. 
Through the ADI-R, autism is practiced as having a temporally unfolding ontology. One 
participant explained the ADI-R in this way: 
I start off by asking what were some of the first things that alerted them that there 
might not be something quite right with their development. How old were they at 
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that point. When did they start toileting, bowel, we ask about specifics around 
imagination, about types of play they engaged in. The ADI, it all depends on the 
age of the child. So let’s say the child is above age five, you ask about current 
functioning but you also ask about what it was like between four and five. If the 
child is younger than that then it’s around current functioning. You ask about 
language development, first words, first phrases, you ask about gesture use, how 
many gestures, you ask about facial expressions, anything that’s under 
communication. Then you ask them about friendships, interest in other children, 
things like that. Then there are questions around behaviors, repetitive behaviours. 
So specific interests, unusual interests, how do they deal with changes in routine. 
(Mary – psychology PhD Student) 
Thus, different situations, events, important milestones in one’s life become implicated in the 
clinical practice of autism. Toilet training, friendships, first words – all of these enter into the 
network of autism as it is practiced in the clinic. There are various assessments which are 
used to capture autism in the clinic. As such, autism in the clinic is practiced as a particular 
score arrived at by a diagnostic algorithm. One participant explained the scoring in this way: 
There’s a scoring system and you have to be trained and get reliability on that. 
And the scores go from 0 where there’s nothing that indicates autism or any 
kind of developmental issue, to a score of one or two. Two or three are usually 
the highest you can get. So the diagnostic algorithm only uses scores of 0, one 
and two. So a three turns into a two. There are other, in certain questions, in 
language or motor movement where if a kid has a severe physical disability or 
has a stutter or something like that then you would put a different type of score. 
So each question indicates which number you should be putting in. (Mary – 
psychology PhD student) 
Scores from these various assessments are looked at together to form a large picture of 
whether or not an individual has autism. The various clinicians who conducted the 
assessments come together to do a “formulation”, discussing strengths and weakness of the 
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child. These formulation sessions last about two hours. They take into consideration several 
rating scales and standardized assessments as well as informal information gathered by 
chatting with parents and interacting with the child. Based on all of this the clinicians make a 
decision about whether the individual has autism or not. The clinicians compare what they 
observed and heard in their meetings with the individual’s family with the criteria of autism 
that is listed in the DSM. One participant stated: 
So impairment of social interaction, impaired communication and stereotyped 
behaviors and things like that.  And then a lot of it just seeing whether the 
information we gathered matches those things. (Clinical Psychologist) 
 At times, an individual receives scores on the various assessments that are considered 
“borderline”. In these cases, clinical judgment is particularly important in the practicing of 
autism. Some assessment tools practice autism in a particular way that may not capture 
various nuances within the autism spectrum. For example, through the ADOS autism is 
practiced as a lack of verbal communication.  
A lot of times, especially for the higher functioning kids, and especially girls, like 
girls with Aspergers, the ADOS does not capture autism very well. So most of the 
time they will actually come out “not autistic”. So they won’t meet the criteria. 
But that doesn’t mean they don’t have autism. So we have to figure out ways to 
support our decision in giving them a diagnosis…On the ADOS you score for 
things like if they don’t talk a lot, but they’re very chatty. They’re actually very 
chatty but then it comes to a point where it’s like a fine line between do they 
understand are they being too chatty, like someone may not want to listen to them 
anymore. But those things aren’t what you score on the ADOS. They don’t score 
for that but that is social impairment. So the ADOS itself doesn’t capture those 
individuals very well. So they will actually score . . . their scores are under 
basically on the ADOS. (Janine – psychology PhD Student) 
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In clinical practice, ASD is a complex set of behaviours that are teased out through various 
assessments and interactions with patients. Scores from these assessments are assembled 
together to construct a nuanced understanding of ASD. While individuals are either given or 
not given a diagnosis of ASD, within that diagnosis there is much variation in the way that 
autism can be practiced.  
7.3b Practicing Autism in the Laboratory 
 
To describe the practice of autism in the laboratory is complicated, largely because 
autism is a clinical diagnosis. A lack of laboratory findings does not preclude a clinical 
diagnosis of autism. Indeed, there is no need for a genetic component for a clinical diagnosis 
of autism. In the laboratory, however, phenotypic information is required to interpret the 
genotype information produced. It is only after the genotype information has been coupled 
with an autism phenotype that the genotype comes to be recognized as causing or 
contributing to autism. The genotype can never stand alone as meaning autism. There could 
be individuals who have a genetic variation consistent with autism that do not display the 
phenotypic characteristics of autism, and are therefore not diagnosed with autism. However, 
certain mutations are becoming closer to standing in for a diagnosis at the clinical level. 
Certain mutations are repeatedly found to have an autistic phenotype. Certain CNVs or SNPs 
are becoming recognized in the laboratory, according to one post-doctoral fellow, as “the 
usual suspects”: the NRXNs, the SHANKs, the Neurolygens.  
 Autism is ontologically fuzzy and ambiguous as it is probed in the laboratory. Its 
genetic ontology, the genetic nature of its existence is only achieved after its clinical 
ontology has been established. There is a complicated reversal that occurs in which autism is 
first clinically identified through the tests and examinations carried out in the clinic. 
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Following this, a whole bunch of work is done in the laboratory which sometimes results in 
genetic findings being reported. If the genetic findings segregate with the clinical findings 
across the family pedigree, then the genetic ontology is recognized. In these cases, autism 
becomes genetic in nature. The genetic ontology is used to explain the underlying cause of 
the clinical nature of autism. Here, autism multiplies; it has both a clinical nature and a 
genetic nature. However, if genetic findings do not segregate with the phenotypic findings of 
a family pedigree then a genetic ontology for autism is thwarted and the clinical nature of 
autism stands alone.  
In practice, most of the variants found in the laboratory are classified as having 
“unknown clinical significance”. Usually, this occurs when variants are found in genes for 
which function is not yet known. The genes may or may not be impacting the brain in a way 
that contributes to an autistic phenotype.  These genetic variants may or may not relate to 
autism as it is done in the clinic. Thus, most of the time in the laboratory, autism is still in the 
process of becoming genetic. It is assumed that advances in technology will eventually lead 
to a concrete and defined genetic nature of autism in all cases. But for now, the ontological 
boundaries of autism as it is constructed through genetics are still being negotiated. 
Therefore, when I describe how autism is practiced genetically, in the laboratory, it is to be 
understood as a fuzzy autism. It will only become solid once it has been mapped onto the 
clinical enactment of autism. Once that happens, only then do we look back on the genetics 
being done in the laboratory and recognize the outputs as being autism. Autism is given a 
genetic ontological status retrospectively. At this point the reversal occurs and it is assumed 
that it was the genetics that was there all the time, lying behind the clinic ontology of autism.  
A pervasive concern that hangs around all of the work in the laboratory is whether or 
not findings are “real” or just “error”. Regardless of the technology being used, microarray or 
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sequencing, error is a fundamental problem. Scientists in the laboratory want to be confident 
about the existence of the CNVs or SNPs which they report out of the laboratory back into 
the clinic.  In order to gain confidence in the variants that are eventually reported, there are 
many places along the experimental trajectory in which a different technology, a different 
way of looking, seeing, measuring, is used for validation. Just as the individual with autism is 
practiced in different ways within the clinic, through ADOS or Intelligence tests, so too is 
autism done differently by the various technologies used in different spaces within the 
laboratory. Previously I described how the laboratory is not actually a single, unified place 
but rather a set of related spaces in which different technologies and tools are used to probe 
the world in various ways. When walking from one place in the laboratory to another, from 
one aisle to another, the object that is made to come into view changes. In the previous 
chapter, I described the journey of DNA, in order to convey all of the changes, the 
translations, that occur as DNA is probed by different technologies.  
 All of these various experiments are finally translated into the report. The words on 
this report summarize the months of work that has been done and the results that were arrived 
at. The report classifies genetic variants into four categories or classes.  A class four indicates 
that a variant is commonly found in controls. A class three is given to variants that are not 
found in controls but which do not overlap with any genes. They are intronic rather than 
exonic. A class two denotes variants that are not in controls and they do overlap genes; 
however it is not known whether they are significant. Class one is reserved for a known 
pathogenic locus. Something interesting happened here, when the scientist was explaining 
these classifications to me. For classes four to two, he described the class in relation to a 
variant. Specifically, he said: “class four is CNVs that are in controls as well, Class three is 
CNVs that are not in controls but don’t overlap any genes, Class 2 are not in controls and 
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they overlap some genes but we’re not sure what they mean. Like, they could be significant 
or they might not be.”  (Ankit) 
When he described class one, however, he said “And class 1 is it’s a known syndrome”. 
What is a known syndrome? The variant is a known syndrome. The variant at a particular 
genomic location is the syndrome. Its ontological status is solidified.  Class one variants are 
allowed to stand in for the syndrome. When a class one variant is called and reported, autism 
is done genetically. Autism acquires an ontological status. In that instance, autism is 
practiced as a genetic variant at a particular locus on the human genome. Autism is practiced 
as a genotype.   
 The practice of autism as a genotype is very precarious as associations between 
genotype and phenotype are not always straight forward. When scientists are engaged in the 
work they are doing with their hands, when I pay attention to the work of the technologies in 
the laboratory, autism is being practiced as a genotype. However, when scientists in the 
laboratory are asked to stop and think about it the tenuous nature of the relationship between 
genotype and phenotype is brought to awareness. For example, in a Monday morning 
meeting that I observed early on in my data collection the director of the laboratory explained 
how someone at a conference had asked him to explain the difference between a mutation 
and a single nucleotide variation. The people sitting around me laughed uncomfortably and 
many of those in the room said there is not a difference. One scientist asked the laboratory 
director how he had responded to this question. The director responded, “a mutation is 
expressed phenotypically, while an SNV refers to the genotype”. Here, he makes clear a 
distinction between genotype and phenotype. At times, however, genotype and phenotype are 
becoming blurred in reports of class 1 variants; in some cases, the genotype is beginning to 
stand in for a syndrome. 
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7.3c Autism in the Family Home 
How is autism done in the home? How is it practiced? All of the participants I 
interviewed had previously been engaged in genetic feedback, meaning that a clinically 
significant genetic result had been mapped to the clinical findings. For these families autism 
had already been practiced both clinically and genetically. It already had two natures. It was 
practiced as scores on clinical tests, such as the ADOS, and ADI-R and it was practiced as a 
genetic variant. Autism was a genotype and a phenotype. Given the limitations of data 
collection in the home, the lack of participant observation in this context, my understanding 
of the practices of autism in the home are very limited. Through interviews, however, I have 
come to learn that in the context of the home, the practice of autism proliferates. Autism is 
done in a variety of ways. Moreover, it is difficult to separate the practice of autism from the 
practice of the individual with autism. It becomes a part of so many different activities during 
the day and night. I could say that autism is practiced through the lived experience of the 
body. For example, participants described autism as a way of living temporally and spatially. 
Routines are established and adhered to.   
We’re very routine. We get up at the same time, we have breakfast, we do 
everything in order in regards to getting to school. 
 
Autism is also practiced retrospectively, as parents look back and remember specific, 
memorable habits or abilities that set the child apart from other children. For example, 
one mother said: 
You see he was very eccentric since he was little and he was brilliant, 
absolutely brilliant. At two and a half he could recite The Night Before 
Christmas. And he would tell me when to turn the page and it was word for 
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word. So we knew. And he always had difficulty socially and sensory and then 
in grade four he got identified gifted LD. 
Autism is practiced in relation to certain material objects: 
 
We really started to see the stickiness, like he couldn’t handle, change the colour of 
his socks and he’d freak out. He had this hat he had to wear. A hundred degrees and 
he still had to wear a wool hat. 
 
Autism is practiced in the roles that family members take on: 
 
I’m an advocate for them. I’ve met advocates. They’ve trained me. I’ve had all 
my training at [an autism centre]. I became an autism intervener for them, not 
for anyone else.  So they let me know what courses there are and I’ve taken 
them all. So I think I know what I’m doing with them. I’m like their extra 
teacher. 
Autism is practiced in special foods that are prepared and eaten: 
I give them power smoothies. I’m trying to enhance their brains. I spend a huge 
amount of money on berries. So every day they have a 12 oz smoothy and that 
motivates [my son].  
A description of the enactments of autism in the home is particularly difficult for me to 
capture. My difficulty in writing about autism practiced in the home is perhaps data in itself. 
I think the difficulty is because, unlike the laboratory or the clinic, in the home autism is not 
easily reduced; it can not be boiled down to scores on an assessment or a classification of 
genetic variants. When I read over the interview transcripts with parents, I find it difficult to 
discern where autism is not being practiced. Autism is part of the life of the family; it is 
enacted through disparate situations, people, objects, settings, times, places. Moreover, each 
home is different. While clinic and laboratory practices are very similar, or even standardized 
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in some cases, from one lab to another or one clinic to another, homes are not. The interviews 
I conducted only scratch the surface of autism as it is practiced in the home.  
7.3d Non-Coherence in the Practices of Autism 
i) Genetic Variant with no Clinical Diagnosis 
At times the clinical and laboratory practices of autism did not cohere.  One woman I 
interviewed described the difficulty she was having in understanding the relationship 
between the genetic and clinical constructions of autism. This woman had a son who was 
diagnosed with autism and who had a Class 1 genetic variant, the NRXN3. The mother had 
also given blood and been genetically tested. She too had been identified as having the 
genetic variant but had never been given a diagnosis of autism.  She had a genotype 
associated with autism in the laboratory but she did not have the phenotype associated with 
autism in the clinic. She described her uncertainty about the ambiguous relationship between 
clinical and genetic practices of autism.  For example, she stated:  
Not to say that I have Asperger’s and I’ve never been diagnosed with ADHD but 
it does help in understanding my tiny idiosyncrasies … it does explain some of 
the things.  
In respect to this woman’s son, autism had a clear clinical and genetic ontology. The two 
practices of autism cohered. For her son, the gene is retrospectively recognized as the cause 
of the clinical nature of autism. For this woman, however, the genetic practice of autism did 
not cohere to the clinical practice of autism. This raised important questions for the mother: 
I often wonder does that gene impact on, my question, I have a number of 
questions. So what it does is it brings forth more questions about myself. So 
because I have the gene I am the carrier or do I have autism on a lower part of the 
spectrum? What does it exactly mean is my question?  
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At home, participants traverse a number of different practices of autism, translating in and 
out of genetic and clinical constructions. For this woman, for whom the genetic and clinical 
practices of autism did not cohere, being in the genetic research was like being on a 
tightrope.  
To have been a part of this research team is like being on a tight rope. You’re 
on the edge and you don’t know anything more. So sometimes you feel like 
you’re left hanging. OK I do have this gene but what does that mean? … Am I 
a carrier or do I have it [autism]? So it does bring up a lot of questions and it 
would be nice to have some follow up with the family so that you can ask these 
questions. But you are like on a tightrope, like you’re wondering, okay, now 
what does this mean? Where do I go from here?  
 
For this woman, genetic and clinical practices of autism do not cohere. She does not have a 
clinical diagnosis of autism. She does have a variant, NRXN3, which for her son did cohere 
with a clinical practice of autism. For her son, the two practices, laboratory and clinic, 
pointed in the same direction. One came to be understood within and explained by the other. 
Conversely, the lack of coherence between laboratory and clinical practices as they pertain to 
this woman has left her feeling stranded, confused, uncertain about whether or not she has 
autism. 
ii) Feedback Session 
The feedback session can be particularly difficult because here clinical geneticists and 
genetic counsellors have to navigate between different practices of autism. It is in the 
feedback session that attempts are made to try to make the different practices of the clinic, 
lab, and home cohere and connect meaningfully. The feedback sessions that the genetic 
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counsellors reported to be the most difficult were the ones in which the different practices of 
autism did not cohere. For example, when researchers in the laboratory sometimes 
prematurely wrote a research report before the genetic results were classified as clinically 
significant, feedback still had to be given to an individual. The findings of the laboratory did 
not, in these cases, relate to the findings of the clinic. The laboratory report did not indicate 
Class 1 variants but the clinical assessments did produce scores indicating autism. In this 
situation, autism was practiced phenotypically but not genotypically. The genetic tests 
capable of being carried out in Laboratory X were so new, and very few samples have been 
deemed clinically significant thus far. During the time of my field work, the scientists and 
clinicians were still figuring out when and under what circumstances a research report should 
be written. Over the course of a few meetings, it was decided that research reports should 
only be written when findings were clinically significant. In other words, when the various 
practices of autism in the laboratory could be made to relate to the various practices of autism 
in the clinic. When the different practices and enactments of autism did not cohere, the report 
was not supposed to be written and feedback was not supposed to be given to the patient 
family.  
It was assumed that the lack of coherence between the laboratory and clinical 
enactments of autism were consequences of the limitations in the technology. Patient samples 
were kept in storage, immortalized cell lines established, so that as technology progressed 
connections would eventually be made between the various practices of autism. Indeed, there 
were several examples that I observed in which samples that had been collected a decade 
earlier were re-run on current technologies and the laboratory work was able to be connected 
to the work performed in the clinic.  
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7.3e Strategies of Coordination  
i) The Pedigree 
The “pedigree” is a ubiquitous site in which different practices of autism are 
coordinated. Through the pedigree autism is practiced as a genotype and as a phenotype. It is 
practiced as a geographic location and a clinical diagnosis. The construction of the pedigree 
involves families, clinicians and scientists. Below is part of an extended pedigree copied in 
my notes from a Monday morning meeting.  
 
Figure 7.2: A Pedigree 
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Through the pedigree, different practices of autism are brought together and made to cohere. 
This coordination comes at a cost. Much of the detail, the nuances of practicing autism in the 
clinic and laboratory and home are removed, bracketed off from the pedigree. For example, 
in the pedigree clinical practices of autism are reduced to a basic binary opposition. One is 
either on or off the spectrum, a circle or square on a pedigree is either coloured in black or 
left white. The nuances and specific circumstances around which an autism diagnosis is made 
are not part of the autism that is practiced through the pedigree. All of the clinical judgment 
and interpretation of social, cognitive, language information gathered through clinical tests is 
eclipsed from the pedigree.  
 Similarly, all of the actors, activities, translations that form the practices of autism in 
the laboratory are not captured in the pedigree. A gene, perhaps SHANK or NRXN stands in 
for all the other work, all the other actors in the laboratory. The microarray, primers, PCR, 
chromosomes, buffers, robots, sequencers – all of these have been black boxed within a few 
letters printed underneath the circle or square.  
 Likewise, the many of the practices of autism in the home are not found in the 
pedigree. Indeed, the rich, complex daily minutia of getting the right socks on or adhering to 
routines, through which autism is practiced in the home, are absent in the pedigree.  Parents, 
however, are not only involved in reporting the pedigree but are likewise re-made by the 
pedigree. Through the process of making a pedigree, parents who just found out they passed 
down a genetic marker for autism to their child began to reassemble themselves and their 
connection with extended family members around genetics. A new type of kinship is 
constructed and enacted through the pedigree. One of the mothers described in an interview 
her complete shock in learning that her son had inherited a CNV from her. As the genetic 
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counselor delivered the preamble about not having to share any of this new information with 
anyone and how it was her own personal and private information, the woman thought to 
herself, “Why is she telling me all this? This is strange.” She had anticipated that the genetic 
variant would have been inherited through her husband. She said:  
So I was quite surprised and shocked because I thought it was my husband. But 
then when you look back it sort of made sense in some respects because my 
mother. So I said to [the genetic counselor], well you know, my mother’s side, 
my mother’s sister has three children and the oldest boy was very, very 
eccentric…And then my mother’s first cousin has a grandson with autism. So it 
just sort of made sense.  
As the counselor began writing out the connections in the form of a pedigree, collecting 
information on traits and neuropsychiatric diagnoses of extended family members, this 
woman’s kinship ties were reassembled according to another layer of connection. Extended 
family members who were once imagined as quite distant are suddenly transformed as new 
lines of connection tracing phenotypic similarities are re-imagined with the possibility of 
genetic similarity. Rabinow’s (1992) concept of biosociality is a particularly fertile concept 
through which to explore how we will increasingly come to understand ourselves in terms of 
genetics. Silverman (2004; 2008a; 2008b) described this process of biosociality among 
individuals with autism and their family members. In particular, she describes how new 
individual and collective identities formed around genetics were leveraged by a parent 
advocacy group, Cure Autism Now (CAN), in order to change that way in which genomic 
research was being practiced. Frustrated by competitive, rival scientists who would not 
collaborate and share DNA samples, the parents who started CAN used their own new 
genetic identities as parents of children with autism to access and recruit other parents in 
order to create their own gene repository.  
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 Parent knowledge of the quirky traits of extended family members is increasingly 
important and essential in the construction of the pedigree in a condition (ASD) with a broad 
and variable phenotype. As the blurry boundaries of ASD are extending further and further, 
with terms such as the broader autism phenotype (BAP), individuals who do not strictly meet 
the criteria for diagnosis are included in the pedigree.  While these types of pedigrees may 
not show up in peer-reviewed publications, this anecdotal information gathered from parents 
about extended family members was frequently included in the pedigrees exchanged at 
Monday morning meetings. Descriptive traits and anecdotal information are increasingly 
included in pedigrees for ASD, making parents a vital actor in the construction of the 
pedigree. A new liminal type of potential patienthood is being practiced through the making 
of the pedigree – one in which extended family members who do not have a clinical 
diagnosis are reconstructed as interesting cases for the laboratory to explore. The changing 
nature of the patient through genetic testing has been explored further by Kessler (1993). 
Kessler explored how the category of “patient” has been reconfigured through DNA testing 
from something that described an individual to a term applied to the entire family. Abby 
Lippman (1998) coined the term “geneticization”, to indicate a process in which differences 
between individuals are reduced to genetic explanations. Gibbon (2002) has specifically 
explored family trees through the concept of geneticization. According to Novas and Rose 
(2000), advances in science, including genetics, are constructing a new figure of an 
individual “genetically at risk” (2000, p.486).  
 The pedigree has been the discussion of many science studies papers (Armstrong, 
Michie, & Marteau, 1998; Atkinson, Parsons, & Featherstone, 2001; Nukaga & Cambrosio, 
1997; Silverman, 2008). Pedigrees are extremely portable, produced with a pen, paper and 
ruler. It is simple to produce and easily moved from one place to another. Fujimura (1996) 
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has commented that the portability of a tool increases its likelihood of being reproduced in 
other situations. I frequently observed pedigrees being constructed on the back side of journal 
articles or loose paper available in genetic counseling situations. Claudia would often have 
scribbled pedigrees along with her in the files she brought to Monday morning meetings at 
Laboratory X; the pedigrees would be reproduced in PowerPoint presentations in later 
Monday morning meetings and finally would be  published in journal articles. Through the 
pedigree the practices of the laboratory, clinic, and home intersect; the practice of autism as a 
genotype is coordinated with the practice of autism as a phenotype. Nukaga (2002), for 
example, adopted a historical approach in exploring the intersection of laboratory genetics 
and clinical medicine through the pedigree in the specific case of Huntington’s disease. As 
such, the pedigree can be thought of as a coordinating strategy that brings the fluid practices 
of autism into coherence.  
ii) The Published Manuscript  
 One of the primary goals of both the laboratory and the clinic is to publish findings in 
peer-reviewed journals. These publications incorporate many different constructions of 
autism. In the published manuscript connections are drawn between different constructions of 
autism. Columns in tables, for example, lay down genotype and phenotype constructions of 
autism, as well as bringing in new networks that construct autism in terms of brain function. 
Consider a recent article (Berkel et al, 2010) published in Nature Genetics which describes 
the SHANK2 mutation. In this article ASD is described as a “clinically distinct 
neurodevelopmental disorder”; it is also described as having a “complex genetic aetiology”. 
The article describes SHANK2 as a candidate susceptibility gene. This gene is involved in 
the production of proteins that “localize to postsynaptic sites of excitatory synapses in the 
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brain”. The article describes the phenotypic testing using ADOS and ADI assessments, as 
well as the details of the microarray and sequencing performed on cases and controls.  
 A table in this article has eight columns, labelled: Nucleotide Change/ CNV, Amino 
Acid Change, ASD, MR, controls, name, sex of proband, and transmission source. Under the 
third column, ASD, there is either a 0 or a 1 for each of the cases. It is practiced as a binary 
phenomenon, on or off the spectrum.   
 Over lunch one day, I was talking with Ankit about publications. I told him that in my 
discipline, it is really great to publish a paper as a single author, to demonstrate that you can 
work independently. He said that would never happen in science, that it would be rare to see 
a paper with fewer than ten authors in human genetics. This is because so many different 
groups, laboratories, experiments and technologies have to come together in order to produce 
a paper. I probed more about how a paper is produced. He gave me the example a recent 
paper produced in Laboratory X. One of the post docs had presented a poster at a conference 
describing the deletions in SHANK3 that she had found in two ASD cases.  While at the 
conference, a few other people approached the post doc and told her that they too had 
SHANK3 deletions in their samples. So they collaborated and brought their four cases 
together to make a stronger argument for the significance of a SHANK3 deletion in autism. 
There might also be experimental labs involved in the publication. These laboratories might 
do work on understanding, for example, the function of SHANK3, elucidating what it does in 
the brain. They might be working with mouse embryos to identify how a gene is expressed. 
There might also be human cell lines showing where the gene is expressed in human body 
tissue. There are also computational labs involved. These are the people who develop all the 
algorithms used for analyzing data outputs, determining if variants are real or not. Such labs 
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do not have any biological data of their own but instead constantly collaborate with other 
labs. Finally, there are clinicians who provide the phenotypic information used in interpreting 
the molecular biology results. Ankit said, 
This is all done by different people. So the functional work was done by a 
functional lab, and the pedigrees were done by the clinical, like the Autism 
Clinic, and this figure was done in an array facility, the CNV analysis. So we put 
the whole thing together, write a discussion and then get the editors and reviewers 
to buy it. That’s the tricky part.  
Author lists are so long in the area of human genetics because a variety of different people, 
working in very different actor-networks, have to come together in order for the manuscript 
to be produced. The manuscript is a coordinating strategy amongst the various ways of 
constructing autism. 
iii) Hybrid spaces as sites of coordination 
 Hybrid spaces bring together various combinations of clinical, home, and laboratory 
practices. In these hybrid spaces, details, nuances, ambiguity are left aside. One hybrid space, 
for example, was a monthly meeting between laboratory and clinical employees. It was 
primarily a meeting to discuss and prioritize feedback sessions. At one meeting I observed, 
the clinic research coordinator mentioned that the phenotype measure for a particular 
genetics study had been a year in planning and they were still not sure about the exact 
measurements they wanted to include. The laboratory coordinator responded bluntly: “All of 
it is irrelevant to me.” In the laboratory, the details of the clinical practice of autism are not 
important. All the laboratory needs to know is whether or not an individual is on or off the 
spectrum. In hybrid spaces, the nuances of autism are truncated. Here, phenotypic and 
genotypic constructions of autism are brought together; however, in an effort to discuss as 
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many patients as possible in the meeting, the practices of the laboratory and clinic were 
expected to be reduced, black-boxed within this hybrid space.  
Conclusion 
In this chapter I have tried to describe the various ways in which the patient body and 
autism are practiced. Through the different practices of the clinic, laboratory and the home, 
the individual with autism multiplies, and so too does autism. I have described instances in 
which the practices have been brought together through strategies of coordination. In these 
instances some of the practices cohere; they are made to relate to one another. I have also 
described situations in which the various practices of the home, clinic, and laboratory do not 
cohere. In these situations, practices point in different directions, exclude one another. The 
individual with autism multiplies. Autism multiplies.  
Thus far, I have not explicitly explored how these ideas of multiplicity and difference 
relate to knowledge translation. The reader might be asking herself, ‘but how does a 
discussion of the multiply practiced individual with autism relate to knowledge translation’? 
Perhaps the reader is wondering why I have not focused on “knowledge” as it is practiced in 
these various spaces. As such, questions pertaining to the validity of my interpretation may 
be raised at this point. Have I really been describing knowledge? In the following chapter, 
my goal is to convince the reader that I have, in fact, been describing knowledge all along. 
Following actor-network theory, however, knowledge has been de-centred. It has been 
treated as a materially heterogeneous practice. Knowledge is done, with the body; it is 
practiced through patients, assessment tools, pedigrees, classifications, reports, meetings, 
diagnoses, bedtime routines. Following practice theory, embedded within constructionism, 
the “knowledge” that I have been describing does not only inhabit the mind of the subject but 
is also incorporated in material heterogeneous practices. I aim to de-center an overly 
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cognitive construction of knowledge by rejoining knowledge and practice.  As Mol has 
suggested, we can spread the activity of knowing more widely; “Instead of talking about 
subjects knowing objects we may then, as a next step, come to talk about enacting reality in 
practice” (2002, p.50).  
In the particular case of autism genomics, knowledge translation involves 
understanding how the various practices of the laboratory, clinic and home, which may enact 
different realities, are made to relate to one another. Thus, in describing how the individual is 
practiced or how autism is practiced in the laboratory, clinic, and home I am at the same time 
describing a process of knowledge translation. Here, knowledge translation might be better 
understood as an on-going process of ontological translations. It is this particular 
conceptualization of knowledge translation, which is grounded in constructionist theories of 
practice and heavily influenced by actor-network theory that I will explore more fully in 
Chapter 8.  
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Chapter 8: Reassembling Knowledge Translation 
The thesis under consideration is that the products of science are contextually 
specific constructions which bear the mark of the situational contingency and 
interest structure of the process by which they are generated, and which cannot 
be adequately understood without an analysis of their construction. This means 
that what happens in the process of construction is not irrelevant to the products 
we obtain. 
(Knorr-Cetina 1981, pp.5) 
 
 
Throughout this dissertation I have described how knowledge translation can be 
reconceptualized through examples from a particular case study of autism genomics. I 
explored the changes and transformations that occur through the process of translation in 
Chapter 4, as I followed some of the important actors involved in autism genetic testing 
amongst the clinic, laboratory, and family home. In chapter 5, I then unpacked the political 
dimension of the translation process through a framework developed by Callon (1986). 
Chapter 6 highlighted the ontological implications of knowledge translation, illustrating that 
8.1 Reassembling Knowledge Translation 
 a) Conceptualizing KT – What is being translated? 
8.2 KT according to the CIHR 
 a) Discussion of the KTA cycle 
8.3 Time for a new Conceptualization of KT? 
a) On the nature of knowledge: constructing reality through knowledge    
practices 
b) Local Translations of Knowledge in Practice (LTKP) Framework 
c) The LTKP Model 
8.4 Comparing the KTA and LTKP frameworks 
a) Implications 
8.5 Conclusion 
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it is not only knowledge that is being translated but also constructions of reality.  In this 
chapter, I take these insights laid out in previous chapters and apply them to a more general 
discussion of knowledge translation.  
8.1. Reassembling Knowledge Translation 
The KT literature addresses the “research to practice” gap, with the goal of “moving 
evidence into practice” (Lang, Wyer, & Hanes, 2007).  A burgeoning literature has 
developed to explore the process (D. Davis et al., 2003b; Davison, 2009) and evaluate the 
outcomes of KT initiatives (Danseco et al., 2009; Bhattacharyya & Zwarenstein, 2009). 
Knowledge translation (KT) has become an important concept in the Canadian health 
research environment (Straus, Tetroe, & Graham, 2009). In this chapter, I will outline how 
knowledge translation is typically described in the Canadian health sciences literature. After 
this general discussion of KT, I then focus on knowledge translation as it is described by the 
Canadian Institutes of Health Research (CIHR) through the Knowledge to Action (KTA) 
model (I. Graham et al., 2006). I then juxtapose this CIHR understanding of KT with a 
description of knowledge translation that emerges from my interpretation of the work going 
on in the autism genetics study. I introduce an alternative description and framework for KT 
that is based on a constructionist, post-humanist epistemology and strongly influenced by 
actor-network theory. Finally, I compare the CIHR model with the framework I have 
developed and explore ways in which they might complement each other as well as the 
places where they disrupt and conflict with each other.  
8.1a Conceptualizing Knowledge Translation – What is being 
translated? 
There are several frameworks or theories in the KT literature that unpack the idea of 
knowledge translation in slightly different ways. For example, the diffusion of innovations 
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theory (Rogers, 1962)  highlights the spread of ideas and innovations and how the uptake or 
use of knowledge differs depending on the user’s needs. Elsewhere, the push-pull framework 
(Curry, 2000; Landry, Lamari, & Amara, 2007) proposes that knowledge is translated 
according to push factors on the supply side by knowledge producers as well as pull factors 
on the demand side by knowledge users. Lavis et al’s (Lavis et al., 2003) five-point 
framework for KT highlights: the message, the target audience, the messenger, the 
knowledge translation process and support and evaluation. Tugwell et al (Tugwell, Robinson, 
Grimshaw, & Santesso, 2006) have put forward a framework that explicitly forefronts health 
equity, with an emphasis on identifying barriers and facilitators to KT, choosing 
interventions to address the barriers, evaluation, and facilitating knowledge sharing.   
Meanwhile, the CIHR framework for knowledge translation highlights an iterative cycle between 
knowledge producers and users (Canadian Institutes of Health Research, 2004). Finally, the two-
communities theory (Bowen, Martens, & Need to Know Team, 2005; Canadian Institutes of 
Health Research, 2004; Caplan, 1979) emphasizes cultural differences between researchers 
and decision makers. This idea is described in the CIHR Knowledge Translation Strategy 
2004-2009 (2004, p.4) suggesting that the difficulty in moving research into practice could 
be due to the “two-communities” problem, in which “researchers and policy makers inhabit 
different worlds with different language and culture”.  
Within the KT literature, some writers have made the distinction between tacit and 
explicit knowledge (Kothari, Bickford, Edwards, Dobbins, & Meyer, 2011; McWilliams, 
2007; Nonaka & Noboru, 1998; Straus et al., 2009). McWilliams (2007), captured the 
complexities involved in integrating new knowledge into tacitly-held understandings and 
beliefs, emphasizing the role of transformative learning and reflective practice in addressing 
the social and cultural dimensions of KT. Greenhaalgh and Russel (T. Greenhalgh & Russell, 
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2006) conceptualized knowledge in KT as being socially shared and tacit. Tacit knowledge is 
“non-verbalized, intuitive, and unarticulated” (T. Greenhalgh & Russell, 2006; Polanyi, 
1966). Explicit knowledge can be articulated in formal language, codified, and is more easily 
transmitted amongst people (Collins, 2010).  Nonaka and Noboru (Nonaka & Noboru, 1998) 
likened the idea of tacit knowledge to the Japanese concept of ba.  Ba, can be thought of as 
“a shared space for emerging relationships…a context which harbors meaning” (1998, p.40). 
According to Nonaka and Noboru, knowledge resides in ba; however, when separated from 
ba knowledge turns into information. Elsewhere, in the context of knowledge management, 
Alavi and Leidner (2001) have compared knowledge as a state of mind, an object, a process, 
a condition of having access to information, and a capability. Each way of conceptualizing 
knowledge has implications for how translation is imagined.  
While KT research tends to focus on research knowledge (Collins, 2010; D. Davis et 
al., 2003a; Grimshaw, Santesso, Cumpston, Mayhew, & McGowan, 2006; Lavis et al., 2003; 
Lavis, 2006), the question of what constitutes knowledge and evidence is beginning to be 
explored (Estabrooks, 1999)  leading to calls for more theory-driven approaches to KT (R. 
Greenhalgh et al., 2004; McWilliams, 2007). For example, Estabrooks (1999) problematized 
the emphasis on research knowledge as evidence in KT, drawing attention to the many types 
and sources of knowledge that are used in nursing practice. Weiss (1979) critically addressed 
the various uses of research (problem solving, tactical, political, etc), indicating that the 
practice-based goals or intended outcomes for knowledge use might be other than those 
anticipated by researchers. Greenhalgh et al (2004, p.615-616) have called for a much 
broader conceptualization of KT, arguing that it should be "theory-driven, process rather than 
‘package’ oriented, ecological, address common definitions, measures, and tools, be 
collaborative and coordinated, multidisciplinary and multi method, meticulously detailed, 
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and participatory.” Drawing on concepts in continuing education, McWilliams (2007) has 
also called for more theory-based strategies in KT.   
One of the central concerns that has been repeatedly pointed out in various KT 
publications is the issue of context (Jacobson, Butterill, & Goering, 2003; Reimer Kirkham, 
Baumbusch, Schultz, & Anderson, 2007).   Recent models of KT have explicitly considered 
local contextual factors that can impede the objectives of knowledge uptake (Kitson, Harvey, 
& McCormack, 1998; Logan & Graham, 1998; McCormack et al., 2002; Rycroft-Malone et 
al., 2004). For example Dobrow et al (2006) questioned whether the same evidence should 
lead to the same decisions in different contexts. Using a multiple case study design within a 
policy-making context, they found that resource constraints, political interests, and varying 
skills and abilities to use decision-support tools were some of the factors leading to different 
interpretations and utilization of available evidence. The authors pointed out that while 
hierarchies of evidence are useful tools when interpreting the quality of effectiveness for 
interventions, as we shift toward an examination of appropriateness of interventions these 
same hierarchies might not be as useful. The authors proposed a model that acknowledge 
three different objectives for using evidence (effectiveness, appropriateness, and 
implementation issues) alongside three stages of evidence utilization (identification, 
interpretation, and application).  
Kothari and Armstrong (2011) recently emphasized the need for local information 
with contextual relevance in community-based knowledge translation. These authors 
acknowledge that local information is often criticized for not being related to the broader 
literature or mapping well onto “evidence hierarchies”. However, they suggest, a preference 
for local information may be based on epistemological differences. These authors call for a 
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broader conceptualization of evidence and state that “there are health service delivery 
systems for which traditional ways of approaching KT are insufficient” (2011, p.e5). 
Thus, a more complex conceptualization of the process of KT is starting to be captured in 
this body of literature. Fox's description of practice-based evidence, "re-privileges the role of 
the practitioner in generating useful knowledge" (Fox, 2003, p.82). Fox explored the role of 
criteria such as internal and external validity in producing exclusionary definitions of 
evidence and consequently setting up a binary dualism, constructing "practice as an 
irrational other" to research. Within a post-structuralist and action-research-oriented 
approach, Fox challenged this research-practice opposition by positioning research within 
practice, adopting a perspective that knowledge is local and contingent.  Thus, for Fox 
(2003), research and evidence should be both produced and used within practice.  
8.2. Knowledge Translation According to the CIHR 
The Canadian Institutes of Health Research (CIHR) is the major funding agency in 
Canada for health-related research. It was created in 2001 under an Act of Parliament 
(http://laws-lois.justice.gc.ca/eng/acts/c-18.1/index.html). The CIHR consists of 13 institutes 
which together shape Canada’s health research agenda. The CIHR funds four types of 
research or “pillars” as they are called by the CIHR: clinical; biomedical; health systems and 
services; and population and public health. Recent changes to the mandate of another tri-
counsel agency, the Social Sciences and Humanities Research Counsel (SSHRC), have 
streamlined funding opportunities, forcing all social science and humanities research that is 
related to health to be funded by the CIHR (J. Graham et al., February 7, 2011). The CIHR, 
by mandating a knowledge translation component in each of its funded projects, has 
popularized a particular conceptualization of KT for Canadian health researchers. The 
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rationale for this keen interest in knowledge translation is given by CIHR as two fold: first, 
the creation of new knowledge does not automatically lead to widespread adoption or health 
impact, and second, the CIHR cites that it needs to be accountable for the tax dollars invested 
in health research and wants to increase the benefits of this investment by moving research 
into practice (www.cihr-irsc.gc.ca/e/33747.html). According to the CIHR, knowledge 
translation is defined as: 
…a dynamic and iterative process that includes synthesis, dissemination, exchange 
and ethically-sound application of knowledge to improve the health of Canadians, 
provide more effective health services and products and strengthen the health care 
system (Straus et al., 2009). 
According to Tetroe (2007, p.2) knowledge translation is a broad concept that “encompasses 
all steps between the creation of new knowledge and its application to yield beneficial 
outcomes for society”. Reading through the CIHR documents and publications, it is quickly 
clear that the word knowledge has a very specific meaning and is confined to a particular 
type of knowledge, namely knowledge acquired through research. Graham et al (2006) 
described the confusion and inconsistency in terms related to the concept of knowledge 
translation used in health research and health services. The authors then put forward the idea 
of the knowledge to action (KTA) process, which they identify as having 2 components: 
knowledge creation and action. Their KTA model involves two sets of individuals: 
knowledge producers-researchers and knowledge implementers-users.  
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Figure 8.1: The CIHR’s KTA Process 
 
As stated above, the KTA process consists of a knowledge creation component as well as an 
action component. According to Graham and co-authors (2006, p.18), the knowledge 
creation component is best illustrated by a funnel, which the authors describe as follows: 
As knowledge moves through the funnel, it becomes more distilled and refined 
and presumably more useful to stakeholders. Another analogy would be to think 
of the research being sifted through filters at each phase so that, in the end, only 
the most valid and useful knowledge is left (Graham et al, 2006, p.18). 
 
The funnel begins with knowledge inquiry. This knowledge is described by the authors as 
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comprised of the “unmanageable multitude of primary studies or information of variable 
quality that is out there”. The authors describe this as “first-generation knowledge that is in its 
natural state and largely unrefined, like diamonds in the rough” (Graham et al 2006, p.18). In 
order to make sense of all of this “first generation” knowledge, the second stage, knowledge 
synthesis involves systematic reviews to appraise all the knowledge out there. Finally, the 
most refined section of the funnel consists of knowledge tools or products, such as practice 
guidelines, decision aides, and care pathways. These tools are intended to present knowledge 
in clear concise and user-friendly formats “thereby facilitating the uptake and application of 
knowledge” (2006, p.19). This then, the tools, are the end result of the knowledge creation 
process. According to the KTA model it is practice guidelines, decision aides and care 
pathways that are the objects of translation. These tools are what count as knowledge and what 
ought to be applied in the second part of the KTA process, the Action Cycle. 
The second component of the KTA process is what Graham and co-authors call the 
Action Cycle, which “represents the activities that may be needed for knowledge 
application” (Graham et al, 2006, p.20). This action phase is modeled after planned-action 
theories which deliberately engineer change in groups. Lomas (Lomas, Sisk, & Stocking, 
1993) for example, is often sited for his differentiation between dissemination (tailoring a 
message for a particular audience), diffusion (a more passive process such as a journal 
publication), and implementation (planned efforts to encourage adoption). Graham et al 
(2006) suggest the following as being integral to a planned action approach: 
Identify a problem that needs addressing; identify, review, and select the knowledge 
or research relevant to the problem (e.g., practice guidelines or research findings); 
adapt the identified knowledge or research to the local context; assess barriers to 
using the knowledge; select, tailor, and implement interventions to promote the use 
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of knowledge (i.e., implement the change); monitor knowledge use; evaluate the 
outcomes of using the knowledge; sustain ongoing knowledge use’’ (Graham et al, 
2006, p.20). 
The authors are clear that “generic knowledge is seldom taken directly off the shelf and 
applied without some sort of vetting or tailoring to the local context”. Graham et al (2006) 
also describe various types of knowledge use. Conceptual use describes changes in 
understanding or attitudes. Instrumental use describes changes in behaviour or practice. 
Finally, strategic use is described by the authors as the manipulation of knowledge “to attain 
specific power or profit goals” 
8.2a Discussion of the KTA cycle as proposed by the CIHR 
The KTA cycle developed by Graham et al (2006), widely promoted by the CIHR, is a 
model of knowledge translation that is exclusively focused on widespread adoption of 
research knowledge. It describes a large-scale, deliberate and planned attempt to move 
research knowledge into practice. Furthermore, this model describes a process in which the 
objects of translation are the distilled tools that culminate at the end of a research funnel. The 
KTA model of translation put forward by the CIHR, however, excludes certain types of 
research translation. For example, Graham et al 2006 stated:  
Translational research (the transfer of basic science discoveries into clinical 
applications) does not fall under our conceptualization of KTA because 
translational research falls short of widespread adoption (Graham et al 2006, p.18).  
 
In a related article, Tetroe further explained: 
 
Translational research is about finding solutions to clinical problems. Ideally it 
involves two-way interactions between basic/fundamental scientists and clinicians 
and requires moving between scientific discoveries and clinical applications. 
Translational research stops short of widespread dissemination of the clinical 
application once it has been proved beneficial by clinical research (2007, p.2). 
 
The KTA model, then, describes a process that is removed from the local practices and 
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places in which knowledge is actually produced. There are many types of interactions and 
activities that are not captured in the KTA model of knowledge translation. For example, the 
on-going, day-to-day local interactions and meetings in which research is discussed between 
different groups of scientists, clinicians, and families are not captured in this model.  
 Embedded within the “knowledge creation funnel” are some of the assumptions on 
which the KTA model rests, assumptions about what constitutes knowledge, how this 
knowledge is created and by whom. For example, in the KTA model the knowledge that is 
created at the end of the funnel are tools and products. One of the limitations of the KTA 
model which explores only distilled tools that have been tailored through the knowledge 
creation funnel is that we loose appreciation for the underlying contexts in which research 
knowledge is first produced. When we zoom in and examine the local conditions of knowledge 
production, we are better able to pay attention to the assumptions, values, and cultures of the 
groups of people who produce knowledge. These assumptions, values and cultures are not 
necessarily lost when knowledge is distilled down to tools. They are, perhaps, embedded 
within the tools.  
However, the KTA model does not capture this context of knowledge production. The 
KTA model considers the cultural and contextual factors that might impede widespread 
adoption of knowledge by users but it is limited to exploring the culture and context of 
knowledge users themselves, not the culture and context of knowledge production. Since this 
model only begins after the research has already been published, how could it be otherwise? 
By the time tools and products are tailored it would be very difficult to trace them back and 
uncover the original contexts and cultures in which the research was conducted upon which 
the tools are based.  
The KTA model brackets off the work that occurs during the production of knowledge 
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prior to publication from a discussion of knowledge translation. The conditions of knowledge 
production are exempt from scrutiny and examination in the KTA model. In a positivist 
epistemology, scientific knowledge mirrors nature or reality. Positivist science is not supposed 
to have values or assumption, biases or culture. From a positivist perspective, the conditions of 
knowledge production are irrelevant when considering cultural barriers to knowledge adoption 
because the knowledge itself is assumed to be culture-free. 
There is a second, related, concern that I have about the KTA model and the notion of 
KT that is promoted by the CIHR. In the KTA model, knowledge is assumed to be something 
that is separate from the contexts in which it was produced. It can be severed off from the 
laboratories and clinics, captured in a journal article, distilled, funneled and tailored into tools 
and products, all the while never losing its shape, its essence, its relation to nature.  From an 
actor-network theory perspective, however, knowledge cannot be extricated from the 
network of humans and non-humans that constructed it, at least not without changing. To be 
fair, an iterative and on-going quality to knowledge translation is captured in the KTA model. 
The arrows move around in a circle, the cycle is repeated indefinitely. What is lost, however, 
is an understanding of how the knowledge has changed as it has moved out of the contexts of 
production and down through the Knowledge Creation Funnel. How is knowledge 
synthesized and tailored? According to what values and assumptions? What new networks of 
human and non-human actors does the knowledge become a part?  
8.3. Time for a New Conceptualization of KT? 
While the KTA cycle might accurately describe some of the activities that took place in 
the settings in which I conducted my research, much more is going on that is not being 
captured in this KTA model. All models have limitations and no single model could possibly 
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hope to describe all contexts and situations in which one might consider KT. Limitations are 
inevitable and this is not a criticism of the KTA model or of the CIHR definition of KT. 
Unlike the KTA model, I propose that the local conditions in which knowledge is created are 
important to the discussion of KT. In the KTA model the “doing” of science in the first place 
is left untouched, unexamined. The KTA model starts with an “unmanageable multitude” of 
peer-reviewed journal articles. All of the work and collaborations that lie behind these primary 
studies is precluded from this model of KT.  In other words, the KTA model begins where my 
research ends. According to the KTA model, translation happens after knowledge has been 
created. While my research suggests that knowledge translation is occurring long before 
research results are reported in journals.  
The recent calls for theory-driven conceptualizations of knowledge translation and the 
fervent attention being paid to the concept of “context” are an entryway for a constructionist, 
post-humanist description and framework of KT that I will put forward in this chapter, based 
on my research in autism genomics and influenced by actor-network theory and theories of 
practice. Knowledge translation is enacted very differently when approached through a 
language of difference, multiplicity, non-coherence and partial connections. Approaching the 
notion of knowledge translation through actor-network theory (ANT) raises questions about 
some of the assumptions typically made in the KT literature.  Specifically, ANT affords the 
opportunity to forefront a different set of actors, events, and practices than those that are 
typically acknowledged and explored in KT.  Through ANT and constructionism, I aim to 
explore the softer underbelly of KT, in which knowledge is not confined to the cold, hard 
facts residing at the top of evidence hierarchies.  Instead knowledge is viewed as 
transforming and changing through the process of translation.  
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ANT brings attention to the non-human actors (the material world) as central to a 
discussion of translation. It also includes and focuses squarely on the networks of knowledge 
production as integral to (and not separate from) the process of knowledge translation. As 
Armstrong et al (R. Armstrong, Waters, Roberts, Oliver, & Popay, 2006) have commented, 
most models of knowledge translation “have generally been used to explore links between 
researchers and end-users rather than those involved in the generation of knowledge” (2006, 
pp 384). Conversely, my research has attempted to explore the local contexts of knowledge 
production and the day-to-day translations amongst laboratories, clinics, and families of 
individuals with autism.  
8.3a On the Nature of Knowledge: Constructing Reality through 
Knowledge Practices  
In this thesis, I have tried to illustrate how knowledge might be conceptualized as 
much broader and more diffuse than it is typically represented in the scientific literature. In 
particular, knowledge is not detached or separate from the actors bound together in the 
networks that create knowledge. Knowledge is not something that lives in the mind, apart 
from the physical world.  Instead, I adopt a philosophical position in which knowledge is 
practiced in the material world. The Cartesian split between mind and body is side-stepped 
by focusing on how knowledge is continuously constructed, through interacting hands, tools, 
bodies, machines. From this position, knowledge is not exclusively relegated to the mind; it 
is performed and enacted through the body and through heterogeneous material objects in the 
physical world. Following this, I propose that the science of knowledge translation should 
consider the broader ontological implications of the KT endeavour.  
Constructionism assumes that knowledge is not a perfect mirror of nature. From this 
standpoint, the scientists in the laboratories and clinician-scientists in the clinics are not merely 
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discovering nature, already there. They are actively participating in constructing and shaping 
nature, and in turn being constructed by it. Latour views constructivism as the only way to 
bypass the dichotomy between an unconstructed world that is "already there" and a world 
made purely of subjective value claims (Latour, 2005). Starting from a constructionist 
position, then, considering the conditions of knowledge production is very important in a 
discussion of knowledge translation. When considering obstacles to widespread adoption, a 
constructionist model might scrutinize not only the cultures of “so-called” potential knowledge 
users but also the cultural contexts of knowledge producers. A constructionist model might be 
better able to understand the conflicts and places of non-coherence that might arise between 
the practices of knowledge production upon which tools and products are derived and the 
practices of knowledge users.  
Following from a notion of knowledge that is practiced in the material world, 
translation could be conceptualized as a process of ontological politics (Mol, 2003), as actors 
(e.g., researcher, stakeholders) vie to become obligatory passage points, constructing through 
practice what counts as real. This conceptualization of KT is informed by Callon’s (1986) 
framework which considered four moments of translation: problematization, interessement, 
enrolment, and mobilization. Another way of approaching translation, however, is to follow 
the work of Mol (2003) and Law (2000; 2012). These authors emphasize multiplicity and 
coordination. From this perspective knowledge translation may be conceptualized as finding 
windows of partial connection among networks of knowledge practices interacting with one 
another. Translation might only require that connections are made between networks, that 
actors might be simultaneously enrolled in several networks at once. Each of these 
conceptualizations of the translation process allows us to redirect our focus, de-centering the 
object of translation, and attend to the complex connections and associations through which 
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the reality of an object is constructed and reconstructed. 
8.3b Local Translations of Knowledge in Practice (LTKP) Framework 
Drawing on theories of practice, a methodology of actor-network theory and based in 
a constructionist epistemological position, I propose a new framework for exploring 
knowledge translation. This framework is called the Local Translations of Knowledge in 
Practice (LTKP). Underpinning this new framework for KT are five key ideas. First, 
knowledge is intricately tied to the networks of human and non-human actors within which 
knowledge is constructed. Knowledge is considered an on-going activity, a process, which is 
constantly enacted or practiced. Perhaps it would be more useful to think of knowledge not as 
a noun (a thing) but rather to think about knowing, a verb (an action). As this 
conceptualization of knowledge relates to KT, it would probably be more accurate to 
describe this as “knowing translation” rather than knowledge translation. From an ANT 
perspective, understanding the process of knowledge translation depends on one’s ability to 
unpack and “de-centre” knowledge. In many ways the framework I am putting forward 
considers knowledge in the opposite way as the KTA model. Where the KTA model seeks to 
distil and refine knowledge into a tangible applied tool or product, the LTKP framework 
seeks to trace the expansive, heterogeneous practices which together shape a particular way 
of knowing. Knowledge, here, is a much more diffuse concept and not as easily bounded as 
the distilled tools and products described in the KTA model. In the KTA model, knowledge 
is objectified; through the distillation of the knowledge funnel it becomes reified in an object 
(e.g., a practice guideline or care pathway), separated from the practices in which it was 
constructed. In my constructionist description of KT, knowledge is not understood as an 
ontologically stable object but rather as a materially-heterogeneous practice.    
Secondly, in the LTKP framework, translation is conceptualized as the fluid 
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movement and associations of human and non-human actors between and amongst networks. 
It is an on-going affair and is never completed. Translation implies change and 
transformation. Stability is not an inevitable quality of that which is being translated. For 
example, in Neylands (2006) work on a university strategy for managing information, the 
movement of information is conceptualized as “a series of sociotechnical connections, each 
connection forming an opportunity to confirm the continuity of information usage or to 
reconstruct the usage and, thereby, the information itself” (2006, p.35). Any addition or 
subtraction of an actor (human or nonhuman) in a network changes the network and all the 
actors involved. Actors exist in practice as they relate to one another.  As new humans and 
non-humans enter or leave a network the relationships between the remaining actors change.  
Thirdly, in the LTKP framework, both human and non-human actors are integral to 
the enactment of KT. In any effort to describe and examine the KT process, one must 
consider a wide range of heterogeneous materials involved. In the ANT literature this is often 
referred to as agnosticism – remaining open to whom or what is doing the acting (Callon 
1986). We can not assume that non-humans are passive in the KT process. Instead, non-
human actors are acknowledged to play an active role in shaping how knowledge is 
constructed and in how knowledge changes as it moves amongst various networks.  
Fourthly, in the LTKP framework the knowledge translation process can be 
approached as an inherently political process.  Translation involves a process of 
problematization and enrolment of actors, with certain actors vying to be the spokesperson, 
attempting to mobilize a host of silent actors behind them. The stability of a network, 
however, is always in question. A network can always fail. Over time, some networks 
manage to maintain stability better than others.  
Fifthly, actors may belong to more than one network and as such they may be 
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practiced in relation to different sets of actors. An example from my research would be an 
individual diagnosed with autism. Such an individual exists in a clinical network, a 
laboratory network and a home network (as well as others). In each of these networks, “the 
individual with autism” is enacted or practiced in relation to a different set of actors. As such, 
the individual with autism changes as he/she moves amongst networks. Thus, any actor (in 
this example an individual with autism) cannot be assumed to be a single unified 
phenomenon. Indeed, the very process of translation (moving between networks) often 
results in multiplicity. This is not an opening into a fragmented and incommensurable post-
modern world. Instead, translation is the key to maintaining connections, points of coherence 
amongst multiple ways of enacting the world.  
Multiplicity, here, might be related to the literature on boundary objects (Star & 
Griesemer, 1989), in which a single object is recognized by two different groups but retains 
an idiosyncratic meaning within either group. Polzer & Robertson (2010) for example, have 
explored the genetic pedigree as a boundary object between clinic and patient family. The 
loosely recognized object enables and facilitates a point of connection and a conduit through 
which members of different groups might interact.  
 With each of these ideas in mind, I have constructed a framework to illustrate how 
KT might be considered from a constructionist, actor-network theory perspective. To be sure, 
there are many different ways one could imagine the KT process and this framework is in no 
way meant to replace or supplant any other KT model in the literature. One of the main 
reasons for constructing this framework is to demonstrate that the epistemological 
assumptions one holds deeply influence a discussion of knowledge translation. So far, in the 
field of health research in Canada, this discussion has been overwhelmingly situated within 
positivism. Thus, I have attempted to examine knowledge translation from another 
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philosophical standpoint and in so doing I hope to open up new possibilities for 
understanding the KT process.  
This framework highlights five key components of a constructionist, ANT-informed 
understanding of knowledge translation: (i) networks; (ii) human actors; (iii) non-human 
actors; (iv) multiplicity, and (v) strategies of coordination. These five components are also 
embedded within a political process of translation involving problematization, interessment, 
enrolment, and mobilization.   Below, I will consider each of these components in turn. 
Appendix B illustrates how this framework might be modeled in the case of autism genomics 
and Appendix C illustrates a more generalized model of the LTKP framework. 
(i) Networks 
In Appendix C, there happens to be three networks being examined as they relate to 
autism genomics: the laboratory, the clinic, and the family. These networks are each depicted 
by a circle circumscribed by a dashed line. The dashed line indicates the permeability of the 
network, as human and non-human actors enter and leave a network over time. The 
boundaries of a network can always change. The notion of the network is central to the 
LTKP framework for understanding KT, as knowledge is not viewed as a black-boxed object 
but rather as a complex practice that exists in the associations between and among actors 
within a network. Each network, with its distinct constellation of actors, practices knowledge 
in a particular way.  A focus on the networks of associations amongst actors involved in 
knowledge translation helps to ensure that knowledge is not reified as a single, stable object. 
While I have considered three networks in this research, there are, of course, a multitude of 
other networks that could be considered (e.g., a child’s school network, an autism support 
group network, etc.). One of the effects of conceptualizing KT through an ANT approach is 
that one becomes aware of the limitations of one’s understanding. One could not presume to 
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have explored all the networks that affect a particular local context of KT.  This model 
cannot determine how or where a researcher ought to “cut the networks”. The inclusion or 
exclusion of various networks would presumably be informed by the specific, local, context 
in which KT is being explored.  There are also pragmatic and logistical considerations to be 
taken into account (e.g., funding, time, the jurisdiction of ethics review boards, etc.) when 
deciding how extended one’s exploration will be.  
(ii) Human Actors 
 An important component of this framework of KT is to include all of the relevant 
human actors within the networks. It is important not to assume too quickly who is and who 
is not involved in the KT process. For example, when I first began my fieldwork a young 
post-doctoral fellow approached me and stated that she would be happy to participate in my 
study but that she felt her work would probably seem really boring and all she did was fiddle 
about in the lab. She wasn’t sure if or how her role would be relevant but she was willing to 
let me observe and talk with her. A project manager who happened to be listening to my 
interaction with the post-doc stated, after the post-doc had left the room, “You won’t want to 
talk with her for your study. She doesn’t talk to anyone. She wouldn’t be relevant to 
knowledge translation”. In the end, I found this post-doc was actually an extremely important 
actor in the KT process. She was intimately involved in the production of genetic information 
and in tweaking the quality control processes which helped to filter out the real and true 
variants from experimental artifacts. The project manager was correct that this post-doc was 
not involved in directly translating genetic knowledge with clinicians through meetings or 
research reports. She was however, deeply important to the production of the knowledge that 
was later translated with clinicians and patient families. From a constructionist perspective of 
KT, this post-doc was an important actor because the contexts and practices of knowledge 
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production are part of a constructionist description of knowledge translation. The knowledge 
itself cannot be considered in isolation from the human actors, such as this post-doc, who 
shape the knowledge into being. 
(iii) Non-Human Actors 
 While human actors are considered in the KTA model (although, not the humans who 
produce knowledge before it is funneled down), non-human actors are perhaps less explicitly 
acknowledged. In my model, along with humans, non-human actors are recognized as 
important throughout knowledge production and translation. Knowledge is practiced in 
relationship with a variety of non-human actors within any network. If you take away the 
non-human actors, the knowledge could not be the same. For example, if there were no 
microarray chips, no pipettes, no PCR, no tubes, no research reports, no ovens or centrifuges 
– if any of these non-human actors were to be excluded in the network of the laboratory – the 
genetic knowledge being translated amongst the laboratory, clinic and homes would not be 
the same.  Likewise, if you took away the ADOS, ADI-R, intelligence testing scores, patient 
file or consent forms – if any of these non-human actors were to be removed from the clinic 
network – the genetic knowledge translated amongst laboratory, clinic, and home would not 
be the same. In a constructionist, ANT-informed understanding of knowledge translation, 
non-human actors must be described.  
(iv) Multiplicity 
Multiplicity is another idea important to my constructionist understanding of KT. By 
exploring multiplicity, one is able to understand how an object that is typically considered to 
be a unified, taken-for-granted phenomenon is practiced or enacted differently in different 
networks. Paying attention to multiplicity forefronts the ways in which a phenomenon might 
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be practiced in different ways and thus attempts to prevent any single definition or practice of 
a phenomenon from obfuscating other ways of practicing or defining that phenomenon. In 
Appendix C, I have used the individual diagnosed with autism to illustrate this notion of 
multiplicity. The individual with autism is an integral actor in each of the three networks but 
the ways in which the individual with autism is constructed in relation to the human and non-
human actors in each network is profoundly different.  From a constructionist perspective, 
this recognition of multiplicity allows one to explore the different, sometimes conflicting, 
practices amongst (and even within) networks. Multiplicity allows us to understand how an 
actor is practiced within local contexts, and how an actor changes as it is practiced in relation 
to different sets of actors in different networks.  
(v) Strategies of Coordination 
If multiplicity illustrates how an object can be enacted differently in different 
networks, then strategies of coordination describe the spaces in which differences are made 
to cohere and to relate to one another (Law, 2000).  In addition to describing the differences 
and non-coherence amongst various networks, this model also explores the sites at which 
practices are temporarily coordinated. These strategies of coordination are integral to the 
knowledge translation process, linking the practices of one network with the practices of 
another network. Opportunities which bring actors from various networks together might be 
called hybrid spaces. For example, in my fieldwork the regular Monday morning meetings 
brought laboratory and clinical actors together. Meanwhile the feedback session brought 
clinical and family home actors together. Strategies of coordination often emerge out of these 
hybrid spaces. For example, the pedigree is constructed in the feedback session and 
reconstructed through Monday morning meetings. Related to hybrid spaces and strategies of 
coordination is the notion of the boundary object. Boundary objects may be a key idea for 
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coordination, as highly idiosyncratic practices in local contexts might only need to be loosely 
or partially enacted in hybrid spaces or sites of coordination, such as the pedigree. Boundary 
objects enable partial translations of multiply practiced phenomena. Through strategies of 
coordination that often emerge through hybrid spaces, a phenomenon is practiced as “more 
than one but less than many” (Mol, 2002).  
Each of these five components of the LTKP framework can be viewed as embedded 
within a political process of translation (Callon 1986). The networks described are involved 
in an ongoing negotiation of problematization, interessement, enrolment, and mobilization 
(as described in Chapter 5). Callon’s (1986) framework allows us to connect the local, day-
to-day micro dynamics of translation amongst a few networks to a range of expanding 
networks. For example, in the case of autism genomics, problematization of autism as 
something that needed to be “cured” was contested by some participants in the clinical 
network. These participants were also active in other networks, such as those associated with 
disability rights. Thus, these participants worried about their ongoing enrolment as actors in 
the laboratory network. This example of contested problematization illustrates that actors are 
multiply positioned in other networks and as such there is a fluidity and instability to the 
translation process. Thus, Callon’s framework highlights an element of uncertainty and 
ongoing flux in the associations of actors.  
8.3b The LTKP Model 
In Appendix D the Local Translations of Knowledge in Practice framework is 
illustrated in a general model. Each of the five components within the LTKP framework is 
highlighted in the model. Networks are depicted as circles circumscribed by dashed lines; 
human actors are illustrated with a face symbol; non-human actors are represented with 
yellow triangles. Meanwhile, I have tried to demonstrate the concept of multiplicity with a 
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star shape. As the star moves amongst the networks the colour changes. With this changing 
of colours I am illustrating how we cannot assume that an actor remains the same as it 
traverses various networks and is practiced in relation to different human and non-human 
actors. Finally, the explosion symbol represents strategies of coordination which indicate 
sites in which actors and practices from various networks are combined. For example, the 
pedigree combines practices derived from the family, the clinic, and the laboratory. Hybrid 
spaces, such as Monday morning meetings and feedback sessions are integral spaces that 
bring actors together so that strategies of coordination can occur.  
8.4. Comparing the KTA and LTKP Frameworks 
 There are several differences in the CIHR’s KTA model and the framework and 
model I have proposed. Table 1, compares these models in respect to their conceptualization 
of knowledge, conceptualization of translation, intended purpose, methodological 
underpinnings, and epistemological and theoretical underpinnings.  
Table 8.1: Comparison of the KTA model and LTKP framework 
 Knowledge-to-Action 
(KTA) 
Local Translations of 
Knowledge in Practice 
(LTKP) 
Conceptualization of 
Knowledge - What is 
translated? 
Distilled and tailored 
products and tools; reified 
objects 
Less tangible, materially 
heterogeneous practices; 
ontologically fluid 
Conceptualization of 
Translation Process 
Occurs after knowledge has 
been distilled; iterative 
cycle between producers 
and users of knowledge 
Process in which 
associations among human 
and non-human actors are 
reassembled in a new 
network; implies change 
Intended Purpose Prescriptive; directive; 
widespread adoption of 
knowledge 
Descriptive exploration of 
local translations in 
everyday practice 
Methodological 
Underpinnings 
Quasi-experimental 
research; survey research 
Actor-Network Theory; 
Ethnography 
Theoretical and 
Epistemological 
Underpinnings 
Planned Action Theories; 
Cognitive Psychology 
Theories of Change; 
Practice Theory; 
Constructionism/ 
Interpretivism 
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Objectivism/ Positivism 
 
Conceptualization of Knowledge 
First, the KTA model and LTKP framework differ in what they considered to be the object of 
translation, particularly in how knowledge is conceptualized. In the KTA model knowledge is 
distilled and tailored into products and tools through a funnel. The knowledge that is 
translated consists of these tools and products. In the KTA model knowledge is bound within 
an object, a best practice guideline for example.  In my framework, knowledge is diffuse and 
less tangible. Knowledge is a practice. Again, it would be more useful to think of the verb 
knowing (an action that is engaged in) rather than the noun knowledge (a thing that one can 
possess).  The LTKP model attempts to describe the processes of translation between 
different ways of knowing in practice. The KTA model explores how a reified piece of 
knowledge, a tool or product, is translated. The object of translation in each of these models 
is derived from very different epistemological starting points. While the KTA model might 
be best described as being situated within an epistemology of possession, my model can be 
described as positioned within an epistemology of practice (Brown & Cook, 1999). From an 
Actor-Network Theory perspective, the KTA model treats knowledge as if it were a black 
box, a singe actor. The LTKP model, however, seeks to peer inside the box and uncover the 
vast networks of associations amongst a multitude of human and non-human actors; here, 
knowledge is a permeable, changing network-in-practice rather than a tailored, filtered actor 
being tossed about amongst producers and users. Central to my framework for KT is an 
appreciation for the ontological fluidity of that which is translated. 
Conceptualization of Translation 
A second difference between the two models is in how translation is conceptualized. 
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In particular, these models have very different starting points. In the KTA model, the very 
raw materials that enter the knowledge funnel are the journal articles derived from primary 
studies. It is assumed that the knowledge producers are not the same as the knowledge users. 
In my model, the translation of knowledge occurs far before journal articles are produced and 
it is assumed that knowledge producers are also knowledge users and vice versa. Every 
network both produces and uses knowledge. The distinction between knowledge producers 
and users becomes moot when one considers knowledge from a constructionist epistemology. 
Instead, it might be more helpful to acknowledge that all networks practice or enact 
knowledge. It is knowledge practices that are translated, rather than a reified hunk of 
knowledge. This translation occurs long before a tool or product is distilled. From a 
constructionist, ANT perspective, when a best practice guideline or care pathway is 
translated, it is does not exist in isolation. It carries with it its association with a host of 
hidden actors, both human and non-human with which it was constructed through practice. 
Translation is the process in which associations between actors are re-assembled and 
practiced in relation to other networks of actors.  
Intended Purpose  
A third difference is in the purpose of the models and how they might be used. The 
KTA model is directive; it aims to prescribe a step-by-step template of how translation 
should happen and what factors should be considered for successful translation to occur.  The 
KTA model, as proposed by the CIHR, limits its application to the widespread adoption of 
knowledge.  The KTA model might best be used when attempting to implement a particular 
tool across a widespread group of users. Conversely, the LTKP framework that I propose is 
descriptive. It explores the undirected, sometimes haphazard, local dynamics of translation 
that unfold in everyday practice. It is not a “how-to” guide or template for moving a piece of 
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evidence into practice.  The LTKP framework might be considered when trying to 
understand who and what is involved in knowledge translation. The LTKP emphasis on 
knowledge as a materially heterogeneous practice affords a more symmetrical, multi-
directional understanding of the KT process. The emphasis on multiplicity, difference and 
coordination could contribute, for example, to an exploration of why a tool is not being used 
in a particular situation.  
8.4a Implications 
 When I think back to my fieldwork experiences, the focus of the interactions between 
the laboratory, clinic, and families was not just the translation of genetic results or any 
reified, tangible piece of information. To be sure, the construction and communication of 
genetic results were important. However, much more than that was going on. The translation 
process that I observed was not only about genetic results, but about coordinating different 
ways of practicing autism. As I explored in my research, the nature of autism multiplied as it 
was practiced through different sets of human and non-human actors. In the context of 
knowledge translation, I think when we focus on a particular object (a best practice guideline 
or tool) to be translated we miss the boat; we fail to appreciate that what is being translated 
are different ways of practicing the world. Instead of paying such fervent attention to an 
object of translation (distilled guideline or care pathway), I wonder if the KT process might 
be better understood if we de-centre the object and approach the object as a mere vehicle 
through which we might understand difference, multiplicity and non-coherence as well as the 
places where practices overlap and come together amongst various networks of actors.  
In the quickly changing, cutting-edge world of genomics where new technologies 
rapidly reconfigure the way the body is practiced, it is assumed that results are contingent 
and could change in the future. It is not only a result that is being translated in a feedback 
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session, but a way of practicing autism, such that autism is becoming genomic. By de-
centering the object of translation, we are able to step back and explore what practices and 
ways of knowing and doing the world are implicit in that object. How might these implicit 
practices, which carry epistemological and ontological assumptions, rub up against another 
way of knowing and doing the world? Are there places where partial connections and 
coherence can be found or might a particular object with its implicit epistemological and 
ontological assumptions be incommensurable with another context? 
8.5 Conclusion 
My research has explored the process of knowledge translation from a constructionist 
epistemology and an Actor-Network Theory methodology with an emphasis on theories of 
practice. This approach has informed my interpretation of knowledge translation within the 
context of autism genomics. Insights emerged from my case study of autism genomics that 
might be applied to a more general discussion of knowledge translation. In particular, the 
idea that translation involves transformation and change was demonstrated as I followed 
human and nonhuman actors amongst the clinic, laboratory, and family home. I also raise the 
idea that knowledge translation is an inherently political process and explore Callon’s (1986) 
framework for unpacking the political dynamics involved in translation. Finally, when 
knowledge is conceptualized as being practiced in the material world, knowledge translation 
becomes reassembled as ontological translation; the KT endeavour becomes one of 
translating between different ways of practicing reality. With each of these insights in mind, I 
have constructed the Local Translations of Knowledge in Practice framework and model of 
knowledge translation which highlights networks of human and non-human actors, 
multiplicity, and strategies of coordination.  
 My aim in doing this research is to contribute to the current Canadian 
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discussion on the science of knowledge translation by exploring KT from a 
philosophical and theoretical position that is novel to the prevailing positivist 
discourse championed by the CIHR. I have tried to demonstrate how a 
constructionist, actor-network theory- inspired conceptualization of knowledge 
translation might offer new insights into the on-going, local micro-dynamics of 
knowledge translation. My aim is to demonstrate how the methodological and theoretical 
starting point of any KT research profoundly shapes what is examined and what is left 
untouched and unexplored. Methodological pluralism is needed in order to explore 
knowledge translation in new ways. Expanding the range of philosophical positions attended 
to in KT research will contribute to a richer understanding of the KT process. 
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Appendices 
Appendix A: Key Concepts in Genomics 
Allele - A form of a gene. We inherit one allele of a gene from our mother and the other 
allele from our father. These two alleles can be the same (homozygous) or they can be 
different (heterozygous). 
Phenotype denotes the observable characteristics of an organism. For example, having 
brown eyes is a phenotypic expression. In the context of this research, rigid and repetitive 
interests and activities is considered a phenotypic expression of autism.  
Genotype – A genotype is an organism's full hereditary information, even if not expressed.  
Single nucleotide polymorphism (SNP) - There are four nucleotides (Adanine, Thymine, 
Cytosine, and Guanine) that make up deoxyribonucleic acid (DNA). Normally, A and T align 
together and C and G align together; these are called nucleotide base pairs. Sometimes, 
however, DNA is not replicated exactly and a different nucleotide is inserted. If this occurs 
the DNA sequence has been altered. SNPs can be inherited or spontaneous. 
Copy number variation (CNV) – A copy number variation includes either a deletion or 
duplication of DNA. In a CNV, a chunk of DNA is either deleted or duplicated. All humans 
have CNVs and most of the time these CNVs have no noticeable effect on the individual’s 
phenotype. When CNVs are located in particular places within the genome, such that they 
interrupt a gene, CNVs can affect the phenotype. When CNVs occur in regions that are gene-
rich they are more likely to be clinically significant that CNVs in regions of the genome that 
are gene-poor. Generally, deletions tend to be more pathogenic than duplications (Gropman 
& Batshaw). 
Genome – The genome is the entire sequence of DNA for an individual organism. Each 
individual has a unique genome, with slight variation. In 2001, the Human Genome Project 
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completed the first mapping of a complete human genome. A reference genome is an 
aggregated genome, in which several human genomes are sequenced and the most frequent 
nucleotide base in each position is adopted. In the laboratory in which I conducted fieldwork, 
reference genomes were ubiquitous and invaluable in the process of data interpretation.  
Polymerase Chain Reaction (PCR) – PCR allows one to identify precise segments of DNA 
and to produce millions of copies (called amplification) of that segment of DNA. The 
invention of PCR completely altered the microbiology laboratory and is described in detail 
by Rabinow (Rabinow, 1996). This technology is ubiquitous in laboratory experiments I 
observed. 
Microarray – A microarray, or gene chip, contains a collection of various sections of a 
genome. Each of these sections is called a probe. A single array contains millions of probes 
at specific locations across the genome. Different arrays are designed to specifically probe 
particular areas on the genome. When patient DNA is added to the chip, the sections that 
align to the probes will bind to the probes through hydrogen bonding. A dye is added to the 
chip so that when scanned in the microarray machine each location will become florescent 
and can be photographed. The strength of a florescent signal for any one location is 
dependent on the amount of patient DNA that binds to a particular probe.  The microarray is 
used to detect copy number variations (CNVs). 
Next Generation Sequencing – This technology is used to sequence the order of nucleotide 
bases (A, C, T, G) in a particular stretch of DNA. This sequencing technology is used to 
detect single nucleotide polymorphisms (SNPs) but can also detect CNVs.
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Appendix B: Some of the Equipment Needed for Next Generation Sequencing 
Agilent 2100 Bioanalyzer Agilent p/n G2938C Thermal cycler Applied Biosystems Veriti 
Thermal Cycler, BioRad (MJ Research) DNA Engine PTC 200, or equivalent Covaris S, 
series Single Tube Sample Preparation System, Model S2 Covaris Covaris microTUBE 
with AFA fiber and snap cap Covaris p/n 520045 Eppendorf Microcentrifuge Model 
5417R Eppendorf p/n 022621807 (120 V/60 Hz), Eppendorf p/n 022621840 (230 V/50 
Hz) or equivalent Eppendorf fixed angle rotor with standard lid Eppendorf p/n 022636006 
DNA LoBind Tubes, 1.5 mL PCR clean, 250 pieces Eppendorf p/n 022431021 or 
equivalent E, Gel Safe Imager Combo Kit, 2 magnetic stand, 21D or equivalent P10, P20, 
P200 and P1000 pipettes Pipetman P10, P20, P200, P1000 or equivalent Vacuum 
concentrator Savant SpeedVac or equivalent Mx3005P Real Time PCR System Stratagene 
p/n 401449 or equivalent Ice bucket Powder free gloves Sterile, nuclease, free aerosol 
barrier pipette tips, Timer, Vortex mixer, Heat block at 37°C 
Optional Equipment 
 Mx3000P/Mx3005P 96-well tube plates Agilent p/n 410088 or equivalent 
Mx3000P/Mx3005P optical strip caps Agilent p/n 401425 or equivalent MicroAmp Clear 
Adhesive Film Applied Biosystems p/n 4306311 or equivalent BD Clay Adams Nutator 
Mixer BD Diagnostics p/n 421105 or equivalent Dynal DynaMag-2 magnetic stand 
Invitrogen p/n 123-21D or equivalent P10, P20, P200 and P1000 pipettes Pipetman P10, P20, 
P200, P1000 or equivalent Pipet-Light Multichannel Pipette, 12 channels Rainin p/n L12-20 
or equivalent Sterile, nuclease-free aerosol barrier pipette tips Thermal cycler Applied 
Biosystems Veriti Thermal Cycler, BioRad (MJ Research) DNA Engine PTC-200, or 
equivalent Timer Vortex mixer Water bath or heat block set to 65°C,  Tube-strip capping tool 
Agilent p/n 410099 
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Appendix D: The Local Translation of Knowledge in Practice 
(LTKP) Model 
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